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ABSTRACT 
 
 
Variation between individuals in response to a stimulus is a well-established phenomenon. This thesis 
discusses the drivers of this inter-individual response, identifying three major determinants; genetic, 
environmental, and epigenetic variation between individuals. Focusing on genetic variation, the thesis 
explores how this information may be useful in elite sport, aiming to answer the question “Is there utility 
to genetic information in elite sport?” The current literature was critically analysed, with a finding that the 
majority of exercise genomics research explains what has happened previously, as opposed to assisting 
practitioners in modifying athlete preparation and enhancing performance. An exploration of the potential 
ways in which genetic information may be useful in elite sport then follows, including that of inter-
individual variation in response to caffeine supplementation, the use of genetic information to assist in 
reducing hamstring injuries, and whether genetic information may help identify future elite athletes. 
These themes are then explored via empirical work. In the first study, an internet-based questionnaire 
assessed the frequency of genetic testing in elite athletes, finding that around 10% had undertaken such a 
test. The second study determined that a panel of five genetic variants could predict the magnitude of 
improvements in Yo-Yo test improvements following a standardised training programme in youth soccer 
players. The third study demonstrated the effectiveness of a panel of seven genetic variants in predicting 
the magnitude of neuromuscular fatigue in youth soccer players. The fourth and final study recruited five 
current or former elite athletes, including an Olympic Champion, and created the most comprehensive 
Total Genotype Score in the published literature to date, to determine whether their scores deviated 
significantly from a control population of over 500 non-athletes. The genetic panels were unable to 
adequately discriminate the elite performers from non-athletes, suggesting that, at this time, genetic 
testing holds no utility in the identification of future elite performers. The wider utilisation of genetic 
information as a public health tool is discussed, and a framework for the implementation of genetic 
information in sport is also proposed. In summary, this thesis suggests that there is great potential for the 
use of genetic information to assist practitioners in the athlete management process in elite sport, and 
demonstrates the efficacy of some commercially available panels, whilst cautioning against the use of 
such information as a talent identification tool.  The major limitation of the current thesis is the low 
sample sizes of many of the experimental chapters, a common issue in exercise genetics research. Future 
work should aim to further explore the implementation of genetic information in elite sporting 
environments. 
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CHAPTER 1 – INTRODUCTION 
 
1. Why genetic testing? 
 
Coaches, athletes and support staff have long known and understood that there is considerable 
variation between individuals across a variety of traits. Nowhere is this clearer than at the Olympic 
Games, where only one athlete can take home the gold medal. Achieving such a performance is often 
thought of as the accumulation of years of hard work and dedication. However, inherent within this 
process is the recognition that there are genetic differences between those competing at the highest level, 
those that don’t qualify for the games, and interested observers at home. Whilst we typically think of 
these genetic differences as underpinning our notion of “talent”—and it is clear that elite athlete status is 
at least partly heritable (De Moor et al., 2007)—recent research suggests that a number of genetic variants 
also affect issues such as the response to training (Delmonico et al., 2007, Aleksandra et al., 2016) and 
the effectiveness of ergogenic aids (Guest et al., 2018; Heibel et al., 2018), while also influencing the 
needs of each individual athlete in terms of recovery speed (Yamin et al., 2008;  Baumert et al., 2016a), 
nutrient requirements (Ashfield-Watt et al., 2002; Timpson et al., 2010), and injury risk (Collins et al., 
2009; Willard et al., 2018).  
 
That there is individual variation in response to a stimulus—termed inter-individual variation—
has become of increasing interest from a research perspective in recent times, particularly as 
measurement technologies have improved. Whilst the majority of research tends to explore the mean 
efficacy of a given intervention, the use of gross averages often obscures individual differences in the 
magnitude of response. Historically, this individual response was perhaps considered a frustrating 
outcome that lowered the effect size of an intervention and simultaneously increased the required sample 
size (Hecksteden et al., 2015). However, as interest in personalised medicine has grown over the last 30 
years, individual responses are viewed as increasingly important. Accordingly, research aimed at 
identifying inter-individual variation, as well as its underlying causes, has become increasingly prevalent 
across many domains, including exercise (Bouchard & Rankinen, 2001; Hubal et al., 2005; Karavirta et 
al., 2011; Pickering & Kiely, 2017a), diet (Minot et al., 2011; Williamson et al., 2018), and medicine 
(Yuan et al., 2005; Hamburg & Collins, 2010). Although such findings have been examined critically 
(Senn 2002; Atkinson & Batterham, 2015; Williamson et al., 2017), there remains a consensus that there 
are real differences between individuals in terms of response to an intervention (Mann et al., 2014; 
Bonafiglia et al., 2019), and the potential that both knowledge and understanding of the drivers of this 
response may be used to enhance a variety of interventions (Pickering & Kiely 2018a).   
 
Two experiences from my past have shaped my interest in inter-individual variation. As a 
professional athlete, I was always looking for anything that could potentially improve my performance by 
any appreciable margin, and, as such, I became interested in the use of caffeine as a performance 
enhancer. My journey started aged 18, when I started using a sports drink with 80 mg of caffeine prior to 
races. Over time, this became two cans, then three, and then I moved onto caffeine tablets as my self-
experimentation continued. This journey was not without error, however; on more than one occasion, 
including a national championship final, I had to withdraw from a race due to issues caused by caffeine. 
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This trial and error process, consistently refined over my competitive career, eventually culminated in my 
adoption of the following caffeine strategy; I could consume up to 250 mg of caffeine, split over four 
individual doses, at 10-minute intervals between 90- and 60-minutes pre-race. If I had two races in close 
succession, such as heats and final, I could only consume low doses (less than 80 mg) of caffeine between 
the two; any more and I started to feel nauseated.  
 
What was puzzling to me, as an athlete, was that my training partners and competitors could 
consume far higher doses of caffeine than I could tolerate, and could do so closer to competition than I. 
What was more puzzling to me, as a sports science student, was that the scientific literature generally 
reported that caffeine was typically ergogenic at doses higher than I was consuming. As an example, in a 
meta-analysis of 40 studies exploring the efficacy of caffeine as a performance enhancer, the effective 
dose of caffeine ranged from between 3 and 13 mg/kg, with a median of 6 mg/kg (Doherty & Smith, 
2004). In comparison, I was consistently consuming less than this dose, with a tolerable ceiling of around 
2.5 mg/kg. Similar contrasting results to my experience were reported by Ganio and colleagues (2009) in 
a systematic review, with 3-6 mg/kg reported as the optimum range of doses to exert ergogenic effects.  
 
The second experience came at the 2008 Olympic Games in Beijing, where I was representing 
Great Britain in the 100m. Competing at the quarter-final stage, I was drawn in a tough race, including 
the World Record holder, the current US champion, the European Record holder, and the European 
number 1 ranked athlete for 2008, with only three athletes able to qualify. Against such long odds, I 
produced a seasons best performance, running 10.18 seconds, albeit for 5th place. The winner, Usain Bolt, 
was able to essentially jog to a winning time of 9.92. Reflecting on my lack of progression to the next 
round in the bowels of the stadium post-race, I was forced to consider whether those who did progress to 
the semi-final stage trained harder than me—the common narrative—or whether they were more 
“talented”, whatever such talent might be. 
 
My interest in better understanding these two experiences, and not being able to find a 
satisfactory answer, remained throughout my career. Upon retiring from professional sport in 2014 due to 
injury, I began work at DNAFit Life Sciences, a direct-to-consumer (DTC) genetic testing company 
providing customers with information about how their genes might influence their optimal diet and 
training programmes. This role further piqued my interest in inter-individual variation, and gave me an 
opportunity of potentially understanding this variation via genetic testing.  
 
However, the use of information gleaned from genetic tests is currently in its infancy, and 
remains controversial (Webborn et al., 2015; Vlahovich et al., 2017a). As such, whilst research in this 
area does show that specific genetic variants can influence the response to training (Delmonico et al., 
2007, Aleksandra et al., 2016) or an ergogenic aid (Guest et al., 2018, Rahimi 2018), at present there are 
very few studies exploring the utility of this information as an intervention; i.e., if you know an individual 
has a specific genetic variant or variants, can you enhance their response to a certain stimulus? If such an 
approach is possible, it has the potential to revolutionise practice, ensuring a far more personalised 
approach. Returning to my specific example of caffeine use, I now know that I have a genetic variant 
associated with a reduced ergogenic response following caffeine ingestion (Womack et al., 2012; Guest et 
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al., 2018; Rahimi 2018). Furthermore, I have a second genetic variant, associated with increased anxiety 
and sleep disturbances following caffeine ingestion (Retey et al., 2007; Childs et al., 2008), both issues 
that plagued me during my career following ingestion of higher doses of caffeine.  
 
 As a result, being able to utilise genetic information to enhance training selection and response, 
or use of an ergogenic aid, would be advantageous. This is true from a population health perspective, 
where the increased training adaptations brought about by genetically guided training might help improve 
overall fitness, which has been linked to reductions in both obesity (Blair & Church, 2004) and all-cause 
mortality (Blair et al., 1999; Kodama et al., 2009). Genetically-guided insights would also likely be useful 
in sporting populations, where the margins between success and failure are often miniscule. However, the 
use of genetic information in this way is currently underexplored, with the vast majority of research 
exploring associations as opposed to interventions.  
 
2. Is there utility to genetic information in elite sport? The structure of the thesis. 
 
To that end, the goal of this thesis is to explore the effective utilisation of genetic information in 
sport, with the research question of “Is there utility to genetic testing in elite sport?” This exploration will 
be formed of different sections, utilising a mixture of desktop and empirical studies. The sections are 
formulated as so: 
 
Section 2 – A review of the literature. Here, I will explore the research currently surrounding 
inter-individual variation and exercise response heterogeneity, unravelling some of the drivers of this 
variation in response (Chapters 2 & 3). I will also explore some contemporary methodological issues 
regarding genetic testing in sport, the need for further invention studies, and an outline of the methods I 
will be utilising in the empirical studies in a chapter on Methodology (Chapter 4). This exploration is 
important as it allows a firm understanding of the research literature, including methodological and 
statistical issues which affect the field of exercise genetics research at present. Identification of these 
issues allows for the findings of the subsequent two sections to be better contextually framed and 
interpreted.  
 
Section 3 – Joining the dots. This section will be comprised of a number of theoretical papers 
exploring the potential use of genetic information to enhance outcomes within sporting contexts. Chapter 
5 explores inter-individual variation in the ergogenic effects seen following caffeine consumption in 
athletes, the drivers of this variation, and how this information might be utilised to enhance the use of 
caffeine in athletes. Chapter 6 explores how information on ACTN3 genotype may be used to provide 
insights into the individual response to training, both in terms of adaptation and recovery, as well as 
injury risk. Chapter 7 presents a theoretical method by which genetic information might be useful in the 
prevention of hamstring injuries, a current hot topic within the sports science and medicine sphere 
(Bourne et al., 2018). Finally, Chapter 8 explores whether genetic information can be utilised to discover 
talented individuals, including those genetically primed to respond favourably to training. This section 
serves to discuss the potential use of genetic information in elite sport, before it is explored 
experimentally in Section 4.  
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Section 4 – Practical use of genetic information in sport. This section is comprised of empirical 
data collected as part of my doctorate. Chapter 9 reports the results of an internet-based questionnaire 
exploring the prevalence of, and attitudes towards, genetic testing within sports, from the perspectives of 
athletes, coaches, and support staff. Chapter 10 demonstrates the potential use of a genetic panel in 
predicting the magnitude of improvements in aerobic fitness following a standardised training 
programme. Chapter 11 explores the use of a genetic panel in predicting the magnitude and time-course 
of neuromuscular fatigue following a repeated sprint training session. Chapter 12 reports on the genetic 
data of a cohort of elite athletes, including an Olympic Champion, the first time such data has been 
reported, and attempts to determine if this information would be useful from a talent identification 
perspective. The purpose of this section of the thesis is to experimentally explore whether genetic 
information may be useful in elite sport, both in terms of how widely it is currently used, and how useful 
it might be.  
 
Section 5 – Is there utility to genetic testing in sport? Here, I pull together the various strands of 
my research in order to answer the research question, as well as exploring the real world and practical 
implications of both my work, and genetic testing as a whole. Chapter 13 explores some of the wider 
applications of genetic testing in terms of health and disease. Chapter 14 explores the potential future 
research directions in this field, as well as a discussion of which further questions require answering, and, 
finally, Chapter 15 offers the main conclusions of my doctoral thesis.  
 
With the use of genetic information a hot topic within sports science and exercise medicine at 
present (Webborn et al., 2015), my hope is that this present thesis provides a useful step forward, both in 
our understanding of how genetic information might be used in elite sport, as well as providing practical 
examples where the use of such information may enhance practice. A consistent theme within the earlier 
parts of this thesis is how, whilst there is a relative abundance of research demonstrating how and why 
genetic variation affects the individual response to an exercise stimulus, there is far less research focused 
on utilising this information as a method of enhancing future performance. In seeking to address this 
knowledge gap, I have aimed to publish large parts of this thesis as academic papers, focusing primarily 
on how we might best utilise genetic information in elite sport. The five sections of this thesis (including 
section 1, comprised of the front matter and introduction), seek to build the narrative in a linear manner. 
Section 2 details where we are right now; what does the research suggest are the drivers of inter-
individual variation, and how might this information be useful? Expanding on the traditional literature 
review format, I have aimed to critically analyse some contemporary issues within the exercise genomics 
sphere, before identifying the methodology utilised in the thesis. Section 3 then asks what could we use 
genetic information for in elite sport, and then section 4 explores whether this information, in practice, is 
effective—and how widely used it currently is. The final section, section 5, aims to bring all the previous 
sections together, giving an overview of how this thesis has added to the field, presenting a conceptual 
framework for the use of genetic information in sport, and identifying limitations, as well as future areas 
for research meriting further exploration.   
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SECTION 2 – LITERATURE REVIEW 
 
The content of this section draws on three previously published peer-reviewed papers, along with 
additional work. The published papers are: 
 
Pickering C, Kiely J. Understanding Personalized Training Responses: Can Genetic Assessment 
Help? Open Sports Sci J. 2017;10(1). 
 
Pickering C, Kiely J. Exercise genetics: seeking clarity from noise. BMJ Open Sport Exerc Med. 
2017:e000309. doi: 10.1136/bmjsem-2017-000309 
 
Pickering C, Kiely J. Do non-responders to exercise exist – and if so, what should we do about them? 
Sports Med. 2018; https://doi.org/10.1007/s40279-018-01041-1 
 
 
Section preface: 
 
Whenever humans are subjected to an intervention, there is a variation between individuals in 
response to that intervention. This is the case when it comes to the use of drugs within medicine (Wang et 
al., 2011), exercise and dietary changes for weight loss (King et al., 2008), and response to a food, 
nutrient, or chemical, such as caffeine (Guest et al., 2018), or exercise (Hubal et al., 2005). This variation 
between individuals – often termed inter-individual variation – is a combination of “true” and “false” 
variation. “False” variation refers to issues such as measurement error, random biological variation, and 
regression to the mean (Atkinson & Batterham, 2015). “True” variation is what is left once the “false” 
variation is removed; it is the manifestation of differences in genotype, environment, and life history that 
cause variation in response (Mann et al., 2014). This section, which acts as the literature review portion of 
this thesis, explores the causes of inter-individual variation in greater detail. Chapter 2 is comprised of an 
overview of the “true” underpinnings of inter-individual variation, and results in the development of a 
model which can be utilised to explain and aid our understanding of why such variation occurs. Chapter 3 
is a closer look at some of the contemporary issues surrounding such inter-individual variation, including 
a discussion around “false” variation, and how this may impact whether non-responders to exercise 
actually exist. Additionally, Chapter 3 contains a commentary on whether the findings from sports and 
exercise genetics studies are real, or potential false-positives, which has clear and important implications 
for the use of such information in practice. Finally, Chapter 4 presents a brief summary of the 
methodological challenges within the field of exercise genomics, and identifies the methods utilised in the 
present thesis.
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CHAPTER 2 - INTER-SUBJECT VARIATION IN EXERCISE ADAPTATION: CONTRIBUTING 
FACTORS & THE POTENTIAL UTILITY OF GENETIC TESTING 
 
1. Introduction  
 
Exercise prescription is often comprised of blanket advice. For example, the American College 
of Sports Medicine (ACSM) recommend that adults undertake more than 150 minutes of moderate 
intensity and more than 75 minutes of vigorous intensity cardiovascular exercise per week, along with 
resistance training on two to three days per week (Garber et al., 2011). Regarding resistance training, the 
ACSM recommend repetition ranges of 8-12 for novices, and 1-12 for intermediates (Kraemer et al., 
2009). Given these recommendations, one might think that exercise response is standardised across 
individuals, or at least tightly distributed around the mean. However, a wide range of variation exists in 
exercise adaptation between subjects (Bouchard & Rankinen, 2001; Hubal et al., 2005; Mann et al., 
2014), meaning that there will be a varied response to the typical guidelines, with some individuals seeing 
larger than average improvements, and some seeing little or no improvements.  
 
Given that this variation occurs, it would be useful to understand the factors that cause it. These 
factors themselves are from a wide variety of individual disciplines within sports science; this section 
aims to identify the most pertinent of them, with a brief discussion regarding their effect on inter-subject 
variation to exercise. An earlier review by Mann et al. (2014) introduced some of these elements in the 
context of explaining inter-individual response to a standardised training programme, with subsequent 
reviews exploring more individual factors in greater depth (Camera 2018; Roberts et al., 2018). This 
section aims to build on this earlier work, as well as add some recent findings, particularly in the field of 
epigenetics. Once these factors have been identified, a series of models are created to examine the 
interaction between all these factors, increasing in complexity as the chapter progresses. Finally, ways to 
potentially harness and utilise this information using the new technology of genetic testing in order to 
improve exercise response within a population, with particular interest paid to elite athletes, are 
discussed.  
 
2. Inter-subject variation in response to training 
 
Typically, researchers are interested in understanding the mean response to an intervention in 
order to determine its overall efficacy. For example, when determining the effectiveness of resistance 
training in enhancing one-repetition maximum strength (1RM), subjects will undertake a pre- and post-
training intervention 1RM test, with the average improvements reported. As an illustration, Hubal and 
colleagues (2005) recruited 585 previously untrained subjects to undergo a 12-week resistance training 
programme, with the mean 1RM improvement reported as 54%. Similarly, in randomised controlled 
trials, the mean pre-post change in the intervention group is compared to the mean pre-post change in the 
control group, and the effectiveness of the intervention determined. However, whilst sports coaches have 
long noticed that there is variation in how their athletes respond to a given training stimulus, it is only 
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relatively recently that interest in both quantifying and understanding this individual variation through 
structured research has developed (Bouchard 2012). 
 
2.1 Inter-individual variation following aerobic training 
 
The initial studies exploring this individual response from the perspective of aerobic training 
were published in the mid-1980s. The first, published in 1984, recruited ten monozygotic twin pairs to a 
20-week endurance training programme, with pre- and post-intervention measures of maximal aerobic 
power (MAP), ventilatory aerobic (VAT) and anaerobic (VANT) thresholds determined. Whilst training 
enhanced post-training measures on average by between 12% (MAP) and 20% (VAT), there was 
considerable variation; for MAP, the magnitude of improvements ranged from 0-41% (Prud’Homme et 
al., 1984), for example. Subsequent studies replicated these initial findings (Despres et al., 1984; 
Simoneau et al., 1986), leading to the development of the large-scale HERITAGE (HEalth, RIsk factors, 
exercise Training And GEnetics) family study. Here, 720 subjects underwent a 20-week aerobic training 
programme, and undertook a battery of pre- and post-intervention tests (Bouchard & Rankinen, 2001). 
Again, the results showed significant individual variation; whilst the mean improvement in maximal 
aerobic capacity (VO2max) was 384 mL O2, some subjects saw an improvement of over 1000 mL O2, and 
others a reduction in VO2max. Similarly, whilst the mean improvement in heart rate (HR) at a workload of 
50W was 11bpm, some subjects demonstrated improvements of greater than 40bpm, whilst a small 
number markedly worsened (Bouchard & Rankinen, 2001). 
 
2.2 Inter-individual variation following resistance training 
 
Following the initial interest in quantifying and exploring the inter-individual response to 
aerobic training, an increasing number of studies have explored the individual response to a resistance 
training programme. Perhaps the most famous of these was carried out by Hubal and colleagues (2005), 
who subjected 585 previously untrained males and females to an identical 12-week resistance training 
programme, comprised of three sessions per week. Whilst, on average, subjects improved their 1RM by 
54%, and their muscle cross sectional area (CSA) by 19%, large inter-individual variations in these 
measurements were reported, with changes in CSA ranging from -2% to +59%, and changes in 1RM 
ranging from 0% to +250%. Bamman et al. (2007) recruited 66 untrained males and females to a 16-week 
resistance training programme, comprised of three weekly sessions. Using a cluster analysis, they 
stratified subjects into extreme, modest and non-responder groups; participants in the extreme group 
increased muscle CSA twice as much as those in the modest group. An analysis of three previous studies 
(Verdijk et al., 2009; Tieland et al., 2012; Leenders et al., 2013) by Churchward-Venne and colleagues 
(2015), comprised of training programmes lasting from 12-24 weeks, again reported significant 
heterogeneity in lean body mass gains (mean of +0.9kg, range -3.3 to +5.4kg) at the twelve week point, 
with concurrent large variations in improvements in 1RM (leg press; mean 33kg; range -36 to +87kg). 
Ahtiainen et al. (2016) reported training data on 287 male and female participants who had undertaken 
supervised resistance training programmes of 20-24 weeks duration. On average there was a significant 
increase in leg press 1RM of 21%, although again there was individual variation within that score, 
ranging from -8% to +60%. Similar results were reported for thigh muscle hypertrophy, with an average 
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increase of 4.8%, and an individual variation range of -10.6% to +30%. Finally, following 9 weeks of 
resistance training, Erksine and colleagues (2010) reported increases in 1RM ranging from 18 to 113%, 
increases in quadriceps muscle volume of 0-16%, and increases in MVC from -1% to +52%. 
 
2.3 Other reported inter-individual variations 
 
Other studies have reported large variations in response to high intensity interval training 
(Astorino & Schubert, 2014), fat loss and body composition (Barbeau et al., 1999; Barwell et al., 2009), 
other health-related aspects such as insulin sensitivity, blood pressure, and cholesterol levels (Bouchard & 
Rankinen, 2001), and even response to ergogenic aids such as caffeine (Jenkins et al., 2008). As a result, 
it is clear that inter-individual variation in response to a stimulus, including exercise, is a well-established 
phenomenon within the scientific literature.  
 
2.4 Exercise response: modality specific? 
 
One potential area for further exploration is whether this observed non-response is modality 
specific. Whilst the vast majority of studies reporting exercise non-response focus on a specific training 
modality, such as aerobic training (Prud’Homme et al., 1984; Bouchard & Rankinen, 2001) or strength 
training (Hubal et al., 2005; Erksine et al., 2010), a small number of studies examine exercise non-
response across multiple modalities. Karavirta et al. (2011) randomised 175 male and female participants 
into four groups; endurance training only, strength training only, concurrent strength and endurance 
training, and a control group. All groups showed a large range in exercise response, with improvements in 
peak aerobic capacity (VO2peak) ranging from -10 to +60% in the endurance trained group, and MVC 
improvements ranging from -15 to +60% in the strength trained group. But it is the strength and 
endurance trained group where the crucial data lies; although some participants saw a negative training 
response in either VO2peak or MVC, not a single subject saw a negative response in both. In addition, no 
participant was in the highest quintile of improvement for both VO2peak and MVC.  
 
Similarly, Hautala and colleagues (2005) placed 73 participants through both an endurance and 
resistance training intervention in a randomised cross-over design, with improvements in VO2peak as the 
outcome. As expected, there was individual variation in VO2peak improvements from both the aerobic 
endurance (mean +8%, range -5 to +22%) and resistance training (mean +4%, range -8 to +16%) 
interventions, such that some participants did not improve with a given training modality. Interestingly, 
however, participants exhibiting the lowest magnitude of VO2peak response following the aerobic training 
intervention exhibited a positive VO2peak response following the resistance training intervention, lending 
credence to the possibility that changing exercise modality may eliminate, or at least reduce, exercise 
non-response. One potential limitation of this study is that each training intervention lasted only two 
weeks, a duration shorter than most training studies. Accordingly, it is possible that identified non-
responders might have shown increased responses if the intervention period was over more standard 
timeframes, such as 6-8 weeks. 
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Finally, Bonafiglia and colleagues (2016) reported that, whilst there were non-responders in 
terms of VO2peak, lactate threshold, and HR improvements following either endurance or sprint interval 
training, no subject was a non-responder to both exercise modalities, and very few were non-responders 
across all three measures for a single exercise intervention. As a result, it appears that non-response may 
be modality-specific; such a standpoint is supported by Booth & Laye (2010), whom stated that, with the 
thousands of biochemical adaptations to exercise, as well as the multitude of different training modalities, 
it seems incredibly unlikely that there are individuals who see no improvement at all following exercise. 
This is not necessarily a consensus, however, with Timmons (2011) writing that, whilst the inter-
correlation in non-response to exercise between exercise modalities is low, it is not zero. Additionally, 
Bouchard et al. (2012) reported that across a number of exercise intervention trials, approximately 7% of 
participants experienced an adverse response to two or more markers of cardio-metabolic health. What is 
not clear is whether these adverse or non-responses would disappear with a different training modality or 
dose (Scharhag-Rosenberger et al., 2010). As exercise adaptation occurs through a number of separate 
pathways specific to the exercise modality, the potential lack of global non-responders also suggests the 
driver of individual differences in exercise response could be down to variation within these pathways. 
3. Potential mechanisms driving the individual response 
 
Having identified the potential for significant differences to exist between participants which 
determine the magnitude of response to exercise or other stimuli, the next step is to identify and discuss 
what might be driving these differences. This section will outline some of the main proposed mechanisms 
thought to underpin inter-individual variation in response to exercise.   
 
3.1 Genetics 
 
Contained within all nucleated cells are 23 chromosomes, which contain the genetic code in the 
form of deoxyribonucleic acid, commonly termed DNA. Alongside this, humans also have a small 
amount of genetic material contained within mitochondria, termed mitochondrial DNA (mtDNA). 
Together, the totality of these two aspects is termed the human genome. Within their chromosomes, 
humans have two complimentary strands of DNA; one inherited from their father, and one from their 
mother. DNA is comprised of base nucleotides, of which there are four; adenine (A), cytosine (C), 
guanine (G), and thymine (T). The order and number of these bases determines the protein(s) which can 
be produced from a particular gene. Three base nucleotides are required to produce a single amino acid, 
and these amino acids combine to create the proteins that drive of all the functions required for life. 
However, there is variation between humans with regards to the presence or otherwise of a certain base 
nucleotide at a certain point in a gene. When this variation is comprised of a single nucleotide 
substitution, it is described as a Single Nucleotide Polymorphism, or SNP. Here, one base has been 
substituted for another, which can change the amino acid that is encoded for, which in turn can change the 
protein that is produced, which in turn can have an effect on human function and performance. When it 
comes to understanding how and why genetic variation affects variation in response to a stimulus, it is 
research into such SNPs that has provided the greatest insight.  
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Following the completion of the Human Genome Project in 2003, genetic analysis has become 
increasingly affordable, making research into the effects of genes on fitness and performance more 
feasible. The knowledge of genetic influences has progressed significantly in recent years, and, as a 
result, there has been a shift from the idea that all traits are determined by a single gene, which still holds 
true in select disease states such as Cystic Fibrosis (Riordan 1989) and Huntington’s disease (Walker 
2007), to more complex polygenic interactions. The “single gene as a magic bullet” philosophy has also 
been present in sport (Davids & Baker 2007), with some coaches believing that single genes are 
responsible for athletic performance. However, no single gene has been discovered. Instead, it seems 
reasonable to assume that elite athletes are elite due to the possession of a number of alleles favourable 
for performance (Ruiz et al., 2009; Santiago et al., 2010). Even when an unrealistically low number of 
polymorphisms are examined, it is incredibly unlikely that one person possesses the perfect genetic 
profile for elite performance (Hughes et al., 2011; Williams & Folland 1998).  
 
All traits, therefore, exist on a spectrum; from single gene traits, such as the Cystic Fibrosis 
phenotype at one end, to complex polygenic traits such as injury at the other. Whilst it might be thought 
that complex traits can never be fully understood in terms of their genetic component, recent research has 
identified candidate genes associated with complex traits such as intelligence (Davies et al., 2011), 
educational attainment (Rietveld et al. 2013), height (Silventoinen et al., 2003), and even chances of 
being an elite athlete (de Moor et al., 2007). Of course, these complex traits are also dependent on non-
genetic factors, but there is a genetic component within them. Returning to exercise adaptation, it is now 
understood that the heritable component differs from trait to trait; for example, the results of HERITAGE 
suggest that approximately 50% of heterogeneity of improvement in VO2max following aerobic training is 
determined by heritable factors (Bouchard et al., 1998), whilst variation in muscle fibre type is reported to 
be heritable in a range from approximately 45% to 99.5% (Komi et al., 1977; Simoneau & Bouchard, 
1995). A recent meta-analysis reported that 52% of the variation in muscle strength phenotype is heritable 
(Zempo et al., 2017).  Knowledge of these genes may allow manipulation of environmental factors such 
as volume, intensity, frequency and rest-periods to improve exercise response. Indeed, recent research has 
begun to argue whether true non-responders to specific exercise modalities exist; this is explored in 
greater detail in Chapter 3. Ross and colleagues (2015) conducted a study with three different aerobic 
exercise intensities. In the lowest intensity training group, almost 40% of participants were classified as 
non-responders. However, in the moderate intensity group, this number halved, and in the highest 
intensity group there were no non-responders to exercise. It could well be that response to exercise is 
linked to exercise intensity, although nevertheless there still appears to be large variation in terms of what 
the ideal intensity is for each person (Bonafiglia et al., 2016).  
 
Given that the vast majority of traits are polygenic in nature, there is considerable debate on the 
“optimal” method for identifying genetic variants associated with a variety of traits, including exercise 
adaptation (Pitsiladis et al., 2013; Bouchard 2015). This is explored further in Chapter 4. Initially, the 
field of exercise genomics was built on twin studies, in which the phenotypes of monozygotic (MZ; 
identical) twins are compared to the phenotypes of dizygotic (DZ) twins. If a phenotype appears more 
concordant in MZ compared to DZ twin pairs, then it is likely strongly influenced by genetic variation. 
This approach was initially used to estimate the heritability of VO2max (Williamson et al., 2017).  
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As genetic testing technology improved, researchers began to utilise single-SNP models of 
research, most often with case-control or candidate gene analysis. In this model of research, relative 
genotype frequencies for a SNP/gene of interest are compared between individuals with a phenotype of 
interest (cases) and controls. For example, variation in ACTN3, which influences relative type-II fibre 
types, was initially elucidated when comparing elite speed-power athletes with non-athletic controls 
(Yang et al., 2003). Common criticisms of the candidate gene approach are that it requires prior 
knowledge that a specific SNP may have an effect, and that many studies utilising this methodology are 
underpowered (Bouchard 2015); as a result, replications of SNPs elucidated via this method are often 
lacking (Ahmetov et al., 2010; Ahmetov et al., 2016).  
 
 Due to these criticisms, there has been a move towards Genome-Wide Association Studies 
(GWAS). Here, a large number of SNPs (>100,000) are compared between cases and controls, allowing 
for the discovery of novel SNPs. Due to the large number of comparisons that occur, the typical threshold 
for statistical significance within GWAS is p<5 x 10-8. As many SNPs likely have small effect sizes on 
the trait of interest, this requires exceptionally large numbers of subjects to be recruited to these studies 
(Mattsson et al., 2016) – problematic when dealing with elite athletes, who by definition are few in 
number. Additionally, some authors (Manolio et al., 2009; Yang et al., 2010) argue that this threshold is 
too high, and is a common cause of the “missing heritability problem”, detailed further in Chapter 8 
(Dudbridge 2013).  
 
 As an illustration of the potential issues of the different approaches, many SNPs identified 
through candidate gene studies as having an effect on a specific phenotype are often not replicated in 
subsequent GWAS. Returning again to ACTN3, candidate gene studies show a clear, and well replicated, 
role for the R allele in elite speed-power performance, with this outcome demonstrated at meta-analysis 
level (Ma et al., 2013; Tharabenjasin et al., 2019). However, GWAS of elite sprint athletes (Wang et al., 
2014) or sprint speed in soccer players (Pickering et al., 2019a) have not identified ACTN3 as being 
associated with either trait. This represents a current impasse; are the previous candidate gene studies 
wrong, or is the threshold for discovery in GWAS too high? The right answer is likely a mixture of the 
two, and recent studies utilising lower thresholds for discovery from GWAS appear to hold enhanced 
predictive and explanatory power (Shi et al., 2016; Boyle 2017; Khera et al., 2018). As this field 
progresses, further methodological innovations are expected.  
 
3.1.1 Gene polymorphisms & exercise adaptation 
 
A recent review (Ahmetov et al., 2016) reported that at least 155 genetic markers have been 
associated with elite athlete status, with approximately 10% of these replicated in at least three studies; 
more genes still are implicated with exercise adaptation (Bray et al., 2009). Research in elite athletes is a 
good starting point in the search for candidate genes driving exercise response, as this population 
represent a highly specialised cohort. For example, elite sprinters are likely very good at sprinting 
because they possess alleles that predispose them to adapt favourably to speed-power training. One such 
gene that may play a role here is ACTN3, which creates a-actinin-3, a protein that forms part of the Z-line 
in muscle fibres. A SNP within ACTN3, known as R577X, arises from a C à T substitution, resulting in 
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the formation a premature stop codon (X) in the place of arginine (R). Approximately 18% of individuals 
are homozygous for the X allele (North et al., 1999), causing them to be deficient in a-actinin-3. Whilst 
this lack of an R allele is not associated with any disease state, it does mean that XX genotypes tend to 
have a lower percentage of type-IIx muscle fibres (Vincent et al. 2007). Yang and colleagues (2003) 
examined the impact of this polymorphism in elite sport, comparing ACTN3 genotypes between three 
groups; elite power athletes, elite endurance athletes, and non-athletic controls. Within the control 
subjects, the XX genotype had a prevalence of 18%; however, it did not occur in any of the power 
Olympians, indicating that the XX genotype is unfavourable for elite power performance. Conversely, the 
XX genotype was present in approximately 35% of endurance Olympians, suggesting it potentially has a 
beneficial effect on endurance performance. Subsequent research has confirmed the association between 
the R allele and power performance (Ma et al., 2013), although the link between the X allele and 
endurance is less clear (Papadimitriou et al., 2018). Other genetic variants found to affect athletic 
performance with replication include ACE I/D (Collins et al., 2004; Gayagay et al., 1998; Nazarov et al., 
2001), PPARGC1A Gly482Ser (Eynon et al., 2009a; Lucia et al., 2005; Maciejewska et al.,  2012), 
GABPB1 (rs7181866) (Eynon et al., 2009b; Maciejewska-Karlowska et al., 2012), BDKRB2 +9/-9 
(Saunders et al., 2006; Williams et al., 2004), and HIF1A Pro582Ser (Doring et al., 2010a; Gabbasov et 
al., 2013), to name but a few.  
 
After identifying a relevant polymorphism, the next step is to apply this knowledge within 
studies examining the individual training response. Returning to ACTN3, Delmonico et al. (2007) 
examined changes in knee extensor power following 10-weeks of strength training in older adults, 
discovering that RR genotypes showed greater improvements in peak power than XX genotypes. 
Similarly, Pereira et al. (2013) examined training response following a 12-week resistance training 
programme in elderly women. All ACTN3 genotypes demonstrated significant improvements in tests of 
strength and power following training, but these improvements were greatest in R allele carriers. The 
mechanisms driving these individual changes are not yet fully understood. Norman et al. (2014) reported 
that exercise-induced increases in mTOR and p70S6k, stimulators of skeletal muscle hypertrophy, were 
greater in R allele carriers than XX genotypes following high intensity exercise. Ahmetov and colleagues 
(2014a) reported that testosterone levels were significantly higher in RR genotypes compared to XX 
genotypes in a group of both male and female Russian athletes. R allele carriers also tend to have a higher 
percentage of type-II muscle fibres (Ahmetov et al., 2012), which might allow for greater amounts of 
hypertrophy following resistance training (Campos et al., 2002; Fry 2004).  These aspects go some way to 
explaining the differences in training responsiveness between ACTN3 genotypes. Once again, similar 
research has shown a modifying effect of other polymorphisms on training response, including ACE I/D 
(Cam et al., 2007; Folland et al., 2000; Giaccaglia et al., 2008; Moraes et al., 2018) and PPARGC1A 
Gly482Ser (Ring-Dimitriou et al., 2014; Stefan et al., 2007; Steinbacher et al., 2015).  
 
Research also indicates that genes can influence other traits affecting exercise performance. 
These include injury risk (Brazier et al., 2019)—where SNPs in genes such as COL1A1 (Posthumus et al, 
2009a, 2009b) and COL5A1 (Mokone et al., 2006; Posthumus et al., 2009c; September at al., 2009) can 
influence the risk of tendon and ligament injury—and recovery speed, where SNPs in IL6 and TNFA have 
the potential to influence post-exercise inflammation (Yamin et al., 2008).  
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 Genetic research is still in its infancy and is rapidly developing. The future for this field is 
promising, with many more polymorphisms affecting exercise adaptation remaining to be elucidated. As 
the cost of complete genome sequencing drops, there will be an increased ability to conduct Genome 
Wide Association Studies (GWAS)—generally considered the gold standard (Pitsiladis et al., 2013)—in 
large cohorts, along with replications to remove false positives (spurious positive genetic associations); 
this should further enhance the knowledge in this area.  
 
3.2 Environmental factors  
 
If heritable factors are responsible for a part of exercise adaptation, the obvious question to ask 
is – what is responsible for the other part? These non-genetic factors are often termed “environmental” 
which are defined for the purpose of this literature review as non-genetic factors. This section divides 
them into four groups; individual history, programme design, psycho-emotional factors (including stress 
and prior beliefs), and nutrition. These non-genetic factors can be both acute, affecting a single or small 
number of consecutive sessions—such as a single poor night’s sleep—or chronic, affecting response to 
the training programme as a whole; long-term sleep deprivation, for example. There are doubtless many 
more non-genetic factors that can influence exercise response to varying extents; this section focuses on 
those with the largest effects.  
 
3.2.1 Individual history 
 
A phenotype is the observable expression of an individual’s genotype (Wojczynski & Tiwari 
2008), which is impacted by that person’s environment (Winawer 2006). In terms of exercise response, 
individuals can be viewed as having a highly-, normal-, or under-adaptive phenotype, influenced by their 
genotype (see 3.1), but also environmental variables. One such variable is that of baseline fitness, which 
can impact recovery from exercise (Hagberg et al., 1980; Short & Sedlock, 1997; Tomlin & Wenger, 
2001). Another is training history, with previously trained individuals showing differences in adaptive 
mechanisms post-exercise when compared to beginners (Coffey et al., 2006); this effect can also be 
modified by subject age (Kosek et al., 2006). These differences might, however, be lost with detraining 
(Lindholm et al., 2016). When looking at dietary interventions, diet history can also have a modifying 
impact on responsiveness to the diet, with previous weight loss attempts potentially making future weight 
loss harder (Higginson & McNamara 2016). Finally, higher habitual physical activity can increase the 
response to endurance training (Hautala et al., 2012). Within HERITAGE, environmental correlates of 
VO2max improvements following training included baseline VO2max, age, gender, weight, ethnicity, and 
whether or not the subject achieved the target workload (Sarzynski et al., 2016). Baseline phenotypes 
themselves appear to influence separate traits to different extents; comprising a smaller portion of VO2max 
improvements following exercise (11-16%) and a larger portion of blood pressure response following 
exercise (21-47%) (Mann et al., 2014).  
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3.2.2 Programme design 
 
Training programme design (exercise selection, frequency, duration, intensity, recovery times, 
repetition and set ranges, etc.) can also influence the magnitude of adaptation to training (Campos et al., 
2002; Contreras et al., 2016; Fry 2004; Rossi et al., 2016; Schoenfeld et al., 2016a, Schoenfeld et al., 
2016b; Wilson et al., 1993), as can time of day of training (Ammar et al., 2016; Facer-Childs & 
Brandstaetter, 2015), such that two people with an identical genotype doing different training 
programmes would see a difference in phenotype. Indeed, Sisson and colleagues (2009) found that total 
exercise volume was a factor in the number of non-responders to exercise; by increasing volume 
threefold, the number of non-responders to an aerobic training intervention was reduced from 45% to 
19% 19%, suggesting that environmental influences can perhaps over-ride the genetic pre-disposition to 
exercise non-response.  
 
3.2.3. Psycho-emotional factors 
 
In recent years, attention has turned to how non-physical, psycho-emotional factors can 
influence exercise performance and adaptation. Initially, this attention was focused on fatigue, with both 
the Central Governor (Noakes, 2012) and psychobiological (Smirmaul et al., 2013) models proposed to 
explain the relationship between the brain and fatigue. Since this initial foray into multi-disciplinary 
approaches to explain exercise behaviour, evidence illustrating how inter-individual and transient psycho-
emotional considerations influence individual responses to exercise adaptation has continued to grow. 
The influence of psycho-emotional factors on numerous dimensions of performance has recently been 
illustrated within athletic preparation contexts (Kiely 2016; Mann et al., 2016; Stults-Kolehmainen et al., 
2016). Similarly, the mechanisms underpinning how psycho-emotional states mediated biological 
adaptations have been extensively outlined within the wider psycho-biological (Ganzel, 2010) and 
training specific (Kiely, 2018) literatures.  
 
Existing evidence illustrates that the sense of threat imposed by applied stressors—such as 
exercise-induced stimuli—are evaluated, by the brain’s emotional centres, against the organisms 
perceived capacity to cope with that stress (Ganzel et al., 2010). The direction and magnitude of the 
consequent changes in the neuro-chemical environment (i.e., the stress response) is subsequently heavily 
modulated by the emotional valence attached to that stressor, as the organism strives to appropriately 
prepare for the forecasted challenge. These neurochemical alterations subsequently drive down-stream 
biochemical changes; thereby altering the biochemical backdrop upon which straining stimuli are overlaid 
and, subsequently, modulate the adaptive response to exercise (Viru & Viru, 2004; Kraemer & Ratamess, 
2005). From this, it is apparent that the size of the response to a stressor is not merely dependent on the 
magnitude of the stressor itself, but also on the emotional evaluation of the perceived threat posed by that 
stressor. In effect, emotional valence drives changes in the neurobiological chemical milieu, which in turn 
influences physiological adaptation.  
 
The emotional response itself is complex and is perhaps best summarised by Ganzel and 
colleagues (2010). In their model, the authors describe some of the factors that mediate this emotional 
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response. These include prior context, such as previous traumatic experiences, evolved coping 
behaviours, and general health. This prior context then interacts with the current state of the organism, 
both in terms of emotional capacity (influencing prior mental health, which in turn influences the acute 
emotional response to a stressor) and, via the chemical changes that drive subsequent physical responses, 
physical changes that accompany chronic stress, such as increased cortisol (which influences prior 
physical health, itself a modifier to the acute response to a stressor). These factors combine to shape the 
perception of threat posed by any given stressor, and this perception of threat in turn shapes the specific 
set of neurobiological responses launched to combat the forecasted challenge.  
 
Consequently, it is worth noting that every stressor, including exercise, exerts a neurological, 
biological, psychological, cognitive and emotional load. The magnitude and direction of this load is 
highly context- and individual-specific, and inextricably modulated by non-physical factors; meaning 
that, at the individual level, adaptations in response to exercise will inevitably be modulated by a host of 
non-physical mediators, thereby further customising inter-individual adaptive responsiveness.  
 
3.2.3.1 Factors affecting psycho-emotional response 
 
This response to a stressor is altered by both environmental and genetic factors. Focusing on the 
environment, one such factor is lack of sleep, which can impact exercise recovery (Dattilo et al., 2011; 
Leeder et al., 2012a), and promote the release of stress hormones (Dattilo et al., 2012). This can lead to a 
reduction in aerobic endurance (Azboy & Kaygisz, 2009) and strength (Souissi et al., 2008) performance, 
and also increase the inflammatory response (Heffner et al., 2012)—potentially altering training 
performance and hence adaptation. A lack of sleep, for example, increases vulnerability to a mild stressor 
(Minkel et al., 2012) and alters psychological coping mechanisms (Akersted et al., 2012). The 
interpretation of stress is also modified by heritable factors; polymorphisms in genes such as COMT 
(Clark et al., 2013), BDNF (Clasen et al., 2011; Colzato et al., 2011) and 5HTTLPR (Clasen et al., 2011) 
have been shown to impact both the acute and chronic stress response, which in turn can modify exercise 
adaptation (Petito et al, 2016) and performance (Sanhueza et al., 2016). The microbiome, which is 
influenced by both environmental and genetic factors, can also alter the stress response in athletes (Clark 
& Mach, 2016). Finally, epigenetic modifications (see section 3.4) will affect the stress interpretation 
pathways (Nestler 2012), providing an explanatory framework depicting how childhood trauma can 
influence adult stress behaviours decades later (Heim & Binder, 2012).  
 
The individual response to a stressor can have a sizeable impact on the adaptive mechanisms 
following exercise. Psychological stress can affect exercise adaptation by decreasing immunity and 
recovery (Clow & Hucklebridge, 2001), as well as increasing the risk of injury (Mann et al., 2016). 
Additionally, baseline stress has been correlated with VO2max improvements (Ruuska et al., 2012). Given 
that the stress response is partially hormone led (Huang et al., 2006), and these hormonal changes can be 
fast-acting (Cook & Crewther, 2012), the stress state of the subject at the time of exercise has the 
potential to modify the adaptive response both acutely and chronically (Main et al., 2010). To illustrate 
this, Bartholomew and colleagues (2008) reported that after 12 weeks of resistance training, participants 
with lower levels of self-reported lifestyle stress had greater increases in both bench press and squat 
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strength compared to those participants with a high stress score. Similarly, a subject who has just argued 
with a spouse and has long-term financial worries is likely to have less resources available to mount an 
optimally healthy adaptive response than a subject who is content (Kiely, 2016).  
 
The acute psycho-emotional response to a training session could also possibly cause variation in 
work rate within that session, which may itself determine some of the inter-subject variation in response 
to exercise (Sarzynski et al., 2016). This work-rate is likely comprised of many factors, including residual 
fatigue, but also via psychological factors which can influence within-session work via the 
psychobiological model (Smirmaul et al., 2013). Individual variation in perception of work rate can lead 
to changes in exercise performance (Marcora & Staiano, 2010), and this perception of work rate is 
influenced by a myriad of factors (for review, see Noakes 2012). The perception of effort also has a 
heritable component, which explains 35% of the variance in rating of perceived exertion (RPE) between 
participants (Schutte et al., 2017). Furthermore, acute alterations in hormone levels may influence 
individual motivation to train and perform physical work (Crewther et al., 2016; Crewther et al., 2018). 
Variation in these all of these factors could alter within-session work rate, in turn modifying exercise 
adaptation.  
 
Finally, expected and previously-held beliefs can impact the emotional evaluation of a stressor, 
again potentially modifying training performance and adaptation. An ever-increasing body of literature 
has illustrated that a subject’s prior beliefs can modify how they perform within a session, including 
belief that they have consumed caffeine (Saunders et al., 2016), steroids (Ariel & Saville, 1972; 
Maganaris et al., 2000), sodium bicarbonate (McClung & Collins, 2007), and doping agents (Ross et al., 
2015) within blinded experiments. Returning briefly to sleep, “placebo sleep”—whereby individuals are 
informed they’ve slept for longer than they actually have—can improve cognitive function (Draganich & 
Erdal, 2014), again illustrating the power of belief. The nocebo effect can also influence exercise 
outcomes (Pollo et al., 2012). Given that expected beliefs can alter effort within a training session, 
whether a subject believes a specific exercise or training programme is either positive or effective can 
alter the outcome of exercise- and nutritional-intervention trials (Beedie & Foad, 2009; Mothes et al., 
2016). Interestingly, some research seems to suggest that certain genotypes are more sensitive to 
expectancy, placebo and nocebo effects (Hall et al., 2015), once again illustrating the consistent influence 
of genetics on environmental factors.  
 
3.2.4. Nutrition 
 
An additional factor that can influence exercise adaptation is that of nutrition. Macronutrient 
intake impacts both exercise performance (Bergström et al., 1967) and exercise adaptation (Bartlett et al., 
2014; Hammond et al., 2016). The same is true for micronutrients, with serum vitamin D levels 
associated with muscle power and force, both acutely (Ward et al., 2008), and in response to a training 
programme (Close et al., 2013). Recently, attention has focused on individual variation in the gut 
microbiota, which again can modify the response to exercise (Mach & Fuster-Botella, 2016), including 
modifying post-exercise recovery and mood states (Clark & Mach, 2016). Finally, long-term high dose 
antioxidant use can potentially blunt the adaptive response to exercise (Draeger et al., 2014; Ristow et al., 
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2009)—although these findings are not unequivocal (Yfanti et al., 2010)—leading to the possibility that 
differences in dietary composition could cause some of the inter-subject variation seen in response to 
exercise. Other nutritional factors can modify the acute physiological stress expected following training; 
these include short-term macronutrient intake (Hawley et al., 2011), antioxidant intake (Braakhuis & 
Hopkins, 2015)—which can be both positive or negative depending on the nutrient and dose (Braakhuis 
et al., 2014)—and use of medications such as non-steroidal anti-inflammatory drugs (NSAIDS) (Mackey 
et al., 2007; Mikkelsen et al., 2009; Trappe et al., 2002). 
 
These nutritional factors are also influenced by genetic aspects. The microbiome, for example, is 
influenced by host genetics (Bonder et al., 2016). Returning to vitamin D, polymorphisms in a variety of 
genes, including VDR, can influence muscle strength (Grundberg et al., 2004), which will in turn 
influence response to training. VDR can also influence a person’s vitamin D requirements (Graafmans et 
al., 1997). Close and colleagues (2013) demonstrated that vitamin D supplementation enhances 
improvements to a strength training programme, which raises the question - do non-responders to strength 
training not respond because of genetic factors, or is their response blunted due to vitamin D insufficiency 
(which in turn can be influenced by SNPs)? Given that nutrition can also impact gene signalling post-
exercise (Arkinstall et al., 2004; Churchley et al., 2007), it’s easy to see how both genes and environment 
combine and interact to create the phenotype.  
 
Finally, the use of ergogenic aids can also affect the performance level within an individual 
training session, which in turn can modify the overall adaptation that accumulates over time. One such aid 
is caffeine, which has a clear and replicated ergogenic effect on exercise performance (Astorino & 
Robertson, 2010; Doherty & Smith, 2004; Graham, 2001). Caffeine is examined in greater detail in 
Chapter 5. Another is creatine, which can affect intra-session recovery (Mujika & Padilla, 1997), 
potentially allowing for a greater volume of high intensity efforts to be completed.  
 
3.3. Summarising gene-environment interactions 
 
Having discussed the different genetic and environmental aspects that can affect exercise 
response, it is worthwhile summarising these within a model. Figure 1 shows the typical gene and 
environment model, where genetic and environmental factors are kept separate, and combine in an 
additive manner to determine the post-exercise adaptation phenotype. As a simplified example, two 
individuals homozygous for the R allele of ACTN3 will have different phenotypes based on 
environmental factors. If subject A undertakes high-load resistance training, they will likely see good 
levels of muscle hypertrophy. If subject B is sedentary, then they won’t see hypertrophy, no matter how 
positive their genotype is.  
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Figure 1 – The Gene-Environment Model with ACTN3 example.  
 
However, as explored in all the sections within 3.2, it is clear that there are a variety of 
environmental factors that can affect training response. These factors have a complex relationship with 
genetic factors; they can affect genetic expression, but are also affected themselves by SNPs within 
specific genes. This allows the formation of a more complex model, as per figure 2, which illustrates the 
increasing complexity.  
 
 
Figure 2 – Multi-environmental interactions with genotype. A more complex model illustrating the 
relationship between various environmental and genetic factors to create the outcome, in this case 
exercise adaptation. Further complexity could be added to this model by showing the inter-relationship 
between the environmental factors; nutrition can affect psychological factors, for example.  
 
3.4 Epigenetics 
 
Having introduced genetics and environment, two aspects that are typically thought to combine 
to create the phenotype, the next area to explore is epigenetics, the process by which environment can 
influence genetic expression. Epigenetics can be defined as changes in gene function that occur without a 
change in the nucleotide sequence (Ling & Groop, 2009). These changes have the potential to be 
heritable—although this is controversial (Horsthemke, 2018)—but also changeable over the course of 
time within an individual (Moran & Pitsiladis, 2016). The three main epigenetic mechanisms that have 
been elucidated thus far are DNA methylation, histone modifications, and non-coding mRNA (Moran & 
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Pitsiladis, 2016); all act as a way for the environment, through factors discussed in section 3.2, to modify 
genetic expression.  
 
3.4.1.DNA methylation  
 
The most extensively studied epigenetic mechanism, DNA methylation occurs through the 
addition of a methyl group to a cytosine base (Ehlert et al. 2013), which in turn makes that section of 
DNA less accessible for translation (Rottach et al., 2009). This can be positive or negative depending on 
whether expression of that gene is desired; methylation of oncogenes (Ehrlich 2002) and obesity-risk 
genes (Nitert et al., 2012) is likely positive. In contrast, methylation of tumor suppressor genes (Ehrlich 
2002), and those that drive exercise adaptation (Nitert et al., 2012) is less ideal. Fortunately, the same 
stimulus can lead to both an increase and decrease in methylation in different genes (Voisin et al., 2015). 
As an example, six-months of aerobic exercise lead to a decrease in methylation (hypomethylation) in 
muscle genes (Nitert et al., 2012), promoting adaptation, and an increase in methylation 
(hypermethylation) in adipose tissue genes (Ronn et al., 2013), potentially stimulating weight loss. 
Similarly, PPARGC1A, a gene that drives mitochondrial biogenesis following exercise (Eynon et al., 
2011), showed an increase in methylation following nine-days of bed rest, and a decrease in methylation 
following four-weeks of re-training (Alibegovic et al., 2010). 
 
DNA methylation is modifiable within an individual; the DNA methylation profiles of obese 
patients become more like those of lean subjects’ following a weight-loss intervention, for example (van 
Dijk et al., 2015). The levels of DNA methylation in response to the same stimulus may also change over 
time, with higher levels seen in elderly subjects following exercise—potentially due to the greater 
accumulation of aberrant methylation in these participants that needs correcting with exercise (Brown 
2015). Of the three types of epigenetic modification detailed here, DNA methylation is perhaps the most 
stable (Ehlert et al., 2013), with early life experiences, even those pre-birth, potentially exerting a long-
term effect on gene expression (Champagne, 2010). From an exercise perspective, this was recently 
explored by Seaborne and colleagues (2018). Here, the authors placed eight previously untrained males 
through a seven-week resistance training programme, followed by a seven-week washout phase, before 
undertaking a further seven-week loading period. After completion of the initial training programme, a 
number of epigenetic modifications occurred, including both hypo- and hypermethylation. These 
methylation markers were largely retained during the washout period, and then enhanced during the 
subsequent loading period, leading the authors to suggest that skeletal muscle has an “epigenetic 
memory”, potentially making adaptation to a subsequent training load more efficient.  
 
 Finally, DNA methylation patterns may even be passed from generation to generation (Voisin et 
al., 2015), leading to the interesting possibility that methylation markers affecting elite athlete status and 
fitness levels may be partially inherited, although a more comprehensive body of work is required to 
explore this hypothesis (Horsthemke 2018).   
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3.4.2 Histone modifications 
 
DNA is coiled around histone proteins, giving it a specific shape. The epigenetic variation 
caused by histone modifications occur via acetylation of this structural histone, which changes its shape. 
This makes the specific section of DNA comparatively more available for translation, which in turn 
makes the expression of these genes easier (McGee et al., 2009). The process of acetylation of histones is 
controlled by a histone acetyl-transferase (HAT), whilst histone deacetylase (HDAC) can remove the 
acetyl group, reducing translation at that point (McKinsey et al., 2001). In mice, it has been shown that 
the presence of a particular HDAC (HDAC5) can reduce the adaptations expected following exercise 
(Potthoff et al., 2007), showing how histone modifications might affect exercise response. In humans, 
HDAC5 levels are lower following training, confirming that these proteins play a role in exercise 
adaptation, although at present it’s not exactly clear what causes individual differences in HDAC5 levels 
(McGee et al., 2009).  Histone modifications represent the most transient of the epigenetic changes, and 
are constantly in a state of flux (Ehlert et al., 2013).  
 
3.4.3 Non-coding RNA 
 
RNA is typically used by the body as messenger RNA (mRNA) to pass information from DNA 
to the ribosomes, where protein synthesis occurs. However, the vast majority of RNA found within the 
body is non-coding (Bernstein et al., 2012); instead, this RNA might regulate genetic expression or 
catalyse chemical reactions. Regarding epigenetic translational alterations, of interest is micro RNA 
(miRNA), molecules which appear to exert control over mRNA, either by inhibiting translation or 
causing degradation before translation occurs (Guay et al., 2011). This indicates miRNA could regulate 
gene transcription post-exercise, affecting adaptation. In participants matched for diet, training history, 
age and body mass, a 12-week resistance training programme elicited adaptations of differing magnitude, 
in part mediated by specific miRNAs; levels of these miRNAs were correlated with greater adaptations, 
such as increases in strength (Davidsen et al., 2011), a finding which has been replicated (Hagstrom & 
Denham, 2018). miRNA has also been reported to play a role in aerobic exercise adaptation (Bye et al., 
2013; Mooren et al., 2014; Timmons et al., 2010; Zhang et al., 2017). Similarly, there is disparity in the 
circulating levels of specific miRNAs between athletes primarily engaged in either strength or aerobic 
endurance training (Hecksteden et al., 2014). miRNAs may also reflect the level of fatigue of the athlete 
(Hecksteden et al., 2014), showing potential as a monitoring tool within elite sports programmes, 
although further research is required to enhance understanding in this area (Fernandez-Sanjurgo et al., 
2018). It’s not entirely clear at present which factors affect circulating levels of miRNA, making it 
difficult to harness this knowledge to improve performance, but the use of miRNA as a marker of 
exercise adaptation and load remains an area of increased interest from both a sporting and health 
perspective (Hecksteden et al., 2014; Polakovicova et al., 2016; de Gonzalo-Calvo & Thum, 2018; 
Ultimo et al., 2018). 
 
At this point, an updated model, including the impact of epigenetics on gene-environment 
interactions, can be created, as seen in figure 3.  
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Figure 3 – A simple model of gene-environment interactions, with the addition of epigenetics. In 
this model, environmental factors have been grouped together for simplicity. Here, these environmental 
changes alter genetic expression, although as discussed in 3.4.4 and 3.4.5, this is a complex relationship.  
 
3.4.4 Genetic influences on epigenetic modifications 
 
So far, I have covered how epigenetic mechanisms allow for the environment to impact genetic 
expression, which is typically how epigenetics is viewed. However, genetic variation can also affect the 
efficiency of epigenetic modifications, allowing things to come full circle. This has been most well 
studied in terms of methylation, where a number of genes (Gertz et al., 2011), perhaps the most well-
known of which is MTHFR (Friso et al., 2002), affect DNA methylation, and in turn can modify 
epigenetic modifications following exercise. Teruzzi et al. (2011) reported that elite athletes had a greater 
number of polymorphisms across several genes that affect methylation status, resulting in a genetic 
predisposition to hypomethylate. This lack of methylation potentially increases post-exercise muscle 
hypertrophy by increasing specific gene transcription. These findings were replicated by Zarebska et al. 
(2012), in which the authors speculated that there was an advantage in being a heterozygote of MTHFR 
A1298C. The proposed mechanism was that heterozygotes had decreased methylation of adaptive genes, 
which wasn’t the case in AA homozygotes, but didn’t exhibit increased homocysteine levels, associated 
with lower muscle strength (Kuo et al., 2007a), common in CC genotypes. 
 
3.4.5 Environmental influences on epigenetic modifications 
 
Along with genetics, environmental influences such as nutrition can alter epigenetic 
modifications; a high calorie diet appears to increase methylation of genes controlling metabolism, 
making metabolic dysfunction more likely, for example (Brøns et al., 2010). As discussed in 3.4.4, genes 
influence the efficiency of methylation, but also interact with environmental factors to control these 
changes, adding an extra layer of complexity. As an example, MTHFR encodes for an enzyme that 
coverts the folate derivate 5,10-methylenetetrahydrofolate (5,10MTHF) to 5-methylterahydrofolate 
(5MTHF), creating s-adenosylmethionine (SAM) – an agent for DNA methylation. Simply put, this 
pathway starts with folate, which is converted to intermediaries by MTHFR, with the availability of these 
intermediaries affecting methylation efficiency (Niculescu & Zeisel, 2002; Shelnutt et al., 2004). The two 
MTHFR SNPs, C677T and A1298C, influence the activity of the MTHFR enzyme. Focusing on C677T, 
T allele carriers typically have poorer conversion of folate, which in turn can influence methylation. 
Shelnutt and colleagues (2004) examined this in detail, placing participants on a low folate diet 
(»115µg/d) for seven weeks, and then a high folate diet (»400µg/d) for seven weeks. There was a trend 
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for decreased methylation within both groups with low folate intake; however, this trend was reversed 
during the high folate phase, and to a greater extent in TT genotypes. 
 
Exercise is another environmental influence that can modify epigenetic changes through 
alterations in gene silencing and expression (Ntanasis-Stathopoulos et al., 2013), similar to that discussed 
in 3.4.1 and reviewed by Voisin et al. (2015). The homeostatic stress caused by exercise drives epigenetic 
modifications (Sanchis-Gomer et al., 2012), which in turn can lead to exercise adaptations by increasing 
translation and transcription of enzymes involved in adaptive mechanisms, such as AMPK and PGC-1a 
(Pareja-Galeano et al., 2014).  
 
Environmental influences on epigenetic modification can play a role in determining an 
individual’s phenotype; in individuals with the same genotype (monozygotic twins), differences in 
environment lead to different epigenetic changes occurring (Fraga et al., 2005), which can, for example, 
affect type-II diabetes risk, (Kapiro et al., 1992). Alongside nutrition and exercise, other environmental 
factors that can influence epigenetic modifications include psychological trauma (Yehuda, et al., 2005; 
Yehuda et al., 2009), which can potentially be passed down generations (Dias & Ressler, 2014), but also 
reversed (Weaver et al., 2005). Environmental toxins such as tobacco smoke, dietary polyphenols, alcohol 
and shift work can also all modify epigenetic regulation (Alegria-Torres et al., 2011).  
 
4. A final model to explain the causes of inter-subject variation 
  
As detailed in 3.1, genetic variation can clearly modify the magnitude of adaptation to exercise, 
both in single SNP/gene (e.g. ACTN3) and combined gene (e.g. HERITAGE) models. Section 3.2 
examined non-genetic aspects that influence this response, including nutritional status (both chronic and 
acute) and training history. As an example, total daily protein intake impacts muscle protein synthesis 
following resistance training, and vitamin D status can modify performance (Close et al., 2013). These 
non-genetic factors are also affected by genetic factors; serum 25(OH)D levels both before and after 
supplementation are affected by specific SNPS (Didriksen et al., 2013). It is clear, therefore, that genetic 
and non-genetic factors are linked. The same is true for acute environmental factors, such as a stressor, 
which, as discussed in 3.2.3, might affect response to a single exercise bout. These acute factors will be 
influenced by genetic aspects, such as a SNP in COMT that can modulate stress response (Stein et al., 
2006). They will also be influenced by environmental factors such as previous trauma (Nemeroff, 2004). 
 
Section 3.4 discussed epigenetics, which is a mechanism through which environmental aspects 
can influence genetic expression; 3.4.4 and 3.4.5 explored how genetic and non-genetic factors also 
influenced epigenetic modifications, further illustrating the complex relationship between all factors, and 
requiring an update to the model proposed in figure 3. This culminates in a model of how all these factors 
interact to create a unique response for each individual in response to a stimulus. This response is not 
stable, as the component factors themselves can be highly variable over time; just because an individual 
saw a performance improvement after one training programme does not guarantee the same improvement 
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following the same programme once more (Robertson et al., 2010). This complex relationship is 
illustrated in figure 4.  
 
 
 
Figure 4 – A final model to explain inter-subject variation in exercise response. The complex interaction 
between genes, environment and epigenetics on response to a stimulus, in this case a training programme.  
 
5. Harnessing this knowledge to improve performance 
 
Having discussed the main aspects that affect individual adaptation to exercise, the next step is 
to attempt to make this information usable to athletes. Being able to compete at the highest level is a 
function of talent alongside optimal training – but how does an athlete know their training or use of an 
ergogenic aid is optimal? Typically, this requires trial and error, which is costly in terms of both time, 
and, if the trial is ineffective, performance. As athletes only have a window of a few years to be able to 
compete at their peak, time spent doing sub-optimal training can be very damaging. Being able to have 
more information on which to base decisions regarding training methodology would obviously be very 
attractive to everyone involved in sport. Currently, most testing carried out in athletes is of the phenotypic 
variety; VO2max and vitamin D tests being two examples. This testing has use, as it provides a snapshot of 
where the athlete is at a given point in time; it can inform training requirements, but has minimal long-
term predictive ability.  
 
Given that a large proportion of inter-subject variation is down to genetic factors, testing for 
these factors through a genetic test might hold some promise. This could be single gene/SNP testing, or, 
more promisingly, large scale testing such as partial or whole genome sequencing. The cost of these tests 
has dropped in recent years (Hayden, 2014), making them much more accessible. This raises the potential 
for genetic tests to be used to inform training programme design, which may have some predictive ability 
(Jones et al., 2016; Monnerat-Cahli et al., 2016; Timmons et al., 2010). Whilst single gene models might 
give some insight into how humans respond to exercise (Delmonico et al., 2007; Kikuchi & Nakazato, 
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2015; He et al., 2018), adaptation to exercise is not determined by a single gene. Instead, groups of genes 
influence the various different cellular pathways (Camera et al., 2016) that control adaptation. By looking 
at just one gene, such as ACTN3, there is a risk of ignoring the effects of these other genes. One way to 
overcome this is to use a multi-gene model, comprised of an algorithmic approach that allows for the 
evaluation of a number of gene polymorphisms. 
 
One method that has been used in this regard is that of the Total Genotype Score (TGS). This 
method has been used against retrospective data to improve identification of at-risk individuals for both 
cardiovascular disease (Thanassoulis et al., 2012), and type-II diabetes (Meigs et al., 2008). Within the 
sports and exercise world, TGS have so far been examined primarily as a potential tool for the discovery 
of elite athletes (Ruiz et al., 2009; Ruiz et al., 2010; Santiago et al., 2010), although the consensus is that 
there is currently no predictive ability of genetic testing in the identification of talented sports people 
(Webborn et al., 2015). Bouchard et al., (2011) pooled data from three independent aerobic training 
programmes—HERITAGE, DREW and STRRIDE—conducted in untrained individuals, and found that 
those with a TGS of ≥ 19 saw VO2max improvements 2.7 times greater than those with a score of ≤ 9, 
although this was conducted post-hoc and not used to inform programme design. As of yet, the use of a 
TGS or other algorithm has not been widely utilised in regard to interventions to improve exercise 
response. Meckel and colleagues (2014) used a TGS to retrospectively explain training response over the 
career of an athlete. Jones et al. (2016) used a weighted algorithm to personalise an eight-week resistance 
training programme; those doing genetically matched training saw significantly greater improvements in 
both a test of power and endurance than those doing genetically mismatched training. In addition, over 
80% of athletes identified as high responders were from the matched group, whilst 82% of non-
responders were from the mismatched group – suggesting that genetic testing might be useful in reducing 
non-response to exercise; something that will excite elite athletes, but which may also have public health 
connotations in the fight against obesity. Another method, utilised by Timmons et al., (2010), combined 
the use of RNA profiling with genetic information to create a molecular predictor of VO2max response to 
aerobic training, although again this has yet to be satisfactory replicated (Sarzynski et al., 2016). It is still 
early on in this journey, and a far greater body of research is required; nevertheless, it does appear that the 
effective utilisation of this knowledge is drawing closer. Effective utilisation will also require 
manipulation of environmental factors, such as exercise intensity, duration, volume, as well as nutritional 
interventions; it must always be remembered that the use of genetic information can better inform how to 
make these manipulations, but does not serve to replace them.  
 
The use of genetic testing within sport is still somewhat controversial (Vlahovich et al., 2017a, 
2017b; Webborn et al., 2015; Williams et al., 2016), with this controversy comprised of a variety of 
factors. One of these regards the use of genetic testing for talent identification; currently, there is no 
evidence that genetic testing should be used in this way (Webborn et al., 2015). The second controversy is 
whether these tests have utility in terms of exercise modification. A recent consensus statement (Webborn 
et al., 2015) suggests that they don’t, although no evidence is given in the consensus statement to support 
this standpoint. It’s certainly true that, at present, only a small number of studies have looked at training 
modifications based on genetic information, but this number is expected to grow in the future, leading to 
the possibility that genetic information might have some use, alongside other more traditional information 
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sources (Grimaldi et al., 2012; Heffernan et al., 2015). Finally, there are a number of ethical issues to 
consider and overcome. Should there be a minimum age for genetic tests? Can the results of a genetic test 
be placed in the correct context for an athlete? Who owns the genetic data – the athlete or the team? If an 
athlete refuses a genetic test, will they be discriminated against? What happens if a genetic test unearths a 
potential medical issue, such as increased Alzheimer’s disease risk? These questions, and others, will 
need to be answered before genetic testing can become widespread in sport, even though, in a recent 
study of elite-level athletes and coaches, the majority believed such information could be useful (Varley 
et al., 2018a). Finally, there needs to be assurances that the results of a genetic test will not be used for 
selection purposes, or any other discriminatory practices. If these ethical hurdles can be overcome, there 
is a potential use for genetic testing in exercise prescription and modification, alongside other more 
traditional aspects.  
 
6. Conclusions & future directions 
 
This chapter has explored some of the factors that modify the individual response to a stimulus, 
primarily exercise adaptation, demonstrating how the environment can affect adaptation, through aspects 
such as sleep and nutrition. Additionally, this chapter examined how epigenetic modifications allow 
communication between the environment and genetic expression. However, a constant theme throughout 
has been the influence of genetic factors on the response to a stimulus. Differences in genotype are 
responsible for a large amount of variation in exercise adaptation, but genetic factors also influence 
environmental aspects such as nutrition and epigenetic efficiency. Given that genetic factors are such a 
consistent and fundamental modulator of how someone responds to exercise, knowledge of these factors 
within an individual could potentially prove useful. For the first time, this knowledge is affordable and 
available through genetic testing, allowing athletes and coaches to have an idea of how they will respond, 
and to modify training to account for this. The information gained from a genetic test represents an 
additional piece of information to inform needs much like a vitamin D screen, heart rate variability for 
recovery, or a 1RM strength test. It is still early in the use of genetic testing for sports people, and a 
significant body of research is required to identify yet more genetic variants involved in exercise 
adaptation, along with other areas of interest to athletes; injury risk, recovery speed, and the ergogenic 
effects of nutritional aids. However, research is starting to indicate the utility of these tests. Indeed, some 
sports teams have been using genetic information (Dennis, 2005), but without any evidence-based 
practice. Given the apparent desire of high-level sports people to utilise genetic information to inform 
programme design, the development of evidence-based guidelines is paramount, which of course means 
that further research on the potential use of genetic information in training response in required, 
particularly from a predictive standpoint. As such, it is important for further research to focus on: 
• Replication of existing, and discovery of further genetic variants that impact exercise 
adaptation. 
• Examining the interplay between genes, environment, and epigenetic modifications on 
exercise adaptation.  
• The development of evidence-based guidelines on the use of genetic assessments in sport, 
with particular reference to ethical considerations.  
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The ability to harness this information potentially represents a new dawn in understanding 
exercise adaptation, allowing athletes to better guide their quest to become faster, higher, and stronger.  
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CHAPTER 3 – CONTEMPORARY ISSUES REGARDING EXERCISE NON-RESPONSE & 
EXERCISE GENOMICS 
 
 
Chapter preface: 
 
As detailed in Chapter 2, the results of a number of studies suggest that there is the potential for 
considerable inter-individual variation in the response to an exercise training programme. This inter-
individual variation, from a biological perspective, can be explained as the interaction between genes, 
environment, and epigenetic modifications (Pickering & Kiely, 2017a; Pickering and Kiely, 2018a). 
However, recently a number of authors have cast a skeptical eye on the data underpinning the individual 
response (Atkinson & Batterham, 2015; Hecksteden et al., 2015; Williamson et al., 2017; Atkinson et al., 
2018; Atkinson et al., 2019). The main causes of contention are that some components of inter-individual 
variation are related to measurement error (Atkinson & Batterham, 2015; Hecksteden et al., 2015) or 
flaws in study design (Williamson et al., 2017). Such components are commonly termed “false” inter-
individual variation (Atkinson & Batterham, 2015), and potentially hamper the ability to fully understand 
the magnitude of “true” inter-individual variation. Furthermore, there is the potential that any variability 
in response, whilst ”true”, is not clinically relevant (Williamson et al., 2018). This chapter further 
explores some of these issues, attempting to answer whether non-responders to exercise exist. 
Furthermore, as the genetic component of inter-individual variation is commonly estimated as 
approximately 50% (Williams et al., 2014) there is a need critically appraise some of the findings of 
gene-association studies to determine the validity of the findings.  
 
 
PART 1 – DO NON-RESPONDERS TO EXERCISE EXIST? 
 
1. The terminology problem: “Non-responder” vs “Did not respond” 
 
 Given the increased interest in individual variation in response to exercise, along with the 
potential for some individuals to exhibit no (Bouchard & Rankinen, 2001), or negative (Bouchard et al., 
2012), responses, the term “non-responder” has increasingly been employed to describe those who fail to 
exhibit positive change in the measured variable following an intervention (Booth & Laye, 2010). The 
pejorative connotations implicit in such a term, however, may promote a damaging and misleading 
perception that exercise is perhaps not universally beneficial. This belief is potentially hugely damaging 
from a public health perspective, given the well-established and wide-ranging positive effects of regular 
exercise training on reducing obesity risk (Ross et al., 2000; Slentz et al., 2009), enhancing 
cardiometabolic health (Jennings et al., 1989; Grace et al., 2017), increasing function in the elderly (Li et 
al., 2018), improving mental health (Scully et al., 1998; Cooney et al., 2014), and reducing the risk of 
various disease states (Booth et al., 2012; Fiuza-Luces et al., 2013; Pareja-Galeano et al., 2015). 
Accordingly, it is crucial to approach such a term, and its related findings, with a critical eye. An area 
worthy of exploration is whether the observed non-response is modality specific. As detailed in Chapter 
2, this appears to be the case. When exposed to divergent exercise stimulus, such as strength and aerobic 
 40 
training, individuals appear to exhibit non-response to one, but not both, training interventions (Hautala et 
al., 2006; Karavirta et al., 2011). As such, exercise non-response appears to be modality-specific; and, 
whilst it has previously been suggested that global non-responders to exercise likely do exist (Timmons 
2011), this is not currently supported by experimental data.  
 
 
2. Exercise non-response: statistical insights 
 
 Given the increased interest in exercise non-response and individual variation, a number of 
researchers have cast a welcome skeptical eye on the underpinning data (Atkinson & Batterham, 2015; 
Hecksteden et al., 2015; Williamson et al., 2017; Atkinson et al., 2018). When determining whether a 
subject has responded to training, research designs typically require a pre- and post-intervention test, with 
the difference between the two test scores determining responsiveness (Hecksteden et al., 2015). 
However, inherent within any measurement are both technical error and random within-subject variation 
(Atkinson & Batterham, 2015; Hecksteden et al., 2015); such confounders are said to represent “false” 
individual variation (Atkinson & Batterham, 2015), potentially leading to the mis-identification of 
individuals as non-responders. To guard against this, a method to determine “true” individual variation 
has been proposed, whereby the standard deviations of the intervention group are compared to a 
control/comparator group, as both groups will have similar measurement error and random within-subject 
variations (Atkinson & Batterham, 2015; Atkinson et al., 2017). Many of the studies supporting the 
concept of exercise non-response, particularly with regards to aerobic training, lack such a comparator 
arm (Williamson et al., 2017). Accordingly, the “true” occurrence of exercise non-response may be 
overstated, and is currently unclear.  
 
 Furthermore, exercise non-response has no set definition; it can refer to the lack of a clinically 
meaningful change, the lack of a measurable change, a value above the technical error of the test, or as 
the lowest set percentage of participants in terms of response (Scharhag-Rosenberger et al., 2009; 
Vollaard et al., 2009; Bouchard et al., 2012; Hecksteden et al., 2015). This obviously makes comparisons 
between trials difficult, as individuals classed as a responder in one trial may be classed as a non-
responder in another, thereby hampering discernment of the true rate of non-response.   
 
 There is also the potential that the type of evaluation utilised may cause differences in test 
performance that masquerade as individual responses. For example, maximal VO2max tests are often used 
to determine improvements in cardiovascular fitness following training. These tests impose significant 
physical stress and discomfort, ensuring test performance is modulated by subject motivation (Noonan & 
Dean, 2000). Hence, an individual may have undergone significant physiological adaptations from a 
training programme, but performed poorly on the quantifying test due to motivational, non-physiological 
reasons. Whilst this individual would have responded positively to training, this improvement would not 
be reflected in test performance. This obviously has important implications for gene association studies 
exploring exercise non-response; for example, is a particular single nucleotide polymorphism associated 
with enhanced improvements in aerobic fitness, or does it merely predispose to greater exercise 
discomfort tolerance (Pickering & Kiely 2017b)?  
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 Finally, the selection of tested variables appears to affect the identification of exercise non-
responders. Typically, non-responders are identified within one measure, such as 1RM change or 
improvements in VO2max. However, when data on more than one variable is collected, exercise non-
response seems to disappear. For example, Scharhag-Rosenberger and colleagues (2012) had 18 
previously untrained participants undergo a year-long aerobic training programme. Pre- and post-
measures were collected for four variables; VO2max, resting HR, exercise HR, and individual anaerobic 
threshold. 10 participants showed no improvement in at least one variable, but, crucially, every subject 
improved in at least one metric. Similarly, Churchwood-Venne et al. (2015) analysed data after 
participants completed a 24-week resistance training programme, collecting data on lean body mass, type 
I and II fibre size, and chair-rise time, along with leg press and leg extension 1RM. Again, there were 
non-responders for each individual measure, but no single subject exhibited non-response in all measures.  
 
 
3. Should exercise non-response be a concern? 
 
 At this point, it appears that the individual variation in response to exercise is a normal and 
natural occurrence. This non-response has a statistical component, with the definition of non-response 
(Hecksteden et al., 2015), and the variables measured (Scharhag-Rosenberger et al., 2012), impacting 
whether an individual is labelled as a non-responder. However, at a population-wide level, by measuring 
only a few variables and labelling an individual as a non-responder, there is a risk of taking a reductionist 
approach to exercise. Exercise is commonly considered a “polypill”, exerting a plethora of positive 
benefits (Fiuza-Luces et al., 2013; Pareja-Galeano et al., 2015), and by focusing on a small number of 
measures of response, it is possible to miss the bigger picture; exercise works through so many different 
pathways and mechanisms, that the chances of an individual exhibiting no single biological benefit is 
highly unlikely. Additionally, exercise clearly exerts benefits above the physiological; reducing stress and 
improving mental health (Scully et al., 1998; Cooney et al., 2014), as well as serving as a social aid 
(Hanson & Jones, 2015).  
 
 Nevertheless, some physiological measures appear to be more important than others. Timmons 
(2011) referred to this as an “hierarchy of health benefits”, with improvements in aerobic fitness likely to 
have a greater bearing on health (Blair et al., 1996) and longevity (Blair et al., 1989; Kodama et al., 2009) 
than other measures. As such, exercise non-response in these higher-tier aspects is clearly important, as 
maximising the responsiveness of larger numbers of individuals to exercise could drive important 
improvements in population health. Additionally, when it comes to those at risk of certain diseases, 
chasing a response in a specific variable may be important. For example, when aiming to reduce type-II 
diabetes risk in a cohort of at-risk individuals, reductions in fasting glucose and/or BMI are typically 
prioritised (Hu et al., 2004). In this case, non-response to critical variables, and the targeting of effective 
exercise interventions to overcome non-response, demands greater attention.  
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4. “Did not respond” – potential interventions 
 
 The measurable differences in the magnitude of adaptations following an exercise training 
programme, if clinically relevant, raise the question “what should be done about it?” Findings from a 
small number of studies provide potentially important information on how best to mitigate, and 
potentially eliminate, exercise non-response. The simplest approach would be to undertake the training 
programme for longer; Churchward-Venne and colleagues (2015) reported that the longer a resistance 
training intervention lasted, the less prevalent non-response was, and, after 24 weeks, all participants 
exhibited a positive response in at least one outcome measure. Sisson et al. (2009) demonstrated that the 
rate of non-response decreased as exercise volume increased, from 45% at 4 kcal/kg per week (the lowest 
volume) to 19% at 12 kcal/kg per week (the highest training volume). Similarly, Ross and colleagues 
(2015) randomly assigned obese participants to different exercise protocols over a 24-week intervention; 
low intensity, low volume exercise (180 – 300 kcal per session at 50% VO2peak); low intensity, high 
volume exercise (360 – 600 kcal per session at 50% VO2peak); or high volume, high intensity exercise 
(360 – 600 kcal per session at 75% VO2peak). On average, all groups increased their aerobic fitness, 
although there were a number of participants deemed to exhibit no response. Interestingly, there were no 
non-responders in the high intensity training group, demonstrating that increasing exercise intensity 
represents a viable method of reducing exercise non-response. Additionally, in the two low intensity 
training groups, the group undertaking higher total volumes had fewer non-responders (18%) compared to 
the group with the lower volume (39%). Furthermore, Astorino & Schubert (2014) reported that, 
following two weeks of low volume sprint interval training, the frequency of non-response was greater 
than following prolonged, high volume high-intensity training, again suggesting that exercise intensity is 
important. Finally, in a paper entitled “Refuting the myth of non-response to exercise training”, Montero 
and Lundby (2017) reported that exercise non-response is dose dependent, finding that it was more likely 
to occur in participants exercising 1-2 times per week than in those exercising 4-5 times per week; indeed, 
there were no non-responders in this latter group. Furthermore, when the individuals identified as non-
responders to the initial exercise intervention underwent a second intervention, identical to the first but 
with two additional weekly training sessions, there were no non-responders. As such, increasing exercise 
intensity and/or duration appear to be useful strategies for reducing, or perhaps even eliminating, exercise 
non-response.  
 
A further option for enhancing training outcomes is changing training modality. Because the 
molecular pathways and gene networks underpinning adaptations to aerobic and resistance exercise are 
distinct (Baar, 2009; Joseph et al., 2006; Canto et al., 2010; Timmons 2011; Egan et al., 2013), 
performing exercise types that an individual can more favorably adapt to holds promise. This has been 
illustrated by Hautala and colleagues (2006), whereby individuals termed non-responders following 
aerobic training enhanced their cardiovascular fitness following resistance training. Additionally, 
Bonafiglia and colleagues (2016) reported that non-response to either typical endurance training or sprint 
interval training was largely abated when participants undertook the other exercise intervention.  
 
 Finally, there remains the possibility that, as the magnitude of exercise response is partially 
governed by various molecular drivers (Timmons 2011), and as these drivers are partially genetically 
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determined (Bouchard et al., 2011; Bouchard 2012), the use of genetic information may assist in the 
selection of more individually-optimal training prescription (Pickering & Kiely, 2017a). The potential 
influence of genotype on training outcomes is an emerging, currently contentious field, with both early 
promise (Delmonico et al., 2007; Jones 2016) and null results (Charbonneau et al., 2010). As such, the 
utility of using genotype to guide training interventions requires further research.  
 
 
5. Summary—Do non-responders to exercise exist? 
 
 Based on available evidence, there is an individual variation in response to exercise (Bouchard 
& Rankinen, 2001; Hautala et al., 2005; Ahtiainen et al., 2016), with some participants experiencing 
larger improvements than others. This individual response is a combination of “true” and “false” 
variation, whereby “false” variation refers to both technical measurement error and random within-
subject biological variation (Atkinson & Batterham, 2015) and “true” variation to real, between subject 
differences, comprised of differences in both genotype and individual history, amongst other influencing 
factors (Mann et al., 2014; Pickering & Kiely, 2017a; Sparks, 2017). Within published studies, there are a 
sub-group of individuals whom appear to exhibit either no (Ahtiainen et al., 2016) or a negative response 
(Bouchard et al., 2012) to exercise training programmes. The extent to which this non-response is “true” 
or “false” within each study remains, currently, unclear; as is whether this non-response is static (i.e., the 
individual will always be a non-responder to that particular exercise training programme), or merely a 
temporary reflection of the adaptive capacity of specific individuals at a given time (i.e., the individual 
did not respond to that exercise training programme, but might if the intervention was repeated). 
Additionally, a crucial consideration is that exercise response is often determined by measurement of one, 
or at most a small number, of all the potential variables that can typically change with exercise. Thus, just 
because an individual does not improve their VO2max or 1RM with training, does not mean that they 
haven’t derived a multitude of other benefits from exercise, many of which, such as increased social 
interaction seen in community exercise settings (Hanson & Jones, 2015), are non-physiological in nature.  
 
 Furthermore, there is limited evidence that increasing the number of measured variables reduces, 
and likely even eliminates, the prevalence of “global” exercise non-response (Scharhag‐Rosenberger et 
al., 2012), such that it seems likely that no person exhibits absolutely no true benefit from exercise. 
Additionally, there is emerging evidence that the observed non-response to a single variable from a 
singular training intervention can be removed, either by increasing training volume, intensity, or duration 
(Sisson et al., 2009; Churchward-Venne et al., 2015; Ross et al., 2015; Montero & Lundby, 2017).  
 
 In summary, despite the eye-catching title of Montero and Lundby’s paper on “the myth of non-
response to exercise” when subjected to a standard exercise intervention, a small subgroup of individuals 
appear to exhibit no improvement in a given measured variable (indeed, in the initial phase of their study, 
there were some individuals who did exhibit no positive response to the training intervention). These 
individuals are commonly labelled as non-responders. However, by evaluating a greater number of 
variables, or by manipulating the training programme through alterations in intensity, frequency, or 
modality, it appears that all individuals have the potential to show improvements following exercise. 
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Researchers might, therefore, be better off stating that people “did not respond” to a particular 
intervention in a given measure, as opposed to labelling them as “non-responders”, because it seems 
likely that a different training programme (in terms of intensity, volume, duration, or modality) would 
elicit a positive response. This is similar to the ideas of Booth and Laye (2010), who believed the term 
“non-responder” should be replaced by “low sensitivity”; in this case, these low sensitivity individuals 
merely require increased volumes and/or intensity to drive a favourable response. Undoubtedly, this is a 
positive finding, given the wide ranging benefits of exercise on health and wellbeing; however, further 
research is required to identify the optimal way to align individuals to the training type most likely to 
elicit the greatest adaptations, especially given the limited time many people perceive they have available 
to exercise, along with concerns about the applicability of increased exercise intensities for all exercisers 
(Biddle & Batterham, 2015). Furthermore, future research should focus on predicting who will exhibit a 
lower response to exercise, so that they can be given an alternative, more efficacious training 
intervention. Such research has the potential to have a huge impact on the heath of populations, increasing 
the health and fitness of time poor individuals in a more effective manner.  
 
 
PART 2 - EXERCISE GENETICS: SEEKING CLARITY FROM NOISE 
 
1. Introduction 
 
Having discussed whether non-responders to exercise exist, a second issue emerging within 
contemporary exercise genetics research is that of signal and noise; are the associations found within 
studies true, or spurious? Unravelling the genetic underpinnings of exercise performance is currently a 
hot topic in sports science and medicine, which, although controversial (Webborn et al., 2015), has 
extensive potential implications. One such potential application is the use of genetic information to 
enhance exercise prescription, thereby positively influencing athletic performance and public health 
domains. Recent research suggests that this is both feasible and potentially beneficial (Timmons et al., 
2010; Jones et al., 2016). However, the effective use of genetic information often requires a clear 
understanding of the mechanism by which each reported single nucleotide polymorphism (SNP) mediates 
physical performance. One such problem area is that of genetic association studies, where a SNP or group 
of SNPs are associated with a trait, such as VO2max improvements. Whilst an association is suggestive, the 
question remains as to whether this association is potentially causative, or spurious. If spurious, then the 
subsequent conclusions and exercise prescription are potentially misleading. The following sections 
highlight some complexities evident within this realm, illustrating the need for further research.  
 
 
2. Association or causation? 
 
Within the HERITAGE Family Study, variation in CREB1 (rs2253206) was predictive of the 
heart-rate (HR) response to exercise (Rankinen et al., 2010). Specifically, the A allele was associated with 
a smaller reduction in HR during a sub-maximal exercise test following training, with the proposed 
mechanism relating to long-term cardiac memory. However, research in a separate cohort associated the 
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A allele with a greater exercise-induced temperature increase, contributing to a less pleasant subjective 
experience of exercise, potentially reducing motivation to train or carry out an aerobic test (Karoly et al.., 
2012). Accordingly, it is unclear whether HR-responsiveness was modified via biologically-mediated 
adaptations, or an increased perception of effort.   
 
Similarly, a SNP within COL5A1 (rs12722) has been linked to exercise-associated muscle 
cramps (EAMC), with the CC genotype associated with protection from EAMC during an ultra-marathon 
(O’Connell et al., 2013). However, CC genotypes also recorded significantly slower ultra-marathon times 
compared to TT genotypes (O’Connell et al., 2013). Does this genetic variation directly protect against 
EAMC, or, does it result in slower race times? This latter point is important; as EAMC is associated with 
increased neuromuscular fatigue (Bergeron 2008), is this what acts in a protective manner? Again, the 
biological impact of this SNP on EAMC isn’t clear, requiring more evidence before advice can be given.  
 
A final example is that of TTN, the gene which encodes for titin, a protein found within striated 
muscle cells. A SNP within this gene was found to affect maximal oxygen uptake response to exercise in 
HERITAGE (Rankinen et al., 2003), the proposed mechanism being that this variation affects the 
elasticity of cardiac muscle, impacting stroke volume (SV). This increase in SV enhances oxygen 
delivery to the muscles, improving aerobic fitness. However, the same SNP has been found to modify 
muscle fascicle length and marathon time in marathon runners (Stebbings et al., 2017). Here, the T allele 
is associated with shorter muscle fascicles, which is hypothesised to increase the efficiency of the running 
action. In this case, the SNP does not directly affect aerobic fitness, but running economy. Either or both 
proposed mechanisms may be correct, but greater certainty of the biological mechanism is required 
before training intervention advice can be given. 
 
 
3. Are these relationships consistent? 
 
In addition to resolving the biological mechanisms underpinning the impact of genetic variation 
on exercise, it is crucial to also consider whether these genetic associations are consistent over time and 
across different cohorts. As demonstrated in part one of this chapter, much is made of non-responders to 
exercise, and yet it’s not clear whether this non-response is consistent, or whether it is a one-time 
response to an intervention. In addition, it’s unclear whether SNPs associated with exercise response in 
sedentary individuals have similar effects in trained individuals. A SNP in ACSL1, rs6552828, had the 
strongest association with training-induced VO2max improvements in HERITAGE (Bouchard et al., 2011), 
a sedentary cohort. However, in an elite athlete cohort, there was no association between this SNP and 
elite endurance status (a proxy of high VO2max) in Caucasians (Yvert et al., 2012) or Israelis (Ben-Zaken 
et al., 2018). No further ACSL1 replications exist. Does variation in ACSL1 impact exercise adaptation in 
all humans, or only the subset of humans who took part in HERITAGE? If HERITAGE were to be 
repeated with the same participants, would the ACSL and aerobic fitness association remain constant? 
Does this variation affect trained and untrained individuals to the same extent? Answers to these 
questions are needed before these SNPs should be used to modify the training process.  
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4. Effective utilisation  
 
Despite these issues, there are a number of SNPs in which the biological mechanisms are well 
understood. A common SNP in ACTN3, the gene that encodes for a-actinin-3, a protein found exclusively 
in fast-twitch muscle fibers, results in a premature stop codon. Individuals homozygous for this 
polymorphism are unable to produce the protein, and as a result tend to have fewer fast-twitch fibers 
(Vincent et al., 2007). This in turn affects the response to strength training (Delmonico et al., 2007). The 
utilisation of this information holds promise; a recent paper used this SNP in conjunction with fourteen 
others to enhance resistance training response (Jones et al., 2016), and evidence-based guidelines have 
been proposed (Kikuchi & Kakazato, 2015). These initial findings underscore both the effectiveness and 
utility of genetic information in informing training methodologies when the biological mechanism is well 
understood. 
 
 
5. Summary 
 
Research into the genetics of exercise adaptation is both exciting and promising. However, 
whilst genetic associations are interesting, their underpinning biological mechanisms must be understood 
before the information can be utilised in training programme design. As exemplified in the examples of 
CREB1, TTN and COL5A1, it may be that each SNP has multiple mechanisms, or the gene-trait 
association may be spurious, and hence misleading. Elucidation of this is crucial, and when it comes to 
interpreting the results of gene-association studies, practitioners should be mindful that association is not 
evidence of causation, with a host of confounders potentially skewing the findings. Perspectives on the 
promise of exercise genetics vary widely, with polarised extremes of staunch advocates and deniers. For 
the majority, the complex relationship between genotype and phenotype promotes a healthy skepticism; 
nevertheless, a total rejection of the potential utility of gene panels to categorise adaptive sub-types, given 
promising preliminary findings (Timmons et al., 2010; Delmonico et al., 2007; Kikuchi & Nakazato, 
2015; Jones et al., 2016), is premature. Beyond a formulaic statement of the obvious—that correlation is 
not causation—it seems wise to proceed cautiously, skeptically, but with an open mind as more evidence 
unfolds.  
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CHAPTER 4 – METHODOLOGY 
 
Chapter preface: 
 
As discussed within Chapters 2 and 3, there is considerable inter-individual variation in response 
to a stimulus. This was explored in detail with regards to the individual response to exercise, concluding 
that, in terms of the “true” biological variation between individuals who are subjected to an identical 
training programme, these differences can be thought of as either genetic, environmental, or epigenetic in 
nature. Estimates of the genetic component of individual response vary depending on the trait, but, on 
average, around 50% of the inter-individual variation in exercise response is thought to be driven by 
genetic variation. As the genetic component is both a large and fundamental modifier of the training 
response, there is the potential that knowledge of an individual’s genetic make-up may aid in training 
programme design. The aim of this thesis is to explore this from the perspective of elite sport, and this 
chapter will explain the methodologies utilised to achieve this aim.  
 
 
1. A brief history of sports genetics research – from twins, to candidate gene association 
studies, to GWAS. 
 
Research into the realm of the genetic underpinnings of exercise initially focused on a 
combination of family and twin studies. Twins are a useful proposition for genetics research, because 
monozygotic (MZ) twins have (essentially) identical genotypes, whilst dizygotic (DZ) twins share only 
half of their DNA in common. As a result, it is possible to collect information on a trait, and compare the 
between twin-pair variation for both MZ and DZ twins. By dividing the difference of the variance 
between DZ and MZ twins by the variance of DZ twins, it is possible to determine the heritability 
estimate (h2) of that trait (Wang et al., 2013). Such an approach was utilised in the early days of sports 
genetics research with an aim to determine the heritability of VO2max (Williamson et al., 2017). 
Subsequent research utilising twin models determined the h2 of many traits, including the heritability of 
elite athlete status, which was estimated at 66% (De Moor et al., 2007). However, the often unrealistically 
high h2 value attributed to traits, such as 83% for muscle strength (Beunen & Thomis, 2004), lead to 
criticisms of this approach.  
 
Over the following years, improved gene sequencing ability, coupled with a lowering in cost of 
the process, lead to an increase in gene-association and candidate gene analysis studies. Here, researchers 
have a prior hypothesis that a specific genetic variant impacts a specific trait, and then test that 
hypothesis. Typically, this occurs through a case versus control analysis, whereby individuals with the 
phenotypic trait of interest are compared to individuals without that trait. For example, in order to 
determine whether gene X is associated with type-II diabetes, researchers would collect genetic 
information from a group of type-II diabetics, and compare the relative genotype frequencies for gene X 
in a normal, non-diabetic population. Such an approach is certainly valid, especially when there is a 
plausible underlying mechanism, although it does rely on the prior identification of potential candidate 
genes (Wang et al., 2013; Bouchard, 2015).  
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Due to the requirement for a prior understanding of which SNPs may be associated with a 
specific trait within gene-association studies, when it comes to attempting to identify novel genes 
associated with that trait, there has been a move towards Genome-Wide Association Studies (GWAS). 
Here, large numbers of SNPs (100,000+) are compared between cases and controls, allowing for an 
increased chance of the discovery of novel SNPs, given that such an approach is hypothesis free. 
However, as the many genetic variants underpinning a phenotype likely have a small effect size, and, due 
to the number of comparisons that are tested resulting in the genome-wide significance level of a p-value 
of <5 x 10-8, GWAS require very large cohorts. As such, the utility of GWAS when determining trait 
associations for relatively rare phenotypes, such as elite athlete status, is limited, given the low number of 
individuals with the required traits.  
 
 
2. Just how much utility does current sports genetics research bring? 
 
Based on evidence reviewed in Chapters 2 and 3, it’s clear that genetic variation has a role to 
play in a number of traits pertinent to elite sport. However, at present, it is not clear just how useful this 
information is to athletes and practitioners in its current format. Recently, Varley and colleagues (2018a) 
reported the results of a survey exploring the prevalence of genetic testing within elite sport in the UK, 
and the opinions of athletes and their support staff towards the use of such tests, which, given the on-
going debate around the use of genetic tests in sport (Webborn et al., 2015; Vlahovich et al., 2017a, 
2017b) was both timely and relevant. The results themselves were interesting, with almost all (97%) of 
the support staff and 79% of the athletes expressing the belief that genetics played some role in the 
development of elite athletes. Interestingly, whilst the majority of support staff (~72%) felt that genetic 
testing would be useful, and most athletes (~79%) would be willing to take such a test, the prevalence of 
genetic testing at this level was reportedly low (≤17%). As such, there appears to be a relative mis-match 
between the perceived utility of genetic testing in elite sport, and the actual uptake. The authors did not 
explore the underpinnings of this mis-match, which sensibly requires further research. 
One obvious potential explanation, however, is the perceived lack of evidence supporting the 
utility of genetic testing within elite sport contexts. At present, the majority of studies exploring the 
genetic influence on exercise tend to focus on explaining the variation, as opposed to attempting to utilise 
this information. For example, whilst it is well-supported that a polymorphism in ACTN3 has a well-
replicated effect on speed-power athlete status (Yang et al., 2003; Druzhevskaya et al., 2008; 
Papadimitriou et al., 2016) as well as modifying the response to a resistance training programme 
(Delmonico et al., 2007), so far only one study (Jones et al., 2016) has used information on participants’ 
ACTN3 genotype, as part of a panel of 15 SNPs, to guide training programme design. Similarly, whilst 
researchers have identified a number of SNPs associated with injury risk (Mokone et al., 2006; 
Posthumus et al., 2009a, 2009b, 2009c; Ficek et al., 2013), as of yet no genotype-based interventions 
have been made in an attempt to reduce the occurrence of injuries. 
 
Furthermore, at present the majority of the explanatory studies tend to focus on single SNPs. As 
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each SNP may only have a small effect size, the utility of such information is perhaps limited. As a result, 
a potential solution is to utilise Total Genotype Scores (TGS), which are explored in greater detail later in 
this chapter. Such an approach combines the results for a number of genetic variations into a single 
output, which should explain a greater amount of the variance than single SNP information does. 
 
3. Bridging the gap? 
 
  If a perceived lack of utility to genetic information in elite sport is preventing increased uptake 
of such information, then an important next step is for researchers to bridge this gap by supplementing 
more observational research, such as gene-association studies, with hypothesis-driven intervention 
studies. Such studies are needed to test the practical utility of genetic information, not just in elite sport, 
but across the spectrum of physical abilities and activity levels. There is scant research exploring the use 
of genetically guided interventions within sport, with only one study, to the present authors knowledge, 
taking such an approach (Jones et al., 2016). Although this research was well received (Monnerat-Cahli et 
al., 2017), the study utilised a commercially available test, and clearly it is appropriate that scientists and 
practitioners view research conducted by such commercial companies with a healthy scepticism. 
Nevertheless, it is important to be both pragmatic and open minded; if athletes and sports teams do 
engage in genetic testing, which most seem amenable to (Varley et al., 2018a), then potentially the most 
readily available avenue to pursue is via commercial products. This is particularly true for assessments 
screening for multiple SNPs associated with specific phenotypes, as is the case with TGS and genetic-
based algorithms. Given that both exercise response and injury risk—the most popular proposed avenues 
for the use of genetic information within sport—are polygenic traits, such approaches appear the most 
promising route forward. As such, by virtue of providing a testable product utilising TGS/genetic-based 
algorithms, direct-to-consumer (DTC) companies perhaps should form part of this evidence gathering 
process, either by partnering with more traditional research outlets, or by subjecting their own internal 
studies to the peer-review process. Such research partnerships have previously been utilised by 23andme, 
a DTC genetic testing company based in the U.S., which has explored the genetic basis of numerous 
pathologies (Chang et al., 2017; Ferreira et al., 2017). 
 
Interventional research, although necessary, can often be problematic, particularly in elite sport 
contexts. Genetics-based studies often require large numbers of participants to uncover genotype-
phenotype associations, and typically—and indeed by definition—there is a limited availability of elite 
athletes within any population. Similarly, sports practitioners and athletes arguably do not care about gene 
association studies conducted in non-elite cohorts, in which the environmental conditions, such as 
training history and lifestyle, are inevitably different than in elite athletes (Buchheit, 2017). To overcome 
such limitations within genetic intervention studies, researchers should perhaps place elite athletes into 
sub-groups based on their TGS, and treat each group as discrete from one another. Such an approach, 
whilst not perfect for genetics research, at least makes such intervention studies more practically viable 
with the subject numbers most commonly found in professional sports teams – and, indeed, is an 
approach common in sports science research.  
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4. The DNAFit test 
 
One potential issue with the use of a TGS is that of practicality; how does the user in the field—
the athlete, coach, or practitioner—develop a TGS for their use, and then collate that information? Doing 
so would be very difficult; many coaches and sports practitioners are not experts in genetics, and nor 
should they be. However, such a lack of expertise makes it difficult for them to develop an optimal TGS 
for their needs. Additionally, the collection of genetic information outside of universities, without relying 
on a commercial company to do so, is practically difficult. Fortunately, some commercial genetic testing 
companies utilise TGS in the reporting of their data, and, as discussed in section 3, the use of such 
commercial companies to undertake both genotyping and analysis represents a potential avenue for 
exploration. Commercial companies, by virtue of having the required technology and refined reporting 
techniques, have a testable product that may hold utility to those in the field; it is important, therefore, to 
test these products to determine if they have utility to athletes and their support staff. This is one of the 
undertakings of the present thesis, and the company providing genetic testing will be DNAFit Life 
Sciences (London, UK).  
DNAFit provide genetic testing services through different laboratories depending on the depth of 
data required. Both methods require the same method of DNA sample collection, which is via a sterile 
buccal swab. For smaller SNP (n=~50) analysis, the samples are sent to IDna Genetics Laboratory 
(Norwich, UK), where DNA is extracted and purified using the Isohelix Buccalyse DNA extraction kit 
BEK-50 (Kent, UK), and amplified through PCR on an ABI7900 real-time thermocycler (Applied 
Biosystem, Waltham, USA). For larger SNP (n=~700,000) analysis, the samples are sent to AKESOgen, 
Inc (Peachtree Corners, GA, USA), where DNA is extracted from the saliva samples using Qiagen 
chemistry on an automated Kingfisher FLEX instrument (Thermo Fisher Scientific, Waltham, MA, US), 
following the manufacturer’s recommended protocols and standard operating procedures. PicoGreen and 
Nanodrop measurements are taken to measure the quality and quantity of the DNA. Input to the custom 
testing array occurs at 200ng in 20µL. Amplification, fragmentation, and resuspension are performed 
using Biomek FXP following Affymetrix’s high throughput protocol for Axiom 2.0. Hybridisation is 
performed for 24 hours at 48°C in a Binder oven, and staining and scanning of the arrays are performed 
using GeneTitan instrumentation (Thermo Fisher Scientific, Waltham, MA, US), all following the same 
Affymetrix high throughput Axiom 2.0 protocol. Data analysis can then be performed using a raw CEL 
file data input into the Affymetrix Axiom Analysis Suite (Affymetrix, Santa Clara, CA, US).  
 
The reliability of each laboratory testing method is internally assessed via DNAFit. The 
company holds a number of anonymised genetic samples, which it sends to different laboratories. The 
results of each laboratories analysis are then compared to previous analysis, either from that laboratory or 
other laboratories, to check for anomalies. Both the IDna and AKESOgen methods have been well-tested 
using this methodology, with a number of different samples across different time points. The laboratories 
provide reliable results which are concordant with their previous analysis, and the analysis from other 
providers. As such, the genetic analysis provided by both methods is believed to be reliable and accurate.  
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Once the raw data is received from the respective laboratories by DNAFit, it is then populated 
into set reports through automated software. At the time of writing, DNAFit provide two major report 
categories; one for fitness, and one for diet. In selecting the SNPs to report on in each report, DNAFit 
require a minimum evidence threshold to be met. Each SNP should have a minimum of three peer-
reviewed studies, conducted on humans, showing a consensus as to the effect of that SNP. Finally, 
DNAFit specifically will not report on genetic variants that are considered to be related to a serious 
medical condition, such as cancer (e.g. BRCA genes and breast cancer [Miki et al., 1994]) or Alzheimer’s 
Disease (e.g. APOE4 [Sanan et al., 1994]).  
 
All of the fitness related traits are reported by utilising a Total Genotype Score (TGS). Of 
interest in this thesis will be the Aerobic Trainability and Recovery Speed TGS sections of the report, 
which are experimentally explored in Chapters 10 and 11. The use of TGS as opposed to the reporting of 
single SNPs has the potential to increase both the utility and accuracy of the information provided. Such 
an approach—termed a “polygenic profile”—was first utilised by Williams and Folland (2008). As 
individual polymorphisms only have a small impact on particular phenotypes, the authors suggested 
combining multiple polymorphisms into a total score in order to better understand how such 
polymorphisms may contribute to performance. Here, typically the most favourable performance 
genotype for each SNP was given a score of 2, with the least favourable genotype a score of 0. 
Heterozygotes (i.e. those with a favourable and unfavourable allele) were given a score of 1. The scores 
were then added, divided by the total possible score, and multiplied by 100 to get a percentage. As such, 
an individual with a TGS of 100 would have had a “perfect” polygenic score, whilst a score of 0 would 
represent the worst possible score. Other studies have taken a similar approach, both for exploring SNPs 
associated with elite athlete status (Ruiz et al., 2009; Santiago et al., 2010), the magnitude of post-
exercise muscle damage (Del Coso et al., 2018a), and, in a wider context, for disease prediction (Meigs et 
al., 2008; Dudbridge, 2013).  
 
For the Aerobic Trainability and Recovery Speed TGS sections of the commercially available 
DNAFit report, previous analysis (https://blog.dnafit.com/am-i-normal-aerobic-trainability and 
unpublished data by Pickering) has provided some information around the relative frequency of different 
outcomes. These relative frequencies were calculated from 17,000 customer samples collected from 
2013-2016, which were de-identified and analysed by the author as part of his employment. This 
information is referenced in Chapters 10 and 11 when placing the study results in context.  
 
 
5. Why use Total Genotype Scores? 
 
The use of TGS for the reporting of information to athletes, coaches and support staff holds 
some potential advantages. Most traits are polygenic in nature, meaning that a large number of genetic 
variants likely contribute to the observed phenotype. For example, when it comes to adaptations observed 
following resistance training, variation in genes across a number of adaptive pathways could modify the 
response (Timmons, 2011). This variation could be within the mTORC1 pathway, a molecular driver of 
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hypertrophy (Drummond et al., 2009; Timmons 2011), or within the number of available satellite cells 
(Petrella et al., 2008). Variation could occur on a structural level, such as in the type and relative 
proportions of muscle fibre, which may respond differently to imposed training loads (Fry, 2012). It 
could also be down to variations in anabolic hormone concentrations, such as testosterone (Basualto-
Alarcon et al., 2013), which again will modify the potential hypertrophic response. By focusing on just a 
single pathway, or, even more commonly, just a single gene, there is a likelihood of misunderstanding the 
complexities of adaptation. Furthermore, because exercise adaptation is a polygenic trait, an individual 
will almost certainly possess more favourable versions of some SNPs, and less favourable versions of 
others. By reporting individual SNPs, this can lead to confusion to the end-user. For example, some DTC 
genetic companies do report these SNPs individually; by uploading genetic data to one such company, an 
athlete may get the following advice; for SNP1 “would likely respond better to power-based training”; for 
SNP2 “would likely respond better to endurance-based training”; for SNP3 “would likely respond better 
to endurance-based training”, etc. As such, the athlete will be confused – which training type would they 
respond better to? A TGS can overcome this by combining the results into a single, hopefully usable, 
output for the person who needs to utilise the information.  
 
An example of the potential utility of a TGS, as opposed to single SNP reporting, was provided 
by Jones and colleagues (2016). Here, the authors gave 67 participants a DNA test, and determined their 
results for 15 SNPs thought to impact the response to power- or endurance-based training. A TGS was 
then calculated that balanced the scores for alleles thought to confer greater improvements from power- 
and endurance-based training, and reported as a balanced percentage. The participants were determined to 
be those who would respond more favorably to power (balanced percentage score of >50%) or endurance 
(balanced percentage score of <50%) based training. They were then randomised to receive either a 
genetically matched (i.e. those predicted to respond favourably to power-based training received power-
based training) or mismatched (i.e. those predicted to respond favourably to power-based training 
received endurance-based training) eight-week resistance training programme, with a pre- and post-
intervention testing session comprised of countermovement jump (CMJ) and Aero3 (maximum 3-minute 
cycle) tests. The results suggested that those undertaking genetically matched training saw much greater 
improvements than those following mismatched training.  
 
 
6. Methodology for thesis  
 
As discussed previously, one of the main challenges currently facing sports genetics research is 
the potential usability of the information gained from such tests. At present, the majority of the research 
appears to focus primarily on single gene-associations, although there have been recent papers utilising 
TGS to determine the magnitude of post-exercise muscle damage (Del Coso et al., 2017a, 2018a). 
Furthermore, there is a movement towards the utilisation of GWAS studies, generally seen as the gold 
standard in genetics research (Wang et al., 2013). However, whilst such studies help explain the 
differences between people, what they don’t do is provide usable information to practitioners and 
information in real-world terms. This is the main area for exploration in the present thesis; an attempt to 
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move away from explaining the differences between athletes, and towards being able to use that 
information as a method to enhance performance.  
 
In order to explore the use of genetic information in elite sport, my thesis is split into two main 
sections. Section 3, entitled “Joining the dots”, is a theoretical exploration of the potential use of genetic 
information within sport. This will be across multiple realms, including the use of caffeine as an 
ergogenic aid and the reduction of hamstring injuries, but all have the overarching goal of enhancing the 
performance of a given athlete. These chapters focus heavily on bringing together information gleaned 
from previous research, and attempting to make connections that have not previously been made. As 
such, the main methodological considerations for this section are the requirements for a thorough review 
of the literature. This will take place through structured literature review via established databases such as 
PubMed. Having reviewed and understood the underpinning evidence, the next section attempts to “join 
the dots” between genetics and performance, making suggestions for how this information could be used 
to enhance performance, and which directions future research will need to travel in order to enhance 
knowledge in this area.  
 
Section 4, entitled “Practical use of genetic information in sport”, is the section containing novel 
experimental data. Chapter 9 focuses on reporting the results of an internet-based questionnaire exploring 
the attitudes towards, and prevalence of, genetic testing in athletes, coaches, and support staff. The online 
questionnaire was comprised of a maximum of 44 potential questions, with participants directed towards 
specific questions based on their answers. The full questionnaire can be found in the appendix. The link 
to the online questionnaire was shared via social media accounts (both on Twitter and Facebook) in order 
to ensure maximal coverage. The questionnaire was anonymous in order to reduce any perceptions that 
the information could be used for marketing by DNAFit, which would represent a significant conflict of 
interest. Upon completion of the questionnaire, which ran for three months, the answers were collated 
into a database for qualitative analysis. Further in-depth methodological details are found in the chapter 
itself.  
 
Chapter 10 reports on the results of a study aimed at determining whether the use of a five SNP 
TGS could help identify those individuals likely to exhibit the greatest and smallest improvements 
following a standardised aerobic training programme. Here, 42 male soccer players aged 16-19 years 
volunteered for and gave informed consent to take part in the study, and provide genetic information. The 
players were from a convenience sample of a college soccer academy that had an agreement in place with 
DNAFit Life Sciences to conduct genetic testing. The sample size of 42 was chosen as it best represents 
the size of a typical soccer squad (first and reserve team), providing the real-world utility that the present 
thesis aimed to explore. The participants were well trained, with an average of 11 years’ playing 
experience. Both prior to, and immediately after, an eight-week aerobic training block, the players 
underwent an aerobic fitness assessment. The test utilised was the Yo-Yo Intermittent Recovery Test, 
Level 1 (Yo-Yo IR1), which has previously been shown to be both a reliable and valid measure of aerobic 
fitness (Krustrup et al., 2003). The aerobic training intervention was an eight-week block of two weekly 
training sessions primarily comprised of small sided games, which represent a sport specific method of 
enhancing aerobic fitness (Impellizzeri et al., 2006). Each session was comprised of four sets of four-
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minute exercise blocks, interspersed with three-minute recovery periods. Genetic information was 
determined via the IDna method detailed above, and genetic information was determined for five SNPs; 
PPARGC1A (rs8192678), VEGF (rs2010963), ADRB2 (rs1042713 and rs1042714), and CRP (rs1205). 
These SNPs were chosen as they fulfilled the DNAFit inclusion criteria, and the scores on each were 
combined in a weighted algorithm format to create a TGS. Such a process has been used in previous 
studies (Ruiz et al., 2009; Meckel et al., 2014; Jones et al., 2016). Based on their TGS, participants were 
then stratified into three groups; “low”, “medium”, and “high”, with the higher score indicating the 
possession of a greater number of SNPs considered favorable for adaptation. In terms of statistical 
analysis, a mixed methods ANOVA was run to determine group changes in Yo-Yo score, with individual 
t-tests used to determine differences between groups. Effect sizes (Cohen’s d) were also calculated for 
both within- and between-group differences. Full methodological details are contained within Chapter 10.  
 
Chapter 11 focuses on a study exploring the impact of genetic information on determining the 
recovery speed of individual athletes. Here, 18 male soccer players aged 16-19 years of age underwent a 
repeated sprint session of two sets of seven 25m sprints, with 30 seconds recovery between sprint reps, 
and 5 minutes recovery between sets. Immediately prior to, immediately upon completion, and at 24 and 
48 hours following the repeated sprint session, the participants underwent countermovement jump (CMJ) 
testing as a measure of neuromuscular fatigue. The CMJ has previously been shown to be a reliable and 
valid measure of such fatigue (Cormack et al., 2008a, 2008b, 2008c; McLean et al., 2010; Gathercole et 
al., 2015), and is widely used within sporting settings (Taylor et al., 2012). At each time point, the 
participants underwent three CMJ trials, separated by two minutes recovery. The score of the trials were 
averaged to give a mean score. As per Chapter 10, genetic testing was conducted utilising the IDna 
method outlined earlier. Genetic information was determined for seven genetic variants thought to 
influence post-exercise recovery speed; CRP (rs1205), GSTM1 & GSTT1 INDEL, IL-6 -G174C 
(rs1800795), IL-6R (rs2228145), SOD2 (rs4880), TNF G-308A (rs1800629). Using a proprietary 
algorithm from DNAFit Life Sciences, the participants genetic results were applied to a weighted TGS, 
and, based on the results of this TGS, participants were assigned to “slow”, “medium”, or “fast” recovery 
speeds. Such a method has been previously utilised in published research on exercise-induced muscle 
damage (Del Coso et al., 2017a; 2018a) and physical performance (Ruiz et al., 2009; Meckel et al., 2014; 
Jones et al., 2016). Given the small sample size of this cohort, and given that typical null hypothesis 
significance testing is sensitive to such small sample sizes (Buchheit 2016), only effect sizes (Cohen’s d) 
were calculated for difference between the groups at all three post-training time points. Full 
methodological details of this study are contained in Chapter 11.  
 
Chapter 12 reports on the extended genotype data of a number of elite athletes, including an 
Olympic Champion, an Olympic Medallist, and a World Championship medallist. Here, participants were 
contacted to determine their interest in taking part in such a study, giving informed consent and providing 
a DNA sample. In this case, the DNA was analysed via the Akesogen method detailed above, allowing 
for a richer data set of up to 700,000 SNPs to be determined. Such a richer data set allows for deeper 
analysis than in currently commercially available from DNAFit Life Sciences via the IDna method, and 
was required in order to explore a greater number of SNPs that may contribute to performance. For each 
athlete, their genetic results were then compared to a number of established markers for elite athlete 
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status, primarily derived from two recent review articles (Ahmetov & Fedotovskaya 2015; Ahmetov & 
Egorova, 2016). These results were then compared to a control population, in order to discover whether 
the athletes represented genetic outliers in terms of their TGS, which is what would be required to use 
genetic information to identify future talented performers. Full methodological details of this study are 
contained in Chapter 12.  
 
Following these two sections, in which the use of genetic information in sport will be both 
discussed and experimentally explored, there will be a final section. This section contains a discussion 
around the wider, public-health related aspects of exercise genomics, a chapter examining a personalised 
training framework, and a final chapter, which serves as a discussion of the findings of the thesis, 
culminating in gaining an answer to the question of “is there utility to genetic information in elite sport?”   
 
 
7. Summary 
 
As discussed in this section, over the years the exploration of genetics within sports and exercise 
has shifted from a gross, blunt tool in the form of twin studies, to the precise use of single SNP 
association studies that test a specific hypothesis. More recently, as technology has evolved, there has 
been a shift towards Genome-Wide Association Studies (GWAS), which are used in the discovery of 
novel genotype-phenotype associations in a hypothesis-free approach. However, so far, the evidence base 
tends to be focused on the identification of genetic variants that help to explain the variation between 
people. Whilst such information is useful in enhancing the knowledge base, it is arguably less useful for 
people involved in the field; athletes, coaches, and support staff. Research suggests these individuals are 
amenable to utilising genetic information, but many have yet to do so (Varley et al., 2018a). The reasons 
for this are currently unknown, which is why they are explored in Chapter 9. However, one potential 
reason for the lack of utilisation of genetic information is that, in its present format, there is little evidence 
of its utility. Chapters 5-8 explore potential avenues for the use of genetic information to enhance the 
sports performance and preparation processes. Additionally, in order for genetic testing to become more 
useful to the people who will be using it, there is a need for an increased emphasis on multi-gene models, 
such as Total Genotype Scores, which combine the results of many genes into a single output. At present, 
the only way to gain such information outside of a university partnership is through commercial, Direct-
to-Consumer genetic testing companies. As such, a commercially available test, that has a number of TGS 
already developed, will be explored in Chapters 10 & 11. Finally, Chapter 12 applies a TGS to a small 
group of elite athletes, and compares their scores against a normal population, to determine whether their 
results could be used as a talent identification tool. As such, the totality of this work should represent the 
first steps towards a more effective utilisation of genetic information within sport.  
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SECTION 3 – JOINING THE DOTS: A THEORETICAL APPROACH TO THE UTILISATION 
OF GENETIC INFORMATION IN SPORT 
 
The content of this section draws on six previously published peer-reviewed papers, along with additional 
work. The published papers are: 
 
Pickering C, Kiely J. Are the current guidelines on caffeine use in sport optimal for everyone? Inter-
individual variation in caffeine ergogenicity, and a move towards personalised sports nutrition. Sports 
Med. 2018;48(1):7-16. 
 
Pickering C, Kiely J. ACTN3: More than just a gene for speed. Front Physiol. 2017;8:1080. 
 
Pickering C, Kiely J. Can the ability to adapt to exercise be considered a talent—and if so, can we test for 
it? Sports Med Open. 2017;3(1):43. 
 
Pickering C. Caffeine, CYP1A2 genotype, and sports performance: is timing important? Ir J Med Sci. 
2018; doi: 10.1007/s11845-018-1811-4 
 
Pickering C, Kiely J. Hamstring injury prevention: A role for genetic information? Med Hypotheses. 
2018;119:58-62. 
 
Pickering C, Kiely J, Grgic J, Lucia A, Del Coso J. Can genetic testing identify talent for sport? Genes. 
2019b;10(12):972. 
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CHAPTER 5 - ARE THE CURRENT GUIDELINES ON CAFFEINE USE IN SPORT OPTIMAL FOR 
EVERYONE? 
INTER-INDIVIDUAL VARIATION IN CAFFEINE ERGOGENICITY, AND A MOVE TOWARDS 
PERSONALISED SPORTS NUTRITION 
 
Chapter preface: 
 
Caffeine is a widely used ergogenic aid at all levels of sport. However, as discussed in the 
introduction to this thesis, there is considerable variation in how individuals respond to caffeine, both in 
terms of performance enhancement, and regarding issues such as sleep disturbances and anxiety. This 
chapter explores the evidence demonstrating the inter-individual variation in caffeine ergogenicity, as 
well as the underlying drivers of this variation. Building on this, it then provides a rationale for the future 
potential use of genetic information in the development of personalised caffeine guidelines within sport. 
This chapter draws on a paper published in Sports Medicine (Pickering & Kiely, 2018a), which was the 
first to review the observed inter-individual variation seen following caffeine ingestion, as well as the 
underlying causes of this variation.  
 
1. Introduction 
 
1,3,7-trimethylxanthine (caffeine) is one of the most widely used performance enhancing drugs. 
Between 1984 and 2004, caffeine was banned for in-competition use, although only at very high doses 
(12µg.ml-1). Nevertheless, this did not deter athletes, with research demonstrating that 74% of samples 
tested via the anti-doping process contained measurable levels of caffeine (Van Thuyne et al., 2006). 
Since the removal of the ban, caffeine use has remained consistent, with measurable levels found in 74% 
of samples between 2004 and 2008 (Del Coso et al., 2011), illustrating that the use of caffeine is 
widespread in athletic populations. 
 
The performance enhancing effects of caffeine have been known for over 100 years (Rivers & 
Webber, 1907), and it is now a well-established ergogenic aid, with performance-enhancing effects 
confirmed at meta-analysis level (Grgic et al., 2019). These ergogenic effects are present across a variety 
of exercise types, including aerobic and muscular endurance, anaerobic power, speed, and jumping 
performance (Burke, 2008; Glaister et al., 2008; Astorino & Roberson, 2010; Duncan et al., 2013; Da 
Silva et al., 2015; Polito et al., 2016; Grgic et al., 2018; Grgic et al., 2019; Grgic & Pickering, 2019), 
whereas its impact on maximum strength is less clear (Beck et al., 2006; Goldstein et al., 2010a; Eckerson 
et al., 2013). 
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Caffeine exerts its ergogenic effect via several different proposed mechanisms. Within the 
central nervous system (CNS), caffeine acts as a competitive adenosine receptor antagonist (Urry & 
Landolt, 2014), thereby reducing adenosine’s downregulation of arousal and nervous activity (Ribeiro & 
Sebastiao, 2010). Additionally, the binding of caffeine to adenosine receptors increases neurotransmitter 
release and muscle firing rates (Kalmar 2005). Caffeine also stimulates adrenaline secretion (Graham 
2001), alters substrate utilisation (Cruz et al., 2015), increases cellular ion release (Sokmen et al., 2008) 
and decreases pain perception (Laurent et al., 2000; Gonglach et al., 2016), all of which can improve 
exercise performance.  
 
Elevated caffeine concentrations appear in the bloodstream as quickly as 15 minutes post-
ingestion, peaking after about 60 minutes, with a 3-to-4-hour half-life (Graham 2001). Caffeine is 
primarily metabolised in the liver, almost exclusively by Cytochrome P450 enzymes, into paraxanthine, 
theophylline, and theobromine (Tang-Liu et al., 1999); these in turn may mediate some of caffeine’s 
performance enhancing effects (Graham 2001). There remains the possibility that caffeine metabolism 
also occurs with the Central Nervous System (CNS), although this has been primarily studied in animal 
models (Fredholm et al., 1999). There is also evidence of Cytochrome P450 expression and activity 
within the CNS, raising the possibility that localised CNS caffeine metabolism is partially mediated by 
these enzymes (Dutheil et al., 2010). However, overall the pharmacokinetics of caffeine metabolism 
within the human CNS are poorly understood at present.  
 
Typically, generalised guidelines recommend ingestion of 3-9 mg/kg of caffeine approximately 
60-minutes prior to exercise, and suggest there are no additional benefits associated with higher doses 
(Ganio et al., 2009; Goldstein et al., 2010b; Brooks et al., 2016). However, recent research has illustrated 
that ergogenic effects of caffeine can occur with a wide variety of caffeine doses and timings. For 
example, a recent review (Spriet 2014) focused on the effects of low doses of caffeine (< 3 mg/kg) on 
performance enhancement, finding that lower intakes of caffeine do tend to exert ergogenic effects. 
However, it isn’t clear whether these effects are equivalent to those seen with doses of 3 mg/kg or above. 
In relation to optimal timings of intake, Cox and colleagues (2002) illustrated that 6 mg/kg of caffeine 
consumed 60-minutes prior to exercise was no more effective than six doses of 1 mg/kg of caffeine 
spread throughout the exercise bout. Accordingly, at least in some longer duration athletic events, 
caffeine ingestion during the event may be advisable. The prevalent use of caffeine within sport, and the 
assumed universal applicability of these generalised caffeine guidelines, seem to suggest there is a 
standard, predictable response to caffeine across individuals. This chapter discusses why this is not the 
case, and illustrate that, in fact, there is considerable inter-individual variation in the ergogenic effects of 
caffeine ingestion. This chapter also identifies the various interacting causes underpinning this diversity 
in inter-individual response, and, finally, proposes potential research questions that, if answered, will 
facilitate the evolution of more personalised guidelines for caffeine use within sporting contexts.  
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2. Inter-subject variation in the response to caffeine 
 
Whilst caffeine’s ergogenic effects are clear, the research findings demonstrating these benefits 
are conventionally calculated using the mean cohort responses. Crucially, these mean responses are 
considered an accurate estimation of the likely responses of each individual within the group. Yet 
numerous studies over the course of the past two decades illustrate the extent of individual variation 
commonly occurring subsequent to introduced interventions. The magnitude of this inter-individual 
response is well demonstrated in studies investigating individual fitness adaptation responses to carefully 
controlled exercise interventions (Bouchard & Rankinen, 2001; Hubal et al., 2005; Mann et al., 2014). Is 
this also the case when it comes to the ergogenic effects of caffeine ingestion? 
 
A small number of papers provide some insight into this question, either by directly studying the 
inter-subject variability in response to caffeine, or by publishing individual subject data. Jenkins et al. 
(2008) compared the effects of low caffeine doses (1, 2, & 3 mg/kg) against placebo on a 15-minute 
maximum cycle in 13 cyclists. The main finding was that caffeine improved mean performance by 3.9% 
(2 mg/kg) and 2.9% (3 mg/kg) respectively versus placebo, with no improvements in the 1 mg/kg trial. 
This suggests that doses of 2 mg/kg and 3 mg/kg are ergogenic for endurance performance. However, 
inspection of the individual data demonstrates large inter-individual variation in these effects. Most 
participants exhibited large variations, with a performance decrement at some doses of caffeine, and 
performance enhancement at others. One subject, for example, did not demonstrate an ergogenic effect at 
any dose, whereas four participants found caffeine ergogenic at all doses. Similarly, in a randomised, 
cross-over trial design, Graham and Spriet (1991) put seven runners through treadmill and cycle 
ergometer exercise trials to exhaustion with either placebo or 9 mg/kg of caffeine. The caffeine dose 
significantly improved time to exhaustion for all participants, but there was a large variation in the 
magnitude of this effect, with performance in the caffeine trial lasting between 105-250% of the length of 
the placebo trial. Other studies support this variation in ergogenic response to caffeine supplementation, 
with some individuals showing large improvements, and others no, or even negative, effects of caffeine 
supplementation (Meyers & Cafarelli, 2005; Vanata et al., 2014; Guest et al., 2018).  
 
3. Why does this individual response exist? 
 
3.1 The genetics of individual variation in caffeine response 
 
As with other complex phenotypes, individual responses following caffeine ingestion are 
polygenic phenomena, mediated by multiple interacting genes (Bouchard et al., 2011; Timmons 2011). 
This doesn’t mean that it is impossible to determine the genetic drivers of individual differences, 
however. For example, habitual caffeine use is a highly complex trait, but genome-wide association 
studies have found single nucleotide polymorphisms (SNPs) associated with this behaviour (Cornelis et 
al., 2011). Such findings indicate that, whilst genetic differences cannot explain all the variation, they can 
at least explain some. The below section examines variation within two genes that may impact caffeine 
ergogenicity, including a discussion regarding the mechanisms underlying this variation. 
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3.1.1 CYP1A2 
 
The gene CYP1A2 encodes cytochrome P450 1A2, an enzyme responsible for up to 95% of all 
caffeine metabolism (Gu et al., 1992). A SNP within this gene, rs762551, affects the speed of caffeine 
metabolisation. AA homozygotes (“fast” metabolisers) tend to produce more of this enzyme, and 
therefore metabolise caffeine more quickly. Conversely, C allele carriers (“slow metabolisers”) tend to 
have slower caffeine clearance (Sachse et al., 1999). The effects of this SNP are most well-established in 
regard to health, with myocardial infarction and hypertension risk increased in slow metabolisers 
consuming moderate (3-4 cups) amounts of coffee, whilst fast metabolisers exhibit a protective effect of 
moderate coffee consumption (Cornelis et al., 2006; Palatini et al., 2009). 
 
These earlier medical studies prompted research into how the CYP1A2 polymorphism might 
modify the ergogenic effects of caffeine. Womack and colleagues (2012) put thirty-five trained male 
cyclists through two 40-km cycle time trials, following consumption of either 6 mg/kg of caffeine or 
placebo 60-minutes beforehand. There was a significant effect of CYP1A2 genotype on the ergogenic 
effects of caffeine, with AA genotypes (fast metabolisers; 4.9% improvement) seeing a significantly 
greater performance improvement than C allele carriers (slow metabolisers; 1.8% improvement). Within 
AA genotypes, caffeine improved performance by at least one minute for 15 out of 16 participants, whilst 
in C allele carriers only 10 of 19 participants saw an improvement greater than one minute. These 
findings allowed the authors to conclude that caffeine has a greater ergogenic effect for CYP1A2 AA 
genotypes than C allele carriers.  
 
Since this initial paper, a small number of subsequent studies have been published. The same 
group published a paper hampered by a lack of CC genotypes, putting 38 recreational cyclists through 
four 3-km time trials under different experimental conditions; placebo mouth rinse + placebo ingestion, 
placebo mouth rinse + caffeine ingestion, caffeine mouth rinse + placebo ingestion, and caffeine mouth 
rinse + caffeine ingestion (Pataky et al., 2015). Both AC (4.1%) and AA (3.4%) genotypes saw 
performance improvements in the combined caffeine mouth rinse and ingestion trial, but only AC (6%) 
genotypes saw a performance improvement in the caffeine ingestion trial. The conclusion was that AC 
genotypes saw greater performance enhancement with caffeine ingestion, in contrast to Womack and 
colleagues (2012). One potential confounder identified by Pataky and colleagues (2015) was the shorter 
exercise trial duration (~5 minutes) when compared to Womack et al. (2012). A second potential 
confounder is that Womack and colleagues (2012) utilised trained participants, whilst Pataky et al. (2015) 
did not. Exercise appears to increase CYP1A2 expression (Vistisen et al., 1992; Kochanska-Dziurowicz et 
al., 2015), such that trained and untrained individuals may metabolise caffeine differently. Algrain et al. 
(2006) reported no modifying effect of the CYP1A2 polymorphism on the ergogenic effects of caffeine; 
however, they noted the small subject number (n=20), the untrained status of these participants, and the 
lower caffeine dose (approximately 255 mg). Klein et al. (2012) and Salinero et al. (2017) found no effect 
of the CYP1A2 polymorphism on the effects of caffeine on tennis and Wingate test performance 
respectively, although with modest sample sizes (n=16 and 21).  
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More recent studies have been able to add some clarity to the potential impact of this 
polymorphism with CYP1A2 on the ergogenic effects on caffeine. In a study with by far the largest 
sample size yet, Guest and colleagues (2018) put 101 trained male participants through three 10-km cycle 
ergometer time trials with placebo, 2 mg/kg caffeine or 4 mg/kg caffeine. Whilst these caffeine doses 
exerted ergogenic effects in AA genotypes, leading to a 4.8% and 6.8% improvement at the 2 and 4 
mg/kg doses respectively, the ergogenic effects were not present in C allele carriers. The AC genotypes 
exhibited no performance improvements following caffeine ingestion, whilst for CC genotypes the 4 
mg/kg dose lead to a 13.7% increase in time trial performance, representing a significantly (p=0.04) 
ergolytic effect. Similarly, Rahimi (2018) recruited 30 resistance trained males to undertake two 
resistance training sessions, one with placebo and one with 6 mg/kg caffeine, in a randomised cross-over 
study design. For A allele carriers, the participants were able to carry out a greater number of repetitions 
following caffeine consumption, whilst caffeine had no such impact on C allele carriers.  
 
Finally, whilst this polymorphism may well have positive effects on physical performance, it’s 
not yet clear whether these improvements enhance team sport performance. Kingsley et al. (2017) 
examined the interaction of caffeine (3 mg/kg) and CYP1A2 genotype on a simulated soccer game, 
specifically exploring differences in sprint performance. Whilst individual differences in caffeine 
response were evident, CYP1A2 genotype did not explain this variation; potentially due to a lack of 
statistical power on account of the low subject numbers (n=10). Similarly, Puente et al., (2018) recruited 
19 elite male (n=10) and female basketball players and subjected them to a vertical jump and agility test, 
as well as a simulated basketball game, with no difference between the genotype groups in terms of match 
performance in the caffeine trial (dose = 3 mg/kg), although the caffeine itself was ergogenic.  
 
 At present, the initial Womack et al. (2012) paper has only recently been satisfactory replicated 
(Guest et al., 2012), with some subsequent published research finding no impact of the CYP1A2 
polymorphism (Algrain et al., 2016), or the opposite effect (Pataky et al., 2015). Many of these 
subsequent papers have, however, tended to employ small sample sizes, in untrained individuals, or void 
of CC genotypes, present in approximately 10% of the population (Sachse et al., 1999). Further work is 
required to determine the full effect of this polymorphism on the ergogenic effects of caffeine on 
exercise, and whether knowledge of CYP1A2 genotype can enhance performance.  
 
3.1.2 ADORA2A 
 
A SNP in the adenosine receptor gene ADORA2A, rs5751876, affects both habitual caffeine use 
(Cornelis et al., 2007) and sleep disturbances following caffeine use (Retey et al., 2007; Byrne et al., 
2012). Currently, only one pilot study has examined the effect of this SNP on the ergogenic effects of 
caffeine (Loy et al., 2015). Twelve female participants underwent a randomised, double-blinded 
crossover trial comprised of two 10-minute time trials following caffeine ingestion (5 mg/kg) or placebo. 
The TT homozygotes found caffeine ergogenic; the C allele carriers tended not to, with only one out of 
the six C allele carriers exhibiting an ergogenic effect. These participants habitually consumed no 
caffeine or only low doses of caffeine (<250 mg/day), so it’s not apparent how this might affect users 
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habituated to higher doses. Subsequent research is required to replicate these findings, including within 
habitual caffeine users.  
 
Single 
Nucleotide 
Polymorphism 
Study Design Sample 
Characteristics 
Caffeine 
Dose 
Measurement Primary 
Outcome 
CYP1A2 
(rs762551) 
Womack 
et al. 
(2012).  
Caffeine 
vs 
placebo 
36 male 
recreationally 
competitive 
cyclists 
6 mg/kg, 
60 
minutes 
prior.  
40km cycle 
time trial 
Caffeine 
reduced 40km 
time trial time 
vs placebo by a 
greater (p<0.05) 
magnitude in 
AA vs C allele 
carriers. 
Klein et 
al. 
(2012). 
Caffeine 
vs 
placebo 
16 Collegiate 
male (n = 8) and 
female (n = 8) 
tennis players 
6 mg/kg, 
60 
minutes 
prior 
Maximal 
treadmill 
exercise test, 
tennis skills 
test.  
No significant 
impact of 
polymorphism 
on caffeine 
ergogenicity. 
Pataky 
et al. 
(2015). 
Caffeine 
ingestion, 
placebo 
ingestion, 
caffeine 
mouth 
rinse, 
placebo 
mouth 
rinse.  
30 male (n = 25) 
and female (n = 
13) recreational 
cyclists 
6 mg/kg, 
60 mins 
prior, 
along 
with 25 
mL of 
1.14% 
caffeine 
mouth 
rinse 
3km cycle time 
trial.  
Greater 
performance 
enhancement in 
AC vs AA in 
both caffeine 
ingestion and 
caffeine rinse 
trials (no CC 
genotypes 
present).  
Algrain 
et al. 
(2016). 
Caffeine 
gum vs 
placebo 
20 
recreationally 
active males (n 
= 13) and 
females (n = 7) 
300 mg 
caffeine 
gum, 10 
minutes 
prior.  
15-minute 
steady state 
cycle, 10 
minutes 
recovery, 15 
minute 
performance 
ride at 75% 
VO2max. 
No significant 
impact of 
polymorphism 
on caffeine 
ergogenicity. 
Salinero 
et al. 
(2017). 
Caffeine 
vs 
placebo 
21 
recreationally 
active males (n 
3 mg/kg  30 s Wingate 
Test.  
No significant 
impact of 
polymorphism 
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= 14) and 
females (n = 7) 
on caffeine 
ergogenicity. 
Guest et 
al., 
(2018). 
Caffeine 
vs 
placebo 
101 active 
males 
2 mg/kg 
& 4 
mg/kg 
10km cycle 
ergometer TT. 
Caffeine 
reduced 
performance at 
4 mg/kg for CC 
genotypes, but 
increased 
performance for 
AA genotypes.  
Rahimi 
(2018). 
Caffeine 
vs 
placebo 
30 resistance 
trained males.  
6 mg/kg 3 sets to failure 
over 5 
exercises. 
AA genotypes 
performed a 
greater number 
of repetitions 
with caffeine vs 
placebo; C 
allele carriers 
did not.  
Puente 
et al., 
(2018). 
Caffeine 
vs 
placebo 
19 (male = 10) 
elite basketball 
players.  
3 mg/kg Vertical jump, 
agility test, 
simulated 
match.  
AA genotype 
had a 
performance 
enhancement in 
the vertical 
jump test with 
caffeine, whilst 
C allele carriers 
did not. There 
were no 
genotype 
differences in 
the other tests.  
ADORA2A 
(rs5751876) 
Loy et 
al. 
(2015). 
Caffeine 
vs 
placebo 
12 females 5 mg/kg  20 min cycle at 
60% VO2max, 
followed by 10 
minute 
maximum 
cycle.  
Total work 
increased for 
time trial 
genotypes 
following 
caffeine 
ingestion vs 
placebo. There 
were no 
improvements 
in the caffeine 
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vs placebo trial 
for C allele 
carriers.  
 
Table 1 – Summary of published studies examining CYP1A2 and ADORA2A polymorphisms and the 
ergogenic effect of caffeine on performance.  
  
 
3.1.3 Potential mechanisms – A role for caffeine timing? 
 
It is clear that genetic factors exert a large influence on individual responses to caffeine 
ingestion, even if these genetic factors have not yet been well elucidated. The mechanisms through which 
this genetic variation modifies caffeine ergogenicity are also unclear; regarding CYP1A2, it is speculated 
it could be due to a more rapid accumulation of caffeine metabolites in AA genotypes, which are 
hypothesised to potentially have a greater ergogenic effect than caffeine itself (Womack et al., 2012). The 
mechanism proposed by Guest et al. (2018) is that, because C allele carriers metabolise caffeine at a 
slower rate than AA genotypes, they experience prolonged vasoconstriction, which is likely to be 
performance limiting in endurance events where the transfer of oxygen and nutrients to the working 
muscle is crucial. If either, or both, of these mechanisms are correct, then caffeine timing becomes 
important; it might not be that C allele carriers find caffeine less ergogenic, just that it requires longer for 
caffeine to be metabolised to its ergogenic metabolites. Given caffeine’s many different mechanisms of 
action, it’s likely each mechanism has polymorphisms that modify the ergogenic effects. For example, as 
caffeine reduces exercise induced pain (Gonglach et al., 2016), SNPs related to pain tolerance could 
modify this effect. Similarly, genetic variation in adenosine receptors (such as polymorphisms within 
ADORA2A) are similarly promising. In the pilot study carried out by Loy et al. (2015) there were a 
number of mechanisms proposed by the authors through which ADORA2A variation might affect caffeine 
ergogenicity, including enhanced motivation and motor unit recruitment in TT homozygotes. 
 
 3.1.4 Indirect impact of genetic variation on exercise performance 
 
Genetic variation also likely impacts exercise performance indirectly. Thomas et al. (2016) 
examined the modifying effects of the CYP1A2 polymorphism on recovery from exercise. Whilst overall 
there was no effect of the polymorphism on cardiac markers of recovery, there were significant 
differences in the square root of the mean of squared differences between successive R intervals 
(RMSSD) in heart rate variability monitoring. Similarly, polymorphisms within ADORA2A can 
predispose individuals to increased anxiety following caffeine ingestion (Alsene et al., 2003; Rogers et 
al., 2010). This is potentially of interest in individuals who suffer from pre- and within-competition 
anxiety, but also to individuals who may benefit from elevated levels of pre-competition arousal.  
ADORA2A polymorphisms are also associated with increased sleep disturbances following caffeine 
ingestion (Retey et al., 2007), which could affect individuals involved in evening competitions, or those 
involved in tightly spaced consecutive day competitions; here, sleep disturbances could negatively affect 
exercise recovery. 
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3.2 Environmental factors affecting caffeine response 
 
There are also a variety of different non-genetic factors that can affect caffeine ergogenicity, 
many of which are often controlled for in research. These include habitual use of caffeine, with habitual 
use assumed to potentially reduce the ergogenic effect of caffeine (Bangsbo et al., 1992; Bell & 
McLellan, 2002; Beaumont et al., 2016), although this finding is equivocal (Irwin et al., 2011; Goncalves 
et al., 2017); perhaps habitual users simply require higher doses of caffeine to maintain the ergogenic 
effect. Other non-genetic factors affect caffeine metabolisation speed, often by increasing cytochrome 
P450 activity. These include smoking (Parsons & Neims, 1978; Schrenk et al., 1998), dietary vegetable 
intake (Lampe et al., 2000), oral contraceptive use (Rietveld et al., 1984; Abernethy & Todd, 1985), 
pregnancy (Knutti et al., 1981), menstrual cycle stage (Lane et al., 1992), training status (Vistisen et al., 
1992; Kochanska-Dziurowicz et al., 2015) and hormone replacement therapy (Pollock et al., 1999). Other 
non-genetic, but controllable, factors affecting caffeine ergogenicity are related to the nature of caffeine 
ingestion, including caffeine dose (Graham & Spriet, 1995), source (Graham et al., 1998; Hodgson et al., 
2013; Higgins et al., 2016), age (Tallis et al., 2017), timing (Boyett et al., 2016), time of day (Mora-
Rodriguez et al., 2015, Boyett et al., 2016) and training status (LeBlanc et al., 1985; Collomp et al., 
1992).  
 
Finally, expectancy effects influence caffeine response. Saunders et al. (2016) put participants 
through time trials with either 6 mg/kg of caffeine, placebo or control (neither caffeine nor placebo). 
Correct identification of caffeine ingestion gave a greater relative performance enhancement than the 
overall caffeine trial. Similarly, the belief that caffeine had been ingested in the placebo trial lead to a 
likely beneficial effect, quantified via the magnitude-based inferences method. Correct identification of 
placebo lead to possibly harmful effects, with some participants showing a performance decrement 
compared to the control trial. This mirrors results of earlier research on expectancy effects and caffeine. 
For example, Beedie et al. (2006) showed that placebo caffeine ingestion improved endurance cycle 
performance in a dose-response manner, with higher placebo doses leading to greater performance 
improvements. Similarly, Pollo et al. (2008) demonstrated that belief of caffeine ingestion improved time 
to fatigue in a maximal quadriceps extension task. When participants are informed they have ingested 
caffeine, it appears to improve performance, even if they have been deceptively administered a placebo 
(Foad et al., 2008; Saunders et al., 2016). 
 
It is also important to consider that genetics also modify these environmental factors. For 
example, habitual caffeine use itself has a genetic underpinning (Josse et al., 2012), and certain genotypes 
appear to be more sensitive to the effects of placebo (Hall et al., 2015).  
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3.3 Epigenetic modifiers of caffeine response 
 
Epigenetics refers to changes in gene function that occur without a change in nucleotide 
sequence (Ling & Groop, 2009). Such changes can be heritable, but also modifiable over time within an 
individual (Moran & Pitsiladis, 2016). Caffeine use undoubtedly induces epigenetic modifications 
(Buscariollo et al., 2014; Ping et al., 2014; Wendler et al., 2014), and these epigenetic modifications can 
impact caffeine clearance by altering CYP1A2 activity (Hammons et al., 2001; Jin et al., 2004). However, 
it is not entirely clear how this might alter caffeine’s ergogenic effects. Long-term caffeine use potentially 
leads to habituation through both increased caffeine clearance—mediated by epigenetic modifications on 
cytochrome P450 genes (Hammons et al., 2001)—and a decrease of excitability caused by caffeine, 
possibly via inhibition of genes affecting the dopaminergic and adenosine pathways (Van Soeren et al., 
1993). Further research is required to establish the effects of epigenetics on the ergogenic effects of 
caffeine.   
 
 
3.4 “Non-responder” vs “Did not respond” 
 
Clearly, the individual response to caffeine is complex, and subject to genetic, non-genetic (i.e. 
environmental), and epigenetic influence. Given that both environmental and epigenetic influences are 
not stable across time, an individual’s response to caffeine will vary. A clear example of this is that of 
habituation, briefly discussed in section 3.2. In this context, regular use of caffeine may modify the 
ergogenic effects of caffeine at a particular dose. Beaumont et al. (2016) illustrated that regular intakes of 
3 mg/kg of caffeine daily attenuated the ergogenic effects of a pre-exercise dose of 3 mg/kg. Conversely, 
Goncalves et al. (2017) showed that habitual daily caffeine intakes of 350 mg/day were insufficient to 
reduce the ergogenic effects of 6 mg/kg of caffeine. This indicates that it is perhaps important that the 
pre-exercise caffeine dose exceeds the level of habitual intakes. So, whilst an individual might initially 
find a caffeine dose of 3 mg/kg ergogenic, if they then habitually consume 3 mg/kg of caffeine per day, 
this ergogenisis may be attenuated. As such, in an initial trial, the subject would be labelled as a caffeine 
“responder”, whilst in the subsequent trial, they would be labelled a “non-responder”. Such labels are 
becoming commonplace when reporting on inter-individual response to a stimulus. However, recent work 
(Montero & Lundby, 2017) indicates that non-response to exercise can be reduced by changing training 
variables. As discussed in depth in Chapter 3, based on the available research, it appears likely that the 
same is true for caffeine. As such, perhaps a more reflective characterisation would be to state that a 
subject “did not respond” to a particular intervention, as opposed to labelling them a “non-responder” 
(Betts & Gonzalez, 2016; Pickering & Kiely, 2018b), as this non-response may not occur were the 
intervention to be repeated and/or modified. 
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4. Conclusions – what next? 
 
Academic studies have repeatedly demonstrated a performance enhancing effect of caffeine 
ingestion (Graham 2001; Burke 2008; Glaister et al., 2008; Astorino & Roberson, 2010). Yet, 
simultaneously, this ergogenic response shows considerable inter-individual variation (Graham & Spriet, 
1991; Jenkins et al., 2008). This variation occurs via numerous factors, many of which are influenced by 
genetic predispositions (Womack et al., 2012; Loy et al., 2015). Although these individual responses are 
undoubtedly complex and subject to various modifying factors, the possibility remains that practitioners 
can glean sufficient partial insights to personalise caffeine intake. Polymorphisms in genes affecting 
caffeine metabolisation speed (CYP1A2) (Womack et al., 2012; Guest et al., 2018) and nervous system 
excitability (ADORA2A) (Loy et al., 2015) appear to directly modify the ergogenic effects of caffeine. 
Given the number of mechanisms through which caffeine appears to exert its action, it could be 
speculated that a variety of other polymorphisms will also have a contributing role. Recent developments 
in genetic profiling technology and more widespread access to, and affordability of, such technology 
raises the possibility that such insights may soon be readily available to sporting populations. This 
information could potentially be paired with knowledge of individual variation in other factors, such as 
circadian rhythm (Mora-Rodriguez et al., 2015; Boyett et al., 2016), habitual caffeine use (Bangsbo et al., 
1992; Bell & McLellan, 2002; Beaumont et al., 2016), medication intake (Rietveld et al., 1984; 
Abernethy & Todd, 1985), and expectancy (Beedie et al., 2006; Pollo et al., 2008; Saunders et al., 2016), 
all of which also affect the magnitude of performance enhancement seen after caffeine ingestion. 
 
These individualised caffeine guidelines could also vary depending on the timing and 
importance of the competition. Given that genetic variation can modify sleep disturbances after caffeine 
ingestion (Retey et al., 2007), individuals more likely to suffer from these disturbances might consume 
less caffeine for an evening competition than a morning competition. This would be especially important 
if there were a number of competitions in close proximity, whereby reduced recovery following initial 
caffeine dose may impact subsequent exercise performance. Genetic variation can also impact feelings of 
anxiety following caffeine ingestion (Alsene et al., 2003; Rogers et al., 2010). This creates the possibility 
that certain genotypes should consume less caffeine for competitions where anxiety is likely to be higher, 
such as the Olympic Games or World Cup final, and more for competitions where anxiety will be lower, 
such as a league match. Figure 5 below details some of the potential recommendations that could be made 
based on an individual’s genotype in the future.  
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Figure 5 – Genetic and non-genetic factors influencing caffeine ingestion decisions. Working from the 
top, the current best-practice guidelines are applied to different genotypes of genes identified to impact 
caffeine response. Based on the current evidence, genotype-based guidelines are then produced. Finally, 
these genotype guidelines must then be interpreted in the context of non-genetic factors, such as habitual 
use, to create individualised caffeine guidelines. As CYP1A2 and ADORA2A polymorphisms haven’t yet 
been studied together, the potential interacting effects of these polymorphisms are currently unknown. 
Finally, the recommendations themselves are somewhat speculative, and further research is required to 
elucidate best practice in this area.  
 
 
The above discussion drives an interesting situation; whilst caffeine is ergogenic, the current 
generalised guidelines of 3-9 mg/kg, 60-mins prior (Ganio et al., 2009; Goldstein et al., 2010b; Brooks et 
al., 2016) are clearly not optimal for everyone. What is not clear, however, is what these guidelines 
should be. Being able to develop more precise, individualised guidelines would be beneficial, especially 
given the prevalent use of caffeine in elite sports. To enhance the advice given to athletes regarding 
caffeine use, a number of different questions will need to be answered: 
 
1. Can the existing research on CYP1A2 and ADORA2A be replicated, and can other genes that 
modify caffeine ergogenicity be identified? 
2. Are there different optimal dosages and timing strategies for different genotypes? 
3. Does caffeine habituation occur differently across genotypes? 
4. Does the individual’s sex further alter the modifying aspect of genotype on caffeine 
ergogenicity? 
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Furthermore, if the proposed mechanisms regarding how the CYP1A2 polymorphism affects caffeine 
ergogenicity are indeed correct (section 3.1.3), then there remains the possibility that caffeine can still be 
ergogenic for C allele carriers, but that such individuals need to consume it a greater amount of time prior 
to exercise. In the majority of studies exploring the ergogenic effects of caffeine, it is consumed ~60 
minutes pre-exercise. However, for C allele carriers, could the ergogenic effects of caffeine be restored by 
utilising a caffeine dose 90- or 120-minutes pre-exercise? Such a hypothesis is, of course, speculative, 
and requires testing—but it does represent a potential way by which caffeine can indeed be ergogenic for 
all. The resolution of whether caffeine is truly ergolytic or neutral for CYP1A2 C allele carriers, or if it 
merely necessitates a different caffeine strategy, represents an important step on the journey towards 
more personalised sports nutrition guidelines. By answering this, and the above, questions and creating 
personalised caffeine guidelines, athletes will be able to fully maximise the performance enhancing 
effects of caffeine in a way that is matched to their unique biology. In addition, the awareness from 
coaches and athletes that sizeable variation exists in the response to caffeine ingestion may encourage 
them to be more experimental and flexible in the evolution of their caffeine strategies.  
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CHAPTER 6 – ACTN3: MORE THAN JUST A GENE FOR SPEED 
 
Chapter preface: 
 
 ACTN3 is the most well-research gene in terms of sports performance, and a common SNP within it 
is strongly associated with elite speed-power status. As such, this gene has often been referred to as a 
“gene for speed” (MacArthur & North, 2004; Chan 2008; Berman & North 2010). However, recent 
research suggests that this SNP has the potential to modify other aspects of performance, such as exercise 
adaptation, post-exercise recovery, and injury risk. As such, the purpose of this chapter is to present 
evidence of a modifying effect of ACTN3 on these dimensions of sports performance, suggesting that 
knowledge of ACTN3 genotype might be useful within a sporting setting. This chapter was published as a 
paper in Frontiers in Physiology (Pickering & Kiely, 2017d), and was the first review article to explore 
ACTN3 beyond the realm of its association with elite athlete status.  
 
 
1. Introduction 
 
ACTN3 is a gene that encodes for a-actinin-3, a protein expressed only in type-II muscle fibres 
(North et al., 1999). A common polymorphism in this gene is R577X (rs1815739), where a C-to-T base 
substitution results in the transformation of an arginine base (R) to a premature stop codon (X). X allele 
homozygotes are deficient in the a-actinin-3 protein, which is associated with a lower fast-twitch fibre 
percentage (Vincent et al., 2007), but does not result in disease (MacArthur & North, 2004). The XX 
genotype frequency differs across ethnic groups, with approximately 25% of Asians, 18% of Caucasians, 
11% of Ethiopians, 3% of Jamaican and US African Americans, and 1% of Kenyans and Nigerians 
possessing the XX genotype (Yang et al., 2007; MacArthur et al., 2008; Scott et al., 2010). ACTN3 
genotype is associated with speed and power phenotypes. Yang et al. (2003) reported that elite sprint 
athletes had significantly higher frequencies of the R allele than controls, a finding that has been 
replicated multiple times in speed, power, and strength athletes (Druzhevskaya et al., 2008; Roth et al., 
2008; Eynon et al., 2009c; Ahmetov et al., 2011; Cieszczyk et al., 2011; Kikuchi et al., 2016; 
Papadimitriou et al., 2016; Weyerstraß et al., 2017; Yang et al., 2017), although these findings are not 
unequivocal (Gineviciene et al., 2001; Scott et al., 2010; Sessa et al., 2011). Whilst Yang et al. (2003) 
found a trend towards an increased XX genotype frequency in endurance athletes versus controls, this 
relationship is less robust, with most studies reporting a lack of association between XX genotype and 
endurance performance (Lucia et al., 2006; Saunders et al., 2007; Doring et al., 2010b; Kikuchi et al., 
2016). In addition, whilst Kenyan and Ethiopian endurance runners are highly successful (Wilber & 
Pitsiladis, 2012), the frequency of the XX genotype within this group is very low at 8% (Ethiopian) and 
1% (Kenyan) (Yang et al., 2007). As such, the general consensus is that ACTN3 X allele likely does not 
modify elite endurance athlete status (Vancini et al., 2014).  
 
Much of the attention on ACTN3 has focused on the robust relationship with the R allele and 
strength/power phenotype, with a number of reviews further exploring this relationship (Eynon et al., 
2013; Ma et al., 2013; Ahmetov & Fedotovskaya 2015). Indeed, a number of papers have referenced 
 71 
ACTN3 as a "gene for speed" (MacArthur & North, 2004; Chan 2008; Berman & North 2010). However, 
emerging evidence suggests that this polymorphism may influence a number of other traits, including 
exercise recovery, injury risk, and training adaptation (Delmonico et al., 2007; Pimenta et al., 2012; 
Massidda et al., 2017). The purpose of this chapter is to further explore these potential relationships, as an 
increased understanding of the role played by ACTN3 on these traits may lead to improvements in the 
utilisation of genetic information in exercise training.  
 
 
2. ACTN3 as a modulator of training response 
 
Over the last twenty or so years, the consistent underlying impact of genetics on exercise 
adaptation has been well explored (Bouchard et al., 2011; Bouchard 2012). Whilst it is clear that genetic 
variation has an undoubted influence on both exercise performance (Guth & Roth, 2013) and adaptation 
(Mann et al., 2014), fewer studies examine the influence of individual single nucleotide polymorphisms 
(SNPs) (Delmonico et al., 2007), or a combination of SNPs (Jones et al., 2016), on this process. This sub-
section explores the evidence regarding the impact of ACTN3 on the post-exercise adaptive response.  
 
Following a structured literature search, five studies examining the influence of ACTN3 on 
exercise adaptation to a standardised training programme were found (table 2). Four of these studied 
resistance training (Clarkson et al., 2005b; Delmonico et al., 2007; Pereira et al., 2013; Erskine et al., 
2014), and one focused on aerobic training (Silva et al., 2015). An additional study (Magi et al., 2016), 
monitored changes in VO2peak over a five-year period in elite skiers, with no significant ACTN3 genotype 
differences. However, the exercise intervention in this study was not controlled (i.e. participants were 
undertaking differing training programmes in a real-world setting), and so it is not included within table 
2. There was considerable variation in the findings. For resistance training, two studies reported that the 
RR genotype was associated with the greatest increase in strength (Pereira et al., 2013) and power 
(Delmonico et al., 2007) following resistance training. One study reported no effect of ACTN3 genotype 
on training adaptations following resistance training (Erskine et al., 2014). Another reported greater 
improvement in one-repetition maximum (1RM) strength in X allele carriers compared to RR genotypes 
(Clarkson et al., 2005b). A further study utilised ACTN3 within a 15-SNP total genotype score (TGS), 
finding that individuals with a higher number of power alleles (such as ACTN3 R) exhibited greater 
improvements following high-intensity resistance training compared to low-intensity resistance training 
(Jones et al., 2016). However, because participants could have the ACTN3 XX genotype and still be 
classed as those who would best respond to high-intensity training (due to the possession of a higher 
number of alleles in other power-associated SNPs), this study is not included within table 2. 
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Study Method Sample Characteristics Main Outcome 
Clarkson et al. 
(2005b) 
12 weeks progressive 
resistance exercise 
training on non-
dominant arm. 
Progression from 3 
sets of 12 repetitions 
to 3 sets of 6 
repetitions, with 
concurrent increase in 
load.  
602 (355 females) aged 
18-40 (n=133 XX 
genotype. 
In females, the X allele 
was associated with 
greater absolute and 
relative improvements 
in 1RM vs RR 
genotypes.  
Pereira et al. (2013)  12-week high-speed 
power training 
programme. 
Progression from 3 
sets of 10 repetitions 
@ 40% 1RM to 3 sets 
of 4 repetitions @ 
75% 1RM.  
139 Older (mean = 
65.5y) Caucasian females 
(n=54 XX genotype). 
RR genotypes exhibited 
greater performance 
improvements (maximal 
strength, CMJ) 
compared to X allele 
carriers.  
Erskine et al. (2014) 9-week unilateral knee 
extension resistance 
training programme.  
51 previously untrained 
young males (n=7 XX 
genotype).  
Responses to resistance 
training were 
independent of ACTN3 
genotype.  
Silva et al. (2015) 18-week (3 sessions 
per week) endurance 
training programme, 
comprised primarily 
of 60-minutes 
running, individually 
controlled by heart 
rate monitor use.  
206 male Police recruits 
(n=33 XX genotype). 
At baseline, XX 
genotypes had greater 
VO2 measure scores 
than RR genotypes. 
Following training, this 
difference disappeared; 
i.e. RR had greater 
improvements than XX.  
Delmonico et al. 
(2007) 
10-week (3 session 
per week) unilateral 
knee extensor strength 
training comprised of 
4-5 sets of 10 
repetitions.  
155 (n=86 females) older 
(50-85y) participants 
(n=39 XX genotype).  
Change in absolute peak 
power greater in RR vs 
XX (p=0.07) for males. 
Relative peak power 
change greater in RR vs 
XX (p=0.02).  
 
Table 2 – Studies examining the interaction between ACTN3 genotype and exercise adaptation.  
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The variation between studies is likely due to heterogeneity at baseline between genotypes, and 
differences in exercise prescription. Given the prevalence of the R allele in elite speed-power and strength 
athletes (Yang et al., 2003, Vincent et al., 2007), it is speculatively considered that R allele carriers would 
respond best to speed-power and strength training (Kikuchi & Nakazato 2015). However, as illustrated 
here, there is perhaps a paucity of data to support this position. Nevertheless, there are some potential 
molecular mechanisms that could underpin this proposition. Norman et al. (2014) reported that 
mammalian target of rapamycin (mTOR) and p70S6k phosphorylation was greater in R allele carriers 
than XX genotypes following sprint exercise. Both mTOR and p70S6k regulate skeletal muscle 
hypertrophy (Bodine et al., 2001; Song et al., 2005), providing mechanistic support for the belief that 
hypertrophy, and hence strength and power improvements, should be greater in R allele carriers following 
resistance training. In addition, Ahmetov and colleagues (2014a) reported that testosterone levels were 
higher in male and female athletes with at least one R allele compared to XX genotypes. Whilst the 
direction of this association is not clear, it again supplies a possible mechanism explaining why R allele 
carriers may experience greater training-induced strength improvements.  
 
A single study examined the impact of this polymorphism on the magnitude of VO2 
improvements following endurance training (Silva et al., 2015). Here, VO2 scores at baseline were greater 
in XX genotypes, but following training this difference was eliminated, indicating that RR genotypes had 
a greater percentage improvement following training. The population in this cohort were police recruits. 
Given that the X allele is potentially associated with elite endurance athlete status (Yang et al., 2013), it is 
not clear whether these results would be mirrored in elite endurance athletes. Clearly, further work is 
required to fully understand what relationship, if any, exists between ACTN3 and improvements in 
aerobic capacity following training.  
 
 
3. ACTN3 as a modulator of post-exercise recovery 
 
ACTN3 R577X has also been associated with exercise-induced muscle damage; here, increased 
muscle damage will likely reduce speed of recovery, suggesting a potential modifying effect of this 
polymorphism on between-session recovery. Of the eight studies identified that examined the impact of 
this polymorphism on post-exercise muscle damage (table 3), six reported that that the X allele and/or the 
XX genotype was associated with higher levels of markers associated with muscle damage (Vincent et 
al., 2010; Djarova et al., 2011; Pimenta et al., 2012; Belli et al., 2017; Del Coso et al., 2017b; Del Coso et 
al., 2017c). One study found no effect of the polymorphism (Clarkson et al., 2005a), and one found that 
RR genotypes experienced a greater exercise-induced reduction in force compared to XX genotypes 
(Venckunas et al., 2012). An additional investigation (Del Coso et al., 2017a) examined the impact of 
ACTN3 as part of a TGS on creatine kinase (CK) response following a marathon race. Within this TGS, 
the R allele was considered protective against increased CK concentrations. The results indicated that 
those athletes with a higher TGS, and therefore greater genetic protection, had a lower CK response to the 
marathon. Whilst not direct evidence of the R allele’s protective effect, as it is possible that the other 
SNPs used in the TGS conveyed this effect, it nevertheless strengthens the supporting argument.  
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Study Method Sample Characteristics Main Outcome 
Pimenta et al. (2012) Eccentric-contraction 
based training session 
37 male professional 
soccer players based in 
Brazil. (n=9 XX 
genotype) 
Greater creatine kinase 
(CK) activity in XX 
genotypes vs RR  
Clarkson et al. 
(2005a) 
50 maximal eccentric 
contractions of the 
elbow flexor 
157 male (n=78) and 
female participants of 
various ethnicities 
(n=115 Caucasians; n=48 
XX genotype) 
No association of 
R577X with increases in 
CK and myoglobin 
(Mb) following 
eccentric exercise.  
Vincent et al. (2010) 4 x 20 maximal single 
leg eccentric knee 
extensions 
19 healthy young males 
(n=10 XX genotype) 
XX genotypes had 
greater peak CK activity 
post-training compared 
to RR genotypes, and 
reported greater 
increases in muscle 
pain.  
Venckunas et al. 
(2012) 
Two bouts of 50 drop 
jumps 
18 young males (n=9 XX 
genotype) 
RR showed greatest 
decrease in voluntary 
force, and slower 
recovery, compared to 
XX genotypes.  
Djarova et al. (2011) Resting blood sample 31 South African Zulu 
males (n=14 Cricketers 
and n=17 controls). No 
XX genotypes. 
R allele associated with 
lower CK levels (RR vs 
RX) 
Del Coso et al. 
(2017b).  
Marathon race, pre- & 
post-race Counter 
Movement Jump 
(CMJ).  
71 experienced runners 
(n=8 XX genotype). 
X allele carriers had 
higher CK and Mb 
levels post-race 
compared to RR 
homozygotes. X allele 
carriers also had a 
greater reduction in leg 
muscle power compared 
to RR genotypes.  
Del Coso et al. 
(2017c).  
Triathlon competition 
(1.9km swim, 75km 
cycle, 21.1km run), 
pre- & post-race CMJ. 
23 healthy, experienced 
triathletes (n=19 males, 
n=5 XX genotype). 
X allele carriers had a 
more pronounced jump 
height reduction 
compared to RR 
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genotypes. In X allele 
carriers, there was a 
tendency towards higher 
post-race Mb 
concentrations (P = 
0.10) and CK 
concentrations (P = 
0.06) compared to RR 
homozygotes.  
Belli et al. (2017)  37.1km adventure 
race (22.1km 
mountain biking, 
10.9km trekking, 
4.1km water trekking, 
30m rope course). 
20 well trained athletes 
(n=15 males; n=4 XX 
genotype). 
XX genotypes had 
higher concentrations of 
serum Mb, CK, lactate 
dehydrogenase (LDH) 
and AST compared to R 
allele carriers.  
 
Table 3 – Studies examining the interaction between ACTN3 genotype and exercise recovery 
 
The increase in post-exercise muscle damage in X allele carriers is likely due to structural 
changes associated with this polymorphism. Alpha-actinin-3 is expressed only in fast-twitch muscle 
fibres, and X allele homozygotes are a-actinin-3 deficient; instead, they upregulate production of a-
actinin-2 in these fast-twitch fibres (MacArthur et al., 2007; Seto et al., 2011a). Both a-actinin-3 
(encoded for by ACTN3) and a-actinin-2 are major structural components of the Z-disks within muscle 
fibres (Beggs et al., 1992). The Z-disk itself is vulnerable to injury during eccentric contractions (Friden 
& Lieber 2001), and knock-out mouse models illustrate these Z-disks are less stable during contraction 
with increased a-actinin-2 concentrations (Seto et al., 2011a). A number of the studies in table 3 
exclusively utilised eccentric contractions, whilst others focused on prolonged endurance events that 
include running, which incorporates eccentric contractions as part of the stretch shortening cycle with 
each stride (Komi 2000).  
 
The overall consensus of these studies is that the X allele, and/or the XX genotype, is associated 
with greater markers of muscle damage following exercise that has an eccentric component; either 
through direct eccentric muscle action (Vincent et al., 2010), from sport-specific training (Pimenta et al., 
2012), or from a competitive event requiring eccentric contractions (Del Coso et al., 2017b & 2017c, 
Belli et al., 2017). However, there are a number of weaknesses to these studies, potentially limiting the 
strength of these findings. The overall subject number is modest, with a total of 376 (mean 47) across all 
eight studies; indeed, the study with the greatest number of participants, Clarkson et al. (2005a), reported 
no modifying effect of this polymorphism on post-exercise muscle damage. The total number of XX 
genotypes was also low, with 85 reported across the studies. This is partly a function of the lower 
prevalence (~18%) of this genotype, but again the study with the largest number (n=48) of XX genotypes 
found no effect of this polymorphism (Clarkson et al, 2005a). It is clear that, in order to increase the 
robustness of this association, further investigations, with greater participant numbers, are required.  
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4. ACTN3 as a modulator of exercise-associated injury risk 
 
Six studies were found to examine the association between ACTN3 genotype and sports injury 
prevalence (table 4). Three of these examined ankle sprains (Kim et al, 2014; Shang et al., 2015; Qi et al., 
2016), with one each for non-contact injuries (Iwao-Koizumi et al., 2014), professional soccer players 
(Massidda et al., 2017), and exertional rhabdomyolysis (ER) (Deuster et al., 2013). Whilst ER is strongly 
related to increased CK following exercise (Clarkson & Ebbeling 1988; Brancaccio et al., 2010), because 
it requires medical treatment it was classified as an injury, and hence papers exploring ER are included 
here. Of these papers, five reported a protective effect of the R allele and/or the RR genotype against 
injury (Deuster et al., 2013; Kim et al., 2014; Shang et al., 2015; Qi et al. 2016; Massida et al., 2017). 
Specifically, Deuster and colleagues (2013) found that XX genotypes were almost three times more likely 
to be ER patients than R allele carriers. Qi et al. (2016) reported a significantly lower frequency of the RR 
genotype in a group of ankle sprain patients versus controls. Kim and colleagues (2014) found that XX 
genotypes were 4.7 times more likely to suffer an ankle injury than R allele carriers in their cohort of 
ballerinas. Shang et al. (2015) reported the R allele as significantly under-represented in a cohort of 
military recruits reporting ankle sprains. Finally, Massidda and colleagues (2017) demonstrated that XX 
genotypes were 2.6 times more likely to suffer a muscular injury than RR genotypes, and that these 
injuries were more likely to be of increased severity. Only one study (Iwao-Koizumi et al. 2014) reported 
that the R allele was associated with an increased risk (OR = 2.52) of a muscle injury compared to X 
allele carriers in a female cohort. 
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Study Method Sample Characteristics Main Outcome 
Iwao-Koizumi et al. 
(2014) 
Sports injury data 
survey 
99 female students (n=34 
XX genotype)  
R allele associated with an 
increased odds ratio (OR) 
of 2.52 of muscle injury 
compared to X allele.  
Deuster et al. (2013) Controls – lower body 
exercise test. 
Cases – anonymous 
blood or tissue sample 
collected after an 
exertional 
rhabdomyolysis (ER) 
incident.  
134 controls and 47 ER 
patients (n=38 XX 
genotype) 
XX genotypes 2.97 times 
more likely to be to ER 
cases compared to R allele 
carriers.  
Qi et al. (2016) Ankle sprain case-
control analysis 
100 patients with non-
acute ankle sprain vs 100 
healthy controls (n=89 
XX genotype) 
Significantly lower 
frequency of RR genotype 
in ankle sprain group 
compared to controls (p = 
0.001).  
Kim et al. (2014) Ankle injury case-
control analysis.  
97 elite ballerinas and 
203 normal female adults 
(n=65 XX genotype) 
XX genotypes 4.7 times 
more likely to suffer an 
ankle injury than R allele 
carriers.  
Shang et al. (2015) Ankle injury case-
control analysis. 
142 non-acute ankle 
sprain patients and 280 
physically active controls 
(n=87 XX genotype). All 
military recruits.  
RR genotype and R allele 
significantly under-
represented in the acute 
ankle injury group.  
Massidda et al. (2017) Case control, 
genotype-phenotype 
association study 
257 male professional 
Italian soccer players and 
265 non-athletic controls.  
XX players were 2.6 times 
more likely to suffer a 
sports injury than RR 
genotypes. Severe injuries 
were also more likely in X 
allele carriers compared to 
RR genotypes.  
 
Table 4 – Studies examining the interaction between ACTN3 genotype and sports injury.  
 
Regarding ER, the likely mechanism is similar to that discussed in the post-exercise muscle 
damage section; increased damage at the Z-disk during exercise. For ankle sprains, the mechanism is 
potentially related to muscle function. R allele carriers tend to have greater levels of muscle mass 
(MacArthur & North, 2007), and specifically type-II fibres (Vincent et al., 2007), indicating that both the 
RX and RR genotypes tend to have increased strength capabilities (Pimenta et al., 2013). For other soft-
 78 
tissue injury types, again, the decreased potential of damage at the Z-disk likely reduces injury risk. This 
would be particularly true for eccentric contractions; given the importance of this contraction type in the 
aetiology of hamstring injuries, this could be a further causative mechanism (Askling et al., 2003), 
alongside that of reduced muscle strength (Yamamoto 1993).   
 
Alongside the modifying role of ACTN3 on muscle strength and injury risk, emerging evidence 
suggests this SNP may also affect flexibility and muscle stiffness. Two studies reported an association 
between the RR genotype and a decreased flexibility score in the sit-and-reach test (Zempo et al., 2016; 
Kikuchi et al., 2017). Conversely, Kim et al. (2014) reported that XX genotypes had decreased flexibility 
in the same test. This lack of consensus is largely due to the small total study number, with greater clarity 
expected as research in the area evolves. It also mirrors the lack of consensus as to whether flexibility 
increases or decreases the risk of injury (Gleim & McHugh, 1997), indicating the complex, multifactorial 
nature of injuries and their development (Bahr & Holme, 2003).  
 
 In summary, it appears that the R allele of ACTN3 is somewhat protective against injuries. The 
mechanisms underpinning this are likely varied, and related to a combination of the modifying effects of 
this SNP on both strength (particularly eccentric strength), exercise-induced muscle damage, and 
flexibility.  
 
 
5. Discussion 
 
The results of this mini-review indicate that, aside from its established role in sporting 
performance, the ACTN3 R577X polymorphism also potentially modifies exercise adaption, exercise 
recovery, and exercise-associated injury risk. As this polymorphism directly influences both muscle 
structure and muscle fibre phenotype, this is perhaps unsurprising, and points to the potential use of 
knowledge of this polymorphism in the development of personalised training programmes. However, it is 
important to consider the limitations surrounding many of these studies. The subject numbers in the 
considered studies tended to be low, with large heterogeneity between study cohorts, ranging from 
untrained participants to professional sports people, as well as differences in sex. Both of these aspects 
likely affect the study findings; the effect of this polymorphism may be smaller in untrained individuals, 
for example, whereas in elite, well-trained athletes, who are likely closer to their genetic ceiling, the 
effect may be greater. The low subject numbers are troubling due to the relatively low XX genotype 
frequency, which is ~18% in Caucasian cohorts, and even lower in African and African-American 
cohorts. As such, XX genotypes are considerably under-represented across the research.  
 
The above limitations indicate further work is required to fully understand the impact of this 
polymorphism on these phenotypes. That said, there is some consistency between trials, allowing 
speculative guidelines to be developed for the use of genetic information in the development of 
personalised training. XX genotypes potentially have increased muscle damage following exercise that 
includes an eccentric component (Pimenta et al. 2012, Del Coso et al. 2017b+c, Belli et al. 2017). This 
information may, consequently, be used to guide between-session recovery, and during the competitive 
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season, recovery times post-competition. For example, in an elite soccer club, ACTN3 genotype could be 
utilised alongside other well-established markers to determine training intensity in the days following a 
match, with players genetically predisposed to increased muscle damage either having a longer recovery 
period, or an increased focus on recovery interventions such as cold-water immersion. In addition, recent 
research has illustrated the positive impact of Nordic Hamstring Exercises on hamstring injury risk (van 
der Horst et al., 2015), making these exercises increasingly common in professional sports teams. These 
exercises have a large eccentric component, upon which this polymorphism may have a direct effect. As 
such, it would be expected that XX genotypes would have increased muscle soreness and damage 
following these exercises, potentially affecting the timing of their use within a training programme. The 
potential for genetic information, including that of ACTN3, to inform hamstring injury prevention is 
further explored in Chapter 7. 
 
Focusing on sporting injuries, the general consensus from the studies found is that the X allele 
increased the risk of ankle injuries (Kim et al., 2014; Shang et al., 2015; Qi et al., 2016) and general 
sporting injury (Massidda et al., 2017). Again, this information could guide training interventions. In this 
case, X allele carriers might undertake increased general strengthening exercises and neuromuscular 
training targeting injury risk reduction. Furthermore, knowledge of this information could increase athlete 
motivation to undertake these exercises (Goodlin et al., 2015).  
 
Finally, maximising the training response is crucial, both to elite athletes looking to improve by 
fractions of a second, and to beginners looking to decrease their risk of disease. Increasingly, there is 
evidence that polymorphisms, including ACTN3 R577X, can modify this adaptive process (Delmonico et 
al., 2007; Pereira et al., 2013). If further research replicates these early findings, then again, this 
information could be used in the development of training programmes. Regarding ACTN3, at present it 
appears that R allele carriers potentially exhibit greater increases in strength and power following high-
load resistance training (Delmonico et al., 2007). As such, Kikuchi and Nakazato (2015) speculate that R 
allele carriers should prioritise high-load, low-repetition resistance training if improvements in muscle 
strength are required, and high intensity interval (HIT) training to specifically elicit improvements in 
VO2max.  
 
 
6. Conclusion 
 
There is a clear, undoubted effect of genetic variation on both sporting performance and exercise 
adaptation. In this regard, one of the most well-studied genes is ACTN3, variation in which has been 
reliably shown to impact speed-power and strength phenotypes. However, emerging research indicates 
that this polymorphism may also affect other exercise associated variables, including training adaptation, 
post-exercise recovery, and exercise-associated injuries; this research is summarised in figure 6 below. 
This information is important, not just because it illustrates the wide-ranging impact SNPs can have, but 
also because it represents an opportunity to personalise, and therefore enhance, training guidelines. At 
present, there are no best-practice guidelines pertaining to the use of genetic information in both elite 
sport and the general public. However, sports teams have been using genetic information for over ten 
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years (Dennis 2005), and continue to do so. Consequently, the development of these guidelines represents 
an important step from lab to practice. Clearly, further research is required to fully develop these 
guidelines, and at present such information is speculative. Nevertheless, the use of genetic information 
represents an opportunity to enhance training prescription and outcomes in exercisers of all abilities.  
 
 
 
Figure 6 – A summary of the potential wider implications of ACTN3 genotype on outcomes from 
exercise.   
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CHAPTER 7 - GENES, HAMSTRING INJURY, AND THE RESPONSE TO ECCENTRIC 
TRAINING  
 
Chapter preface: 
 
Hamstring injuries are prevalent within a diverse range of sports, and yet a plethora of research 
suggests that it should be reasonably easy to reduce their occurrence (Brukner 2015). In recent years, 
there has been an increased focus on the prevention of hamstring injuries within sport, with an emphasis 
on increasing the hamstring muscle’s fascicle length and strength capabilities through eccentric loading. 
However, even with both this increased attention and evidence of the effectiveness of various 
interventions, hamstring injuries haven’t declined appreciably within elite sport. One often cited reason 
for this lack of eccentric loading uptake and adherence is that of increased muscle soreness following 
eccentric loading, which, in the context of weekly competitions, often comes at a recovery cost. This 
chapter, which was published in Medical Hypotheses (Pickering & Kiely, 2018c), reviews the evidence of 
a genetic influence on the risk of hamstring injury, as well as both the adaptive and acute damage 
response to eccentric training bouts. Such information may better inform hamstring injury prevention 
techniques, which, given the current interest in this field, has the potential to be highly impactful.  
 
 
1. Introduction 
 
During the 2016/17 football season, there were 614 significant injuries recorded amongst the 
players of the twenty English Premier League clubs. These injuries resulted in a loss of over 20,000 
training days, with the associated costs imposed in terms solely of injured player’s wages exceeding £131 
million. Over the course of this season, the most frequently injured site was the hamstring muscle group, 
representing 27% of all injuries suffered (Coates 2017). The ubiquity of hamstring strain injury (HSI) is 
not unique to soccer, and HSIs typically represent the most prevalent form of non-contact injury within 
competitive athletics (Edouard et al., 2016), American Football (Elliot et al., 2011), rugby union (Brooks 
et al., 2006), cricket (Orchard et al., 2002a), Australian Rules Football (Orchard et al., 2002b), and 
basketball (Meeuwisse et al., 2003). Alongside the substantial financial implications, HSIs also exert a 
large time-cost, with average recovery times ranging from 8 to 73 days depending on injury severity 
(Ekstrand et al., 2012). Furthermore, the unavailability of squad members due to injury diminishes team 
performance. As an illustration, in an eleven-season study of 24 European soccer clubs, lower injury 
prevalence was associated with a greater number of points gained per match, and a higher final league 
ranking (Hagglund et al., 2013). Perhaps most insidiously, prior HSI serves to increase the risk of further 
HSI (van Beijsterveldt et al., 2013), other injuries (Opar & Serpell, 2017), and future performance 
potential (Røksund et al., 2017).  Consequently, avoiding, or at least reducing, HSI is a crucial 
consideration for many sports performance staff.  
 
Although HSIs occur at varied locations within the muscle-tendon unit (MTU), the majority of 
injury mechanisms may be categorised within two broad classifications (Askling 2011). Firstly, and most 
commonly, HSIs occur during the late swing phase of high-speed running (Woods et al., 2004; Petersen 
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& Holmich, 2005), as the rapid and forceful deceleration of the lower leg severely increases hamstring 
tension (Petersen & Holmich, 2005, Chumanov et al., 2011). Such high-speed injuries tend to be located 
in the proximal portion of the MTU (Askling 2011). Conventionally, it is assumed that hamstring muscle 
fibres act eccentrically during this breaking action (Chumanov et al., 2011), as well as during the stance 
phase (Yu et al., 2008). This perspective, however, has recently been challenged, with an argument 
suggesting that the hamstring muscle fibres act isometrically during the swing phase (Van Hooren & 
Bosch, 2017). The other main provocative action occurs when the hamstring MTU is suddenly 
lengthened, for example during kicking, sliding, or sagittal splits activities (Askling 2011). 
 
Given both the high frequency and associated costs of HSI, it is unsurprising that, in both 
academic and practical contexts much effort has been dedicated to answering two currently contentious, 
unresolved, and critical questions: 
i) Is it possible to identify players most at risk of HSI? (Ruddy et al., 2017) 
ii) What are the optimal physical training interventions to most productively enhance 
hamstring resilience?  (Bourne et al., 2018) 
 
In relation to screening for HSI risk, although some anatomical and historical features—such as 
age, (Ruddy et al., 2017), low levels of eccentric strength (Ruddy et al., 2017), muscle fascicle length 
(Timmins et al., 2016) and previous injury history (Gabbe et al., 2005)—have been associated with 
likelihood of HSI occurrence, developing tests with true predictive value has proven problematic (Bahr 
2016). Similarly, given the assumed role of eccentric contractions in HSI aetiology, over a decade of 
empirical evidence supports the notion that the capacity to tolerate high forces during an increase in 
muscle length is an important aspect of HSI prevention (Bourne et al., 2018). These findings have led to 
the popularisation of exercises such as the Nordic hamstring exercise (NHE) (Al Attar et al., 2017) and 
Yo-Yo hamstring curl (Askling et al., 2003). Utilisation of these eccentric loading exercises has been 
shown to be effective in reducing the prevalence of HSI in athletic populations (Askling et al., 2003, 
Petersen et al., 2011, van der Horst, 2015; Al Attar et al., 2017), through the likely mechanisms of 
increasing eccentric strength and hamstring muscle fascicle length (Timmins et al., 2016; Bourne et al., 
2018). Given these findings, eccentric hamstring exercises such as the NHE are increasingly prioritsed in 
elite sports programmes as an injury reduction tool (McCall et al., 2015), and as a potential means to 
enhance sprint performance (Ishoi et al., 2017). However, implementation of, and compliance with, these 
exercises is often problematic (Bahr et al., 2015), with concerns regarding increased muscle soreness, and 
a perceived lack of effectiveness, often cited by staff and players alike (McCall et al., 2015).  
 
There is, however, an additional source of insight that may help both illuminate the answers to 
these questions, and, furthermore, may provide practitioners with meaningful guidance relating to the 
personalisation of injury prevention interventions. Previously, this thesis has argued that the utilisation of 
genetic information, alongside other more conventional measures, may aid in both explaining and 
predicting individualised training responses (Chapter 2; Pickering & Kiely, 2017a). Building on these 
previous arguments, this chapter widens the scope to investigate whether genetic information can 
contribute to the prediction of HSI, and in the personalisation of exercise interventions designed to reduce 
HSI incidence.  
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2. SNPs potentially involved in HSI 
 
 The influence of genetics on injury predisposition has been most well studied in relation to 
tendon and ligament injury, with SNPs in two genes, COL1A1 and COL5A1, associated with an increased 
injury vulnerability (Posthumus et al., 2009a+b+c; Collins et al., 2009). There is, however, very little 
research examining the interaction of specific genotypes on skeletal muscle injury, and even less 
specifically looking at HSI. 
 
 Regarding muscle injuries in general, Pruna and colleagues (2013) examined the influence of 10 
SNPs on the type and degree of injury in 73 professional elite male soccer players, playing for FC 
Barcelona, over three seasons. A total of 203 non-contact muscle injuries were recorded. Two SNPs, one 
each in IGF2 and CCL2, were associated with muscle injury severity. IGF2 acts to influence tissue repair 
(Keller et al., 1999), whereas CCL2 is implicated in inflammation (Hubal et al., 2010). Consequently, 
variation in these genes may modify chronic load tolerance. Interestingly, when stratifying for ethnicity, 
an association between a SNP in ELN and injury severity emerged in Hispanics (Pruna et al., 2015), 
illustrating that, although in a low sample size (n=19), ethnicity is a potential modifier in the relationship 
between genetics and injury. ELN encodes for elastin, which is believed to modify tissue elasticity 
(Muiznieks et al., 2010). When these elite soccer players were followed for an additional two seasons, 
with further candidate SNPs analysed, additional tentative associations relating to injury prevalence for 
two SNPs in HGF, and one in SOX15, were established (Pruna et al., 2017). Regarding injury severity, 
the previously reported associations between IGF2 and CCL2 (Pruna et al., 2013) were replicated, and 
further associations uncovered for an additional four SNPs, one in COL5A1 and three in HGF. HGF aids 
in the activation of muscle satellite cells (Pruna et al., 2017), and thus is likely implicated in skeletal 
muscle repair, as is SOX15 (Pruna et al., 2017). 
 
 Similar to the work by Pruna and colleagues (2013, 2015, 2017), Massida et al. (2017) examined 
the effect of a single SNP in ACTN3 on the frequency and severity of muscle injuries in 257 Italian male 
professional soccer players. ACTN3 encodes for a-actinin-3, a protein that is an important component of 
the Z-disc (North et al., 1999). Individuals with the XX genotype cannot produce a-actinin-3, and so are 
believed to be predisposed to greater muscle damage following eccentric loading (Pimenta et al., 2012), 
potentially increasing injury risk. Furthermore, within this cohort, players with the XX genotype were 
significantly more likely to suffer an injury compared to R allele carriers (Odds Ratio = 2.66). These 
injuries were also significantly more likely to be of greater severity (OR = 2.13). In a smaller cohort of 
Italian footballers (n=173), a SNP in MCT1 (rs1049434) was also significantly associated with muscle 
injury incidence (Massida et al., 2015). As MCT1 is a lactate transporter, the proposed mechanism is that 
this SNP partially mediated muscle fatigue, a known injury risk-factor (Opar et al., 2012).  
 
 At present, only one paper has specifically examined the interaction between genotype and 
hamstring injury. Larruskain et al. (2017) recruited 107 elite male soccer players, recording hamstring 
injury prevalence from the start of the 2010-11 season until the end of 2014-15 season (5 seasons in 
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total). The players were genotyped for 37 SNPs previously associated with musculoskeletal injuries 
and/or exercise-induced muscle damage. Five SNPs were significantly associated with the risk of HSI in a 
multivariable model; MMP3 (rs679620), TNC (rs2104772), IL6 (rs1800795), NOS3 (rs1799983), and 
HIF1A (rs1159465). Age (>24y) and previous hamstring injury were also risk factors for hamstring 
injury. However, whilst this model proved useful in explaining the prevalence of historical hamstring 
injury in the predictive stage of the study, it was found to be no better than chance at predicting future 
injury. As such, whilst it might be possible to retrospectively explain hamstring injuries through 
understanding genetic variation, it appears this information cannot be used to predict future injury, 
presumably due to the complex multifactorial nature of sporting injury (Bahr & Krosshaug, 2005). 
 
 In summary, a breadth of SNPs demonstrate tentative associations with muscle injury. However, 
few of these have been tested and/or associated with hamstring specific muscle injury in elite 
sportspeople. These SNPs come from genes influencing a variety of potential injury mechanisms, 
including muscle architecture (ACTN3) (Massida et al., 2017), muscle fatigue (MCT1) (Massida et al., 
2015), inflammation (IL6) (Larruskain et al., 2017), and tissue repair and remodeling (HGF and IFG1) 
(Pruna et al., 2013; Pruna et al., 2017). Whilst these examples illustrate the complexly entangled 
influence of genetic factors on injury risk, as of yet utilisation of this information remains unable to 
predict future HSI (Larruskain et al., 2017).  
 
 
3. A genetic influence on the response to mechanical loading 
 
Adaptive responses to imposed exercise interventions vary extensively between individuals 
(Hubal et al., 2005; Erskine et al., 2010; Mann et al., 2014). This inter-individual diversity has been 
attributed to within-subject random variation (Atkinson & Batterham, 2015) and true between-subject 
neuro-biological variability (Mann et al., 2014). These true between-subject differences can be broadly 
characterised as genetically, environmentally, and epigenetically driven (Pickering & Kiely, 2017a), with 
heritable factors estimated to explain approximately 50% of the between-subject variance in strength 
(Silventoinen et al., 2008).  
 
This phenomenon is most well explored in relation to concentric muscle contractions, the 
contraction mode most commonly used in general resistance training activities. Here, a number of genetic 
variants have been associated with modifying the training response. These include ACTN3 (Delomonico 
et al., 2007; Pereira et al., 2013), IGF1 (Hand et al., 2007), and ACE (Pescatello et al., 2006; Giaccaglia et 
al., 2008). However, there are also considerable inter-individual variations in response to both isometric 
and eccentric training. Heritable factors have been shown to account for between 14-83% of the variance 
in isometric strength (Peeters et al., 2009), with a value typically towards the higher end of this range 
often reported (Thomis et al., 1997; Tiainen et al., 2009). As with concentric contractions, numerous 
genetic variants have been associated with this phenotype, with ACE leading the way; in this case, the D 
allele appears to be associated with enhanced improvements following isometric loading (Folland et al., 
2000).  
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3.1 Genetic insights into the response to eccentric loading 
 
However, perhaps of greatest interest in terms of HSI prevention are eccentric training protocols. 
As discussed in the introduction, exercises designed to increase eccentric hamstring strength are popularly 
used within sport to reduce the prevalence of HSI (Askling et al., 2003). Such interventions have been 
shown to be effective (Petersen et al., 2011; Al Attar et al., 2017), with the proposed mechanism that they 
increase both the strength of the hamstring muscles (Mjolsnes et al., 2004), and also the muscle fascicle 
length (Potier et al., 2009; Reeves et al., 2009). As with other training modalities (Hubal et al., 2005; 
Erskine et al., 2010; Mann et al., 2014) the magnitude of improvement following eccentric training is 
likely to exhibit inter-individual variability (Baumert et al., 2016b), with differences in genotype partially 
explaining this variation (Moeckel-Cole et al., 2010).  
 
3.1.1 Genetics and strength gains 
 
Eccentric training appears to preferentially drive hypertrophy in type-II, and in particular type-
IIx, muscle fibres (Douglas et al., 2017). Variation in muscle fibre type in general, and the magnitude of 
hypertrophy following training, is partially heritable (Simoneau & Bouchard, 1995; Timmons et al., 
2010). One gene that exerts a relatively sizeable influence is ACTN3, where a common SNP results in a 
premature stop codon (X allele). Individuals with the XX genotype cannot produce the a-actinin-3 
protein, which is expressed in type-II muscle fibres (North et al., 1999). As a result, these individuals 
typically present with smaller percentages of type-II fibres (Vincent et al., 2007), and appear to exhibit 
smaller improvements following resistance training (Delmonico et al., 2007). Subsequently, it seems 
feasible to suggest that the ACTN3 XX genotype may attenuate gains in muscle strength following 
eccentric resistance exercise.  
 
3.1.2 Genetics and muscle fascicle length 
 
 Alongside improvements in muscle strength, a further beneficial eccentric training adaptation is 
an increase in muscle fascicle length (Potier et al., 2008; Bourne et al., 2016). Again, inter-individual 
variation in this adaptation is likely to exist, with such variation partially genetically mediated. TTN, the 
gene encoding for the structural protein titin, may modify changes in muscle fascicle length. Here, a C>T 
transition at rs10497520 has been reported to modify muscle fascicle length in males (Stebbings et al., 
2017), with CC homozygotes having longer vastus lateralis fascicles than CT heterozygotes. Whether this 
finding would be replicated in the hamstring muscle group, and whether it would affect changes in 
muscle fascicle length, remains to be elucidated.  
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3.1.3 Genetics and post-exercise recovery 
 
 Muscle damage: Alongside modifying the adaptive response to eccentric training, genetic 
variation may also affect recovery from such training. This was recently covered in a review by Baumert 
and colleagues (2016a). Here, genetic variation was determined to modify both the initial post-exercise 
damage phase and the subsequent inflammatory stage. In the initial damage phase, again ACTN3 has been 
shown to play a role, with XX genotypes expected to exhibit greater muscle damage following exposure 
to eccentric loads (Vincent et al., 2010; Pimenta et al., 2012), although this finding remains equivocal 
(Venckunas et al., 2012). Here, the purported explanation is that the lack of a-actinin-3 in XX genotypes 
leads to weaker z-lines in type-II fibres, increasing their susceptibility to damage from eccentric 
contractions (Beggs et al., 1992; Friden & Lieber 2001; Seto et al., 2011a). Other SNPs that appear to 
affect muscle damage during eccentric contractions include two in MLCK (rs2700352 and rs28497577) 
(Clarkson et al., 2005a), and one in CK-MM (rs1803285), although this SNP has thus far yielded 
conflicting results (Heled et al., 2007; Yamin et al., 2010; Deuster et al., 2013).  
 
 Inflammation: Genetic variation can also predispose individuals to increased inflammation 
following eccentric exercise (Baumert et al., 2016a). Many of these SNPs are from the interleukin family, 
with a polymorphism in IL6 (rs1800795) perhaps the most prominent. Here, the C allele is associated 
with a greater increase in creatine kinase (CK) activity following maximal eccentric contractions (Yamin 
et al., 2008). Genes encoding for other pro-inflammatory cytokines, such as tumor necrosis factor (TNF), 
also modify the post-training inflammatory response following exercise (Lakka et al., 2006; Yamin et al., 
2008), and appear likely to influence recovery following eccentric. 
 
 Taken together, it is clear that genetic variation influences multiple dimensions of eccentric 
exercise recovery. This can be in terms of muscular damage, for example though the mediation of ACTN3 
(Pimenta et al. 2003), or modulation of the inflammatory response, exemplified by IL-6 (Yamin et al., 
2008).  
 
Muscle soreness: A feature of un-habituated eccentric exercise is that it typically results in 
muscle soreness (Lee et al., 2002). This is one of the often-cited reasons why elite athletes, despite the 
demonstrated value of eccentric hamstring exercise, have historically been slow to engage in such 
training (McCall et al., 2015). Accordingly, information relating to the likelihood of suffering from post-
eccentric exercise discomfort could be useful. If the magnitude of soreness following eccentric loading 
can be predicted—even partially—then training interventions can be adjusted to promote engagement and 
adherence accordingly. In the case of acute muscle damage, for example, this could inform the individual 
calibration of training volumes and/or intensities. Here, knowledge of ACTN3 genotype may be helpful, 
with XX homozygotes expected to experience greater levels of soreness. Of further relevance, a second 
SNP in TTN, rs11693372, may affect post-eccentric muscle soreness, with the CC genotype protective 
against subjective soreness (Moeckel-Cole et al., 2010). 
 
This information may also be useful in-season, with those players predicted to experience 
increased soreness being guided to undertake eccentric loading exercises further away from a competition 
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or match-play. The same is true for the inflammatory response, which modulates recovery time, and 
influences soreness (Miles et al., 2008). In this case, personalised nutrition guidelines could be formulated 
based on genotype. Here, individuals with a genetic predisposition to an increased inflammatory response 
may increase intake of flavonoids, omega-3 fatty acids, and other nutrients associated with a reduction in 
inflammatory biomarkers following eccentric exercise (Phillips et al., 2003; DiLorenzo et al., 2014; Kim 
& Lee, 2014). Such genotype-based nutritional interventions have yet to be tested in sports people, but a 
number of SNPs – including ACTN3, CM-MM, IL6, and TNF – have been utilised as part of a Total 
Genotype Score (TGS) to explain individual variations in the level of muscle damage (Del Coso et al., 
2017a & b) following endurance activity.   
 
 
4. Conclusion - Using this information 
 
Whilst certain genetic variants may increase the predisposition to HSI (Pruna et al., 2013; 
Larruskain et al., 2017), as of yet it does not appear possible to use genetic information to predict HSI 
occurrence (Larruskain et al., 2017). This lack of predictability reflects the complex, multifactorial nature 
of sporting injuries (Bahr & Krosshaug, 2005; Bahr 2016). At present, it therefore appears difficult to 
make specific recommendations based on an athlete’s genetic predisposition to HSI, because genetic 
variation appears to explain very little of the between-athlete variance in HSI prevalence. That said, 
whilst injuries cannot be accurately predicted—such that all “at-risk” athletes get injured, and no “low-
risk” athletes do—genetic information could be used alongside other, more traditional methods such as 
acute:chronic workload (Hulin et al., 2016a) and eccentric strength testing (Sugiura et al., 2008) to 
develop a clearer picture of individual risk, perhaps guiding the customisation of hamstring robustness-
enabling interventions.   
 
As discussed, athlete genotype potentially modifies training adaptations to eccentric loading 
(Moeckel-Cole et al., 2010), as well as altering the acute inflammatory (Yamin et al., 2008) and muscle-
damage (Del Coso et al., 2017a) response to such exercises. Accordingly, there remains the possibility 
that genetic information, although inadequate as a predictive tool for HSI, can instead enable a more 
informed application of preventative exercises. In this scenario, genetic information could be used to 
better inform loading schemes (Kikuchi & Nakazato, 2015; Jones et al., 2016) and recovery strategies. 
This could be especially important during the competitive season, when avoiding excessive post-exercise 
soreness prior to key competitions and matches is crucial. In this case, genetic information could be used 
alongside more conventional measures in order to optimally position the eccentric loading bout within the 
training week for that athlete. Similarly, utilising genetic information may aid in the process of 
introducing this training modality to eccentric-naïve individuals, with coaches using information relating 
to post-exercise soreness to modify the load and intensity accordingly.  
 
Such a hypothesis remains largely untested, representing an avenue for future research. This is of 
increased importance given the lack of intervention-based studies in the field of sports genetics, and 
represents an ideal opportunity to move from observational research to that which directly impacts 
practice (Buchheit, 2017), particularly as both athletes and coaches appear amenable to the utilisation of 
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genetic information (Varley et al., 2018a). In moving this field forward, future research should therefore 
aim to elucidate: 
1. The extent to which specific genetic variants modify the HSI risk. 
2. Whether knowledge of this information can be predictive in terms of HSI probability. 
3. Whether modification of training variables based on genotype leads to better outcomes 
following eccentric hamstring exercises in terms of injury resilience and athletic 
performance. 
 
Given the prevalence of HSI within elite sport, such insights have the potential to inform and enhance 
hamstring performance and robustness training process. Whilst not predictive of HSI injury in and of 
themselves, genetic variants do provide insights into the likely predispositions certain athletes may have 
to such to injury, and subsequently provide an additional layer of relevant information that can be 
combined with more conventional assessments to guide the customisation of hamstring-specific exercise 
prescription and monitoring strategies. Despite the recent surge in HSI research, it remains clear that 
hamstring injuries still cannot be prevented (Ekstrand et al., 2016). Solving such a complex, multi-
factorial phenomenon will likely demand the integration of insights and information from multiple 
domains. In pursuing this objective, there is the potential that an appreciation of the underlying genetic 
mechanisms influencing HSI risk and training responsiveness will provide a useful—albeit partial—
insight that can positively contribute to more perceptive management of hamstring health.  
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CHAPTER 8 – CAN GENETIC TESTING IDENTIFY “TALENT” (WHATEVER THAT MIGHT 
BE)? 
 
Chapter preface: 
  
 The use of genetic information to identify future talented performers represents a potential “holy 
grail” within the talent identification sphere. Indeed, some nations are already utilising genetic 
information in this way, even though the general scientific consensus is that genetic testing for talent 
holds no predictive ability (Webborn et al., 2015), and is ethically troubling (Camporesi & McNamme, 
2016; Vlahovich et al., 2017a). This chapter explores the use of genetic information as a talent 
identification tool, and is split into two parts. Part One asks whether genetic information could ever be 
used for talent identification, providing an overview of the challenges in creating an evidence based 
genetic testing programme for talent identification. Part Two explores talent identification from a 
different perspective, asking whether the ability to positively, and substantially, adapt to exercise can be 
considered a talent—and if so, is it possible to test for it? Part One was previously published in Genes 
(Pickering et al., 2019b), and Part Two was previously published in Sports Medicine Open (Pickering & 
Kiely, 2017c).  
 
 
PART ONE – COULD GENETIC INFORMATION EVER BE USED FOR TALENT 
IDENTIFICATION? 
 
1. Introduction 
 
Elite athlete status is a partially heritable trait, with approximately 66% of the variance between 
elite and non-elite athletes explained by heritable factors (De Moor et al., 2007). Furthermore, recent 
advances in genetic technology have allowed for greater exploration of the genetic underpinnings of elite 
performance. This has led to the identification of a number of single nucleotide polymorphisms (SNPs) 
and other genetic variants with the potential to affect performance, both directly and indirectly. For 
example, a SNP in ACTN3, R577X (rs1815739) has been shown to impact attainment of elite speed-
power athlete status (Ma et al., 2013). Here, a common C-to-T base substitution results in the 
transformation of an arginine base (R) to a premature stop codon (X). X allele homozygotes are deficient 
in the protein encoded for by ACTN3, a-actinin-3, which is expressed exclusively in fast twitch muscle 
fibres (North et al., 1999). As a result, these XX genotypes tend to have lower proportions of fast-twitch 
muscle fibres (Vincent et al., 2007), and, given that fast-twitch muscle fibres are an important component 
of speed-power performance, tend to be underrepresented in elite speed-power cohorts (Yang et al., 
2003). The first study demonstrating this was conducted by Yang and colleagues (2003), who reported 
that the X allele was significantly underrepresented in a cohort of elite male and female sprint athletes 
when compared to both non-athletic controls and elite endurance athletes. Whilst in Caucasian 
populations the frequency of the XX genotype is ~20% (Yang et al., 2003), in Yang and colleague’s 
(2003) cohort of Caucasian power Olympians, it was entirely absent. The finding of significantly lower X 
allele frequencies and XX genotypes in elite speed-power athletes has been well replicated 
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(Druzhevskaya et al., 2008; Roth et al., 2008; Eynon et al., 2009c; Ahmetov et al., 2011; Cieszczyk et al., 
2011), although equivocal findings have also been reported (Gineviciene et al., 2001; Sessa et al., 2011; 
Scott et al., 2010). Consequently, despite explaining “only” around 3% of the variance in speed-power 
phenotype (Moran et al., 2007), ACTN3 has subsequently been labelled a “gene for speed” (MacArthur & 
North, 2004; Berman & North 2010; Chan 2008). ACTN3, however, is not the only gene associated with 
elite athlete status, with a recent review reporting that at least 155 genetic markers have been linked to 
elite athlete status (Ahmetov et al., 2016).  
 
Whilst many of the currently established SNPs associated with elite athlete status are linked to 
physiological traits such as speed, aerobic endurance, and strength, there is the potential that other SNPs 
may exert a less direct—but no less crucial—impact on the attainment of elite performance. For example, 
both height (Silventoinen et al., 2003) and Body Mass Index (BMI) are highly heritable (Allison et al., 
1996; Elks et al., 2012); and both likely contribute to the attainment of elite athlete status on a sport-by-
sport basis. Furthermore, psychological traits are also genetically influenced, with a number of SNPs 
associated with anxiety (Stein et al., 2005; Chen et al., 2006; Clasen et al., 2011). As such, the genetic 
influence on performance is broad, multi-factorial, and pervasive.  
 
Given the wide-ranging and potentially powerful influence of genetic variants on both the 
attainment of elite athlete status and the development and possession of the individual physiological, 
psychological and biomechanical traits that underpin elite performance, there is considerable interest in 
collecting genetic information in order to identify athletes with the potential to achieve elite status. 
Indeed, a number of direct-to-consumer (DTC) companies offer such genetic testing (Collier 2012; 
Wagner & Royal, 2012; Roth et al., 2012; Webborn et al., 2015), and contemporary reports detail the use 
of genetic testing within the talent identification process in a number of countries 
(https://www.newsweek.com/china-begin-using-genetic-testing-select-olympic-athletes-1099058). 
However, at present the general consensus amongst researchers is that such tests have no role to play in 
talent identification (Webborn et al., 2015; Vlahovich et al., 2017a), and are also ethically troubling 
(Miah & Rich, 2006; Camporesi & McNamee, 2016). This chapter section discusses why current genetic 
tests cannot predict future sporting success, and explores what advancements would be required to enable 
the utilisation of genetic information to more accurately identify future talented performers. 
 
 
2. Why can’t genetic information currently be used for talent ID? 
 
As previously mentioned, over 155 genetic markers have been linked with elite athlete status 
(Ahmetov et al., 2016). These markers are typically—but not always—divergent, such that they 
predispose towards an increased chance of success in either power-strength or endurance sports/events, 
but not both. These divergent effects demonstrate that there isn’t a singular genetic profile that confers 
sporting success, but that the required genetic profiles are likely specific to individual sports and events. 
Whilst some of these markers, such as ACTN3 (Yang et al., 2003; Druzhevskaya et al., 2008), ACE 
(Gayagay et al., 1998; Jones et al., 2002), and PPARGC1A (Lucia et al., 2005; Maciejewska et al., 2012) 
are well established and well replicated, others, such as TFAM (rs1937), have yet to be satisfactorily 
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replicated (Ahmetov et al., 2010). Currently, only a few of the genetic markers that likely associate with 
elite athlete status have been identified, making predictions of future sporting prowess based on such 
information both difficult and incomplete.  
 
Another issue is that, at present, the currently available markers appear to offer poor specificity 
and sensitivity as talent identification tools. Returning to ACTN3, whilst it is clear that the R allele is 
associated with elite athlete status in speed-power events (Ma et al., 2013), with the XX genotype 
significantly less common in such cohorts (Yang et al., 2003; Papadimitriou et al., 2008; Druzhevskaya et 
al., 2008), it remains unclear how discriminatory this information might be. In Caucasians, for example, 
~80% of individuals possess an R allele (Yang et al., 2003). In some black African populations, this 
percentage can be as high as 99% (Yang et al., 2007). In a study of elite US and Jamaican sprinters—the 
populations providing the fastest eight 100m runners of all time—there was no difference in ACTN3 
genotype frequencies between these athletes and non-athlete controls, with 97% of non-athletes 
possessing at least one R allele (Scott et al., 2010). So, whilst the R allele may be required for elite sprint 
performance, given that the vast majority of the world’s population possess it, this knowledge is not 
particularly useful. Furthermore, there are exceptions to the belief that an R allele is required for elite 
speed-power performance. In their study of elite sprinters, Papadimitriou and colleagues (2016) reported 
that one male and one female 100m sprinter, both of whom achieved the Olympic qualifying standard, did 
not possess an R allele. Additionally, Lucia and colleagues (2007) reported the case of a long jumper with 
a personal best of 8.26cm, just 5cm off the gold medal winning jump at the 2012 Olympic Games, who 
possessed the XX genotype. Such findings demonstrate that the lack of an ACTN3 R allele does not 
preclude elite status in speed-power events. Additionally, many such performance enhancing 
polymorphisms may still have a low prevalence in elite athlete populations. For example, a SNP in NRF2 
(rs7181866) has been associated with elite athlete status, with a significantly higher proportion of the AG 
genotype compared to the AA genotype found in elite endurance athletes when compared to controls 
(Eynon et al., 2009b). However, only 12-14% of these elite athletes possessed the “ideal” AG genotype, 
illustrating that the vast majority of elite athletes were not in possession of this specific performance 
enhancing polymorphism, limiting its use as a discriminating screen. 
 
Such findings demonstrate the problems of a single gene approach to talent, and, indeed, no 
serious researcher or practitioner today would consider such an approach viable. In light of these findings, 
researchers have turned to Total Genotype Scores (TGS), whereby a number of elite athlete-associated 
SNPs are combined into a single polygenic score. Ruiz and colleagues (2009; 2010) utilised such an 
approach involving elite endurance and power athletes. For their endurance study, they combined seven 
polymorphisms into a total score, finding that the mean score was higher in the athlete group compared to 
the control group (Ruiz et al., 2009). This finding was replicated using a TGS comprised of six SNPs for 
power athlete status, with elite power athletes having a higher score than both endurance athletes and 
non-athletic controls (Ruiz et al., 2010). Possession of the “perfect” polygenic profile (i.e. the elite athlete 
genotype of all SNPs) was rare, occurring in only 9.4% of the power athletes, and no endurance athletes. 
In addition, there was considerable overlap between groups, such that a number of controls had better 
TGS than elite power athletes, as did a number of elite endurance athletes (Ruiz et al., 2010). 
Furthermore, whilst a TGS may help in discriminating between athlete and non-athlete, Santiago and 
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colleagues (2010) demonstrated that, in a group of rowers, it did not distinguish between different levels 
of performance (i.e. World vs National medallists). Earlier work (Williams & Folland, 2008; Hughes et 
al., 2011) demonstrates that there is considerable similarity in polygenic scores within humans—athlete 
and non-athletes alike—when a low number of markers (22-23) are used, such that, again, this approach 
would likely have limited real-world specificity and sensitivity. In order to improve the insights provided, 
a far greater number of performance-enhancing polymorphisms are likely required.  
 
As a summary of the above discussion, it’s clear the provision of elite athlete status is a highly 
complex, polygenic trait, and that, at present, very few of the genetic variations that contribute to this trait 
have been identified. As a result, it appears a fundamental requirement that, if genetic testing is to be 
utilised for talent identification purposes, a far greater number of polymorphisms associated with elite 
athlete status need to be uncovered, and then combined into a TGS model.  
 
 
3. What further knowledge is required to potentially use genetic information for talent 
identification? 
 
3.1.  Genome-Wide Association Studies  
 
The evolution of Genome Wide Association Study (GWAS) methodology potentially offers an 
opportunity to expand the number of genetic variants currently associated with elite athlete status. Whilst 
the majority of the SNPs currently associated with elite athlete status were elucidated via gene-association 
studies or candidate gene analysis—where a SNP is hypothesised to have an effect, and that hypothesis is 
then tested—GWAS are hypothesis-free. In a GWAS, a large number of SNPs (e.g. ~700,000) are 
analysed for association with a trait. Because there is no hypothesis to be tested, it provides a robust 
method to detect novel associations. However, due to the very low p-values required to reach genome-
wide significance (p<5x10-8), and the (often) very low effect sizes of any individual SNP, GWAS 
analyses often require very large subject numbers. This is problematic when it comes to research on elite 
athletes, who are, by definition, rare. Such a problem was encountered in a GWAS carried out in multiple 
cohorts of elite endurance athletes by Rankinen and colleagues (2016). Here, the authors utilised a cohort 
of elite endurance runners (n=315) and controls, known as GENATHLETE, along with a cohort of elite 
Japanese runners (n=60) and controls, for the discovery phase of the GWAS. Following this discovery 
phase, in which no SNP met genome-wide significance, forty-two suggestive SNPs were taken through to 
a replication phase involving endurance athletes and controls from seven other countries. Again, no 
genome-wide significant SNPs were found. As such, the authors summarised that there appeared to be no 
common SNP associated with elite endurance athlete status across this cohort, although they 
acknowledged their low sample size as a limiting factor. Such a limitation is difficult to overcome, and 
represents a significant roadblock in the search for genetic variants associated with elite performance. A 
further potential roadblock is that there may be different associations between SNPs and elite 
performance across ethnicities, such that a SNP may be performance enhancing in Caucasians, but not 
East Asians, for example, thereby requiring the development of ethnicity-specific SNP panels for the 
purpose of talent identification.  
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3.2.  Rare variants 
 
A further avenue for exploration is that of rare genetic variants that may predispose to elite 
performance. Generally, research focuses on fairly common polymorphisms, present in >1% of the 
population (Moran & Pitsiladis, 2017). However, there are a few genetic variants identified which are 
very rare, and yet have the potential to impact performance. One such variant occurs at rs121917830 
within the EPO receptor gene. This variant is linked to a disease called erythrocystosis-1, where sufferers 
have increased erythropoietin expression, and hence greater oxygen carrying capacity (Moran & 
Pitsiladis, 2017). This is potentially advantageous for endurance sport, and at least one elite athlete, 
Finnish cross-country skier Eero Mantyranta, possessed this variant (Juvonen et al., 1991). An additional 
example is that of variation in LMNA, a gene related to muscular dystrophy, that was found in Canadian 
sprint hurdler Priscilla Lopes-Schliep (Waggot et al., 2016). Finally, a rare variation in the myostatin gene 
(MSTN) has been reported, where carriers are described as “extraordinarily muscular”. (Schuelke et al., 
2004). Such a variant would potentially be advantageous in sports/events demanding high levels of 
strength or increased muscle mass. One issue with the exploration of rare performance enhancing variants 
is that, given their very low frequency, they can be hard to identify, and, in many cases, are only reported 
a handful of times in the research literature. Furthermore, they may also predispose to disease states; a 
factor raising complex moral and ethical questions. However, despite these potential issues, research 
continues towards their identification (Waggot et al., 2016), not least because identification of healthy 
individuals with disease-causing variants could provide information relating to the underpinning 
mechanisms of these diseases, and potentially inform remedial and resilience-building strategies (Chen et 
al., 2016).  
 
3.3.  Signal or noise? 
 
As the number of variants associated with elite athlete status grows, it will be important to 
distinguish which of these are potentially causal, and those which are “noise” (Pickering & Kiely 2017b). 
For example, recently it was reported that the C allele of rs12722, a SNP within COL5A1, was more 
frequent in a cohort of elite rugby players compared to controls (Heffernan et al., 2017). This SNP has 
previously been associated with soft tissue injuries, with the T allele increasing the prevalence of such 
injuries (Mokone et al., 2006; Posthumus et al., 2009c; September et al., 2009). A potential explanation 
for this increased frequency in elite players is that the avoidance of injury is important for the attainment 
of elite status, and therefore a lower predisposition to injuries is advantageous (Heffernan et al., 2017). It 
is important to consider whether such a SNP should form part of a genetic test for talent, because injury 
risk itself is highly modifiable through environmental changes, such as increased exposure to eccentric 
loading (Fyfe & Stanish, 1992; LaStayo et al., 2003). As a result, possession of the protective allele for 
this SNP may only confer an advantage towards elite athlete status if carriers suffer fewer injuries, which 
can be directly modified, as opposed to a direct effect of this SNP on performance.  
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3.4.  A predictive threshold? 
 
An area of potential previous confusion is the number of performance-enhancing polymorphisms 
an individual may require before they are capable, from a genetic standpoint, of elite performance. Both 
Williams and Folland (2008) and Hughes and colleagues (2011) report that, in panels containing 23 
(endurance) and 22 (strength-power) polymorphisms, the chances of one athlete possessing all 
performance-enhancing alleles was vanishingly small. As such, it seems unlikely that a single athlete 
possesses the “perfect” genetic profile, although such a perfect profile is arguably unnecessary. Instead, 
athletes will likely possess a given number of performance-enhancing polymorphisms. Crucially, the 
polymorphisms possessed will differ between athletes, such that there might be only minimal overlap 
between individuals. In this way, once a large number of SNPs responsible for driving elite athlete status 
are uncovered—should such discovery ever occur—there will be the potential for the development of a 
threshold number, whereby possession of polymorphisms above this number would be associated with 
elite performance. Accordingly, there will not necessarily be commonality in terms of the genetic variants 
present, although some crossover will certainly occur; instead, the main driving factor will be the total 
frequency of performance driving variants. These SNPs will also likely differ between ethnicities, and so 
ethnicity-specific thresholds and genetic panels will be required. The utilisation of a large number of 
SNPs reduces the reliance on individual SNPs that occur either at high frequencies across populations 
(such as the ACTN3 R allele), or those that, whilst linked to elite athlete status, are still present at 
relatively low frequencies in elite cohorts (for example the NRF2 G allele).  
 
3.5.  Epigenetic modifications 
 
Finally, there is the potential that epigenetic modifications—changes in genetic expression that 
are not due to changes in the underlying genetic code—may affect the attainment of elite athlete status 
(Ehlert et al., 2013). These epigenetic changes are typically comprised of DNA methylation, histone 
modifications, and non-coding RNAs, particularly microRNAs (miRNAs) (Ehlert et al., 2013; Voisin et 
al., 2015). For example, miRNAs have been shown to modify the magnitude of exercise adaptation 
(Davidsen et al., 2010; Kirby et al., 2013), which is an important component of the journey towards elite 
athlete status. As of yet, whilst it appears that epigenetic changes may modify exercise adaptation 
(Denham et al., 2013; Ehlert et al., 2013, Voisin et al., 2015), it is not clear specifically what modifying 
effect they may have on the attainment of elite status. Additionally, such modifications have the potential 
to be passed down through generations (Richards 2006; Rissman & Adil, 2014), and thus may form part 
of the heritable aspect of elite athlete status. As a result, the ability to test for epigenetic changes, which 
are often tissue specific, could assist in the identification of talented athletes. 
 
3.6.  Lessons from disease prediction 
 
One area where the use of genetic information to make informed predictions of a future event 
has been well explored is that of disease risk. Whilst some diseases, such as cystic fibrosis, are 
monogenic diseases, most are complex and polygenic in nature (Chatterjee et al., 2016). Similar to elite 
athlete status, whilst many diseases have been shown to have a large genetic component, the disease-
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causing variants identified to date often explain little of the variance between individuals; this issue is 
referred to as the missing heritability problem (Manolio et al., 2009). One suggested method to overcome 
this problem of missing heritability is to lower the threshold for discovery of SNPs affecting the trait of 
interest. Due to the high number of comparisons carried out in a GWAS, statistical significance for 
discovery of new variants is typically set at p<5x10-8. However, the lowering of this threshold has been 
shown to lead to explanation of a greater proportion of heritability (Yang et al., 2010; Shi et al., 2016; 
Boyle 2017). Recently, Khera and colleagues (2018) utilised a TGS comprised of 6,630,150 
polymorphisms to create a risk score for coronary artery disease that had an area under the curve of 0.81, 
suggesting a strong predictive ability; many of these polymorphisms had miniscule effect sizes and weak 
significance, and yet combined to produce a powerful predictive tool. Such a method clearly holds 
promise for traits that have a large—but poorly elucidated—genetic component (Dudbridge 2013), such 
as elite athlete status. Indeed, returning to the recent GWAS on elite endurance status (Rankinen et al., 
2016), whilst no SNP was discovered at the genome-wide significance level (p<5x10-8), a number of 
SNPs had suggestive significance, and may hold predictive ability as part of a TGS. As a result, it appears 
likely that, in order to successfully predict future elite athlete status, models involving genetic variants 
with low effect sizes are likely required. However, the common issue of sample size returns; for 
discovery of relatively common genetic variants with small effect sizes, sample sizes in excess of 10,000 
individuals are likely required (Mattsson et al., 2016)—a number likely greater than that of all truly elite 
athletes on the planet.  
 
 
Figure 7 - A demonstration of the identification of risk variants for disease. The main focus on 
interest is within the dotted line. For the prediction of elite athlete status, rare alleles are likely not useful, 
given their lack of prevalence. Instead, there needs to be a focus on common genetic variants with low 
effect sizes – which require large sample sizes to be identified. (Figure taken from Manilo et al., 2009 and 
reproduced with permission).  
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4. Is genetic testing for talent ethical? 
 
There are serious and well-placed concerns about the use of genetic information for talent 
identification within sport (Webborn et al., 2015; Camporesi & McNamee, 2016; Williams et al., 2016; 
Vlahovich et al, 2017a+b). It is generally considered that, within sporting contexts, genetic testing should 
not be carried out on under-18s (Webborn et al., 2015; Vlahovich et al., 2017a+b). If genetic testing for 
talent does become evidence based, then there will be a requirement for the development of guidelines on 
its use, in part to protect vulnerable young children. For example, should sports clubs be able to demand 
players undergo genetic testing as part of their talent identification programmes? Who can give informed 
consent, and are young children even developed enough to give such consent? Who should have access to 
the genetic data? Will it be used in a discriminatory way? What if a player refuses to undergo a genetic 
test? What happens if genetic testing uncovers a potential disease-causing variant? The latter point is 
potentially an important issue, as whilst it could lead to health-promoting medical interventions, it could 
also lead to unnecessary medical explorations, as well as increased worry, both on the part of the athlete 
tested and their relatives, who may also carry the disease-causing variant. Additionally, it would in theory 
be possible to subject embryos to a genetic test, and, if the desired mix of sporting genes are not present, 
abort it. Such outcomes are highly unpalatable, and likely represent an extreme example, but demonstrate 
the potential mis-use of such information.  
 
Furthermore, if and when genetic testing is used to predict future elite athlete status, there will be 
many false positives and false negatives; i.e., many individuals will be mis-attributed to future elite or 
non-elite status (Breitbach et al., 2014). Whilst such error rates may be acceptable at a population level, 
they are obviously troubling at an individual one; who has the right to tell a young athlete that they don’t 
have the genetic potential to succeed? Perhaps more importantly, what effect would receiving this 
information have on that individual’s future exercise behavior, which, given the wide-ranging health 
benefits of exercise (Pareja-Galeano et al., 2015) is an important consideration for lifelong health.  
 
 
5. What could genetic testing potentially be used for? 
 
The second part of this chapter argues that, instead of using genetic information for talent 
identification in the traditional sense, it could be utilised to identify those athletes with the greatest 
capacity to improve with training (see also Pickering & Kiely, 2017c). Furthermore, this information 
could also be used to match individuals to the type of training to which they are most suited, and from 
which they will elicit the greatest adaptations (Jones et al., 2016; Pickering & Kiely 2017c). Additionally, 
genetic information could be utilised to identify those athletes with an increased risk of injury, allowing 
the provision of pre-emptive strategies to reduce that risk. For example, Varley and colleagues (2018b) 
identified a number of polymorphisms associated with an increased stress fracture risk in a cohort of elite 
athletes; in this case, the high-risk athletes could undergo additional bone mineral density monitoring, 
along with targeted interventions, such as vitamin D and calcium supplementation (Lappe et al., 2008).  
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Furthermore, whilst traditionally research has focused on the physiological drivers of elite 
athlete status, there is the potential to explore the genetic underpinnings of psychological factors, such as 
anxiety, stress resilience, and skill acquisition. Whilst this has not yet been explored in detail, a SNP 
within COMT, rs4680, has been linked with competition performance in swimmers (Abe et al., 2018) and 
personality traits in ultra-endurance athletes (van Breda et al., 2015). This gene encodes for catechol-o-
methyltransferase, which plays a role in the regulation of dopamine within the prefrontal cortex (Stein et 
al., 2006); variation in this SNP affects dopamine levels, which can alter information processing and 
memory (Stein et al., 2006). Emerging research has also implicated a number of polymorphisms in 
altering the skill acquisition process (Jacob et al., 2018). Finally, a number of genetic variants have been 
linked to an increased susceptibility to concussion injuries (McFie et al., 2018; Abrahams et al., 2018). As 
a result, whilst this information could be used to bias against those with the perceived “unfavorable” 
genotypes, it could also be used to personalise the training process, identifying those athletes who need 
greater attention in these areas, and assisting in injury management and monitoring. Furthermore, with 
regards to both injury and concussion, the information could be used to better inform preventative 
methods, along with increasing the personalisation of recovery and return-to-play protocols, particularly 
given the evidence that genetic information may enhance adherence to interventions (Nielsen & El-
Sohemy, 2014).  
 
 
6. Conclusion 
 
Whilst there is a strong and well-replicated modifying effect of genetic variation on the 
attainment of elite athlete status, based on the available evidence, it is clear that the current use of genetic 
tests for the prediction of future elite athlete status is ineffectual, a finding that echoes recent consensus 
statements (Webborn et al., 2015; Vlahovich et al., 2017a). In order to be able to use genetic information 
within the talent identification process, a far greater number of performance-enhancing polymorphisms 
need to be both discovered and replicated. The combination of these performance enhancing 
polymorphisms into a TGS, especially if the evidence threshold is lowered, appears to offer a solution to 
the limited predictive capabilities of small numbers of genetic variants. As the evidence base grows, it 
should be possible to determine a TGS threshold, above which an individual’s chance of achieving elite 
athlete status in a given sport or event is higher. However, and this is a crucial point, there will be 
individuals with a score below this threshold who go on to achieve elite athlete status, and those with 
scores above the threshold who will not be elite athletes. Because elite athlete status is a manifestation of 
a number of variables, not just genotype, it seems unlikely that it will ever be possible to use genetic 
information to identify a future elite athlete with certainty. At best, genetic information may represent a 
potentially useful adjunct to existing talent identification procedures, enhancing the process, particularly 
as genetic information is not subject to some of the issues that commonly plague traditional talent 
identification processes, such as maturation and training age. Additionally, and as argued in the next 
section, genetic information may be used in the future to identify those with the greatest potential to show 
favorable adaptations to training (Pickering & Kiely, 2017c), as well as determine the optimal training 
type to elicit such adaptations (Jones et al., 2016). Furthermore, there is the potential to utilise such 
information to reduce injury occurrence (Heffernan et al., 2015). Again, and this point must be clear; such 
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information should not be used as a standalone, but as an adjunct, to current talent identification 
processes, thereby allowing the training process to become more personalised, and enabling athletes to 
get ever closer to their maximum potential.  
 
 
PART TWO - CAN THE ABILITY TO ADAPT TO EXERCISE BE CONSIDERED A 
TALENT—AND IF SO, CAN IT BE TESTED FOR? 
 
1. Introduction  
 
The accurate identification of youth sporting talent has, in recent decades, emerged as a hugely 
important and yet controversial topic (Vaeyens et al., 2008; Issurin et al., 2017). Interest in Talent 
Identification (TI) is illustrated by a growing academic literature (Vaeyens et al., 2008; Collins et al., 
2016; Issurin et al., 2017), along with a number of best-selling popular-science books on the topic (Colvin 
2008; Coyle 2010; Syed 2010; Ericsson & Pool, 2016). Traditionally, sporting TI programmes have, 
through a mix of subjective and objective tests, sought to identify young athletes with “talent”, using this 
identification as a prediction of adult performance. However, despite the massive allocation of resources 
into the identification and development of young talent, it remains unclear whether or not early TI 
processes are either empirically justified or practically effective.   
 
One fundamental limiting factor is that physical performance tests employed to discern between 
those who have the talent to excel in the future, and those who do not, actually only provide a snapshot of 
current abilities. The subsequent logical leap is the presumption that those who perform well at that given 
time are most likely to be successful as adults. Yet, due to the inherently non-linear complex nature of 
biological maturation, these performance snapshots offer inherently poor predictive value. 
 
The reasons why countless high performing youth and junior athletes do not maintain their 
relative early high performance standards are obviously complex, varied and multifactorial (Abbott & 
Collins, 2002; Abbott et al., 2005). This illustrates the gross inaccuracies associated with current 
approaches to predicting future senior potential based on youthful performance. Similarly, where TI 
processes have been empirically evaluated, these inefficiencies remain, with fewer than 2% of athletes 
identified as having the potential to be elite within a school sports programme winning senior 
international medals (Vaeyens et al., 2009). 
 
Despite these inefficiencies, however, clubs and organisations invest large sums on TI and 
development initiatives in the hope of unearthing future talent. Manchester City’s Academy programme, 
for example, reportedly costs £12m per year to run (Ashton 2017). Yet such large investment is perceived 
as both economically feasible and justified by the occasional unearthing of exceptional talent; over 15 
Manchester City Academy graduates have been capped at senior international level, and one, Shaun-
Wright Phillips, was sold by the club for £21m.  
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A clear limitation of the TI process is that, during maturation, current performance is not directly 
indicative of future potential. In fact, no standard physical assessment provides insight into how an 
individual is likely to respond to future training. This chapter section explores the possibility that the 
utilisation of genetic markers associated with the capacity to favorably respond to imposed training stress 
may provide valuable, and currently missing, insights relating to future trainability, rather than current 
ability; thus providing clues as to whether the athlete has the innate “talent” to respond to training.  
 
2. The hereditary aspect of talent 
 
A standardised, widely accepted definition of talent is hard to find. A review of the complexities 
surrounding an adequate definition of talent is beyond the scope of this chapter; however, Issurin recently 
utilised a broad definition of talent as “a special ability that allows someone to reach excellence in some 
activity in a given domain” (Issurin 2017). In conceptualising this definition, Issurin leaned heavily on 
Howe and colleagues (1998), who proposed that talent has five properties; it is partially innate; its full 
effect may not be evident at an early stage; it has early indications that provide a basis for predicting who 
might excel; only a few possess it; and it is domain specific. 
 
Implicit within any definition of talent is the assumption that it is at least partially genetically 
determined. This is most obvious when considering the physiological underpinnings of elite performance, 
all of which are, to some degree, genetically influenced. Approximately 50% of variation in baseline 
maximal oxygen uptake (VO2max) is heritable (Bouchard et al., 2000), as is 45-99.5% of muscle fibre type 
(Komi et al., 1977; Simoneau & Bouchard, 1995). Furthermore, variation in muscle strength is estimated 
to be ~52% heritable (Zempo et al., 2017). Anthropometric qualities, often used as TI indicators, are also 
genetically mediated, with variation in height approximately 80% heritable (Silventoinen et al., 2003). So 
too are non-physical traits associated with elite performance; for example, stress resilience has a genetic 
component (Petito et al., 2016; Sanhueza et al., 2016), as does motivation to exercise (Schutte et al., 
2017). All of these findings suggest that talent is at least partially mediated by genetic factors. Indeed, it 
has previously been reported that ~66% of the variance in elite status is heritable (De Moor et al., 2007).  
 
Whilst elite athlete status appears to have a strong genetic component, to date it remains 
apparent that the available genetic information is insufficient to reliably predict those most likely to reach 
elite status in the future. As discussed in the earlier part of this chapter, genetic variants most frequent in 
elite athletes appear to hold little to no predictive ability on their own. For example, a single nucleotide 
polymorphism (SNP) in ACTN3, a gene encoding for a protein found in fast-twitch muscle fibres, is 
associated with elite sprint athlete status (Yang et al., 2003). Here, between 97% and 100% of elite 
sprinters have at least one R allele, making the XX genotype rare in this population (Scott et al., 2010). 
However, the fact that at least some elite sprint and speed-power athletes have the XX genotype (Lucia et 
al., 2007) illustrates that it perhaps lacks the sensitivity required to correctly identify talent. In addition, 
approximately 80% of the world’s population possess at least one R allele (North et al., 1999), thereby 
illustrating its lack of discriminatory power in discerning between potential athlete and non-athlete.  
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The inability of single SNPs to effectively discriminate between eventual phenotypes has led to 
the suggestion that utilising a panel of SNPs, each associated with a physical capacity deemed 
contributory to elite performance, may provide greater predictive ability. Using such an approach, a Total 
Genotype Score (TGS) is calculated, with a higher TGS indicative of a greater chance of achieving elite 
status. This approach has had some success, with mean TGS in athlete groups greater than controls (Ruiz 
et al., 2009; Ruiz et al., 2010), although it doesn’t yet appear to distinguish between competitive levels 
within athlete groups (Santiago et al., 2010). Again, however, the sensitivity and specificity are not 
sufficient to rule out false positives (identifying someone as a future athlete who is later unsuccessful in 
this endeavor) or false negatives (identifying someone as a future non-athlete, who goes on to become a 
world class athlete). As such, the current consensus is that genetic testing has no role to play in the TI 
process (Webborn et al., 2015; Vlahovich et al., 2017a; Pickering et al., 2019b), although this opinion is 
formed on the assumption that elite athletes have common genotypes. 
 
3. Is the ability to adapt to exercise a talent? 
 
Whilst traditional TI programmes attempt to identify future elite performers through the 
application of physical, psychological and subjective evaluations, it’s not clear whether this is the best 
approach. One issue with the use of such performance tests is that they measure the current status of the 
athlete, as opposed to the potential for that athlete to improve and develop. Consider the use of a 60m 
sprint test in order to identify talented sprinters in a cohort of 15-year-olds. Whilst the test is valid and 
will accurately identify the quickest athletes, it’s not clear that the fastest athletes at age 15 will be fastest 
at age 25. There is, therefore, a mismatch between what the test measures—current ability—and the TI 
processes goal—identifying future ability (Abbott & Collins, 2002). Instead, the focus of the TI process 
should be to find individuals with the potential to develop their skills and physiology in order to become 
successful senior athletes (Abbott & Collins, 2002); commonly referred to as talent development (TD).  
 
 101 
 
Figure 8 - A theoretical model illustrating inter-individual variation in performance and potential 
(reproduced from Tucker & Collins, 2012, with permission). Here, six individuals (A-F) have differing 
initial performance levels (performance level range on first exposure); F has the lowest, and C has the 
highest. The individuals also have different ceilings to his/her performance (innate max performance 
range), with A having the highest potential. However, training represents the journey from baseline 
potential to final potential; A and E do not train, and so will never reach their ceiling. Whilst C is the 
current world record holder, B has the potential to outperform them – but only if B can maximise their 
training to drive the required response.   
Legend - Max = maximum; * = maximum performance threshold for each individual; triangle = current 
performance level; black-white circle = initial performance level. 
 
 
 TI programmes, therefore, should attempt to identify those with the greatest ability to develop, 
provided that their maximal ability is sufficient to be an elite athlete. This fits into a model proposed by 
Tucker and Collins (2012), detailed in figure 8 above, whereby athletes have different baseline abilities 
that reflect the untrained state, but also different maximal abilities, which represent the performance 
ceiling for each athlete. There isn’t necessarily a relationship between the two; an athlete with a high start 
point might have a low ceiling. Conversely, an athlete with a low start point might have a higher ceiling. 
In this model, what becomes key is the potential of the athlete to improve with training, and whether they 
maximise this potential. Accordingly, for exercise adaptation to be considered a talent, it needs to fit the 
following five criteria proposed by Howe and colleagues (1998): 
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3.1. Is exercise adaptation partially innate? 
 
An ever-increasing body of research now suggests that genetic factors modify the adaptive 
response to exercise. The seminal research in this regard is the HERITAGE (Health, RIsk factors, 
exercise Training And GEnetics) Family Study, in which sedentary adults undertook a 20-week aerobic 
exercise training programme. The mean post-intervention improvement in VO2max in this cohort was 384 
mL O2 min-1, around 25% of baseline values. However, some participants saw no improvement, whilst 
others exhibited much larger improvements than the mean, as high as 1100 mL O2 min-1 (Bouchard & 
Rankinen, 2001). Genetic factors accounted for almost 50% of this inter-individual variation (Bouchard et 
al., 2011). Genetic association studies also show the modifying impact of single SNPs on exercise 
adaptation. For example, as detailed in Chapter 6, R allele carriers of ACTN3 appear to show greater 
improvements in power following a strength training intervention than X allele carriers (Delmonico et al., 
2007; Pereira et al., 2013). It is clear that exercise adaptation is partly genetically driven, and is therefore 
innate. 
 
3.2. Are the full effects of this talent not fully evident at an early age? 
 
Growth, maturation and the physical development of youth athletes are non-linear in nature 
(Abbott et al., 2005; Lloyd et al., 2016). Children and adolescents are physically less able than adult elite 
athletes due to differences in muscle size, strength (O’Brien et al., 2010; Waugh et al., 2013), and energy 
system development (Van Praagh & Dore, 2002; Ratel et al., 2006), which may limit the magnitude and 
type of adaptations that are possible (Pearson et al., 2006; Vaeyens et al., 2008). These developmental 
differences were illustrated by Radnor et al. (2017), who reported that maturation modified the adaptive 
response to resistance and plyometric training in a group of adolescent males. Based on these findings, it 
appears that knowledge of the full ability of a person to be able to adapt to exercise is likely not fully 
understood until maturation has occurred (Pearson et al., 2006), fulfilling this talent criterion.  
 
3.3. Are there early indications of this talent? 
 
This is perhaps the most difficult question to answer as part of these criteria. In part, this is due 
to a lack of research examining the magnitude of exercise adaptation in youths, and comparing that to 
either the magnitude of adaptation in those same youths as adults, or associating that adaptive response 
with sporting success later in life. There is a variable training response to specific training interventions in 
youths (Jones et al., 2016; Radnor et al., 2017), but it isn’t clear how this affects adaptation in adulthood. 
Nevertheless, the ability to adapt favorably to exercise as a youth will positively impact development by 
taking the athlete from their baseline towards their performance ceiling, increasing the possibility of adult 
success.  
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3.4. Do only a minority of people possess this talent? 
 
Overwhelmingly, research suggests that almost everyone has the ability to adapt to exercise, 
with the small number whom show no improvements labelled as non-responders (Timmons 2011). 
However, as outlined in Chapter 3, emerging research suggests such exercise non-response abates with 
modification of training parameters, such as an increase in training intensity (Ross et al., 2015) or 
frequency (Montero & Lundby, 2017). However, the magnitude of training response differs between 
individuals. As detailed earlier, this was apparent in HERITAGE, with a mean post-training VO2max 
improvement of 19%, although some participants exhibited improvements of less than 5%, and others 
improvements of >40% (Skinner et al., 2001). Similar wide-ranging magnitudes of adaptation have been 
reported after strength training, and combined strength and endurance training (Hubal et al., 2005; 
Hautala et al., 2006; Karavirta et al., 2011). It appears that, whilst almost everyone exhibits positive 
adaptations to exercise, those of the greatest magnitude are limited to a smaller number of individuals; a 
hallmark of a talent.  
 
3.5. Is this talent domain specific? 
 
Whilst genetic variation exhibits a modifying effect on exercise adaptation, the final point to 
consider is whether this is global (i.e. all types of exercise), or modality specific (i.e. individuals 
exhibiting large resistance training adaptations don’t necessarily exhibit the same adaptive magnitudes to 
aerobic training). As previously discussed, the ACTN3 R allele is associated with greater improvements in 
muscle phenotype following resistance training (Delmonico et al., 2007; Pereira et al., 2013). However, 
regarding VO2max adaptation, the X allele appears to be associated with larger improvements (Magi et al., 
2016), illustrating that the genetic predisposition to exhibit a greater adaptive response is domain specific. 
Karavirta and colleagues (2011) randomised participants to receive strength training only, endurance 
training only, concurrent strength and endurance training, or no training. Within each group, participants 
exhibited the expected range of adaptation; however, in the concurrent training group, no subject was in 
the highest quintile of improvement for both VO2peak and maximal voluntary contraction, again indicating 
that an ability to respond aerobically is separate to the ability to respond to strength training. It appears, 
therefore, that the ability to adapt favorably to exercise is specific to particular domains, as opposed to a 
global ability.  
 
3.6. Can exercise adaptation be considered a talent? 
 
Exercise adaptation is a highly complex and individualised process, mediated by genetic, 
environmental, and epigenetic factors (Pickering & Kiely, 2017a). The influence of variation at the 
genetic level accounting for large amounts of the inter-individual adaptive response to exercise is clear 
(Bouchard & Rankinen, 2001; Timmons 2011; Pickering & Kiely, 2017a), allowing the conclusion that 
the magnitude of adaptation is partially innate. It is also domain specific, with those possessing the ability 
to exhibit large improvements following one type of training not guaranteed to exhibit improvements of 
the same magnitude following a different modality (Karavirta et al., 2011). The presence of a small 
number of individuals who have very large post-training improvements in a physical trait (Skinner et al., 
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2001) illustrates that only a few possess this ability. The ability to exhibit large adaptations to exercise is 
also potentially masked by maturation effects. So far, there is a paucity of evidence examining whether 
those athletes who are highly adaptable during their youth remain so during their adult years. 
Nevertheless, based on the evidence available, it does appear that the ability to respond favorably, and 
with a large magnitude, to exercise can be considered a talent.  
 
4. Can this talent be tested for? 
 
Traditional TI processes appear to identify athletes who are already more able than their peer 
group, as opposed to those who represent the greatest ability to improve. The ability to test for this latter 
trait would therefore enhance the TI process, providing some predictive measure as to the future level of 
the athlete. As Abbott & Collins (2002) state, successful prediction of future accomplishments requires 
identification of characteristics indicating that an individual has the potential to both develop in sport, and 
become a successful senior athlete. Crucially, recent research suggests that individuals respond optimally 
to different types of training (Beaven et al., 2008; Jones et al., 2016, Zarebska et al., 2016), illustrating 
that being able to match promising youngsters with the training type most likely to elicit the greatest 
improvements could be valuable. This can reduce the trial-and-error process, increasing the time period 
available for an athlete to maximise their potential by minimising ineffective and inefficient training 
methods.  
 
Since the ability to respond to exercise is partially mediated by genetic factors, being able to test 
for these factors holds promise. A small number of studies have used this process, with early evidence 
suggesting they could have some predictive ability (Timmons et al., 2010; Jones et al., 2016). This 
process is separate from the use of genetic testing to identify the commonly held definition of sporting 
talent—adult performance—whereby promising athletes’ genetic profiles are compared to a pool of elite 
athletes to look for commonalities, the assumption being that a greater number of commonalities is 
associated with a greater chance of being elite. At present, there is no evidence to support this (Webborn 
et al., 2015). Indeed, it’s likely that different genes modify baseline ability (what is commonly identified 
in traditional TI processes) and ability to adapt to exercise, as detailed in figure 8 previously. Certainly, a 
greater body of research is required before evidence-based guidelines for the use of genetic testing to 
support talent development (as opposed to pure TI) can be utilised, but these early findings hold promise. 
Given the issues discussed within the current TI process, it could be argued that anything that improves 
the current offering should be utilised. 
 
In addition, there are a host of ethical questions that surround genetic testing, not just within 
sports, but also public health (Camporesi & McNamee, 2016), some of which were discussed in detail in 
Part One of this chapter. The resolution of these considerations is a challenge to the translation of 
laboratory-based genetics research to the field, but they are related to how the information is presented 
and interpreted, as opposed to whether genetic information should or should not be used.  
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5. Conclusion 
 
Whilst widespread across sport, traditional TI processes have a number of inherent problems. 
Perhaps the biggest issue is that they appear to identify current ability, as opposed to future potential, a 
fact which isn’t helped by the poor predictive ability of currently used tests of talent. Instead, TI 
programmes might be better placed to identify youngsters with the greatest capacity to improve, which is 
partially comprised of the ability to adapt to exercise. As genetic factors account for approximately 50% 
of the variation in adaptation to exercise, profiling to uncover these genetic underpinnings could be a 
useful future adjunct to the TI process, and also allow for athletes to undertake training that they are more 
likely to see favorable adaptations to, creating a personalised training process making athletes more likely 
to achieve their potential. With the many inefficiencies and high costs associated with TI, it’s clear that 
only marginal improvements within the TI process could make the process disproportionately more 
effective at developing talent, and genetic testing potentially represents this marginal gain. This section 
has focused on the physiological aspects of talent, and talent identification. It is, however, worth noting 
that sporting prowess is not dependent solely on physiology, and a number of psycho-emotional and 
cognitive traits are also associated with athletic achievement. Such traits include, for example, innate 
stress resilience, and a host of attitudinal factors, such as motivation, perseverance, and personality 
dispositions (Gould et al., 2007; Collins et al., 2016; Issurin 2017). Importantly, as with other phenotypes, 
these capacities are also partially mediated by hereditary influences, and partly by life history (Penke et 
al., 2007; Krueger et al., 2008). In summary, the ability to positively respond to the training stimuli 
imposed by physical exercise fulfils the required criteria to be considered a talent. The emergence of 
genetic testing may enable the more accurate identification of athletes who, thanks to a favorable genetic 
profile, possess a heightened ability to exhibit the greatest responses to training, thus improving the 
efficiency and efficacy of the talent identification process. 
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SECTION 4 – THE PRACTICAL USE OF GENETIC INFORMATION IN SPORT  
 
The content of this section draws on one previously published peer-reviewed paper, and two submitted 
for publication, along with additional work. The published and submitted papers are: 
 
Pickering C, Kiely J, Suraci B, Collins D. The magnitude of Yo-Yo test improvements following an 
aerobic training intervention are associated with total genotype score. PloS One. 2018;13(11):e0207597. 
 
Pickering C, Kiely J. The frequency of, and attitudes towards, genetic testing amongst athletes and 
support staff. 2019; Under Review.  
 
Pickering C, Kiely J. Can genetic testing predict talent? A case study of five elite athletes. 2019; Under 
Review.  
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CHAPTER 9: THE FREQUENCY OF, AND ATTITUDES TOWARDS, GENETIC TESTING 
AMONGST ATHLETES AND SUPPORT STAFF  
 
Chapter preface: 
 
Whilst there is a plethora of research exploring the impact of specific genetic variants on a variety of 
sporting related phenotypes, at present the extent of genetic testing within sporting contents remains 
poorly understood, with only one previous study (Varley et al., 2018a) attempting to quantify the true 
prevalence of genetic testing in high level sport. The study outlined in this chapter was undertaken in 
order to better understand the frequency of genetic testing in sport.  
 
 
1. Introduction 
 
Over the last few decades, research has illustrated a genetic influence on the attainment of elite 
athlete status (Yang et al., 2003; De Moor et al., 2007), the training-induced adaptive response (Timmons, 
2001; Bouchard, 2012; Sarzynski et al., 2017), and injury risk (Goodlin et al., 2015). Recent reviews 
suggest that at least 155 genetic markers are associated with elite athlete status and/or fitness phenotypes 
(Bray et al., 2009; Ahmetov et al., 2016). As a result of these findings, a number of companies now 
market direct-to-consumer genetic testing to athletes and fitness enthusiasts (Webborn et al., 2015). 
Whilst there are vast differences in the quality of these companies, along with the validity of their claims, 
the current scientific consensus is that “genetic tests, based on current knowledge, have no role to play in 
talent identification or the individualised prescription of training to maximise performance” (Webborn et 
al., 2015; page 1). Similar sentiments have been echoed by the Australian Institute of Sport (Vlahovich et 
al., 2017a), and, furthermore, the provision of genetic testing raises a number of potentially contentious 
ethical issues (Camporesi & McNamee, 2016). Nevertheless, some of the authors of these consensus 
statements remain hopeful that the evidence-base may soon provide support for the practical use of 
genetic tests. Williams and colleagues (2014), for example, predicted that training modifications, both to 
reduce injury risk and increase training adaptations, would soon be evidence-based, and that, in the 
future, talent identification processes could be informed by genetic information, and these objectives 
represent goals of the Athlome Project Consortium (www.athlomeconsortium.org/about/). Indeed, some 
recent research has provided support for the contention that genetically guided training and nutritional 
advice for athletes may be advantageous, but more research and replication are clearly required (Jones et 
al., 2016; Pickering & Kiely, 2018a; Pickering et al., 2018).  
 
Athletes and sporting teams tend to be early adopters of new technologies, as they seek 
innovative and novel means to gain an edge over their competitors (McNamee et al., 2018). In relation to 
genetic testing, this is no different; over ten years ago, the journal Nature reported that the Manly Sea 
Eagles, an Australian Rugby League team, had genetically tested a number of players in order to inform 
training programme design (Dennis, 2005). Since then, this practice has grown, with a number of sporting 
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teams currently known to have used the results of genetic tests in an attempt to better inform holistic 
athlete management and talent identification (Miller, 2016; Singer, 2017; Edwards 2018). Indeed, it was 
announced in 2014 that Uzbekistan’s National Olympic Committee was involved in a genetic testing 
programme aiming to identify future elite athletes (Synovitz & Eshanova, 2014). As a result, it appears 
there is a mismatch between the general scientific consensus and current practice.  
 
At present, the true prevalence of genetic testing in elite sport is largely unknown. Many 
organisations and/or clubs wish to retain confidentiality, potentially in part to retain an advantage over 
competitors, and potentially because such testing may be negatively received by the public and media. 
Recently, Varley and colleagues (2018a) conducted an online survey of 72 elite athletes and 95 support 
staff based within the UK. Their results indicated that fewer than 17% of elite athletes had undergone a 
genetic test, although most athletes and coaches (79%) indicated that they were willing to engage in such 
tests. However, in that online survey, respondent numbers were somewhat limited, and the diversity of 
sports represented was low. In directly addressing this information deficit, the present study was designed 
to a) determine the prevalence of genetic testing in sports, and b) advance understanding of the relevant 
prevailing beliefs and opinions of athletes, sports coaches, sports scientists, and sports medicine 
providers, as to the utility of genetic testing in sports. In addition, the secondary aims were to a) 
determine whether teams or individuals who had utilised genetic testing found the acquired information 
relevant and useful, and b) identify the perceived barriers amongst athletes and support staff towards 
genetic testing.  
 
 
2. Methods 
 
 Prior to the commencement of data collection, ethical approval was granted by the University of 
Central Lancashire Ethics Board in accordance with the Declaration of Helsinki. Athletes and support 
staff were recruited via social media accounts from both the thesis author and his supervisor. Potential 
participants were provided with a link, which directed to the survey home page; this page contained both 
the participant information sheet and informed consent form. The participants were asked to provide 
informed consent, and complete an online survey related to both their views and use of genetic testing 
within sport. The survey was comprised of 42 questions, with participants directed to specific questions 
based on their previous answers. The majority of questions were multiple choice, although two required a 
written answer. The questions broadly fit into four groups: 1) demographic data, 2) beliefs about the 
effects of genetics in sport, 3) prevalence of genetic testing in sport, and 4) the utility of genetic testing in 
sport. The questionnaire can be found in full in the appendix. Following the completion of the 
questionnaire, frequency-based descriptive analysis was carried out.  
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3. Results 
 
3.1 Participant demographics 
 
Two hundred and fifty-six individuals gave consent to take part in this study and completed the 
survey, comprising of 110 current or former athletes (45.3%) and 133 members of support staff (54.7%). 
The majority of respondents (76.5% of athletes and 84% of support staff) were male. The most common 
sport, for both athletes (66%) and support staff (40%), was athletics. Table 5 below lists the sports with 
the frequency of respondents.  
 
 
Primary Sport Athlete [n, (%)] Support Staff [n, (%)] 
Athletics 73 (66%) 53 (40%) 
Football 4 (3%) 17 (13%) 
Rugby (League/Union) 2 (2%) 20 (15%) 
American Football 4 (3%) 3 (2.5%) 
Basketball 0 (0%) 5 (4%) 
Swimming 1 (1%) 3 (2%) 
Racquet Sports 0 (0%) 3 (2%) 
Winter Olympic Sports 7 (7%) 4 (3%) 
Other 19 (18%) 25 (19%) 
 
Table 5 – Frequency of different sports within survey sample 
 
Sports in the “other” category included rowing (4% of athletes; 2% support staff), combat sports 
(4% of athletes; 3% support staff), volleyball (1% of athletes & support staff), field hockey (1% of 
athletes & support staff), cycling (4% of athletes & support staff), and triathlon (1% of athletes).  
 
18% of the athletes taking part in this survey had competed at the Olympic Games or World 
Championships, and a total of 51% had represented their country. A further 22% had competed at the 
highest level within their country, such as the national championships or top league. The vast majority 
(78%) were from the UK and Ireland; 9% were from the US, and 6% from other European Countries.  
 
Within the support staff cohort, 18% most frequently worked with an Olympic or World 
Championships competitor, with 36% of respondents in total working with international athletes, and a 
further 30% working with athletes who had competed at the highest level within their country. Most of 
the support staff (53%) were sports coaches, 18% were strength and conditioning coaches, 12% were 
sports scientists, and 5% were physiotherapists. Most (62.5%) were from the UK and Ireland, with a 
further 11% from other European countries, 7.5% from the US, and 5% each from Australia & New 
Zealand and North America (excluding the US).  
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3.2 Beliefs around the impact of genetics on sporting phenotypes 
 
Participants were asked about their opinion as to the relative contribution of genetics to various 
sporting phenotypes. These results are shown in table 6.  
 
  Athletes Support Staff 
What impact do you 
think an individual’s 
genetic make-up has on 
their chances of being an 
elite athlete? 
None 2% 1% 
Minimal (<25%) 6% 8% 
Somewhat (25-75%) 59% 69% 
Almost Entirely 
(75%+) 
33% 22% 
What impact do you 
think an individual’s 
genetic make-up has on 
their sporting/fitness 
improvements following 
exercise? 
None 3% 2% 
Minimal (<25%) 9% 7% 
Somewhat (25-75%) 59% 71% 
Almost Entirely 
(75%+) 
29% 21% 
What impact do you 
think an individual’s 
genetic make-up has on 
their nutrition 
requirements? 
None 2% 3% 
Minimal (<25%) 23% 27% 
Somewhat (25-75%) 57% 59% 
Almost Entirely 
(75%+) 
18% 11% 
 
Table 6 – Athlete and Support Staff opinions as to the impact of genetics on sporting phenotypes.  
 
These beliefs differed slightly between individual and team sport athletes. A greater proportion 
of individual sport athletes (38%) believed that an individual’s chance of becoming an elite athlete was 
almost entirely down to genetic make-up, as opposed to just 18% of team sport athletes. Outside of this 
question, beliefs around the extent of genetic variation on training response and nutritional requirements 
were similar between team and individual sport athletes.  
 
3.3 Prevalence of genetic testing within sport 
 
10% of the athletes had utilised a genetic test that was targeted at sports performance, and 12% 
of support staff respondents stated that they had utilised genetic testing within their organisation. The 
prevalence differed slightly between team and individual sport athletes, with 8% of individual team sport 
athletes reporting having undertaken a genetic test, compared to 17% of team sport athletes.  
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3.4 Attitudes towards genetic testing 
 
The 90% of athletes and 88% of support staff respondents who had not utilised genetic testing were 
asked for their reasons for having not done so. These results are reported in table 7.  
 
 Athlete Support Staff 
Too expensive 31% 41% 
Unaware that genetic testing was 
possible 
49% 25% 
Insufficient evidence for its use 21% 39% 
Concerns around data protection 1% 6% 
Concerns about negative press 
coverage 
0% 2% 
Ethical considerations 4% 19% 
 
Table 7 – Most common reasons cited for not utilising genetic testing 
 
Of those who had not utilised genetic testing, 10% of athletes and 5% of support staff envisioned 
doing so within the next year, 26% of athletes and 28% of support staff within the next 5 years, and 11% 
of athletes and 29% of support staff within the next 10 years. 53% of athletes and 38% of support staff 
believed they would never utilise genetic testing. Again, there was minimal difference between individual 
and team sport athletes in this regard; 56% of individual and 44% of team sport athletes said they 
envisaged never undertaking a genetic test, 25% (individual) and 28% (team) believed they would in the 
next 5 years, and 11% (both) believed they would within the next 5-10 years. Perhaps the main difference 
between the two sporting types was in the proportion stating they would take a genetic test within the 
next year; 8% of individual compared to 17% of team sport athletes. Table 8 (below) provides the most 
frequent responses to the question “what would cause you to use genetic testing?” 
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 Athletes Support Staff 
Publication of peer-reviewed 
case studies 
29% 63% 
Greater number of intervention 
studies 
14% 36% 
Publication of randomised 
controlled trials 
26% 46% 
More athletes/teams using it 48% 18% 
Players requesting it N/A 25% 
Direct approach from genetic 
testing company 
N/A 18% 
Increased awareness of the 
product 
35% N/A 
Lower price 48% 36% 
 
Table 8 – Responses to the question “what would cause you to use genetic testing?” 
 
3.5 Experience of genetic testing  
 
Of the athletes who had utilised genetic testing, the most common reason cited (44%) was to 
inform training programme design, along with general interest (22%), to identify the best sport to 
compete in (11%), and injury prevention and nutritional insights (11%). 78% of athletes who had 
undertaken a genetic test reported that the information they gleaned from it was useful. Of the 22% who 
did not find the information useful, the main reason (100%) was that the information provided was too 
generic, and not targeted at sports people (50%). Most athletes (75%) found that the results of their 
genetic test were easy to understand, with 75% receiving after-testing follow-ups from the testing 
company to provide them with additional information. The majority of athletes (75%) who had 
undertaken genetic testing reported that they had made changes based on the results of the test.  
 
Similarly, of the support staff members that had utilised genetic testing within their organisation, 
50% had done so primarily to inform training programme design, 21% for injury prevention, and 15% to 
guide nutritional interventions. Interestingly, 7% had done so as a screen for disease risk, and none did so 
as a talent identification tool. 60% of support staff who had used a genetic test found the information 
useful; of those who didn’t, the main reason (80%) was that the results were too generic. Most (85%) 
found the information provided easy to understand, and 65% received follow up information from the 
testing company/institution. 65% of support staff who had utilised a genetic test within their organisation 
made changes based on the results of the test, with 100% of respondents stating they made changes to 
their athletes training programme, 80% to their diet, 67% to their recovery, and 40% to their lifestyle.  
 
All of the genetic testing reported by athletes in this study was conducted by a commercial 
company. Conversely, for support staff respondents, 15% of the genetic testing had been carried out by a 
university or academic institution, with the remaining 85% coming from commercial companies.  
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4 Discussion 
 
This study, which surveyed high level athletes and support staff from across the globe, suggests 
that genetic testing in elite sport remains infrequent and sporadic, with only 10% of athletes and 12% of 
support staff who responded to this survey stating that they utilised genetic testing within their practice. 
This prevalence of genetic testing in athletes is similar to previously published research (Varley et al., 
2018a), although the reported use by sporting organisations was much higher (12%, compared to 2% in 
Varley et al., 2018a). The present study builds on previous research by Varley and colleagues (2018a) by 
increasing the sample size of athlete and support staff, from 167 (72 athletes and 95 support staff) in 
Varley and colleagues (2018a) to over 400 in total. This increases the robustness of the findings of both 
studies. Additionally, the majority of athletes surveyed in Varley and colleagues (2018a) were from the 
sports of rugby, speed skating, and volleyball. In comparison, the majority (66%) of athlete respondents 
in the present study were from the sport of athletics; as a result, the present study serves to add 
respondents from a greater range of sports to the evidence base. 
 
Overall, the survey respondents believed that genetics has a sizeable (>25%) impact on an 
individual’s potential to be an elite athlete (92% of athletes and 91% of support staff). These attitudes 
correspond to the findings of published research exploring the genetic influence on sporting phenotypes. 
For example, De Moor and colleagues (2007) reported that heritable factors explained approximately 
66% of the variance in elite athlete status between individuals. Furthermore, a number of single 
nucleotide polymorphisms have been identified which may increase an individual’s chance of attaining 
elite athlete status (Ahmetov et al., 2016), although the research in this area remains equivocal (Rankinen 
et al., 2016). However, at present, this information does not appear to be all that useful in identifying 
potential elite athletes (see Chapters 8 and 12 for further details), leading to the general scientific 
consensus being that genetic testing should not be used as a talent identification tool (Webborn et al., 
2015; Vlahovich et al., 2017a). This viewpoint appears to be mirrored in the practice of support staff, of 
which none had utilised genetic testing as a talent screen. One athlete did, however, report using their 
genetic results as a means of identifying which sport they should compete in. Interestingly, individual 
athletes were more likely to report that they believed genetic variation had a considerable (>75%) effect 
on the chances of becoming an elite athlete than team sport athletes, although the reasons for this are 
currently unclear.  
 
Additionally, 88% of athletes and 93% of support staff respondents believed that genetics has a 
sizeable (>25%) impact on an individual’s improvements following a training programme. Again, this is 
mirrored in the research literature; individual SNPs, such as ACTN3 and PPARGC1A, appear to modify 
the magnitude of post-training adaptations (Chapter 6; Ring-Dimitriou et al., 2014). More recently, 
studies have started to explore the utility of Total Genotype Scores in explaining the variation in training 
response (Chapter 10; Moraes et al., 2018; He et al., 2018), and potentially in maximising the adaptations 
to exercise (Jones et al., 2016). Of the athletes within this study who indicated they had undertaken 
genetic testing, 44% stated it was to inform training programme design, as did 50% of support staff.  
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Interestingly, fewer athletes (74%) and support staff (70%) believed that genetics had a sizeable 
(>25%) impact on an individual’s nutrient requirements. This is somewhat surprising, given that the field 
of nutrigenetics is well established, with a number of studies demonstrating how SNPs in genes such as 
MTHFR (Ashfield-Watt et al., 2002) and SOD2 (Li et al., 2005) can potentially modify micronutrient 
status and requirements, although this may be outside the scope of practice of many involved within elite 
sport. Only 11% of athletes, and 15% of support staff, utilised genetic testing to gain insights into 
nutritional requirements.   
 
Although the vast majority of both athletes and support staff surveyed believed that genetics had 
a substantial influence on a number of sporting phenotypes, the overall uptake of testing was somewhat 
low (~10%). This study explored some potential reasons for this disparity. 49% of athletes stated they 
were unaware that genetic testing was available, suggesting that one of the main drivers for a lack of 
uptake of genetic testing is due to awareness. A greater number of support staff were aware that genetic 
testing was available, possibly due to the various recent publications in the scientific literature on the 
subject (e.g. Webborn et al., 2015; Jones et al., 2016). However, potentially due to the conclusions of two 
recent consensus statements (Webborn et al., 2015; Vlahovich et al., 2017a), a large proportion (39%) of 
support staff believed that there was insufficient evidence for the use of genetic testing within elite sport. 
Cost was also an issue, with 31% of athletes and 41% of support staff stating that one the reasons they 
had not utilised genetic testing was that it was too expensive. Whilst, historically, genetic testing has been 
costly (Hayden, 2014), in recent years technological improvements and increased sales volumes have 
reduced prices, such that a genetic test today typically costs £100-£200. Neither athletes nor support staff 
appeared especially concerned around data protection or negative press coverage, with few citing these as 
reasons they had not undertaken genetic testing. However, 19% of support staff stated that ethical 
considerations, such as the perceived use of genetic information for talent identification, were one of the 
reasons they had not utilised genetic testing.  
 
Support staff generally noted a need for increased scientific evidence before they would consider 
utilising genetic information in the future. Conversely, athletes were less concerned about this, instead 
stating that, if more athletes and sports teams began using genetic testing, they too would consider it. 
Both athletes (48%) and support staff (36%) stated that a reduction in price would lead them to consider 
genetic testing, and 25% of support staff would consider a genetic test should a player request it. This 
latter finding is interesting, as it demonstrates that many practitioners understand the value of player buy-
in and potential expectancy effects surrounding the use of genetic information, similar to that found in a 
survey of Premier League medical staff regarding the use of Platelet Rich Plasma injections (McNamee et 
al., 2018).  
 
When genetic testing had been used, athletes (78%) and support staff (60%) tended to perceive it 
to be useful. The main reasons cited for a lack of utility were that the information was either too generic, 
or not targeted specifically towards sports people. Most athletes who had undertaken a genetic test stated 
that they had made changes to either their training or lifestyle based on the results of the test, 
demonstrating a perceived utility of the genetic information. The vast majority of genetic testing reported 
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by participants in this survey was carried out by commercial companies, as opposed to academic 
institutions. Most athletes (75%) and support staff (65%) received follow up information from the testing 
company, giving them the opportunity to ask additional questions and clarify any misunderstandings.  
 
4.1 Implications for future work 
 
Whilst not hugely prevalent as of yet, the results of this current survey, and previous work 
(Varley et al., 2018a), suggest there is an appetite for genetic information within elite sport. The use of 
such information brings with it a host of ethical considerations. Many of these have already been 
identified in previous chapters, but are worth repeating. For example, is it ever ethical to test those under-
18, who, in theory, cannot provide informed consent? Can a sporting organisation recommend or even 
require genetic testing of its athletes, and at what point does this constitute coercion? Who owns the 
genetic data, and where and how is it stored? What happens to this data if a player leaves a 
club/organisation, or retires? What provisions, if any, are made for the discovery of potentially disease-
causing or disease-associated variants within an athlete’s genetic data? How would this discovery affect 
relatives of the athlete, who may also require genetic screening for the particular disease variant? What 
are the additional healthcare burdens and costs associated with this? At present, there are no guidelines 
assisting practitioners in answering these questions, or even guiding them towards an informed decision. 
As such, the development of such guidelines represents a potential opportunity to enhance practice. This 
is potentially of significant importance, given that one respondent to the present survey stated that they 
had utilised genetic testing within their organisation to screen for disease risk; it’s not clear how they used 
this information, nor how it may have been communicated to the athlete(s) in question. 
 
Furthermore, a consistent theme throughout the early part of this thesis (see Chapter 4) is that, at 
present, genetic information assists practitioners in explaining what has already happened, but does not 
assist them in predicting a future outcome, which, in elite sport, is of greater importance; a coach does not 
necessarily need to explain why a previous training programme was ineffective, but rather prevent the 
athlete from undertaking ineffective training in the future. As such, future research in this area should 
explore the use of a wider number of genetic variants, and aim to assist athletes and practitioners in 
designing better training programmes. This would overcome one of the major barriers for the use of 
genetic information in elite sport, which is a perceived lack of evidence of utility.  
 
 
4.2 Limitations 
 
Whilst the results of this survey are novel and interesting, with the potential to impact research 
and practice, there are some potential limitations. Firstly, the survey was shared the thesis author and 
supervisor on social media. Given the author’s employment status at that time—as Head of Sports 
Science at a genetic testing company—it is possible that individuals following him (and hence being 
more likely to have seen the survey link) have an increased interest in genetic testing, and may not be 
representative of athletes and support staff in general. However, the extent of athletes stating they had 
undertaken genetic testing in this study (10%) was actually lower than in previous research (Varley et al., 
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2018a), suggesting this had not skewed the results. Additionally, the vast majority (~80%) of respondents 
were male; whilst there is no apparent reason why females would be more or less likely to undertake a 
genetic test, or hold different attitudes towards such a test, this possibility cannot be excluded. 
Furthermore, the questionnaire utilised in this study was not validated, was not tested for face validity or 
internal reliability, and did not undergo principal component analysis. Whilst this is a limitation, the study 
was designed to build upon the work of Varley and colleagues (2018a), whose questionnaire was also not 
validated, but still provided interesting data on a very under-researched topic. Finally, the survey was 
undertaken anonymously; as a result, it is possible that the support staff survey respondents were from the 
same club or organisation, artificially inflating the apparent prevalence of genetic testing based on the 
results of these respondents. Future research should address these limitations by aiming to recruit a higher 
number of female athletes—the lack of female support staff participants may (sadly) mirror actual female 
representation within high-level sport (Kane & LaVoi, 2017)—and verify that only a single support staff 
responds from each club or organisation. Future studies should also aim to recruit an increased number of 
participants in sports inadequately covered here, and explore the attitudes towards genetic testing within 
regions that were not adequately covered here. That said, the present study recruited a number of 
Olympic/World Championship athletes (18%), with over half the sample being international athletes. 
Additionally, of the support staff polled, 36% stated that their most frequent contact was with athletes of 
an international standard, demonstrating that the cohort was of a high standard, a potential strength of this 
study.   
 
 
5. Conclusion 
 
Despite the fact that the majority of athletes and support staff polled in this survey stating their 
belief that genetics exert a sizeable influence on a number of sporting-related traits, the overall uptake of 
genetic testing within this cohort, in which more than half of the athletes polled had represented their 
country, was low, at around 10%. The prevalence of genetic testing is similar to that previously reported 
(Varley et al., 2018a). The reasons for this relatively low uptake are varied, but include a lack of 
awareness, cost, and a lack of scientific evidence underpinning the use of such tests. Despite concerns 
from researchers in this field (Webborn et al., 2015), it appears that the vast majority of those who have 
utilised genetic testing within sport are not doing so as a talent identification tool, and instead are doing 
so as a method to inform training programme design. Whilst there is some evidence supporting the use of 
genetic information in this way (Jones et al., 2018; Chapter 6-8), additional research is required to build 
an evidence-based framework for the use of genetic information within sport, along with the development 
of best-practice guidelines regarding the testing of athletes by a sporting organisation, including how an 
individual’s data can best be shared with clubs/organisations.  
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CHAPTER 10: THE MAGNITUDE OF YO-YO TEST IMPROVEMENTS FOLLOWING AN 
AEROBIC TRAINING INTERVENTION ARE ASSOCIATED WITH TOTAL GENOTYPE 
SCORE  
 
Chapter preface: 
 
 As identified in previous chapters, the majority of exercise genetics research tends to focus on 
exploring the effect of single genetic variants on an outcome, such as the attainment of elite athlete status, 
or the magnitude of training adaptations. However, this information is potentially of limited use to 
practitioners and athletes in the field, who want information that can inform training programme design. 
Furthermore, individual genes are likely to have very poor explanatory or predictive capabilities in 
isolation. Consequently, Total Genotype Scores (TGS), where a number of genetic variants are pooled 
together, are being increasingly used to increase the predictive ability of a genetic test. The study outlined 
in this chapter, which was published in PLoS One (Pickering et al., 2018), is the first to utilise a 
commercially available TGS, in this case comprised of 5 SNPs, in the prediction of the magnitude of 
improvements in Yo-Yo test following a standardised training intervention.  
 
 
1. Introduction 
 
Aerobic capacity (as determined by maximal oxygen uptake, VO2max) is considered crucial for 
sports performance. The greater the aerobic capacity of an athlete, the longer they can exercise at a given 
intensity (Jones and Carter, 2000). Additionally, aerobic fitness enhances recovery from high intensity 
intermittent exercise, such as that found in most team sports (Tomlin and Wenger, 2001), and also 
potentially differentiates between performance levels, with elite team-sport athletes scoring higher than 
their sub-elite and amateur counterparts on tests of aerobic fitness (Bangsbo et al., 2008; Tønnessen et al., 
2013). Furthermore, improvements in aerobic fitness following training have been associated with 
improvements in soccer performance (Helgerud et al., 2001). As such, aerobic fitness training is a 
fundamental inclusion in most professional team-sport physical preparation programmes.  
 
Similarly, within endurance sport training there is on-going debate, in both the academic and 
coaching domains, focused on uncovering the “best” combination of running volumes and intensities 
necessary to optimally drive positive adaptation, and hence improve performance (Seiler et al., 2013). 
However, the belief that there is a universal “best” type of training to develop aerobic performance is 
predicated on the implicit assumption that athletes respond to the imposed training demands in a broadly 
similar fashion. In recent years, this conventional presumption has been challenged by empirical evidence 
showing unexpectedly extensive inter-individual variation in aerobic fitness gains experienced by 
participants undertaking identical training interventions (Bonafiglia et al., 2016; Bouchard et al., 1999; 
Ross et al., 2015; Scharhag-Rosenberger et al., 2012). This inter-individual response diversity is 
exemplified by the collection of studies constituting the HERITAGE (HEalth, RIsk factors, exercise 
Training And GEnetics) Family Study; whilst the mean improvement in aerobic fitness following training 
was 19%, some participants saw improvements as high as 40%, whilst others experienced no 
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improvements (Bouchard et al., 1999). Further analysis of the HERITAGE data revealed that genetic 
variation between participants explained approximately 47% of this variance (Bouchard et al., 1999), 
although this data has recently been critically evaluated (Williamson et al., 2017). Such extensive inter-
individual variability has been replicated in a number of other studies examining adaptations to aerobic 
training (Bonafiglia et al., 2016; Ross et al., 2015; Scharhag-Rosenberger et al., 2012). 
 
The demonstrated magnitude of the inter-individual adaptive response following aerobic training 
poses a potential problem to conventional exercise prescription methodologies. For example, professional 
athletes may fail to elicit expected benefits, and patients prescribed aerobic exercise—under the premise 
that such training will improve health parameters—may fail to realise meaningful benefits, despite 
engaging in the recommended training. Since the completion of the HERITAGE Family Study, the field 
of sports genetics has grown exponentially. Currently, 155 genetic markers are associated with elite 
athlete status (Ahmetov et al., 2016), and more still are associated with training response (Bray et al., 
2009). However, the translation and application of this research to both sports training and general health 
contexts remains both tentative and controversial (Webborn et al., 2015).  
 
Previously, research has focused on exploring the influence of genetic variations on elite 
endurance athlete status, with a general lack of predictive ability (Yvert et al., 2016; Rankinen et al., 
2016). However, with heritable factors potentially accounting for close to half of the variation in exercise 
response between individuals (Bouchard et al., 1999), there is the potential that insight into the genetic 
profile of the individual could improve exercise programme design. Research on the impact of genetic 
variation on exercise adaptation has identified a series of single nucleotide polymorphisms (SNPs) which 
may contribute to observed differences in response to aerobic training. Five of these SNPs from four 
different genes (VEGF [Ahmetov et al., 2008], PPARGC1A [Ring-Dimitriou et al., 2004], CRP [Kuo et 
al., 2007b; Obisesan et al., 2004], and two from ADRB2[(Moore et al., 2001; Wolfarth et al., 2007; 
Sarpeshkar and Bentley, 2010]) have been collated into an algorithm used in a commercially available 
test. These SNPs affect different dimensions of cardiovascular function, and are associated with either 
VO2max scores, or improvements in this capacity following aerobic training.  
 
Given the observable inter-subject variations in training-induced aerobic adaptations, the ability 
to identify individuals who may exhibit smaller fitness gains could enable the evolution of more 
personalised training programme designs. Such an innovation would promote greater overall 
improvements within populations, enhancing training efficiency and increasing the chances of positive 
adaptation in a greater number of individuals.  Therefore, the purpose of this study was to determine 
whether a commercially available genetic algorithm was associated with the magnitude of improvements 
in aerobic fitness in a group of youth soccer players following an eight-week training block. It is believed 
that players with a greater number of positive alleles for genes associated with higher aerobic fitness 
would see larger improvements following aerobic training than those with fewer positive alleles. A 
secondary aim is to attempt to bridge the gap between genetics research and sports science practice. The 
ability to utilise genotype assessment panels to inform training programme design holds the potential to 
revolutionise exercise prescription in medical, health and sporting domains. Yet genetic research, whilst 
potentially impactful, can often appear confusing to field-based practitioners and athletes, who require 
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real-world data to inform their decision-making processes (Buchheit, 2017). Accordingly, this work is 
framed as a training observation study, as opposed to a genetic association study. The outcomes may 
provide meaningful, actionable training insights promoting the strategic incorporation of genetic 
information into training programme designs. 
 
 
2. Methods 
 
2.1 Participants  
 
Following University of Central Lancashire Ethics Committee approval according to the 
Declaration of Helsinki, a convenience sample of 42 male soccer players aged between 16-19 years of 
age (height 176 ± 6 cm, weight 69 ± 9 kg) from a college soccer academy volunteered to participate in 
this study. The sample was chosen to best represent the size of a typical soccer squad. Each player had an 
average of 11 years’ football training experience, and was actively competing in the English College 
Football Association Leagues.  
 
2.2 Methodology 
 
Participants were in a phase of training aimed at increasing aerobic capacity via sport specific 
conditioning, in this case small sided games. Sessions took place twice a week for the eight-week training 
block. Within each session, the participants undertook small-sided games on pitches of differing sizes and 
with a different number of players, ranging from 3 v 3 to 5 v 5. The work periods were uniform in all 
sessions, consisting of four sets of four-minutes exercise and three-minutes of active recovery. Small-
sided games have previously been demonstrated to be an effective method of enhancing aerobic fitness in 
soccer players (Impellizzeri et al., 2006; Hill-Haas, 2009; Dellal et al., 2012; Radziminski et al., 2013; 
Clemente et al., 2014), and, as they also enhance sport-specific technical and tactical skill (Radziminski et 
al., 2013), they represent a preferred method of player development to many soccer coaches (Clemente et 
al., 2014). A recent meta-analysis (Hammami et al., 2018), across all team sports, reported a large 
beneficial effect (ES = 1.94) of small-sided games on VO2max fitness improvements in team sport players, 
suggesting that this training method is an effective means of enhancing the physiological capabilities of 
soccer players. An eight-week study period was utilised as this has previously been shown to be a 
sufficient period of time to elicit aerobic and other performance improvements following the use of small-
sided games (Impellizzeri et al., 2006; Radziminski et al., 2013), with most small-sided games studies 
utilising intervention periods of 6-8 weeks (Hammami et al., 2018). The training protocol of four sets of 
four-minute exercise bouts, interspersed with three-minutes of active recovery was selected based off 
current best practice guidelines (Clemente et al., 2014).  All sessions were supervised by a UEFA A 
Licensed coach, who set and monitored the intensity of each training session, through the use of Rating of 
Perceived Exertion (RPE). The participants were also taking part in a minimum of one competitive match 
per week during this time. No additional training was prescribed during the intervention period. There 
was no control group, as requesting a group of competitive footballers to refrain from exercise is 
potentially in violation of the Declaration of Helsinki, and is almost certainly unethical (Shepherd 2001). 
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Before and after the training block, participants’ aerobic fitness was assessed by the Yo-Yo 
Intermittent Recovery Test, level 1 (Yo-Yo IR1), a reliable and valid measure of aerobic fitness 
(Krutstrup et al., 2003). Briefly, the test is comprised of repeated 2 x 20 m runs back-and-forth performed 
to an audible beep, separated by an active rest period of 10 seconds. The time allowed for each 20 m 
section decreases as the test progresses, resulting in a faster required running speed; this begins at 10 
km·h-1, and is increased by 2 and then 1 km·h-1 for the respective next two speed levels. After this, the 
speed increases by 0.5 km·h-1 for each additional level. The test is halted when a participant fails to cover 
the distance in the required time on two consecutive occasions, indicating that exhaustion has occurred. 
All participants were provided with verbal encouragement during the test. Participants refrained from 
caffeine for at least 12 hours before testing, which took place outdoors on a soccer pitch, at the same time 
of day on both occasions. Individual results were expressed as distance covered in metres. Participants 
had carried out Yo-Yo tests previously, and were fully accustomed to the assessment protocol.  
 
2.3 Genetic testing 
 
Alongside the training programme, participants underwent genetic testing using a commercially 
available self-testing kit from DNAFit Life Sciences. Participants provided a saliva sample, collected 
using a sterile buccal swab. The samples were sent to IDna Genetics Laboratory (Norwich, UK), where 
DNA was extracted and purified using the Isohelix Buccalyse DNA extraction kit BEK-50 (Kent, UK), 
and amplified through PCR on an ABI7900 real-time thermocycler (Applied Biosystem, Waltham, USA). 
Through this process, genetic information regarding SNPs believed to affect aerobic trainability (VEGF 
rs2010963, ADRB2 rs1042713 and rs1042714, CRP rs1205 & PPARGC1A rs8192678) (Ahmetov et al., 
2008; Kuo et al., 2007b; Obisesan et al., 2004; Ring-Dimitriou et al., 2004; Moore et al., 2001; Wolfarth 
et al., 2007; Sarpeshkar and Bentley, 2010) was determined. Each allele was given a score of between 0 
and 4 points depending on the expected magnitude of its effects on improvements in aerobic fitness 
following training. The strength of the rating was based on the evidence from cumulative literature results 
averaged over time. The sum of these points was combined to give an overall score. This method is 
identical to Jones et al. (2016), and similar to the methods used in other studies utilising genetic 
algorithms (Meckel et al., 2014; Ruiz et al., 2009). The participants were stratified into three groups; 
“low”, “medium” and “high” depending on their weighted total genotype score (TGS), with a higher 
score indicating possession of a greater number of alleles expected to improve adaptation to aerobic 
training. Those with an overall score of 40% or less were classed as “low”. Scores of 41-70% were 
classed as “medium”. A score of >70% was classed as “high”. These divisions were used in the absence 
of previous work, and represents a gross sub-division into categories based on the expectation that 
approximately 60% of individuals have a score of between 40-70% (Pickering, 
https://blog.dnafit.com/am-i-normal-aerobic-trainability). The divisions used here mirror those utilised by 
DNAFit Life Sciences in their commercially available genetic test; as discussed in Chapter 4 
(Methodology), a main aim of the present thesis is to explore the utility of commercially available tests in 
the athlete preparation process. All athletes were blinded to their genetic results until completion of the 
final testing.  
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2.4 Statistical analysis 
 
Means, standard deviations and 90% confidence intervals (CI) were calculated for whole group 
and sub-groups for both pre- and post-training test scores. 90% CI were used as per the recommendations 
of Sterne and Smith (2001) and Hopkins et al., (2009). These were examined by a 3 X 2 (Group X Time) 
mixed methods ANOVA, with repeated measures on the second factor. The dependent variable was the 
Yo-Yo score (pre- and post-) obtained by each participant. Tukey’s HSD was also run. To further 
discover the differences between groups, pre- and post-training test scores were compared within groups 
using a paired sample t-test, and between groups using unpaired t-tests. Statistical significance was set as 
P £0.05, which after adjustment using Bonferroni correction led to a significance level of 0.008 for the six 
t-tests. Cohen’s d was calculated for within- and between-group effect size. The thresholds used were 
<0.2 (trivial), 0.21 - 0.5 (small), 0.51 - 0.8 (moderate), 0.81 – 1.2 (large), 1.21 – 2 (very large), >2 (huge) 
(Cohen 1988; Sawilowsky 2009). Data were analysed using Microsoft Excel 15.29 (Microsoft 
Corporation, Redmond, WA, USA) and IBM SPSS Statistics 23 (IBM Corporation, Armonk, NY, USA).  
 
 
3. Results 
 
 Table 9 illustrates the genotype-group data. After examination with a 3 X 2 (Group X Time) 
mixed methods ANOVA, there was a significant main effect of time (F (1, 39) = 67.8, P <0.001) and a 
significant interaction (F (2, 39) = 10.9, P <0.001). The main effect of Group (F (1,39) = 5.11) was not 
significant.  
 
The significant main effects of Time support the impact of the aerobic training intervention, as 
all groups showed an improvement in fitness. In contrast, follow up on the between group main effect 
using Tukey’s HSD showed no significant differences (all pairwise comparisons non-significant). As 
such, groups were taken as being equivalently fit at baseline.  
 
The interaction effects were of most interest, in that these addressed the main purpose of the 
study. Building on the significant overall differences demonstrated by the significant interaction, follow-
up was conducted by use of three paired t-tests on the before and after data of the three groups. These 
results are shown in table 9.  
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Group Pre-training Yo-
Yo Score (m) 
[mean (SD; 90% 
CI)] 
Post-training Yo-Yo 
Score (m) [mean 
(SD; 90% CI)] 
P-Value for 
Difference Between 
Pre- and Post-
training Scores 
(paired t-test) 
Effect Size 
(Cohen’s d) 
(90% CI) 
Low     (n 
= 6) 
1006 (292; 766 to 
1247) 
1073 (281; 842 to 
1304) 
0.0041 0.23 “Small” 
Medium (n 
= 23) 
1045 (472; 876 to 
1213) 
1409 (453; 1246 to 
1571) 
<0.0001 0.79 
“Moderate” 
High     (n 
= 13) 
969 (493; 725 to 
1212) 
1529 (508; 1278 to 
1780) 
<0.0001 1.12 “Large” 
 
Table 9 – Pre- and post-training Yo-Yo test scores, stratified for individual genotype groups.  
 
The data for between-group interactions was then analysed, and is summarised in figure 9. The 
key finding is that there was a significant difference (P < 0.05) between all groups, which remained after 
Bonferroni correction for differences between “low” and “high”, and “low” and “medium” comparisons. 
The effect sizes were very large (1.32) for the difference between “low” and “medium” groups, large 
(0.82) for differences between “medium” and “high”, and huge (2.59) for differences between “low” and 
“high” groups.  
 
In all groups, the mean improvement was 382 ± 270 m (90% CI 312 to 452 m), which represents 
an improvement of 37.5%. Within the “low” group, the mean improvement was 67 ± 33 m (90% CI 40 to 
94 m), representing a mean improvement of 7.5%. No participant in the “low” group exhibited an 
improvement greater than 120 m. In the “medium” group, the mean improvement was 364 ± 248 m (90% 
CI 274 to 452 m), representing a mean improvement of 43.8%. Within this group, two participants 
exhibited a negative improvement (i.e. got worse), whilst all other participants (21/23; 91%) showed 
improvements greater than 120 m. Five participants (22%) from the “medium” group showed an 
improvement of greater than 500 m. In the “high” group, the mean improvement was 560 ± 225 m (90% 
CI 449 to 671 m), representing a mean percentage improvement of 72.6%. In the “high” group, 9/13 
(69%) of participants demonstrated an improvement of greater than 500 m, with all participants (100%) 
showing an improvement of 120 m or greater. There was considerable inter-individual variation in 
magnitude of aerobic improvements between participants, as illustrated in figure 10.  
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Figure 9 – Between group interactions for post-training improvements in Yo-Yo Score.  
 
 
 
Figure 10 – Individual percentage improvement scores across “low”, “medium” and “high” groups. 
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4. Discussion 
 
 The results of this study indicate that, following an eight-week training period, the magnitude of 
improvements in Yo-Yo test scores show significant inter-subject variation. This finding is in agreement 
with previous research examining variability in aerobic fitness improvements following training 
(Bouchard et al., 1999; Timmons et al., 2010). Crucially, the magnitude of training improvements was 
associated with a five SNP TGS determined by genetic profiling before training began.  
 
 The use of this genetic algorithm did not predict absolute performance in the Yo-Yo test. This 
observation adds to previous work suggesting that genetic testing should not be used as a talent 
identification tool (Webborn et al., 2015). However, the results of the algorithm were associated with the 
magnitude of improvements in Yo-Yo score following training. To illustrate how this algorithm does not 
predict aerobic “talent”, the lowest pre-training (440 m) and post-training (640 m) score occurred within a 
participant from the “high” genotype group. If genetic tests were to have utility in the prediction of talent, 
it would be expected that the lowest aerobic test scores would occur in the “low” group. However, this 
same participant’s test improvement (200 m) was greater than every participant in the “low” group. This 
supports the assertion that the genetic-based algorithm has utility in predicting training response, not 
talent. Similarly, when the two participants who exhibited a reduction in Yo-Yo score in the post-training 
test are removed, every participant from the “medium” and “high” group showed improvements equal to 
(n = 1) or greater than (n = 25) those in the “low” group. Of the two participants exhibiting lower post-
training scores, one had a score reduction of 40m (from 2440 m to 2400 m), a 1.64% reduction, which is 
within the range of Yo-Yo test-retest variation previously reported (Krustrup et al., 2003). The second 
participant had a performance decrement of 240 m; which, whilst substantial, remains unexplained. 
 
The potential to predict response to aerobic training may be useful to ensure that appropriately 
individualised training methods are utilised to maximise training adaptations. For example, if an 
individual is classed as having a low aerobic trainability, it might be prudent for them to follow a 
different training programme to an individual classed as having a high aerobic trainability. There are 
many ways to increase performance in aerobic endurance activities, including improvements in VO2max, 
running economy, lactate threshold, and VO2 kinetics (Jones and DiMenna, 2011). In individuals with a 
low aerobic trainability, diverting training resources towards optimising improvements outside of VO2max 
might be appropriate; there are various methods of achieving this, including resistance and plyometric 
training (Beattie et al., 2004). Knowledge of predicted training responsiveness can also lead to more 
personalised manipulation of common training factors such as volume, intensity, frequency and duration 
to improve exercise adaptation. As an example, it has been previously reported that the number of low 
responders to an aerobic training intervention could be significantly reduced, and even eliminated, with 
an increase in exercise intensity (Ross et al., 2015). Similarly, a recent paper found that an increase in 
exercise frequency and volume, with the same intensity, completely eliminated the occurrence of non-
response to aerobic training (Montero and Lundby, 2017). The demonstrated predictive validity of this 
genetic algorithm potentially adds useful information to coaches, aiding in the interpretation of fitness 
assessments, and ensuring information is available for the planning of more effective training 
programmes.  
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The SNPs utilised in this study occur within genes demonstrated to affect either aerobic 
capacity, or the magnitude of improvements in aerobic fitness following exercise. Most of these SNPs 
occur in genes that affect the cardiopulmonary system or mitochondrial biogenesis. VEGF encodes for 
vascular endothelial growth factor, which influences the growth of new blood vessels in and around 
skeletal muscle. The C allele of this common polymorphism (rs2010963) increases expression of this 
gene, likely leading to increased blood vessel growth and hence greater oxygen availability during 
exercise (Ahmetov et al., 2008). ADRB2, which has two common polymorphisms (rs1042713 and 
rs1042714) included in this algorithm, encodes for the b2-adrenergic receptor. This receptor is the site to 
which catecholamines bind, increasing cardiovascular parameters such as stroke volume and cardiac 
output. These two common polymorphisms are associated with increases in receptor density, leading to 
increased stroke volume, cardiac output, vasodilation, and bronchodilation, all of which increase oxygen 
delivery. These polymorphisms may also increase exercise-based lipolysis, improving performance at 
lower exercise intensities (Sarpeshkar and Bentley, 2010), and have previously been associated with both 
elite athlete status (Wolfarth et al., 2007) and maximal oxygen consumption (Moore et al., 2001). The 
CRP rs1205 polymorphism can lead to an increase in C-reactive protein release at both rest and during 
exercise, potentially negatively impacting VO2max (Kuo et al., 2007b). PPARGC1A encodes for PGC-1a, 
the master regulator of mitochondrial biogenesis. G allele carriers at rs8192678 typically have higher 
VO2max values following exercise training (Ring-Dimitriou et al., 2004). The SNPs used in this algorithm 
are not exhaustive, but represent those that have, to date, been well replicated. As other SNPs which 
modify improvements in aerobic fitness are discovered and replicated in multiple cohorts, their addition 
to this genetic algorithm would likely enhance its association with aerobic fitness improvements.  
 
Regarding the practical application of these findings, astute coaches have long been aware that 
improvements in aerobic fitness following training vary extensively between athletes. This is true even 
when those athletes have similar training histories, dietary habits and lifestyles. In addition, prediction of 
adaptation to aerobic training is currently not possible using conventional physiological assessment tools 
(Timmons et al., 2010). This study suggests that a simple, non-invasive genetic test is associated with the 
magnitude of improvements in aerobic fitness following a training programme, and so may potentially 
help in the programming of training. The identification of athletes who are more likely to see smaller 
improvements allows for such athletes to follow a different training intervention, potentially with greater 
intensity (Ross et al., 2015), frequency (Montero and Lundby, 2017) or perhaps with an increased 
emphasis on repeated sprint or resistance training. This contrasts with the current best practice, which is 
the application of training to an athlete, and the measuring of that response. If the response is less than 
expected, then either the athlete is considered to have reached their potential, or a different training 
method is utilised. This trial and error approach is costly in terms of time. Given that a high-level sporting 
career can last around 10 years, a training cycle spent following ineffective training can seriously harm 
the athlete’s performance. The ability to more accurately predict the magnitude of exercise response 
could potentially: 
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1. Improve training prescription accuracy, and therefore training efficiency  
2. Enhance the personalisation of athlete-specific training programmes 
3. Reduce the costly trial and error process of executing unnecessary and/or inefficient training 
modalities. 
 
 These results potentially represent an early step on the journey to a higher level of 
personalisation within the training process. A possible limitation of this initial study is the modest sample 
size (n = 42). Nevertheless, whilst modest, this sample size is similar to other research in this field (Del 
Coso et al., 2017a; Erskine et al., 2013; Santiago et al., 2010). This sample size is also representative of 
the size of a typical soccer squad (first and reserve teams), giving it real-world validity. The participants 
were all male, so it is not clear if the results would be applicable for females. In addition, the number of 
participants in the “low” group was small (n = 6); pre-test power calculations were not possible because 
the genetic results of the athletes were not available until completion of the study. With information 
regarding frequency of athletes expected to be in the “low” group now available, this information can be 
used to ensure adequate sample sizes in future. Further research should build on these initial findings in a 
larger cohort, other sports, and females, as well as studying interventions aimed at enhancing aerobic 
training response. The Yo-Yo IR1 test used in this study is a maximal test, and so scores are potentially 
influenced by participant motivation. Whilst none of the SNPs used in this study have been found to 
influence participant motivation, there is a small possibility that variation in these genes could influence 
exercise tolerance, and hence test performance (Pickering & Kiely 2017b). Additionally, improvements in 
Yo-Yo test performance may occur outside of adaptations in aerobic capacity, such as improvements in 
technical performance and anaerobic capacity. Future studies may wish to use laboratory-based tests to 
directly explore aerobic fitness improvements. Additionally, as no comparator arm was present, there is 
the potential that random-within subject variation contributed to the observed inter-individual variation 
(Atkinson & Batterham, 2015). Furthermore, the relative work or training loads of the small-sided games 
were not quantified via external methods such as through the use of GPS and/or accelerometers to 
determine distance travelled and running intensity, or via additional internal measures such as heart rate. 
Although training intensity was prescribed via RPE, other means of quantification may have proved 
useful. Additionally, controlling for a number of covariates, including player age, maturation, playing 
position, and training history/experience, outside of baseline testing data—in which there were no 
differences between groups—would have strengthened the conclusions of the present study. A final 
limitation is that there were no set progressions built into the small-sided games training program in terms 
of increasing the relative intensity of the exercise bouts in a periodised or linear manner, although 
variation was provided through changes in team and pitch size.  
 
Finally, whilst the results of this study indicate that the current five-SNP algorithm has utility, 
the addition of a greater number of polymorphisms would likely enable it to become more precise. 
Indeed, it is envisioned that the current algorithm is not a definitive end-point, but instead an initial 
attempt to predict training response that will become more refined and precise as more information is 
available. Nevertheless, the fact remains that very little research has been done in utilising genetic 
information in sporting practice, despite there being an undoubted genetic influence on the magnitude of 
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adaptation following aerobic training. The novel findings of this study, even at this early stage in the 
evolution of such technology, should contribute to the further development of this area.  
 
 
5. Conclusion 
 
The results of this study indicate there is considerable inter-subject variability in response to aerobic 
training in a group of well-trained male soccer players. In addition, it also demonstrates that the 
magnitude of these improvements is associated with a genetic test comprised of five SNPs. This 
previously unavailable information has the potential to provide insight to coaches, medical practitioners, 
personal trainers and athletes, enabling more informed decision making and evidence-led customisation 
of training programmes aimed at improving aerobic fitness. This potentially aids athletes, and their 
support staff, in selecting the optimal training modality, allowing for a more personalised training 
approach, and, in future, the maximisation of training adaptations for all athletes.  
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CHAPTER 11: A GENETIC-BASED ALGORTIHM FOR RECOVERY  
 
Chapter preface: 
 Post-exercise recovery is an important component of the adaptive process in athletes (Bishop et 
al., 2008). There is, however, an apparent trade-off between too much recovery, and hence too little 
stimulus, and not enough recovery, a balancing act which, if inexpertly negotiated, can drive issues such 
as underperformance, injury, and accumulation of residual fatigue (Mair et al., 1996; Soligard et al., 
2016). As a result, considerable time and money is spent at the highest level in optimising athlete 
recovery processes, often with mixed results. This chapter outlines a study which utilised a commercially 
available Total Genotype Score to determine whether the magnitude of reduction in Countermovement 
Jump, a valid and reliable test of neuromuscular fatigue (Cormack et al., 2008a), following a repeated 
sprints session were associated with genotype score.  
 
1. Introduction 
 
Exercise training produces a variety of acute physiological challenges to the body, perturbing 
homeostasis and inducing a stress response, the overcoming of which leads to exercise adaptation. 
Successful adaptation is comprised of the accumulation of periods of stress-induced response (training), 
and periods of recovery, which takes place away from exercise (Bishop et al., 2008). This relationship is 
finely balanced, and if there is insufficient time between training sessions for recovery to occur, the 
athlete increases their risk of undue accumulation of fatigue, potentially resulting in acute 
underperformance, injury (Mair et al., 1996), illness (Schwellnus et al., 2016), and eventually non-
functional overreaching and unexplained underperformance syndrome (UPS) (Soligard et al., 2016). 
These indicators of maladaptation are common in athletes, with 10-20% of endurance athletes suffering 
from UPS each year (Budgett, 2000). Overuse injury incidence is also frequent, with rates between 37% 
and 85% reported, depending on the sport (DiFiori et al., 2013; Wilber et al., 1995). The prevalence of 
these symptoms of stress-recovery imbalance at epidemic proportions indicates that there is a mismatch in 
knowledge of how to create stress and how to recover from it. Indeed, a search on PubMed yields over 
37,000 papers with “exercise training” in the title and abstract. A similar result with “exercise recovery” 
as the search field only results in 13,000 papers. 
 
At the cellular level, the physiological challenges induced by exercise include increased 
oxidative metabolism within the mitochondria, leading to increased formation of reactive oxygen species 
(ROS) (Fisher-Wellman & Bloomer, 2009). Under normal, non-exercise conditions, the body can 
neutralise ROS through its endogenous antioxidant defence system, which is comprised of enzymes such 
as superoxide dismutase (Belviranli & Gokbel, 2006). However, when ROS production is increased 
through exercise, an imbalance between ROS production and neutralisation occurs, leading to elevated 
oxidative stress (Fisher-Wellman & Bloomer, 2009). In turn, this elevates lipid peroxidation and tissue 
damage. Mechanical load also increases muscle damage (Baumert et al., 2016), initiating an 
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inflammatory response partially driven by pro-inflammatory cytokines such as interleukin-6 (IL-6) and 
tumour necrosis factor (TNF) (Yamin et al., 2008).  
 
These changes at the molecular and cellular level drive the whole-body symptoms of under-
recovery that athletes and coaches are well aware of. Increases in plasma IL-6 levels occur following 
exercise (Robson-Ansley et al., 2007), and administration of exogenous IL-6 into athletes induces 
feelings of fatigue and impairs performance (Robson-Ansley et al., 2004). Increased IL-6 is also a risk 
factor for the development of UPS (Robson, 2003). Both TNF and IL-6 can act on the central nervous 
system (Ament & Verkerke, 2009), potentially decreasing the drive to exercise. Increased ROS and 
oxidative stress are also associated with a decrease in physical performance (Powers & Jackson, 2007), 
and increased feelings of muscle soreness following exercise (Konig et al., 2001).  
 
A number of best practices for recovery have been put forward (Bishop et al., 2008; Leeder et 
al., 2012b; Soligard et al., 2016; Schwellnus et al., 2016). However, there is likely considerable inter-
individual variation in the time course of exercise recovery (Nosaka et al., 1996). This is partially 
governed by genetic variation between individuals, with several single nucleotide polymorphisms (SNPs) 
already identified as potentially affecting the speed of post-exercise recovery (Baumert et al., 2016). 
Knowledge of this variation may enable athletes and support staff to create individualised recovery 
interventions based on the identification of individuals at increased risk of exercise induced muscle 
damage or oxidative stress (Del Coso et al., 2017a).  
 
Whilst this emerging research of the impact of genotype on exercise recovery is interesting, the 
translation of these findings to the field are currently under-explored. Given the proposed impact of 
genetic polymorphisms on exercise recovery, the purpose of the present study was to attempt to bridge 
this gap, by determining whether a seven SNP algorithm successfully differentiated between the recovery 
speed of male soccer players. It is believed that individuals possessing a greater number of alleles 
associated with increased oxidative stress, muscle damage or inflammation would see a greater reduction 
in neuromuscular function post-training, and that this reduction would take longer to abate relative to 
those individuals in possession of a more favourable genetic profile.  
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2. Methods 
 
2.1 Participants 
 
18 male soccer players aged between 16-19 years of age from a college soccer academy 
volunteered to participate in this study. Each player had an average of 11 years’ football training 
experience, and was actively competing in the English College Football Association Premier League.  
 
2.2 Methodology 
 
As part of their normal soccer training, and following 24-hours rest, the participants took part in 
a repeated sprint testing session. Both before, and immediately upon completion of this session, the 
participants underwent Countermovement Jump (CMJ) testing. This test was repeated at 24- and 48-hours 
post-training to monitor their recovery status. Participants were familiarised to all tests as they are 
regularly used during their normal soccer training. Within the CMJ trials, participants undertook three 
trials at each time point, which were averaged to give a mean score. Participants had two minutes’ 
recovery between trials. Prior to the initial exercise bout and subsequent testing, players carried out a 
standardised 15-minute warm up, consisting of pre-activation exercises and dynamic drills. The initial 
exercise bout was comprised of two sets of seven 25m sprints undertaken outdoors on a soccer pitch. The 
recovery period was 30 seconds passive recovery between sprint reps, and 5 minutes passive recovery 
between sets. Previous work has demonstrated that similar high-intensity repeated sprint efforts induce 
neuromuscular fatigue—as evidenced by a reduction in CMJ height—for up to 72 hours post-exercise 
(Keane et al., 2015), along with elevations in Creatine Kinase (CK), increased sensations of muscular 
soreness (Keane et al., 2015), and general fatigue (Goodall et al., 2015). As such, this protocol is likely 
suitable as a method of examining neuromuscular fatigue and exercise-induced muscle damage in 
sporting contexts (Howatson & Milak, 2009).  
 
The CMJ was chosen as it has previously been shown to be a reliable and valid measure of 
neuromuscular fatigue (Cormack et al., 2008a, 2008b, 2008c; McLean et al., 2010; Gathercole et al., 
2015) that is widely used in sporting settings (Taylor et al., 2012). The CMJ was measured using 
Optojump (Microgate, Italy), a valid and reliable tool for the assessment of vertical jump height in the 
field (Glatthorn et al., 2011). Prior to undertaking each CMJ, participants were instructed to keep their 
hands on their hips throughout the jump to eliminate any influence of arm swing. If the arms lost contact 
with the hips, the jump was classed as a no-jump, and an additional jump was performed following two-
minutes recovery. In each CMJ trial, participants began standing upright, then performed a fast 
downwards eccentric action followed immediately by a jump for maximal height. Individual results were 
expressed as height jumped in centimetres (cm). Average CMJ height was utilised, primarily as a recent 
meta-analysis reported it to be more sensitive than peak individual CMJ height when monitoring 
neuromuscular fatigue (Claudino et al., 2017); the authors of that meta-analysis therefore recommended 
average CMJ height as a method of assessing neuromuscular fatigue.  
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2.3 Genetic testing 
 
Alongside the training programme, participants underwent genetic testing by DNAFit Life 
Sciences; this occurred via a sterile buccal swab. The samples were sent to IDna Genetics Laboratory 
(Norwich, UK), where DNA was extracted and purified using the Isohelix Buccalyse DNA extraction kit 
BEK-50 (Kent, UK), and amplified through PCR on an ABI7900 real-time thermocycler (Applied 
Biosystem, Waltham, USA). Through this process, genetic information regarding SNPs believed to affect 
post-exercise recovery speed (CRP rs1205, GSTM1 & GSTT1 INDEL, IL-6 -G174C rs1800795, IL-6R 
rs2228145, SOD2 rs4880, TNF G-308A rs1800629) was determined. The DNAFit test uses an algorithm 
to stratify participants into “slow”, “medium” or “fast” recovery speed by utilising a Total Genotype 
Score (TGS) method. Each allele is given a score of between 0 and 4 points depending on the expected 
magnitude of its impact on post-exercise recovery speed. The strength of the rating was based on the 
evidence from cumulative literature results averaged over time. The sum of these points was combined to 
give an overall score. This method is identical to Jones et al. (2016), and similar to the methods used in 
other studies utilising genetic algorithms (Ruiz et al., 2009; Meckel et al., 2014; Pickering et al., 2018). 
An overall score of 40% or less is classed as a “fast” genetic recovery speed. Scores of 41-60% are 
classed as a “medium” genetic recovery speed. A score of >60% is classed as a “slow” genetic recovery 
speed. The athletes were blinded to their genetic results until completion of the final testing.  
 
2.4 Statistical analysis 
 
As this is not a genetic association study, but an observational study into the effects of TGS on 
exercise recovery, gene-by-gene analysis was not carried out. Instead, data pertaining to exercise recovery 
was compared to individual athlete TGS group. Means and standard deviations were calculated for whole 
group and sub-groups for both pre- and post-training (0h, 24h and 48h) test scores. CMJ height at the 
three post-training time points was converted to a percentage of pre-training height. Given the small 
sample size, along with the fact that significance testing is sensitive to low sample sizes, and doesn’t 
inform as to the magnitude (Buchheit 2016), effect sizes (Cohen’s d) were instead calculated for between 
group differences at the three post-training time points. The thresholds used were 0.2 (trivial), 0.5 (small), 
0.8 (moderate), >0.8 (large) (Cohen 1988). Data were analysed using Microsoft Excel 15.29 (Microsoft 
Corporation, Redmond, WA, USA). All data are reported as mean ± SD. 
 
 
3. Results 
 
Overall, 12 participants were classed as having a fast recovery speed, with 6 participants having 
a medium recovery speed. No participants were found to have a slow recovery speed; based on an 
analysis of 17,000 samples tested by DNAFit (Pickering, unpublished data – detailed in Chapter 4), 
approximately 6% of all individuals within a population would be expected to be in the slow group. 
Within this sample population, it would therefore be expected that one participant would be in the slow 
group; the lack of such an individual in the present study is therefore not unusual. Table 10 shows the 
absolute CMJ results for the fast and medium genetic recovery speed groups. Figure 11 illustrates the 
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between group differences as a percentage over the 48-hour period following the exercise bout, along 
with effect sizes.  
 
Group CMJ Pre-
Training 
CMJ Post-
Training 
CMJ 24h Post-
Training 
CMJ 48h Post-
Training 
Fast (n=12) 37.6 ± 6.2 cm 37.0 ± 6.2 cm 36.0 ± 6.9 cm 37.0 ± 6.1 cm 
Slow (n=6) 35.7 ± 5.6 cm 34.1 ± 6.3 cm 33.3 ± 5.5 cm 33.7 ± 5.6 cm 
 
Table 10 – CMJ values for both groups across all time points.  
 
 
 
Figure 11 – Percentage change in CMJ height immediately post-training, 24h post-training, and 48h post-
training as a percentage relative to pre-training values. Effect sizes are # = 0.7 (medium), * = 0.5 
(medium), § = 1.0 (large). 
 
 
4. Discussion 
 
The results of this study indicate that rate of recovery, as measured by CMJ, is potentially 
modified by a total genotype score comprised of seven SNPs thought to impact exercise recovery. 
Overall, players in the “fast” genetic recovery speed group tended to demonstrate a smaller reduction in 
CMJ height relative to those players in the “medium” genetic recovery speed group, and were closer to 
baseline score following 48-hours of recovery. Immediately upon completion of the exercise bout, and 24 
hours later, the magnitude of this effect was representative of a medium effect size. Forty-eight hours 
after training, this effect size had grown in magnitude to large. This suggests that these seven SNPs 
potentially modify recovery speed, such that individuals with more favourable alleles suffer a smaller 
percentage loss in CMJ height after repeated sprints, and have regained a greater percentage of their pre-
training CMJ height 48 hours post-training. However, when interpreting these results, it is important to 
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consider that that the coefficient of variation in CMJ performance is ~3-5% (Gathercole et al., 2015), 
which, in the present cohort, equates to a ~1-1.6cm reduction in jump height following repeated sprint 
exercise. These values are similar to the reduction in jump height demonstrated here, so it is possible that 
these changes in performance may be due to both technical error and random within-subject variation. 
Furthermore, the reported baseline standard deviations suggest a smallest worthwhile change (0.2 x SD; 
Buchheit 2018) that corresponds to a value larger than the performance changes demonstrated here. As 
such, the real-world significance and utility of these results is unclear.  
 
Nevertheless, the ability to predict the recovery time needed following intense exercise may be 
useful for several reasons. Firstly, it ensures that optimal recovery time can be given to individual 
athletes, reducing the fatigue that will accumulate across a training programme. This will ensure that the 
athlete is not placed at undue risk of suffering from injuries, of which the risk increases under fatigue 
(Dugan & Frontera, 2000), and may guard against the developing of unexplained underperformance 
syndrome. It may also be useful when planning the final physical conditioning session before a 
competition, with players genetically predisposed to slower recovery speeds having a longer rest period 
pre-competition. Finally, it may increase the motivation of individuals to carry out the correct recovery 
modalities post-training or post-competition, particularly if they are shown to have a slower recovery 
speed. However, the results from nutrigenetic research indicate that, at present, individuals do not always 
make behavioural changes based on genetic information (McBride et al., 2010); whether this is the case in 
highly motivated sports people is unclear.  
 
The SNPs that comprise the genetic algorithm used here have previously been shown to 
potentially influence both the inflammatory response to exercise and the ability to tolerate oxidative 
stress. IL-6 -G174C (rs1800795) has been shown to influence creatine kinase (CK) levels following 
eccentric exercise, with the C allele of IL-6 associated with higher levels (Yamin et al., 2008; 
Lappalainen 2009). The IL-6 C allele is also associated with increased post-exercise plasma IL-6 
(Huuskonen et al., 2009), which is associated with increased fatigue in athletes (Robson-Ansley et al., 
2007). IL-6R (rs2228145) is also associated with post-exercise IL-6 levels, with the C allele associated 
with higher concentrations (Reich et al., 2007). Increases in plasma IL-6R concentrations are associated 
with increased C-Reactive Protein (CRP) levels post-exercise, as well as increased feelings of fatigue in 
athletes (Robson-Ansley et al., 2009). The TNF G-308A (rs1800629) polymorphism is associated with 
plasma CRP levels following aerobic exercise, with AA genotypes having higher CRP levels (Lakka et 
al., 2006). CRP (rs1205) alters plasma CRP concentrations, a common exercise recovery marker (Miles et 
al., 2007; Ingram et al., 2009), with G allele carriers having significantly higher CRP levels than AA 
genotypes (Eiriksdottir et al., 2009).  
 
SOD2 (rs4880) encodes for manganese superoxide dismutase (MnSOD), which supports the 
dismutation of mitochondrial superoxide radicals into hydrogen peroxide and oxygen (Li et al., 2005). 
The T allele of this SNP is associated with increased CK post-exercise (Akimoto et al., 2010; Ahmetov et 
al., 2014b), although this relationship is complex and potentially modified by a subject’s habitual 
antioxidant nutrient intake (Li et al., 2005). GSTM1 (glutathione S-transferase M1) and GSTT1 
(glutathione S-transferase T1) are insertion/deletion polymorphisms, with deletion genotypes having poor 
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activity of the enzymes encoded for by these genes. Whilst these polymorphisms are well studied with 
regards to health and diet interactions (Palli et al., 2004), only one study has examined their impact on 
post-exercise muscle damage markers, with no significant differences between the inserted or deleted 
genotypes (Akimoto et al., 2010). These SNPs were included in the algorithm based on their theoretical 
impact on exercise recovery (Evelo et al., 1992; Vani et al., 1990).  
 
The identification of athletes who may be genetically predisposed to increased recovery times 
can lead to the use of targeted recovery modalities, including nutritional interventions. Phillips and 
colleagues (2003) reported that 14 days of supplementation with vitamin E, omega-3 and flavonoids 
blunted the release of IL-6 and CRP following eccentric exercise. Similar results have been reported from 
other studies (Satoshi et al., 1989; Jouris et al., 2011; Sacheck et al., 2003). Other interventions that may 
enhance recovery include cold water immersion (CWI) and the use of compression garments, although 
the results are currently equivocal (Leeder et al., 2012b; Bleakley & Davison, 2009; Ascensao et al., 
2010; Jakeman et al., 2009; Duffield et al., 2010; Duffield et al., 2008; Jakesment et al., 2010). It should 
be noted that exercise adaptation relies on the application of stress to the body, and the use of antioxidant 
supplements and CWI may blunt this adaptation (Draeger et al., 2014; Yamane et al., 2015), or in some 
cases reduce the speed of recovery (Close et al., 2006).  
 
In addition to the potential lack of meaningful change in CMJ induced by fatigue within this 
study, there are some additional potential limitations. The use of CMJ as a measure of neuromuscular 
fatigue in football has recently been questioned (Carling et al., 2018), although it has been previously 
shown to be valid and reliable in this context (Cormack et al., 2008a, 2008b, 2008c; McLean et al., 2010; 
Gathercole et al., 2015). The cohort size is very modest (n=18). A standard soccer team is often 
comprised of 20-25 players; although at any given time some players may be injured and unable to train. 
The sample size in this study therefore represents a realistic size that coaches and practitioners may 
encounter in the real world. It is also representative of sample sizes often used in genetic pilot studies 
(Loy et al., 2015). However, this research requires replication in a larger cohort. In addition, this study 
had no participants with a TGS that suggested they had a slow genetic recovery speed, only medium and 
fast. The result of having a slow recovery speed is uncommon, with approximately only one participant 
for every sixteen tested expected to be in this category (Pickering, unpublished data), requiring very large 
sample sizes in order to recruit sufficient individuals into this category. The participants were all male, so 
it is unclear whether the results would be the same in females. Finally, it must be recognised that the use 
of this algorithm represents a crude measure, as many other SNPs doubtless affect exercise recovery. 
However, the results of this initial study are both novel and promising, such that further research in this 
field should assist in the development of personalised recovery guidelines.  
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5. Conclusion 
 
This study demonstrates that there is variation in the rate of recovery from a repeated sprint 
exercise in a group of well-trained male soccer players, although the real-world meaningfulness of this 
variation is unclear (Carling et al., 2018). The use of a seven SNP genetic algorithm appears to potentially 
aid in the identification of those players who may require longer recovery times between intense exercise 
bouts, or who may most benefit from targeted recovery interventions. These findings are similar to those 
of Del Coso et al. (2017a; 2018a), although the SNPs utilised vary. The implications of these findings 
suggest that knowledge of genetic information may be important in individualising recovery timings and 
modalities in athletes; future research exploring differences in perception of fatigue and recovery, based 
on genetic variation, may also be warranted. Future research is also required to replicate these findings in 
a larger cohort, as well as in females, and attempt to demonstrate real world utility; nevertheless, the 
results potentially herald a further step towards an individualised training process.  
 
 136 
CHAPTER 12 - CAN GENETIC TESTING PREDICT TALENT? A CASE STUDY OF FIVE 
ELITE ATHLETES  
 
Chapter preface: 
 
 As explored in Chapter 8, there is increasing interest in being able to use genetic information to 
predict the likelihood of an individual becoming a future elite sports performer. Whilst, at present, the 
general consensus is that genetic information cannot (Webborn et al., 2015; Vlahovich et al., 2017a), and 
perhaps should not (Camporesi & McNamee, 2016) be used in this way, further exploration is required to 
determine whether it holds real-world potential. This chapter presents a study which utilises the most 
comprehensive panel of genetic variants associated with elite athlete status compiled within published 
literature. Using this expanded gene panel, Total Genotype Scores (TGS) were calculated for five elite 
athletes, including an Olympic Champion. These TGS were then compared to a reference population of 
503 non-athlete controls, to determine the effectiveness of the TGS in discriminating athlete from non-
athlete. This study has been submitted for publication, and is currently undergoing peer-review.  
 
 
1. Introduction 
 
Over the last thirty years, there has been a rapid increase in the appreciation of how genetics 
influences elite sports performance. General heritability studies have estimated the heritability of elite 
athlete status to be approximately 66% (De Moor et al., 2007), and an understanding of how specific 
genetic variants, such as ACTN3 (Yang et al., 2003), may predispose towards elite performance has 
continued to grow. These advances have served to increase speculation that genetic testing may be used 
to identify individuals with an increased likelihood of achieving elite athlete status in the future, with 
some direct-to-consumer genetic testing companies offering this service to customers (Webborn et al., 
2015).  
 
However, at present, the scientific consensus is that genetic information is ineffective at 
identifying future talented performers (Webborn et al., 2015), and, furthermore, poses significant ethical 
problems (Camporesi & McNamee, 2016)—both aspects are discussed at length in Chapter 8. Previously, 
Williams & Folland (2008) incorporated 23 genetic variants associated with elite endurance performance 
in a data simulation, with subsequent results suggesting that there was only a 0.0005% chance of any 
single person in the world having the optimal form of all 23 performance-associated variants. A further 
issue is that, within this simulation, there was considerable similarity in polygenic profiles between 
individuals, with the clustered distribution of genotype scores limiting the emergence of genetic outliers, 
who might be predicted to be more likely to be elite athletes. Similar findings, relating to muscular 
strength and power characteristics, have also been demonstrated (Hughes et al., 2011). These issues have 
also been explored experimentally, most commonly via the use of Total Genotype Scores (TGS). Here, a 
score is assigned for each genotype of interest, and then summed into a final score for that athlete. For 
example, Ruiz and colleagues (2009) collected data on elite Spanish endurance athletes and controls. 
Whilst, on average, the athletes had a greater TGS for a panel of seven endurance-related polymorphisms 
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than non-athlete controls, there was considerable overlap in score between the populations, indicating that 
the predictive capability of this TGS was low. Indeed, it was determined that individuals with a TGS 
above 74.71% were over five times more likely to be elite athletes; however, only 43.5% of the elite 
athletes attained such a score. Similar results were reported for elite power athletes (Ruiz et al., 2010); 
again, the athletes had a higher average power TGS compared to controls and endurance athletes, but 
there was a large crossover of the standard deviations, indicating limited sensitivity and specificity.  
 
Such evidence suggests that utilising a relatively low number of polymorphisms to identify elite 
athletes is unlikely to provide meaningful insights (Williams & Folland, 2008; Ruiz et al., 2009; Ruiz et 
al., 2010; Santiago et al., 2010). However, many more polymorphisms than the 23 or fewer utilised in the 
studies to date have been associated with elite performance. A recent literature review (Ahmetov et al., 
2016) reported that at least 155 genetic markers have been associated with elite athlete status, with further 
associations recently emerging (Guilherme & Lancha Jr, 2017). Additionally, in a recent survey in the 
UK, 67% of athletes and 48% of support staff stated that genetic testing would form a valuable tool to 
talent identification processes within their sport (Varley et al., 2018a), suggesting that there is an appetite 
for genetic information within the sports performance world.  
 
As such, further research in this area is clearly required. If genetic information is to offer utility 
in the identification of talented performers, it needs to be able to discriminate between elite performers 
and the general public. The aim of this investigation, accordingly, is to determine whether the use of an 
increased number of genetic variants as part of a TGS can achieve such a goal, through the utilisation of a 
case study approach with five elite athletes. It is believed that such a large scale TGS has not previously 
been utilised to potentially identify talented athletes, demonstrating the novelty of this case study.  
 
2. Methods 
 
2.1 Participants 
 
The participants were five former or current high-level athletes. All participants gave written 
consent for their results and identity to be shared here. The study protocol was approved by the University 
of Central Lancashire Ethics Committee, in accordance with the Declaration of Helsinki.  
 
Participant A (Andrew Steele) is a former 400m runner. He competed at one Olympic Games, 
winning a medal in the 4x400m relay. His personal best time is 44.94s.  
 
Participant B (Greg Rutherford) is a former long jumper. He has competed at three Olympic 
Games, winning a Gold and a Bronze medal. His personal best distance is 8.51m.  
 
Participant C (Craig Pickering) is a former sprinter. He competed at one Olympic Games, and 
has a World Championships Bronze medal in the 4x100m relay. His personal best 100m time is 10.14s. 
He also won a Silver Medal at the European Indoor Championships over 60m.  
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Participant D (Tom Lancashire) is a middle-distance runner, competing primarily over 1500m, 
the distance at which he was selected for an Olympic Games. His personal best 1500m time is 3:33:96. 
 
Participant E (Andrew Lemoncello) is a long-distance runner, with a Marathon personal best 
time of 2:13:40. He competed at two World Championships, and one Olympic Games.  
 
2.2 Genetic testing 
 
Each participant volunteered a saliva sample, which was collected through sterile and self-
administered buccal swabs. The samples were sent to AKESOgen, Inc (Peachtree Corners, GA, USA), 
where DNA was extracted from the saliva samples using Qiagen chemistry on an automated Kingfisher 
FLEX instrument (Thermo Fisher Scientific, Waltham, MA, US), following the manufacturer’s 
recommended protocols and standard operating procedures. PicoGreen and Nanodrop measurements were 
taken to measure the quality and quantity of the DNA. Input to the custom testing array occurred at 200ng 
in 20µL. Amplification, fragmentation, and resuspension was performed using Biomek FXP following 
Affymetrix’s high throughput protocol for Axiom 2.0. Hybridisation was performed for 24 hours at 48°C 
in a Binder oven, and staining and scanning of the arrays was performed using GeneTitan instrumentation 
(Thermo Fisher Scientific, Waltham, MA, US), all following the same Affymetrix high throughput 
Axiom 2.0 protocol. Data analysis was then performed using a raw CEL file data input into the 
Affymetrix Axiom Analysis Suite (Affymetrix, Santa Clara, CA, US).  
 
2.3 Creation of Total Genotype Scores 
 
In order to best examine the potential use of genetic information in identifying elite athletes, 
polymorphisms previously linked to elite speed-power and elite endurance athlete status were collated 
through a structured literature search.  
 
Speed-power athlete status: 48 genetic variants associated with power athlete status were 
identified from two review articles (Ahmetov & Fedotovskaya, 2015; Ahmetov et al., 2016). Of these 48, 
one marker (IL1RN) could not be genotyped due to lack of coverage on the AKESOgen chip array. A 
further SNP, rs2854464 in ACVR1B, was added to the panel (Voisin et al., 2016). Three SNPs in the 
carnosine genes CNDP1 and CNDP2, associated with elite power athlete status (Guilherme & Lancha Jr, 
2017) were also not present on the chip array, and so were not assessed. Mitochondrial DNA (mtDNA) 
was not assessed. The effect allele of one SNP, rs11091046 in AGTR2, was reversed given the findings of 
a recent meta-analysis (Yvert et al., 2018).  
 
Endurance athlete status: 68 genetic variants associated with endurance athlete status were 
identified from two review articles (Ahmetov & Fedotovskaya, 2015; Ahmetov et al., 2016). Of these, the 
genotype of 5 (ADARA2A 6.7/6,3kb, BDKRB2 +9/-9, COL5A1 rs71746744, NOS3 4A/4B, PPP3R1 
5I/5D) could not be determined due to insufficient coverage. An additional SNP, rs10497520 in TTN, was 
added to the TGS (Stebbings et al., 2018). mtDNA was not assessed.  
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2.4 Scoring 
 
For each genetic variant, a score of 0, 1 or 2 was given depending on the genotype of the athlete. 
A score of 2 represents the possession of two alleles associated with elite athlete status (e.g. CC for 
ACTN3 rs1815739 within the power TGS); a score of 1 represents carriage of one such allele (e.g. CT for 
ACTN3 rs1815739 within the power TGS); and a score of 0 represents the possession of no elite athlete-
associated alleles for that genetic variant (e.g. TT for ACTN3 rs1815739 within the power TGS). For each 
trait, the scores were then summated, divided by the total possible score, and multiplied by 100 to get a 
percentage. This method is identical to that employed in previously published research utilising a TGS to 
explore elite athlete status (Williams & Folland, 2008; Ruiz et al., 2009; Ruiz et al., 2010; Santiago et al., 
2010). The analysis was performed in Excel 16.13.1 (Microsoft, Redmond, WA, USA). 
 
2.5 Control population 
 
In order to develop an adequate control population, genotype scores for 503 European 
Caucasians were downloaded from e!GRCh37 (http://grch37.ensembl.org/index.html) into a spreadsheet 
for analysis. For each genetic variant, a score of 0, 1, or 2 was given as per the speed-power and 
endurance TGS detailed previously. The sum of scores for each variant was then calculated, and 
converted into the TGS% as per the previously detailed method. Additionally, the mean and standard 
deviation score for this reference population were calculated.  
 
 
3 Results 
 
3.1 TGS Scores 
 
Figure 12 shows the results of all five participants’ speed-power TGS, as well as the mean score 
expected in European Caucasians. The three speed-power athletes (A-C) had the highest TGS, whilst the 
two endurance athletes (D & E) had the lowest. This trend held up in comparison to the mean score for 
European Caucasians, with the speed-power athletes having a higher than mean score, and the endurance 
athletes a lower than mean score.  
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Figure 12 – The speed-power TGS of all participants, along with the mean (±SD) for European 
Caucasians. 
 
In comparison, figure 13 demonstrates the results of the endurance TGS. Here, the two 
endurance athletes still have the lowest TGS—lower than the elite speed-power athletes and the mean for 
European Caucasians.  
 
 
 
Figure 13 – The endurance TGS of all participants, along with the mean (±SD) for European Caucasians. 
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3.2 Comparison to previously published TGS 
 
The next stage of the analysis involved calculation of the TGS from previously published 
research by Ruiz and colleagues (2009; 2010). The results for the speed-power TGS are shown in figure 
14, and the results for the endurance TGS are in figure 15.  
 
 
 
 
Figure 14 – The speed-power TGS from Ruiz et al. (2010) for all participants in the present cohort, the 
mean for European Caucasians, and elite power and endurance athletes from Ruiz’s cohort.  
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Figure 15 - The endurance TGS from Ruiz et al. (2009) for all participants in the present cohort, the mean 
for European Caucasians, and elite endurance athletes from Ruiz’s cohort. 
 
3.3 Non-athlete control results 
 
The frequency distributions for 503 non-athletic Caucasian controls for both the power (figure 
16) and endurance (figure 17) TGS were then calculated. In general, the results of the control population 
are fairly tightly distributed around the mean. Within the power TGS, no subject fell below a score of 
26%, or above a score of 53%. Similarly, within the endurance TGS, no subject had a score below 34% or 
above 55%. 
 
 
 
Figure 16 – Frequency distribution of power TGS% for non-athletic controls. 
 
0
10
20
30
40
50
60
70
80
A B C D E
Av
era
ge
 EU
R
Ru
iz E
nd
ura
nce
TG
S 
%
Participant 
0
10
20
30
40
50
60
26
-2
7
27
-2
8
28
-2
9
29
-3
0
30
-3
1
31
-3
2
32
-3
3
33
-3
4
34
-3
5
35
-3
6
36
-3
7
37
-3
8
38
-3
9
39
-4
0
40
-4
1
41
-4
2
42
-4
3
43
-4
4
44
-4
5
45
-4
6
46
-4
7
47
-4
8
48
-4
9
49
-5
0
50
-5
1
51
-5
2
53
-5
3
Fr
eq
ue
nc
y
TGS%
 143 
 
 
Figure 17 – Frequency distribution of endurance TGS% for non-athletic controls. 
 
 
4 Discussion 
 
Using a 48 SNP TGS of speed-power associated SNPs, there was a general trend for a higher 
score in the elite speed-power athletes (range 42.7-44.8%) compared to the elite endurance athletes 
(37.5%) in the present cohort. These findings also held up favorably compared to the mean score for 
Caucasian Europeans (39.4%); in this case, the speed-power athletes had a higher TGS than non-athlete 
controls, who in turn had a higher TGS than the elite endurance athletes. This suggests that the use of 
genetic information to identify talented performers may hold utility; however, both endurance athletes 
and two of the three power athletes were within one standard deviation of the non-athlete mean score. 
Indeed, in the 503 European reference samples utilised, 68 individuals had a higher speed-power TGS 
than athlete A, the highest scoring athlete in the present cohort. The highest score in the control 
population was a TGS of 50%, just over 2SDs greater than the mean.  
 
The results for the 64 SNP endurance TGS further demonstrated the lack of utility of genetic 
testing for talent identification. Here, all three speed-power athletes (range – 43.8-48.7%) out-scored the 
endurance athletes (39.8 – 42.2%), who in turn scored lower than the mean for European Caucasians 
(43.8%). The SD for scores in the 503 European reference samples was 3.8%, with 82 control subjects 
having an endurance score >1SD outside of the mean. The highest score was 54.6%. 
 
The comparisons to the previously published TGS utilised by Ruiz and colleagues (2009; 2010) 
provide some interesting results. In the present cohort, the elite endurance athletes scored more highly on 
Ruiz and colleagues’ endurance TGS (64 and 71%) than the speed-power athletes. This is the opposite 
result to that seen when utilising the larger scale TGS developed for this study. This potentially suggests 
that the utilisation of fewer genetic variants within a TGS may enhance the predictive ability of such a 
model, potentially because the selected variants have a greater effect size. Larger sample sizes are 
required to further test this. Regarding the power TGS (Ruiz et al., 2010), the athletes in the present 
cohort all scored lower than the mean power score in the Ruiz cohort; two just outscored the mean for 
European Caucasians, whilst participant C—a European medalist over the 60m sprint—scored below the 
mean for European Caucasians, and was outscored by participant E, the long-distance runner. Again, this 
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is in contrast to the results of the present study, where the speed-power athletes all outscored the 
endurance athletes, suggesting that the larger scale TGS is potentially more sensitive in determining 
speed-power athlete status.   
 
The two genetic variants with the most well-established associations with elite athlete status are 
ACE and ACTN3 (Gayagay et al., 1998; Yang et al., 2003; Papadimitriou et al., 2016). Regarding ACTN3, 
the C allele of rs1815739 is consistently associated with elite speed-power athlete status, with two recent 
meta-analyses (Ma et al., 2013; Weyerstraß et al., 2018) finding that individuals with the TT genotype 
were significantly less likely to achieve elite speed-power athlete status compared to those with at least 
one C allele. The three speed-power athletes within the present cohort exhibit the full range of ACTN3 
genotypes (data not shown). Participant B, the highest achieving athlete of the cohort, has the CC 
genotype. Participant C, the short sprinter, possesses the CT genotype, whilst participant A, the Olympic 
400m relay medallist, has the TT genotype. This latter result may be somewhat surprising given that this 
genotype is considered unfavourable for elite speed performance, a result which has also been 
demonstrated in 400m runners (Papadimitriou et al., 2016). The endurance athletes in this cohort 
possessed the CT and CC genotype respectively. Both of these genotypes would be considered slightly 
unfavourable for elite endurance athletes (Ma et al., 2013). This relationship, however, appears complex 
and poorly understood; whilst some studies suggest an association between the ACTN3 T allele and elite 
endurance status (Yang et al., 2003), others do not (Papadimitriou et al., 2018).  
 
The genotype results for ACE were similarly heterogenous (data not shown). For this genetic 
variant, the D allele is considered favourable for elite speed-power athlete status (Ma et al., 2013; 
Weyerstraß et al., 2018), with the I allele favourable for elite endurance athlete status (Ma et al., 2013). 
Within the speed-power athletes in this cohort, two athletes had the ID genotype, and one the II genotype; 
neither is considered optimal for elite sprint performance. Conversely, both endurance athletes had the 
favourable II genotype.  
 
It's clear from the results of the non-athletic controls that there is a minimal spread of results 
within the general population. This similarity in polygenic profiles in non-athletes has previously been 
reported with a lower number of generic variants for both endurance (Williams & Folland, 2008) and 
strength/power (Hughes et al., 2011) phenotypes. Within this case study, none of the elite athletes were 
significant outliers in terms of TGS%, demonstrating that, for the polymorphisms tested, genetic 
information is not sufficient to discriminate between elite athletes and non-athletic controls 
 
4.1 Would genetic testing have helped identify these athletes at a young age? 
 
Based on the results presented here, it’s not clear that the use of genetic testing on these athletes 
during their teenage years would have identified them as potential future elite athletes relative to a group 
of non-athletes. It’s unlikely that this information would have proved more useful than traditional talent 
identification methods. Participant A, for example, was English Schools 400m Champion at age 16. 
Participant B is the British under-20 Long Jump record holder and former European under-20 Champion. 
Participant C won multiple national age group titles at under-15 and under-17, and the European under-20 
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Championships. Participant D won multiple junior national titles. Participant E also won national age-
group championships. Consequently, given the failure of genetic information to provide insights over and 
above that provided by inspecting results and observing performances, the practical utility of such tests 
for the specific purpose of talent identification is not supported by these case study results. 
 
4.2 Limitations 
 
There are some limitations to the present study that must be considered when interpreting the 
results. Firstly, data on mitochondrial DNA (mtDNA) was not collected due to testing limitations. 
Mitochondrial haplotypes have been associated with elite athlete status, with different variations 
conferring an advantage or disadvantage in achieving elite athlete status for both speed-power and 
endurance athletes (Niemi & Majamaa, 2005; Castro et al., 2007; Scott et al., 2009; Eynon et al., 2011; 
Ahmetov et al., 2016). Furthermore, there were a small number of polymorphisms for which genotype 
data could not be collected due to a lack of coverage on the testing array. There is the potential that the 
athletes in this study may have held favorable versions of these variants, which would have increased 
their scores. However, even with these limitations, the TGS created for use in this study represents the 
most comprehensive gene score to appear in the published literature with regards to elite athlete status. 
Furthermore, the study utilised an unweighted TGS, with each variant having a score of 0, 1, or 2 
depending on genotype. A weighted TGS, with genetic variants with demonstrably larger effect sizes 
receiving a greater score, may have proved more accurate. However, at present, very few genetic variants 
associated with elite athlete status have been adequately replicated, making the development of such a 
weighted TGS with a large number of variants difficult to achieve. 
 
 
5 Conclusion 
 
These results of this study suggest that, at present, the use of genetic testing to identify talented 
athletes appears to hold no clear predictive ability in discriminating between elite athletes and non-
athletes. This is demonstrated in the current study by the TGS scores of five elite athletes, whose scores 
do not deviate substantially from mean population scores, nor do they reach the thresholds typically seen 
in elite athletes from other published TGS-elite athlete status associations (Ruiz et al., 2009; Ruiz et al., 
2010), although the number of genetic variants used within these earlier studies was very small. Indeed, 
within this present cohort, and utilising the larger-scale TGS, all three of the elite power athletes had a 
higher endurance score than both the middle-distance and long-distance runners, demonstrating the lack 
of predictive power of the present TGS.  
 
As a greater number of genetic variants associated with elite athlete status are identified, 
especially in areas involved in the psychological (Petito et al., 2016; Abe et al., 2018), anatomical 
(Marouli et al., 2017), and skill acquisition (Jacob et al., 2018) factors associated with elite athlete status, 
it is feasible that the predictive ability of future TGSs may improve; any improvement could further be 
aided by the use of weighted algorithms, where genetic variants with a relatively larger effect size achieve 
a higher relative score compared to variants with a smaller effect size. However, at present, and as clearly 
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illustrated by this case study involving elite athletes, the similarity of polygenic profiles within 
populations appears to limit the discriminatory power of genetic information to identify talented athletic 
performers.  
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Section 5 – Is there utility to genetic information in sport? 
 
The content of this section draws on three previously published peer-reviewed papers. These papers are: 
 
Pickering C, Kiely J. ACTN3, morbidity, and healthy aging. Front Genet. 2018;9:15. 
 
Pickering C, Kiely J. Exercise Response Efficiency – A novel way to enhance population health? 
Lifestyle Genom. 2019. 
 
Pickering C, Kiely J. The Development of a personalised training framework: Implementation of 
emerging technologies for performance. J Functional Morphol Kinesiol. 2019;4(2):25. 
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CHAPTER 13 – WIDER IMPLICATIONS: GENETIC INFORMATION FROM A PUBLIC 
HEALTH PERSPECTIVE  
 
 
Chapter preface: 
 
The sports science and medical worlds are inextricably linked, especially given the well-established and 
well-replicated preventative and treatment effects of exercise on a variety of diseases and health issues 
(Janssen et al., 2004; Frank et al., 2004; Latino-Martel et al., 2016; Pareja-Galeano et al., 2015); as a 
result, both worlds borrow ideas liberally from one another. Whilst this thesis has focused on the use and 
utility of genetic information within elite sport, there are potential wider applications emanating from 
these findings which may have important implications from a public health perspective. This chapter 
explores how the findings of the present thesis, as well as the wider body of exercise genetics research, 
might be used to improve public health. Part One contains a discussion on the modifying effects of 
ACTN3 on morbidity and healthy aging, whilst Part Two explores the potential role genetic information 
can have on increasing both the effect of, and adherence to, an exercise training programme aimed at 
improving an individual’s health. The first two parts have previously been published as review articles 
(Pickering & Kiely, 2018d; Pickering & Kiely, 2019b). Finally, Part Three, briefly explores how genetic 
information may be utilised to inform diet choice, with particular reference to the treatment and 
management of obesity and cardiometabolic health. Given the ever-increasing prevalence of obesity 
(Finucane et al., 2011), type-II diabetes, and other diseases associated with inactivity (Colditz 1999), a 
discussion focused on bridging the gap from elite sport to increased public health is warranted, and, 
hopefully, impactful, particularly given the increased healthcare burden these diseases create (Kelly et al., 
2008; Wang et al., 2011).  
 
 
PART ONE - ACTN3, MORBIDITY, AND HEALTHY AGING 
 
1. Introduction 
 
There is a frequently quoted axiom, often attributed to Benjamin Franklin, suggesting that 
“nothing is certain but death and taxes”. Whilst recent scandals suggest that, for some, taxes may be 
optional, death remains a universal certainty. Fortunately, life expectancy has increased dramatically over 
a very short timeframe. Within the UK, for example, the expected lifespan has roughly doubled over the 
past 150 years, such that a child born today can expect to live until 80 years of age (Majeed 2013). Whilst 
reductions in infant mortality undoubtedly play a role, they only provide a partial explanation. This 
substantial leap in life expectancy is attributable to multiple—medical, societal, cultural, economic, and 
public health—factors. As a consequence, the number of people surviving into old age is rising, a trend 
which is expected to continue (He et al., 2016).  
 
This trend has piqued interest in healthy aging, particularly as longer lifespans don’t always 
correlate with sustained wellbeing (Christensen et al., 2009; Kuh et al., 2014). As health is multifactorial, 
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the research in this field has a wide scope, including disease avoidance and the maintenance of physical 
function into old age (Christensen et al., 2009; Kuh et al., 2014). Focusing on the latter, a number of 
physical performance measures are associated with healthy aging, including grip strength, standing 
balance, and walking speed, with lower scores in these tests typically associated with increased all-cause 
mortality (Rantanen, 2003; Cooper et al., 2010; Studenski et al., 2011). Accordingly, along with the 
absence of disease states such as type-II diabetes, the maintenance of muscle strength is an important 
component of healthy aging.  
 
A second population to which muscle strength is important are elite athletes (Maughan et al., 
1984; Hakkinen et al., 1989). With both muscle strength and elite athlete status being heritable traits (De 
Moor et al., 2007; Silventoinen et al., 2008), over the last twenty years there has been an increased focus 
on identifying the specific genes and single nucleotide polymorphisms (SNPs) affecting the inter-
individual variation evident in athletic performance (Timmons 2011; Hughes et al., 2011). At present, 
over 100 SNPs associated with elite athlete status (Ahmetov & Fedotovskaya, 2015) and the exercise 
training response (Bray et al., 2009) have been identified. One SNP with a well-established influence on 
muscle phenotype is rs1815739, a C-to-T base substitution in ACTN3 (Yang et al., 2003; Ma et al., 2013). 
This SNP results in the transformation of an arginine base (R) to a premature stop codon (X), with X 
allele homozygotes deficient in the a-actinin-3 protein (North et al., 1999). The main function of a-
actinin-3 appears to be as a structural protein, forming part of the Z-line of the muscle fibre, which acts to 
anchor the actin filaments within the sarcomere (Yang et al., 2009). This protein is expressed exclusively 
in type-II muscle fibres, and as a result, XX genotypes tend to have a lower percentage of these fibres 
(Vincent et al., 2007). As such, the XX genotype tends to be significantly under-represented in elite 
speed, power, and strength athletes (Yang et al., 2003; Roth et al., 2008), although these results are not 
unequivocal (Sessa et al., 2011; Scott et al., 2010).  
 
Both strength and muscle mass are protective against all-cause mortality in the elderly (Li et al., 
2017). As ACTN3 genotype can modify muscle phenotypes, this section will explore the relationship 
between this common polymorphism in ACTN3 and healthful aging, with a particular focus on muscle. 
Such exploration provides a basis for an enhanced understanding of indivdualised risk factors for the 
morbidities associated with the aging muscle, and may soon guide the customisation of prophylactic 
exercise interventions such as resistance training.  
 
 
2. ACTN3, muscle mass, and healthy aging 
 
Sarcopenia is the loss of skeletal muscle mass and function associated with increased age 
(Rosenberg 1997; Cruz-Jentoft et al., 2010). This process begins relatively early in life, with reported 
onset at age 25 (Lexell et al., 1988), a 10% loss in peak lean mass at age 40, and 40% loss at age 70 
(Porter et al., 1995). This loss of muscle mass and strength can be troubling for a variety of reasons, such 
as a reduction in overall physical function (Janssen et al., 2002; Rantanen 2003) and an increase in fall 
risk (Wickham et al., 1989). In knock-out (KO) mouse studies, those without ACTN3 have a greater 
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muscle mass loss with aging (Seto et al., 2011b); the question arises - are these results mirrored in 
humans? 
 
A number of studies have examined the impact of ACTN3 on muscle strength and function in an 
elderly population. Delmonico and colleagues (2008) undertook an observational study of over 3000 
well-functioning elderly participants over a five-year period. In males, increases in 400m walk time were 
significantly greater in XX homozygotes than RR genotypes, with a non-significant difference between 
XX homozygotes and RX genotypes (p=0.075). In females, RR genotypes had approximately a 35% 
lower risk of persistent lower extremity limitation (defined as difficultly walking 400m or climbing 10 
steps without resting) than XX genotypes. Interestingly, there were no significant differences between 
genotypes with regards to other muscle and performance phenotypes. Kikuchi and colleagues (2015) 
reported a similar loss of function in elderly Japanese individuals, with a significantly poorer chair stand 
test score in XX genotypes compared to RR and RX genotypes. Judson et al. (2011) examined ACTN3 
genotype interaction on fall risk in over 4000 elderly Caucasian females. Here, individuals with at least 
one X allele had a significantly increased risk of falling compared to R allele carriers; this was true at 
both baseline and at multiple follow-up points. These results were mirrored by Frattini et al. (2016), who 
reported that falls were more prevalent in XX genotypes than R allele carriers. Walsh and colleagues 
(2008) reported that, in females, the XX genotype was associated with significantly lower total-body and 
lower-limb fat free mass (FFM). In addition, these female participants had lower peak torque values 
compared to R allele carriers. There were no genotype effects in male participants. Similar lower values 
for muscle mass in elderly female XX homozygotes were reported by Zempo et al. (2010), with mean 
thigh cross-sectional area 4.5cm2 lower in XX vs R allele carriers (p<0.05). Finally, Cho and colleagues 
(2017) reported a significantly higher sarcopenia risk in XX genotypes than RR genotypes in a cohort of 
elderly Koreans. However, other studies have found no effect of this polymorphism on muscle phenotype 
and function in the elderly (San Juan et al., 2006; Bustamante-Ara et al., 2010; McCauley et al., 2010), 
and one study (Lima et al., 2011) reported significantly greater FFM values in X allele carriers. 
 
The general consensus from these studies is that ACTN3 genotype exhibits a potentially 
modifying effect on muscle mass, maintenance of muscle function, and sarcopenia risk in elderly 
individuals, with the R allele associated with greater maintenance of strength and physical function, along 
with increased sarcopenia protection. From a muscle phenotype perspective, an association between 
ACTN3 genotype and sarcopenia seems logical; specific type-II muscle fibre atrophy is a hallmark of 
sarcopenia (Lexell et al., 1988; Fielding et al., 2011), and, in athletic populations at least, the R allele is 
associated with an increased proportion of type-II muscle fibres (Vincent et al., 2007). This ability to 
more effectively maintain fast-twitch fibre size and mass with age is perhaps the mechanism by which 
ACTN3 genotype modifies the age-related loss in muscle function, and concurrent fall and sarcopenia 
risk. 
 
Given that resistance training is an important tool in sarcopenia prevention and treatment (Roth 
et al., 2000), and that ACTN3 genotype may modify resistance training adaptations (Kikuchi & Nakazato, 
2015), it is important to explore whether such a relationship exists in an elderly population. In elderly 
Caucasian females undertaking a 12-week resistance training programme, Pereira and colleagues (2013) 
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reported that ACTN3 RR genotypes exhibited greater leg extension and bench press one-repetition 
maximum (1RM) improvements than XX genotypes. Delmonico et al. (2007) put elderly participants 
through a 10-week unilateral knee extensor strength training programme. In the male sub-group, absolute 
peak power increased to a greater extent in RR homozygotes compared to XX homozygotes, although this 
difference was not significant (p=0.07). In females, relative peak power change was greater in the RR 
group compared to the XX group. At present, these are the only two studies examining the impact of 
ACTN3 on resistance training response in an elderly cohort, with the consensus being that the R allele, 
and specifically the RR genotype, is associated with enhanced strength and power improvements. Based 
on these findings, it appears that elderly ACTN3 R allele carriers are more responsive to resistance 
training.  
 
 
3. ACTN3 genotype and bone mineral density with aging 
 
Alongside age-related loss of muscle mass and function, a further risk factor is the loss of bone 
mineral density (BMD) and its related disease state, osteoporosis, with a well-established association 
between lower BMD scores and increased all-cause mortality (Browner et al., 1991; Johansson et al., 
1998), stroke death (Browner et al., 1991), and fracture risk (Marshall et al., 1996). A small number of 
studies have examined the interaction between ACTN3 genotype and BMD loss in elderly populations. 
Min et al. (2016), for example, reported a significant difference in BMD at both the spine and pelvis 
between genotypes, with XX and RX genotypes having lower scores than RR genotypes. Cho and 
colleagues (2017) reported similar findings, although the lower BMD in XX genotypes wasn’t significant 
after covariate correction (p=0.075). Yang et al. (2011) found that, in postmenopausal women, ACTN3 
genotype was significantly associated with BMD, with XX genotypes having the lowest scores. 
Accordingly, overall it appears that the ACTN3 R allele is somewhat protective against age-related BMD 
loss.  
 
As discussed above, ACTN3 genotype is likely associated with muscle function in the elderly. 
This may be the driving force between genotype differences in BMD, with individuals possessing greater 
muscle function able to be more active day-to-day. Such individuals are subsequently more likely to 
experience regular skeletal loading, thereby promoting structural maintenance, and diminishing BMD 
loss over time. Indeed, grip strength is positively correlated with BMD (Iida et al., 2012), as is increased 
muscle mass (Visser et al., 1998), indicating that perhaps the increased muscle mass and strength 
associated with the R allele is protective in this manner. However, using KO mice, Yang and colleagues 
(2011) reported a lower BMD in mice deficient in a-actinin-3. They reported evidence that a-actinin-3 is 
expressed in bone tissue and involved in osteogenesis, with KO mice having a reduced osteoblast and 
increase osteoclast activity. Perhaps both mechanisms play a role in the relationship between ACTN3 and 
BMD, with further research required to understand the relative contributions of each.  
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4. ACTN3 genotype and metabolic health with aging 
 
Alongside muscle and BMD loss, aging populations also have to contend with an increased 
prevalence of a number of metabolic issues, including insulin resistance and type-II diabetes 
(Gunasekaran & Gannon, 2011; Suastika et al., 2012). These disease states are associated with a reduced 
mortality (Panzram, 1987), as well as an increased risk of further health issues (Williams et al., 2002) and 
cognitive decline (Strachan et al., 1997). Given that higher levels of muscle mass are associated with 
better insulin sensitivity (Srikanthan & Karlamangla, 2011), and that ACTN3 genotype can modify 
muscle cross sectional area and fibre type, there is the potential that ACTN3 genotype may alter type-II 
diabetes risk, either directly or indirectly. There is a paucity of research in this area; however, Riedl et al. 
(2015) reported that the prevalence of XX genotypes was greater in type-II diabetes patients than 
controls, indicating that the X allele may increase risk, although there were no differences between 
genotypes in terms of metabolic control or obesity. Research on ACTN3 KO mice indicates that 
deficiency of Actn3, characterised by the XX genotype, does alter skeletal muscle metabolism 
(MacArthur et al., 2007), potentially by increasing fatty acid oxidation and glycogen storage.  
 
As of yet, any relationship between this SNP and type-II diabetes requires further elucidation. 
The tentative findings of Riedl and colleagues (2015) are further complicated by research on the 
relationship between ACTN3 and extreme longevity. In a cohort of Spanish centenarians, the XX 
genotype frequency was the highest reported in non-athletic Caucasians (24%), although there were no 
significant differences between X allele frequency in centenarians and controls (Fiuza-Luces et al., 2011). 
The authors concluded that this preliminary data suggests a potential survival advantage of the XX 
genotype. Similar complex results were found in a cohort of Japanese centenarians. Whilst there were no 
significant differences in genotype distribution between centenarians and controls, the frequency of the 
XX genotype in supercentenarians (over 110 years) was the highest seen in a non-American population, 
at 33% (Fuku et al., 2016). Indeed, whilst it appears that the evidence suggests that the R allele may 
confer a longevity advantage, likely mediated through its impact on muscle function, bone health, and 
metabolic wellbeing as discussed in this section, the lack of increased RR genotype frequencies seen in 
centenarians (Fiuza-Luces et al., 2011; Fuku et al., 2016) does not support this. Such a finding is mirrored 
in the longevity of elite athletes, with elite endurance athletes tending to live for longer than power 
athletes (Sarna et al., 1993; Teramoto & Bungum, 2009; Clarke et al., 2015). As the R allele is more 
prevalent in elite power athletes than elite endurance athletes (Yang et al., 2003), this again appears to 
suggest a paradox. The mechanisms underpinning the longevity advantage of elite endurance athletes is 
currently unclear, although there is the potential that the enhanced cardiorespiratory fitness exhibited by 
elite endurance athletes offers greater longevity than the improved muscle strength and function expected 
in former elite power athletes (Wisloff et al., 2005). This is particularly pertinent given evidence of more 
efficient aerobic metabolism in XX homozygotes (North 2008). Alternatively, the X allele could confer 
some as of yet unclear survival benefit; if this is the case, then there is the possibility that RX 
heterozygotes may have the greatest longevity benefit, by enjoying the benefits associated with each 
allele. Such an explanation would provide a potential mechanism explaining the lack of expected 
increases in RR genotypes in centenarian populations.  
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Nevertheless, given that loss of muscle mass increases risk of insulin resistance—a precursor to 
type-II diabetes (Srikanthan & Karlamangla, 2011)—and that type-II diabetes itself increases the risk of 
sarcopenia (Park et al., 2009; Kim et al., 2010), it appears that ACTN3 genotype may modify type-II 
diabetes risk in the elderly. Again, it would be expected that the R allele, which is associated with 
increased muscle mass and performance, would be protective against age-related metabolic decline. 
Further research in this field should attempt to uncover such a relationship, should one exist.  
 
In addition, ACTN3 may alter health through other metabolic disturbances. In mouse models, 
there is evidence that the XX genotype may be protective against obesity (Houweling et al., 2017), 
although as of yet this association has not been replicated in humans (Moran et al., 2007; Houweling et 
al., 2017), with Deschamps and colleagues (2015) reporting increased obesity in XX genotypes. 
Similarly, there is evidence in younger populations that this polymorphism may affect other health 
markers, such as blood pressure (Deschamps et al., 2015) and high-density lipoprotein cholesterol 
(Nirengi et al., 2016); in both cases, the X allele was beneficial, although it is not clear if this is clinically 
meaningful, with further replication required.  
 
 
5. Is this trifecta caused by ACTN3’s influence on muscle? 
 
So far, this chapter has discussed the potential influence of ACTN3 on three conditions 
associated with poorer outcomes with aging; sarcopenia and the resulting loss of muscle function, a loss 
of BMD, and a potential increase in metabolic disturbances, such as insulin resistance. These conditions 
likely have some degree of inter-relation; a loss of muscle function is likely associated with a lack of 
movement, which in turn reduces bone loading and turnover, leading to a loss of BMD (Vincent & Bray, 
2002; Korpelainen et al., 2006). This loss of movement capacity could further cause a behaviorally-
mediated reduction in type-II muscle fibres, further reducing muscle strength and function. Again, this 
loss of function might change habitual movement behaviors, thereby subsequently altering the metabolic 
profile of the individual and increasing the likelihood of some negative metabolic changes.  
 
Accordingly, it seems feasible to speculate that the impact of ACTN3 on these three risk-factors 
occurs either due its directly modifying effect on skeletal muscle, or through separate mechanisms for all 
three. This raises the question of whether elderly X allele carriers have lower BMD because they have 
less muscle mass and physical function, or if there is mechanism through which ACTN3 influences bone 
turnover and mineral content. As detailed in section 3 above, there are tentative results that suggest 
ACTN3 genotype influences both of these considerations, although whether its influence is greater on one 
than the other is currently unclear. As the results regarding ACTN3 and insulin resistance are under-
explored (Riedl et al., 2015), this leg of the trifecta is the most unknown; whilst there is a mechanism 
underpinning muscle mass and insulin resistance (Srikanthan & Karlamangla., 2011), and ACTN3 does 
modify muscle mass and type in athletic cohorts (Vincent et al., 2007), it is not clear whether this holds 
true in the elderly. 
 
 154 
If, as seems likely, the potentially modifying effect of ACTN3 genotype on these three 
morbidities occurs primarily, although not exclusively, through its role in regulating muscle fibre type 
and strength, then this further underscores the need for elderly adults to undertake resistance training in 
order to maintain their health and function as they age. Whilst there is a clear protective effect of 
resistance training on the reduction of sarcopenia (Johnston et al., 2008), enhancing BMD (Rhodes et al., 
2000), and reducing risk of insulin resistance and type-II diabetes (Dunstan et al., 2002) in the elderly, the 
insights outlined here do suggest some additional questions. Do those with the XX genotype, who would 
be expected to exhibit smaller improvements with resistance training, need to increase their training 
frequency and/or intensity (as suggested with regards to aerobic endurance training by Montero & 
Lundby, 2017), or should they undertake lower-load, higher-volume resistance training, as suggested by 
Kikuchi and Nakazato (2015) and supported by Jones et al., (2016)? Do other genetic variants, such as 
those found in ACE (Pescatello et a., 2006) or AGT (Aleksandra et al., 2016), influence the resistance 
training response in the elderly, and to what extent? There is also the possibility that ACTN3 genotype 
may interact with these other genetic variants to modify the aging process in individuals. This has perhaps 
been most well studied in regard to ACE I/D, which is a polymorphism in the gene encoding for 
angiotensin-converting enzyme. Here, the results are equivocal, with some studies finding no effect of the 
ACE I/D polymorphism on muscle phenotype (McCauley et al., 2010; Garatachea et al., 2012), and others 
reporting that it modified the response to resistance training (Pereira et al., 2013), both on its own and in 
combination with ACTN3. Like ACTN3, ACE may also affect longevity through a variety of different 
pathways, including metabolic disease risk (Kajantie et al., 2004), blood pressure control (Yoshida et al., 
2000; Santana et al., 2011), and Alzheimer’s disease risk (Narain et al., 2000). Further work exploring the 
impact of resistance training on the elderly should perhaps take into consideration differences in 
genotype, either for single or multiple SNPs, to inform the design of more efficient and effective 
personalised exercise guidelines targeting positive outcomes for this population.  
 
 
6. Conclusion 
 
Variation in ACTN3 has a demonstrable, clear and robust effect on muscle phenotypes in young, 
athletic populations (MacArthur & North, 2007; Vincent et al., 2007). Based on the research cited in this 
review, it appears to also have a modifying effect on muscle strength, size and function in the elderly 
(Walsh et al., 2008; Delmonico et al., 2008; Frattini et al., 2016), as summarised in figure 18 below. In 
particular, the R allele of ACTN3 tends to be associated with better maintenance of muscle mass, strength 
and function (Delmonico et al., 2008), a greater adaptive response to training (Pereira et al., 2013), and is 
protective against the development of sarcopenia (Cho et al., 2017). There also appears to be a (less 
robust) relationship between ACTN3 genotype and BMD in the elderly, with the R allele again being 
protective (Min et al., 2016; Cho et al., 2017). It is not clear whether this is due to ACTN3 directly 
influencing bone metabolism, or whether the increased muscle mass and function of R allele carriers 
leads to greater bone loading, and therefore BMD maintenance. Similarly, there is an unclear relationship 
between ACTN3 genotype and metabolic health; one study (Riedl et al., 2015) indicates that the XX 
genotype is present with an increased frequency in type-II diabetes patients, but clearly further research is 
required to better understand this relationship. Overall, whilst this indicates that the R allele should be 
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associated with increased health and function in the elderly, the picture is made more complex by 
research on centenarians (Fiuza-Luces et al., 2011; Fuku et al., 2016); in this case, the XX genotype is 
potentially more frequent in those over 100 years of age, although such a relationship is not statistically 
significant. If further research does support the early evidence that the ACTN3 R allele is associated with 
a decrease in frailty risk factors, then knowledge of ACTN3 genotype may better inform patients and 
medical practitioners as to each individuals’ risk factors. This information could consequently inform 
personalised management strategies for the aging individual. 
 
 
Figure 18 – A summary of the impact of polymorphisms within ACTN3 and healthy aging.  
 
 
PART TWO - EXERCISE RESPONSE EFFICIENCY – A NOVEL WAY TO ENHANCE 
POPULATION HEALTH? 
 
1. Introduction 
 
Obesity, the condition of excess body fat or adipose tissue (Sweeting 2007), has become 
increasingly prevalent over the last thirty years (Finucane et al., 2011; Flegal et al., 2012). Between 1980 
and 2008, mean Body Mass Index (BMI) increased globally by 0.4 kg/m2, resulting in 1.47 billion adults 
being categorised as overweight (BMI ³ 25 kg/m2), and 503 million adults classified as obese (BMI ³ 30 
kg/m2) (Finucane et al., 2011). These increases were most pronounced in Western countries, with the 
US—in which 35% of all adults are classed as obese—leading the way, closely followed by the UK and 
Australia (Finucane et al., 2011; Flegal et al., 2012). As obesity is recognised as a leading cause of a 
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number of co-morbidities, including cardiovascular disease, type-II diabetes, dyslipidemia, and cancer 
(Must et al., 1999; Gallus et al., 2014), these increased obesity rates represent a significant healthcare 
burden globally (Kelly et al., 2008; Wang et al., 2011), with the costs associated with treating obesity and 
its related diseases forecast to increase by up to $66 billion per year in the US and £2 billion per year in 
the UK by 2030 (Wang et al., 2011). As a result, considerable effort is being expended by public health 
bodies towards preventing and treating obesity (Must et al., 1999; Kelly et al., 2008). 
 
However, so far, these efforts have done little to arrest the increasing rate of obesity. In part, this 
is due to the complex, multifactorial nature of obesity—whilst tempting to believe that obesity is merely a 
relative overconsumption of energy, the reasons underpinning this can be varied, and include increased 
sugar intake, increased portion sizes, alteration of gut microbiota, and genetic predispositions, along with 
societal and cultural influences (Friedman, 2009; Sahoo et al., 2015). However, a commonly cited reason 
for the recent explosion in obesity rates is that of a lack of physical activity (Janssen et al., 2004; Frank et 
al., 2004). In the US, the increase in obesity rates occurred alongside a significant reduction in leisure 
time physical activity, with no change in caloric intake (Ladabaum et al., 2014), suggesting that a lack of 
physical activity is potentially a major driver of the increase in obesity rates, at least in the US, where just 
under 50% of adults report no leisure time physical activity (Ladabaum et al., 2014). Furthermore, 
increasing physical activity has been shown to promote fat loss (Ballor & Keesey 1991; Boutcher 2010; 
Hazell et al., 2014), suggesting that physical activity could be important in the prevention and treatment 
of obesity and its related co-morbidities.  
 
Alongside the associations between a lack of physical activity and obesity, and increased 
physical activity and weight loss, physical activity also reduces the risk of a number of other chronic 
diseases, including cancer (Latino-Martel et al., 2016) and cardiovascular disease (Myers et al., 2015), 
and has demonstrated efficacy as a treatment for type-II diabetes (Grace et al., 2017). As a result, physical 
exercise has been termed a “polypill” (Piepoli 2005; Fiuza-Luces et al., 2013; Pareja-Galeano et al., 2015; 
Sanchis-Gomar et al., 2015), with wide-ranging health benefits; indeed, the positive health benefits of 
exercise can be greater than a comparative treatment with drugs, particularly with regards to 
cardiovascular disease (Fiuza-Luces et al., 2013; Sanchis-Gomar et al., 2015).  
 
Accordingly, it’s clear that physical activity and exercise have important, wide-ranging health 
promoting aspects, serving to both reduce the risk of chronic disease and obesity (Janssen et al., 2004; 
Frank et al., 2004), and serve as a treatment to these issues (Epstein & Goldfield, 1999); as a result, 
exercise can be thought of as medicine (Sallis 2009). However, current rates of physical activity in adults 
are low, having declined over the past thirty years (Ladabaum et al., 2014) in correlation with a large 
increase in obesity and other chronic disease rates. As such, there a plausible relationship between the 
demonstrated reduction in physical activity, and the increase in obesity seen globally. Free-living adults 
are aware of this, with many stating that their reasons for taking part in physical exercise stem from 
weight management and reducing the negative impact of aging (Allender et al., 2006). And yet, given this 
knowledge, many adults do not take part in any physical activity at all, and many more fail to meet the 
recommended guidelines (Harris et al., 2011; Ladabaum et al., 2014). Again, the reasons for this are 
multi-faceted, but include a lack of confidence (Allender et al., 2006), time pressures (Welch et al., 2008; 
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Sequeira et al., 2011), and a lack of enjoyment (Ekkekakis et al., 2008). All of these factors appear to 
contribute to poor uptake of, and adherence to, exercise training programme, with this poor uptake and 
adherence a driver of the increased obesity and chronic disease rates. Enhancing exercise adherence is, 
therefore, a potentially major aspect of improving population health. This section proposes the idea of 
exercise response efficiency, whereby individuals are matched to the exercise training modality most 
likely to deliver the greatest improvements in fitness in the shortest amount of time. It is believed that 
such an outcome would be important, as rapid improvements in fitness likely increase both confidence 
and enjoyment, thereby further enhancing adherence, and, as a result, reducing obesity and chronic 
disease rates.  
 
 
2. Exercise – Good for everyone, all of the time? 
 
There are many different modalities of exercise that can be undertaken, existing on a continuum 
from aerobic endurance exercise to resistance exercise (Egan & Zierath, 2013), and from low to high 
intensity. These divergent exercise stimuli have demonstrated, wide-ranging health promoting effects, 
including a reduction in adipose tissue, enhancement of glucose metabolism, reductions in blood pressure, 
and increases in bone mineral density (Egan & Zierath, 2013). Other exercise types, such as high intensity 
interval training (HIIT) have similar health-promoting and weight-management effects (Shiraev & 
Barclay, 2012; Gillen & Gibala, 2013), although such high-intensity exercise may—but not always—
reduce enjoyment and hence adherence (Ekkekakis et al., 2008; Vella et al., 2017).  
 
Given the wide-ranging and well-established health benefits of exercise, it might be believed that 
exercise is good for everyone, all of the time, and that there is a reasonably standard, predictable adaptive 
response to such exercise. However, recent research has called into question some of these long-held 
beliefs. There is now a wide body of evidence suggesting that there is considerable inter-individual 
variation in response to an exercise training programme. For example, in the seminal HERITAGE Family 
Study, which explored inter-individual variation in response to a 20-week aerobic training programme, 
training-induced changes in VO2max ranged from a reduction of approximately 100 mL O2/min to an 
increase of over 1000 ml O2/min (Bouchard & Rankinen, 2001). Furthermore, whilst the majority of 
participants demonstrated a reduction in heart rate (HR) response to a given workload following the 
training programme, approximately 100 individuals (~14% of participants) demonstrated an increase in 
HR response, suggesting a reduction in physical fitness. Furthermore, when analysing pooled data from 
six different training intervention studies, Bouchard and colleagues (2012) reported that, following 
exercise, 8% of participants had an adverse change in fasting insulin, 12% an adverse change in systolic 
blood pressure, 10% an increase in triglycerides, and 13% a reduction in high density lipoprotein—all 
undesired responses that potentially serve to increase the risk of disease.  
 
Individuals demonstrating an increase in risk factors following exercise have been termed 
adverse responders, whilst those demonstrating no measurable improvement in a measured fitness 
variable have been termed non-responders. Recently, a number of researchers have explored the use of 
such terms skeptically (Atkinson & Batterham, 2015; Hecksteden et al., 2015; Williamson et al., 2017; 
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Williamson et al., 2018; Atkinson et al., 2018), suggesting that this heterogeneity in response may be (at 
least partly) due to measurement error and random daily variation, and may not be clinically relevant. In a 
recent review (Pickering & Kiely, 2018b), it was suggested that global non-responders to exercise—i.e. 
individuals demonstrating no beneficial effect of exercise—likely do not exist; nevertheless, when it 
comes to changes in disease-associated measures, such as cardiorespiratory fitness and fasting insulin, 
exercise—or at least specific types of exercise—appear not to have the same beneficial effects for all.  
 
 
3. The causes of exercise response heterogeneity 
 
The drivers of this inter-individual response to a training stimulus are wide and varied. Exercise 
response is often determined by comparing the pre- and post-intervention scores on a given measure. 
Inherent within any measurement are technical error and random within-subject variation; both of these 
are said to represent “false” inter-individual variation (Atkinson & Batterham, 2015). Conversely, drivers 
of “true”—that is, real—inter-individual variation can best be categorised as genetic, environmental, and 
epigenetic factors (Pickering & Kiely, 2017a). As an example of the impact of genetic variation, a single 
nucleotide polymorphism (SNP) within ACTN3 has been demonstrated to affect the adaptive response to 
resistance training in elderly individuals (Delmonico et al., 2007). An example of the environmental 
influence on exercise adaptation is that of stress; individuals who have increased life stress may exhibit a 
reduced adaptation to a training stimulus (Bartholomew et al., 2008). Finally, epigenetic modifications 
and translational control mechanisms, such as microRNAs, may modulate the adaptive response to 
exercise (Davidsen et al., 2010), either by making specific points within DNA more accessible to 
translation, or exerting control over messenger RNA by either inhibiting translation or causing 
degradation before translation occurs (Nielsen et al., 2014).  
 
 
4. A lack of exercise response is both modality and measurement specific 
 
The existence of non- or low-responders to exercise is potentially troubling, as it suggests that a 
sub-group of people may gain no benefit from exercise training. However, it appears that such a low 
response to exercise is both modality and measurement specific (Pickering & Kiely, 2018b), suggesting 
that a change in exercise training type, or the inclusion of additional measurements, may reduce the rate 
of exercise non-response.  
 
A limited number of studies have explored exercise response across more than one exercise 
modality. Hautala and colleagues (2006) placed 73 participants through separate endurance and resistance 
training programmes in a randomised cross-over design, determining improvements in peak oxygen 
uptake (VO2peak) following both interventions. There were inter-individual variations in VO2peak 
improvements following both aerobic (range -5 to +22%) and resistance (range -8 to +16%) training, 
illustrating that some participants demonstrated no improvements following a given training type. 
However, participants with the lowest VO2peak improvements following aerobic training exhibited a 
greater improvement in this measure following resistance training.  
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Furthermore, when increasing the number of measurements taken, exercise non-response 
appears to disappear. This was demonstrated by Karavirta and colleagues (2011), who found that, whilst a 
small number of participants demonstrated a negative training response in terms of VO2peak or maximum 
voluntary contraction following a combined aerobic and strength training programme, no subject 
exhibited a negative response to both. Similarly, Bonafiglia and colleagues (2016) subjected individuals 
to both endurance and sprint interval training, determining improvements in VO2peak, lactate threshold, 
and heart rate following training. Whilst some participants exhibited non-response to one of these 
measures, very few were non-responders across all three.  
 
 
5. Exercise response efficiency 
 
Given the research discussed previously, it is apparent that not everyone can demonstrate 
favorable adaptations to every exercise modality, all of the time. Considering the clear disease prevention, 
control, and treatment effects of exercise, such a finding is potentially troubling, suggesting that not 
everyone can maximally harness such effects—and, in turn, cannot gain the same reduction in disease 
risk as other individuals. Instead, it would perhaps be of greater benefit to match individuals to the type of 
training they are most likely to demonstrate beneficial adaptations to. At present, such an approach 
typically occurs through trial and error; an individual undertakes a training intervention—often lasting 
weeks or months—and then discovers whether they have improved or not. If they have, they may 
continue the intervention; if they haven’t, they can try a different exercise modality. However, this 
approach is costly in terms of time; given that one of the cited reasons for a lack of exercise adherence are 
time pressures (Welch et al., 2008; Sequeira et al., 2011), such an approach may not be viable. 
Additionally, many people who do not currently meet exercise guidelines are anxious and unconfident 
regarding exercise (Allender et al., 2006); failure to demonstrate improvements may further reduce 
individual confidence, and reduce enjoyment, limiting the potential of that person to undertake exercise in 
the future.  
 
Recent evidence suggests that exercise non- or low-response can be abated through increases in 
training volume, intensity, or duration (reviewed by Pickering & Kiely, 2018b); however, in high-risk 
populations, exercise intensity may be poorly tolerated and unpalatable (Hardcastle et al., 2014), whilst 
increased volumes and durations are unlikely to be successful due to a perceived lack of time to exercise 
(Welch et al. 2008; Sequeira et al., 2011). Instead, by matching individuals to the exercise type in which 
they demonstrate the greatest adaptive potential, it might be possible to: 
1) Reduce disease risk factors in a shorter period of time. This is especially important given the 
lack of time—real or perceived—often cited as a reason for non-adherence to exercise 
guidelines. If larger improvements can occur in a shorter amount of time through targeted 
training, this would be hugely beneficial to many people.  
2) Promote greater adherence to exercise. Research from the nutrigenetics field demonstrates that, 
when individuals are placed on a personalised dietary intervention, they are more likely to 
adhere to that intervention for a greater period of time (Arkadianos et al., 2007)—there is no 
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apparent reason why this would not be the case with exercise. Additionally, by increasing the 
improvements gained from exercise, the fulfilment and enjoyment experienced by the individual 
is likely to be increased—further promoting long-term exercise adherence.  
 
 
6. How can individuals be matched to their optimal training type? 
 
The ability to match individuals to the training type most likely to yield the greatest 
improvements in specific outcomes is, at present, hugely under-explored. In part, this is because it 
remains to be fully elucidated what variables may predict the most effective training type. From an 
obesity standpoint, recent work by Leonska-Duniec and colleagues (2018a, 2018b, 2018c, 2018d) has 
explored the effects of a number of SNPs on change in fat mass and improvements in aerobic fitness in a 
group of untrained female participants. Following a 12-week aerobic training programme, only 75% of 
participants lost fat mass, and participants with a greater number of obesity-risk alleles tended to lose less 
fat following training (Leonska-Duniec et al., 2018a). Other obesity SNPs, such as LEP and LEPR, which 
encode for leptin and its receptor, modified the change in glucose and LDL cholesterol levels following 
this same training intervention (Leonska-Duniec et al., 2018d), results which replicated findings from 
HERITAGE (Lakka et al., 2004). Similar results have been reported by Klimentidis and colleagues 
(2016), who found that the possession of a greater number of obesity-risk alleles was associated with a 
lesser reduction in fat mass following resistance training. However, at present, whilst it’s clear that a 
variety of SNPs, such as ACTN3 (Pickering & Kiely 2017d) and the obesity related SNPs discussed 
previously (Klimentidis et al., 2016; Leonska-Duniec et al., 2018d), affect the adaptive, fat loss, and 
health biomarker response to training, at present very few studies have attempted to utilise this 
information to inform training programme design. 
 
A previous study (Jones et al., 2016) utilised a 15 SNP total genotype score to classify 
participants as those expected to respond better to high-volume, moderate-intensity resistance training, 
and those expected to respond better to low-volume, high-intensity resistance training. The participants 
were then randomised to receive either “matched” (i.e. training matched to their genotype score) or 
“mismatched” training over an eight-week resistance training intervention. Those in the matched training 
group experienced significantly greater improvements in a test of power and a test of endurance 
compared to those in the mismatched group. Furthermore, 83% of high responders to the training 
intervention were from the matched group, whilst 82% of low- and non-responders were from the 
mismatched training group. More recently, the study presented in Chapter 11 (Pickering et al., 2018) 
utilised a 5 SNP genetic test to predict the magnitude of improvements in Yo-Yo test score—a measure of 
aerobic capacity—in a group of youth soccer players. Participants in possession of a greater number of 
SNPs thought to be associated with larger improvements in aerobic capacity did indeed demonstrate such 
improvements, whilst those predicted to demonstrate smaller improvements also did so. These findings 
suggest that genetic information may hold promise in matching individuals to the training type most 
likely to elucidate the greatest adaptive response.  
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Similar results have been reported around aerobic training. Timmons and colleagues (2010) 
discovered a specific molecular signature, comprised of 29 RNAs expressed within muscle prior to a 
training intervention, which predicted the improvements in VO2max demonstrated following that training 
intervention. Similarly, Davidsen et al. (2011) uncovered four miRNAs that were differentially expressed 
between low- and high-responders to a twelve-week resistance training programme, adding further to the 
promise of the matching of individuals to their most responsive training type in the future.  
 
At present, tentative research suggests that a combination of genetic and miRNA markers at 
baseline may be able to predict the magnitude of training response to a given intervention (Timmons et 
al., 2011; Davidsen et al., 2011; Pickering et al., 2018). This raises the potential for those individuals 
expected to demonstrate a lower response to a specific intervention to undertake a separate intervention—
one in which they are expected to demonstrate a larger improvement, and hence derive increased health 
benefits. Early research suggests that genetic information may assist in the matching of optimal training 
type to each individual (Jones et al., 2016), although significantly more research is required to confirm 
and expand on these early promising findings.  
 
 
7. Conclusion 
 
This part of the chapter has speculated that, by matching individuals to the type of training they 
are most likely to see the greatest improvements from, it may be possible increase the protective effects of 
exercise against disease and promote long term exercise adherence. Such an outcome, it is proposed, 
represents a type-efficient method to best maximise the health of at-risk populations. Early research 
suggests that genotype-matched training (Jones et al., 2016) can enhance training adaptations, and that a 
number of markers, including miRNA (Davidsen et al., 2010) and genetics (Timmons et al., 2011; 
Pickering et al., 2018), can predict the magnitude of training response prior to an intervention taking 
place—allowing for modifications to be made prior to a lower than optimal adaptation occurring.  
 
However, such an approach requires greater investigation before it can be integrated into disease 
control and treatment plans, with the early findings requiring replication, and further studies needed to 
explore the efficacy of such an approach on training-induced outcomes and adherence in at-risk 
populations. Additionally, the cost of genetic and miRNA testing may make such an approach cost-
prohibitive, at least in the short-term, to publicly funded health bodies, or lower socio-economic status 
individuals wishing to pursue such an approach privately.  
 
Nevertheless, such an approach might be prudent in future when targeting the most high-risk 
individuals in a population. Given the wide-ranging and well-established health benefits of exercise on 
obesity and disease risk and treatment, but with the current poor uptake of exercise programmes, this 
approach may serve to both increase adherence and results. Given the increasing numbers of individuals 
with obesity and chronic disease across the globe, along with declining physical activity rates, such an 
approach represents a potentially useful tool to attack such issues.  
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PART THREE – GENETICS & DIET CHOICE 
 
Whilst exercise is a potentially highly effective treatment for obesity (Epstein & Goldfield, 
1999), its results can be enhanced via improved dietary management. Furthermore, dietary mis-
management, including the overconsumption of total calories, and specific macronutrient types, can serve 
to increase the risk of obesity (Bray & Popkin, 1998), along with that of other diseases, such as type-II 
diabetes (Schulze et al., 2004) and cardiovascular disease (Siri-Tarino et al., 2010). A variety of different 
SNPs have been implicated in modifying the interaction between macronutrients and disease risk, with 
several genotypes associated with an increased risk of developing obesity (Rankinen et al., 2006; 
Sonestedt et al., 2009; Corella et al., 2011); indeed, the heritability of BMI is estimated at up to 70% 
(McPherson 2007). An example of a gene strongly implicated in obesity is that of FTO, the fat mass and 
obesity related gene (Sonestedt et al., 2009; Sonestedt et al., 2011). Here, individuals in possession of a 
risk allele of a common SNP within this gene (rs9939609) are on average 3 kg heavier and 1.67 times 
more likely to be obese than those without any risk alleles (Frayling et al., 2011). This is especially true 
when their overall fat intake is relatively high (Sonestedt et al., 2011), with saturated fat intakes appearing 
to be main driver of this relationship (Corella et al., 2011). Similarly, variation with TCF7L2 has been 
shown to modify the effects of carbohydrate intake on type-II diabetes risk, with risk allele carriers shown 
to be around three times more likely to develop the disease if they were in the highest tertile for high 
glycemic load (GL) carbohydrate intake compared to those individuals possessing no risk allele (Cornelis 
et al., 2009). However, if risk allele carriers were in the lowest tertile for high GL carbohydrate intake, 
they had no increased type-II diabetes risk, demonstrating the potential of genetic information to inform 
diet choice.  
 
As a result, a number of studies have explored the potential utility of genetic information, most 
commonly in the form of a total genotype score, to guide diet choice (Arkadianos et al., 2007; Nielsen et 
al., 2012), with some success. Arkadianos and colleagues (2007) assigned participants at an obesity clinic 
to receive either a nutrigenetic diet (i.e. a diet “matched” to an individual’s genotype), or a standard 
control diet. Initially, both groups lost fat; however, after 300 days, those in the nutrigenetic diet were 
more likely to have maintained this fat loss compared to the control group, who had instead started to 
regain weight. As such, the authors suggested that genetically-matched diets diet increase subject 
compliance. This hypothesis was further supported by the results of the DIETFITS Randomised Clinical 
Trial (Gardner et al., 2018). Here, overweight participants were randomised to receive either a high-fat or 
a high-carbohydrate diet, which were matched for calories. The participants received intensive lifestyle 
coaching and had regular meetings with a dietician and support group. They also underwent genetic 
testing for three SNPs thought to influence fat loss efficiency, but were not informed of their results 
during the trial. The results of DIETFITS demonstrated no significant difference between high-fat and 
high-carbohydrate diets when calories were matched, and no effect of genotype on the efficacy of the 
diet. This suggests, as hypothesized by Arkadianos and colleagues (2007), that the positive outcomes of a 
genetically matched diet are due to adherence; in the DIETFITS study, the high level of support and 
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education, and careful controlling of calories, was not necessarily indicative of free-living individuals not 
enrolled in a clinical trial, where motivation and adherence are likely more important.  
 
Based on these early findings, it appears that, in free-living individuals, the use of a genetically 
matched diet is associated with enhanced outcomes, in terms of changes in both fat mass and 
cardiometabolic health markers. As these results are not seen when participants receive intensive, in-
person coaching and support, it appears that the main benefit of such a personalised approach is linked to 
increased dietary adherence. 
 
 
Chapter summary 
 
This chapter has explored how genetic information might be used to enhance both public and 
individual health. Part One demonstrated how a common polymorphism in ACTN3, with consistent and 
replicated effects on muscle physiology in elite athletes, affects the healthy aging process. Building on 
these findings, it was suggested that knowledge of ACTN3 genotype, in combination with the genotype of 
other SNPs affecting muscle function with age, could be used to motivate individuals to undertake 
physical activity interventions aimed at supporting the healthy aging process, as well as informing the 
design of such interventions. Part Two discussed how obesity—possibly the single biggest public health 
issue in the Western World—could potentially be better controlled through the use of targeted and 
efficient exercise. This led to the promotion of the idea of “exercise response efficiency” as a method to 
match at-risk individuals to the type of training they are most likely to derive the largest adaptations to, in 
the shortest amount of time, and hence achieve the greatest reduction in risk. Finally, Part Three 
discussed the interaction between genotype and dietary intake on various indices of health, reporting 
results demonstrating the efficacy of genetic testing in matching individuals to their optimal diet type in 
terms of treating obesity.  
 
 As a result, based on the three aspects discussed in this chapter, it appears that there is the clear 
potential for genetic information to be utilised in the management of public health across the lifespan. 
Outside of the physiological effects of training and dietary interventions matched to genotype, the 
adherence and compliance outcomes also show strong promise, suggesting that the positive effects from a 
temporary intervention can be converted into lifelong behavioral change. These preliminary findings 
suggest that there is scope for future research in this field to explore the use of genetic information in 
health and wellbeing management, not just in terms of its physiological outcomes, but also from the 
standpoint of long-term compliance. In doing so, there is the potential to affect real positive change in 
those individuals demonstrating the greatest risk for various disease states, which in turn could have 
massive implications for the development and maintenance of optimal population health.  
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CHAPTER 14 – THE IMPLEMENTATION OF GENETIC INFORMATION WITHIN A 
PERSONALISED TRAINING FRAMEWORK  
 
Chapter preface: 
 
 The theme of this thesis is to explore the potential utility of genetic information in elite sport. An 
important consideration is that, even if genetic information holds utility in elite sport, it should not be 
used as a standalone, but instead as an additional piece of information, layered on top of existing metrics 
and data. This chapter presents a framework for the use of genetic information as part of a personalised 
training approach in elite sport. This paper has been previously been published as a review article 
(Pickering & Kiely, 2019a).  
 
 
1. Introduction 
 
Throughout this thesis, a common exploratory theme has been whether genetic information may 
hold utility within an elite sport programme, and be used to enhance performance. The thesis has 
primarily focused on elite sport because this tends to be where innovations can take hold; often, the 
budgets of the teams and individuals at the highest level are greater than at lower levels, and there is the 
potential for enhanced buy-in, from players and staff, who are highly motivated and therefore more likely 
to adhere to any given intervention—in this case, genetic testing.  
 
Early on in this thesis, a critical examination of the current approach to research within the 
sporting genomics sphere suggested that the vast majority of research in this field is focused on 
explaining the differences between two groups of performers, either to explain elite athlete status, or to 
explain differences in exercise adaptation in response to a training stimulus (see Chapter 4 for more 
detail). Whilst this information holds some utility, its usefulness is, arguably, limited; a first-team player 
at an elite sporting club doesn’t require a genetic test for talent identification (and, as shown in Chapter 
12, such a test likely wouldn’t be valid anyway), and their coaches have likely already experienced the 
heterogeneity in response to an exercise stimulus. Instead, there needs to be somewhat of a paradigm shift 
in exercise genetics research, enabling a better understanding of how this information might be utilised to 
enhance training programme design. For example, whilst there is a large body of research demonstrating 
that both ACTN3 and ACE modify the response to strength training (Delmonico et al., 2007; Wagle et al., 
2018), there are far fewer studies exploring how to utilise this information to enhance the response of 
different genotypes. A theoretical paper (Kikuchi & Nakazato, 2015) first explored this, suggesting that 
ACTN3 R allele carriers—those expected to demonstrate the greatest response to high-load resistance 
training—should prioritise high-load resistance training, with an emphasis on eccentric loading, along 
with high-intensity interval training (HIIT). Conversely, those with the XX genotype were suggested to 
be better placed to undertake low-load, high-volume resistance training, minimising eccentric loading (to 
which they have an increased susceptibility for muscle damage [see Chapter 6]), and undertaking longer, 
lower-intensity aerobic training.  
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The first study to attempt to directly test this hypothesis was published in 2016 (Jones et al., 
2016). Here, participants underwent genetic testing in order to establish their genotypes for 15 separate 
single nucleotide polymorphisms (SNPs) thought to influence the adaptive response to resistance training. 
Using a total genotype score (TGS) approach, the participants’ genotypes at each SNP were given a score 
between 0 and 4, allowing the calculation of whether they would be expected to respond better to “power-
biased” (high-load, low-volume) or “endurance-biased “(moderate-load, high-volume) resistance training. 
The participants were then randomly assigned to receive either genetically matched or mismatched 
training. The results showed that those undertaking genetically matched training—i.e. power-biased 
participants undertaking power-biased training, or endurance-biased participants undertaking endurance-
biased training—achieved around three times the magnitude of performance improvement in 
countermovement jump (CMJ) height and Aero3 tests. The results of this study suggested, for the first 
time, that genetic information could be used to enhance training adaptations.  
 
Taken together, the results of this earlier work, both theoretical (Kikuchi & Nakazato, 2015) and 
applied (Jones et al., 2016), along with the theoretical and applied aspects of this thesis, suggest that the 
ability to begin to utilise genetic information to enhance elite sport performance is close. To continue 
down this road, researchers will have to seek to further bridge the gap between lab and field, focusing on 
the practical applications of their work, and supporting coaches and athletes in their quest to enhance 
performance (Buchheit 2017). Specifically, it is important to better understand how a variety of emerging 
technologies—not just genetic information—can be utilised to assist coaches in getting closer to a 
definitive answer to the following questions: 
 
1) To what training will my athlete best respond? 
2) How well is my athlete adapting to training? 
3) When should I change the training stimulus (i.e., has the athlete reached their adaptive ceiling 
for this training modality)? 
4) How long will it take for a certain adaptation to occur? 
5) How well is my athlete tolerating the current training load? 
6) What load can my athlete handle today? 
 
This chapter aims to explore novel methods which, when used alongside existing technologies, 
will hopefully help coaches gain answers to the above questions. This should assist in the decision-
making process, allowing for the targeted use of emerging technology to guide such decisions, and 
contribute to an enhanced understanding of the way in which each individual responds to exercise 
training, both in terms of adaptation and fatigue. 
 
 
2. A personalised medicine approach to performance 
 
The announcement of the Human Genome Project (HGP) lead to the belief that it would soon be 
possible to understand the genetic and molecular underpinnings of disease, and, in turn, be able to 
develop personalised treatments for individuals to combat such diseases. This, coupled with the 
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decreasing costs associated with genome sequencing, lead to the US National Human Genome Research 
Institute to formalise a 20-year plan aiming to translate the insights, from both the HGP and early pilot 
studies, into medical breakthroughs (Green & Guyer, 2011; Manolio & Green, 2014). The spotlight was 
further shone on the promise of precision medicine by President Barack Obama, who, in his 2015 State of 
the Union address, proposed a vision for a Precision Medicine Initiative within the US (Ashley 2015; 
2016). 
 
The precision medicine movement has had some success. For example, an enhanced 
understanding of the genetic mutations within CFTR which cause Cystic Fibrosis (CF) has improved 
treatment for many sufferers. Here, patients can now be stratified into subgroups based on their CFTR 
genotype; the mutation type determines the effectiveness of the drug ivacaftor in the treatment of CF. In 
the ~85% of patients expected to see a reduced effectiveness of ivacaftor, a second drug, lumacaftor, can 
be given in combination, which appears to enhance treatment effectiveness (Wainwright et al., 2015; 
Ashley, 2016). Similarly, it is understood that genetic variants help explain susceptibility to diseases 
(Hofker & Wijmenga, 2009; Yan et al., 2009) allowing for more personalised, targeted advice to be given 
to those with the increased risk (Pine et al., 2016). 
 
Alongside disease prediction and management, an understanding of genetic variation has been 
used to personalise drug treatments through the field of pharmacogenomics (Relling & Evans, 2015). 
Here, information on genetic variants known to influence drug pharmacokinetics or pharmacodynamics is 
utilised to guide drug selection and dosage (Relling & Evans, 2015), such as the success seen in 
genotyping both VKORC1 and CYP2C9 to optimise the dose of warfarin (International Warfarin 
Pharmacogenetics Consortium, 2009). This information can also be used to guard against adverse 
reactions to drugs (Yip et al., 2015; Zhang & Sarkar, 2018); for example, variation in CYP2D6 leads to an 
increased sensitivity to codeine, requiring an alternative drug to be used (Ashley 2016). Additionally, 
within the oncology sphere, there is the potential to sequence individual patient tumors, and utilise this 
information to guide treatment options (Thomas et al., 2014; Damodaran et al., 2017), such as the 
provision of larotrectinib in TRK fusion-positive tumors (Drilon et al., 2018). Alongside genomics and 
pharmacogenomics, precision medicine has expanded to utilise other “-omes” and “-omics” technologies 
(Caudle et al., 2010; Hasin et al., 2017), such as an understanding of the microbiome in human health and 
disease, epigenetics, transcriptomics, proteomics, and metabolomics (IHMP, 2014; Birnet et al., 2016; 
Hasin et al., 2017). 
 
Despite the potential promise of precision medicine, such an approach has yet to fully reach its 
potential, and has been subject to a range of criticisms regarding its effectiveness (Taylor-Robinson & 
Kee, 2018). Nevertheless, it remains a tantalising proposition for the integrated health management of 
patients, and, as research progresses and challenges are overcome, will doubtlessly assist in the 
prevention and treatment of a number of diseases (Ashley 2016). Additionally, the precision medicine 
framework has been proposed as a future method to improve both health and performance in athletes 
(Montalvo et al., 2017). In this case, both genetics and genomics, in partnership with additional -omic 
technologies, could be used to detect underlying conditions that may alter athlete health, such as 
Hypertophic Cardiomyopathy (HCM) (Maron et al., 2012), injury risk (e.g. COL5A1 [Posthumus et al., 
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2009c]), exercise adaptation (see Chapter 2 for more details), nutritional requirements (Ordovas et al., 
2018; Guest et al., 2019) and ergogenic aid use (see Chapter 5 for further information).  
 
The upcoming sections detail how some of the methods inherent within the 
personalised/precision medicine process may be utilised within the elite sports sphere in the future, 
allowing for the development of the personalised training process.  
 
 
3. Novel markers of exercise adaptation and recovery 
 
3.1 Epigenetic modifications—novel markers of exercise adaptation and fatigue 
 
As detailed in Chapter 2, epigenetic modifications act to regulate genetic expression. Epigenetics 
can be very broadly defined as changes in genetic expression that occur without a change in the 
underlying genetic code. There are numerous different epigenetic changes that can occur, of which three 
are most well studied; DNA methylation, histone modifications, and microRNAs (miRNA) (Ehlert et al., 
2013; Ling & Ronn, 2014; Moran & Pitsiladis, 2016). Epigenetic modifications have the potential to be 
heritable (Voisin et al., 2015), but also may be both malleable and transient (Voisin et al., 2014), and have 
been proposed as potentially important modifiers of exercise adaptation (Polakovicova et al., 2016; 
Hakansson et al., 2018). 
 
3.1.1 Methylation 
 
DNA methylation refers to the addition of a methyl (-CH3) group to a cytosine (C) DNA base. 
The methyl group reduces the availability of the cytosine base to the DNA transcription machinery, which 
therefore limits the transcription of that particular section of the gene. Whether this is positive or negative 
is context specific, depending on whether transcription of that specific gene is desired. For example, 
methylation of PPARGC1A, a gene involved in mitochondrial biogenesis, is associated with an increased 
risk of type-II diabetes (Ling et al., 2008). Conversely, methylation of a number of cancer promotor genes 
is likely positive, reducing the risk of the disease (Voisin et al., 2014). Regular exercise is able to both 
methylate disease-associated genetic variants, and de-methylate (i.e. remove the methyl group) genes 
associated with positive exercise adaptations (Voisin et al., 2014; Ling & Ronn, 2014; Pareja-Galeano et 
al., 2014). This relationship is fluid and transient, with methyl markers associated with inactivity removed 
when the individual undertakes exercise training (Ling & Ronn, 2014). Recently, Seabourne and 
colleagues (2018) demonstrated that skeletal muscle has an epigenetic memory, with acute exercise 
producing methylation patterns that are maintained through a period of inactivity, and which appear to 
subsequently enhance later adaptations to resistance training.  
 
As such, there is the possibility of utilising methylation patterns as markers of current status, 
providing insight to the training history of athletes. As research in this area develops, it should be possible 
to gain an understanding as to what the implications of specific methylation patterns are, such this 
information could be used to determine the responsiveness of a given athlete to a stimulus. Additionally, 
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aberrant methylation patterns could be identified, and training programmes designed to remove those 
patterns, potentially enhancing subsequent exercise adaptation.  
 
3.1.2 Histone modifications 
 
DNA is wrapped around structural proteins called histones, giving it a tightly coiled structure. 
The tightness of these coils makes the individual bases poorly accessible to the various different 
transcription factors and enzymes requires to transform the raw code of DNA to the required protein. To 
combat this, the body has evolved a method for various different stimuli—including exercise—to better 
access its DNA when required; that of histone modifications. Here, the histone proteins are acted on to 
allow the DNA to un-coil, making it more accessible for translation to the required protein. This primarily 
occurs via the addition of an acetyl group to the histone protein, which is catalysed by the histone 
acetyltransferase (HAT) enzyme group (McKinsey et al., 2001). In turn, the acetyl group is removed by 
histone deacetylase (HDAC) (McKinsey et al., 2001).  
 
Given their fundamental role to play to gene transcription, and, given that transcription of genes 
is a crucial aspect of exercise adaptation (Egan & Zierath, 2013), it’s clear that both HATs and HDACs 
have the potential to modify the response to exercise. This has been studied in mice models, where an 
increase in a specific HDAC, HDAC5, blunted the expected increase in type-I fibres following aerobic 
training (Berdeaux et al., 2007). Other studies have demonstrated how concentrations of both HATs and 
HDACs may alter muscle plasticity; acetylation of the histone H3, for example, has been linked to 
alterations in the expression of myosin heavy chain genes, which in turn potentially alters muscle fibre 
type (Pandorf et al., 2009). As a result, the monitoring of HAT/HDAC concentrations may assist in 
understanding the training response. If there is an increase in those HATs/HDACs associated with an 
increase in type-I fibre following training, and the athlete is a sprinter, it would seem logical to modify 
the training stimulus to instead provide a more optimal adaptation.  
 
Of the three major epigenetic modifications, histone modifications are perhaps the least well 
understood, in part due to the fact that they are highly site-specific, so changes occurring within the 
muscle would require a biopsy. Given the largely transient nature of histone modifications, frequent 
biopsies would be required, a process which often is not feasible, especially in elite athlete cohorts.  
 
3.1.3 miRNA 
 
 Traditionally, it was believed that RNA served as an intermediate step between DNA and the 
proteins produced; in this early model, RNA, in the form of messenger RNA (mRNA) was produced from 
DNA during transcription, with the mRNA then being transported to the ribosome for production of the 
required protein. However, the results of ENCODE (Encyclopedia of DNA Elements) suggested that, 
whilst ~75% of the human genome is transcribed into RNA, only a very small proportion (~3%) is 
directly involved in the creation of proteins (ENCODE Project Consortium 2012). This suggests that the 
vast majority of RNA is not involved in the creation of protein, but instead, in some cases, may alter the 
translation of proteins by controlling mRNA (Bartel, 2004; Polakovicova et al., 2016). miRNAs play a 
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role in modulating metabolism and inflammation, which in turn may impact exercise recovery and 
adaptation (Polakovicova et al., 2016). As such, they represent potentially important biomarkers in the 
personalised training process.  
 
The role of miRNAs in adaptation to resistance training has been explored in a few studies. Two 
miRNAs, miR-1 and miR-133a, are expressed during skeletal muscle hypertrophy (McCarthy & Esser, 
2007). Importantly, differences in miRNA concentrations may be able to predict exercise training 
response. Davidsen and colleagues (2011) reported that high- and low-responders to a resistance training 
programme differentially expressed four miRNAs, with three (miR-378, miR-29a, miR-26a) 
downregulated in low responders, and one (miR-451) upregulated in low responders. Similarly, Horak et 
al. (2018) demonstrated that baseline levels of miR-93 represented an independent predictor of 
improvements in isometric leg extension following a resistance training programme.  
 
miRNAs have also been implicated in modifying the response to aerobic endurance training. 
Nielsen and colleagues (2010) demonstrated that specific miRNA concentrations altered in response to 
both an acute aerobic training session, as well as a longer-term (12-week) training programme, a result 
which has been replicated (Russell et al., 2013). Aoi and colleagues (2013) demonstrated that a specific 
miRNA, miR-486, was significantly decreased following both acute and chronic endurance training when 
compared to baseline, and the ratio of this change was negatively correlated with changes in VO2max. 
Additionally, Domanska-Senderowska et al. (2017) found a correlation between miR-29a and VO2max 
training improvements in a group of soccer players. miRNAs may also be useful in assessing baseline 
fitness, with three (miR-210, miR-21, and miR-222) associated with lower VO2max (Bye et al., 2013).  
 
Furthermore, the manipulation of training variables has been demonstrated to affect miRNA 
levels. As an example, Schmitz and colleagues (2018) reported that 4 x 30s high-intensity sprint running 
repetitions significantly increased both miR-222 and miR-29c levels, whilst 8 x 15 second sprints did not. 
Both of these miRNAs are associated with adaptations to exercise; miR-222 plays a role in exercise-
induced cardiac growth (Liu et al., 2015), whilst miR-29c is a modulator of cardiac muscle remodeling 
(van Rooij et al., 2008). Additionally, miRNAs appear, at least in some cases, to be sensitive to exercise 
dose, plateauing if there is insufficient progression (Schmitz et al., 2017).  
 
miRNAs also hold potential as markers of exercise load. As an example, Gomes and colleagues 
(2014) reported that three miRNAs (miR-1, miR-133a, and miR-206) were significantly elevated 
following a half marathon when compared to baseline. Further research examined the differences in 
miRNA release following 10km, half-marathon and marathon runs (de Gonzalo-Calvo et al., 2015), with 
the extent of miRNA increases distinct between the distances. These specific miRNAs were associated 
with inflammation, suggesting that practitioners may be able to better understand the individual 
inflammatory response to exercise, allowing for more personalised recovery processes to be put in place. 
Recently, Hakansson and colleagues (2018) identified differences in miR-29a-3p (which was also 
identified by de Gonzalo-Calvo et al., 2015) and miR-495-3p expression between elite athletes and 
peripheral artery disease patients following exercise, suggesting that these miRNAs may hold promise as 
markers of muscle recovery following exercise.  
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As such, the evidence suggests that the monitoring of miRNA concentrations, both before and 
during an exercise programme, may hold utility. The measurement of concentrations prior to beginning 
an exercise programme may be able to identify high- and low-responders to that intervention (Davidsen et 
al., 2011; Horak et al., 2018), allowing for the modification of the subsequent training programme. 
Similarly, the monitoring of miRNA concentrations during the training programme may act as a real-time 
monitor of adaptation, with increases or decreases in specific miRNAs associated with a particular 
training response (Schmitz et al., 2018). In time, as research in this field progresses, it may be possible to 
match specific miRNAs to a specific molecular process; here, coaches will be able to understand whether 
the desired training effects—such as an increase in mitochondrial biogenesis—are actually occurring. 
Early evidence suggests that this innovation is close; the identification of miR-222 and -29c as drivers of 
cardiac adaptations following exercise illuminates the potential utility of monitoring the concentrations of 
these miRNAs—should an individual not see an elevation in these miRNAs, then training 
intensity/duration may have to be modified to elicit such a change (Schmitz et al., 2018). Additionally, 
lower concentrations of miR-33 are associated with greater activation of AMPK following aerobic 
training (Davalos et al., 2011), and miR-29b alters PGC-1a production (Wang et al., 2008)—both 
molecular signals for mitochondrial biogenesis—again demonstrating how real-time monitoring of 
miRNA concentrations could allow coaches to understand the specific adaptations an exercise is 
stimulating. Regular monitoring of miRNAs also has the potential to act as a marker of adaptation, as 
increases in specific miRNAs appear to be blunted when exercise dose is not progressed within a training 
programme (Schmitz et al., 2017). Taken together, the evidence suggests that miRNAs have the potential 
to be utilised as biomarkers of training response (Baggish et al., 2011; Zacharewicz et al., 2013), both in 
terms of adaptation and recovery. However, at present, one major limitation to the use of miRNAs as 
biomarkers is a lack of uniformity in response across studies; very rarely has a single miRNA been shown 
to have a universal response to a type of exercise (Fernandez-Sanjuro et al., 2018). For example, whilst 
increases in miR-1 and miR-133a have been shown following endurance exercise (Mooren et al., 2014; 
Baggish et al., 2014; Clauss et al., 2016), other studies have found no such increase (de Gonzalo-Calvo et 
al. 2015). Further research will need to elucidate whether the miRNA response to exercise is 
heterogenous (and potentially caused by heterogeneity in individuals [Fernandez-Sanjurjo et al., 2018])—
limiting their use as exercise biomarkers—or if some commonalities can be found.  
 
3.1.4 Utilisation of epigenetic markers within training programmes 
 
 As discussed above, the three major epigenetic modifications hold potential utility for a role 
within the personalised training process. Of these, perhaps the most promising are miRNAs, which have 
the potential to serve as markers of responsiveness to a training programme prior to that programme being 
undertaken (Davidsen et al., 2011), allowing for the coach to match the athlete to the required exercise 
type. miRNAs also hold value as a real-time marker of exercise adaptation (Domanska-Senderowska et 
al., 2017), allowing for a change of stimulus to be applied at the most optimal time point, and as a marker 
of fatigue status (Hakansson et al., 2018), allowing for daily changes in training load and volume. 
Methylation markers have the potential to act as markers for previous training exposure (Seabourne et al., 
2018), as well as giving guidance as to the current adaptive potential of an athlete at a given time 
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(Terruzzi et al., 2011), allowing for the required stimulus to be provided to the athlete. Finally, histone 
modifications may serve to allow the coach to better understand which stimulus provides which adaptive 
signals within each individual athlete, again allowing for a highly targeted approach to sports training.  
 
3.1.5 Practical perspectives 
 
 Perhaps the biggest issue facing the provision of epigenetic modifications within an exercise 
training context is that such changes are often both tissue specific and transient (Lokk et al., 2014). As a 
result, the accurate determination of epigenetic changes requires the sampling of the specific tissue, such 
as skeletal muscle, which can be both invasive and traumatic, and hence not palatable to high level 
athletes. Additionally, the samples would have to be taken immediately after exercise for accurate 
analysis to occur. As epigenetic modifications can be both fast acting and temporary, frequent testing for 
such modifications would likely have to occur, increasing the cost and reducing the practicality of such 
technology.  
 
 However, the collection of saliva for the profiling of DNA methylation holds promise (Langie et 
al., 2017), with methylation sites in saliva concordant with methylation within the target tissue for some 
specific biomarkers. At present, this has yet to be explored within an exercise setting but, if salivary DNA 
methylation profiling for exercise-related modifications becomes feasible, it will remove a substantial 
barrier to entry for methylation profiling within elite sport.  
 
3.1.6 Section summary 
 
 Figure 19 acts as a brief summary of the impact of epigenetic modifications on exercise 
adaptations and fatigue. Here, an exercise training session elicits adaptive and fatigue-inducing effects, 
both of which are partially controlled via epigenetic modifications. These epigenetic modifications in turn 
have a feed-forward effect to the next training session, modifying performance, adaptation, and fatigue 
response to that session.  
 
 
Figure 19 – Summary of epigenetic influences on training-induced adaptation and fatigue 
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3.2 Cell-free DNA (cfDNA): a novel marker of exercise adaptation? 
 
Circulating cell-free DNA (cfDNA) refers to the presence of DNA fragments within the blood 
(Breitbach et al., 2012). At rest, small amounts of cfDNA are present in the blood stream; these 
concentrations have been demonstrated to increase under both acute and chronic physiological stress, 
such as sepsis, trauma, cancer, and myocardial infarction (Swarup et al., 2007). This is also true of 
exercise. For example, following a half marathon race, mean cfDNA concentrations increased from 18 
pg/µL (baseline) to 335 pg/µL (Atamaniuk et al., 2004), with similar results being demonstrated 
following an ultra-marathon (Atamaniuk et al., 2008). This is also true for resistance training, where 
increases in cfDNA have been demonstrated following a single training session (Atamaniuk et al., 2010), 
and within a 12-week training programme (Fatouros et al., 2006).  
 
Whilst the mechanism underpinning the increased release of cfDNA during exercise is poorly 
understood, it appears that cfDNA is primarily released from cells involved in immune function 
(Andreatta et al., 2018). The magnitude of cfDNA concentration increases also appears proportional to 
both exercise intensity and duration (Andreatta et al., 2018; Haller et al., 2017), and the time course of 
these changes is remarkably transient, with cfDNA concentrations often returning to baseline within 24 
hours, even after highly exhaustive exercise (Atamaniuk et al., 2004). As a result, cfDNA represents a 
potentially novel biomarker for fatigue and recovery in exercise (Breitbach et al., 2012; Andreatta et al., 
2018; Haller et al., 2018). In participants who undertook a 12-week resistance training intervention, 
cfDNA was strongly correlated with mean training load within each 3-week training sub-block (Fatouras 
et al., 2006). The highest concentrations of cfDNA also corresponded to a decreased performance level, 
leading the authors to suggest that cfDNA was a potential biomarker for overtraining; such a finding is 
potentially crucial given that overtraining/unexplained underperformance syndrome is, at present, largely 
a diagnosis of exclusion (Lewis et al., 2015). Finally, Haller and colleagues (2018) demonstrated that 
cfDNA increases were proportional to, and strongly correlated with, total running distance in a group of 
soccer players. The 23-fold increase in cfDNA concentrations demonstrated in this study is believed to be 
the largest biomarker increase reported following acute exercise training, suggesting a greater sensitivity 
than more traditional markers, such as lactate and CRP. Furthermore, the correlations between cfDNA 
and RPE are stronger (r=0.58) than for that of lactate and RPE (r=0.32), again demonstrating its potential 
utility as an exercise load biomarker (Haller et al., 2017).  
 
The collection of samples for measurement of cfDNA is relatively straightforward, requiring a 
small amount of blood to be collected from a capillary (Andreatta et al., 2018), which can easily be 
achieved through a finger prick. As such, the use of cfDNA as a biomarker of exercise load, recovery, and 
overtraining is highly promising, especially given the evidence suggesting that it is more sensitive than 
traditional biomarkers of training load (Haller et al., 2018); as a result, its use could represent an 
enhancement of current practice.  
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4. The microbiome, exercise, and elite performance 
 
The human gut plays host to more than 100 trillion micro-organisms (Li et al., 2014), which are 
collectively termed the microbiota. The roles these micro-organisms play are multifaceted, assisting in the 
digestion of food (Hsu et al., 2015), along with the production of nutrients such as vitamin K2 (Marley et 
al., 1986), the neutralisation of pathogens and carcinogens (Nicholsen et al., 2012), and regulation of the 
immune system (Nicholsen et al., 2012). More recently, research has shown that the microbiota influence 
neurotransmitters, such as dopamine, via the gut-brain axis (Stilling et al., 2014; Clark & Mach, 2016). 
Additionally, it has been suggested that the microbiota may assist in the control of both the inflammatory 
response and oxidative stress during endurance exercise (Mach and Fuster-Botella, 2017). 
 
Because the microbiome is modifiable by both diet and exercise (Clark et al., 2014), knowledge 
of the current composition of an individual’s microbiome holds promise in guiding interventions. 
Currently, such interactions are poorly understood; whilst it is understood that specific dietary changes, 
such as an increase in protein (Moreno-Perez et al., 2018) or carbohydrate (Chassard & Lacroix, 2013), 
modify the microbiome, the effectiveness of specific changes through targeted interventions has not been 
tested. Additionally, whilst it is clear that diversity of the microbiota is important, with elite athletes 
tending to have increased diversity compared to non-athletes, and active individuals demonstrating an 
increased diversity compared to inactive individuals (Clark et al., 2014), it is not currently possible to 
offer more in-depth advice than “be active”. However, as knowledge in this area increases, it appears 
feasible that regular monitoring of an athlete’s microbiome will be able to inform dietary interventions 
targeted at enhancing immunity, substrate use during exercise, neurotransmitter response—which may 
assist in stress management—and post-exercise recovery. Accordingly, this represents a promising aspect 
of the personalised medicine approach to performance management in elite athletes.  
 
 
5. Pharmacogenomics – personalised sports nutrition? 
 
Pharmacogenomics refers to the identification of genetic variants that modify the effects of a 
given drug, most commonly through alterations in pharmacokinetics (such as the metabolisation of that 
drug), or pharmacodynamics (such as variation in the drug’s receptor) (Relling & Evans, 2015). Chapter 5 
introduced a specific example of this; that of caffeine. Here, genetic variation in CYP1A2, the gene 
encoding for cytochrome P450 1A2, affects caffeine metabolisation speed (Gu et al., 1992). The evidence 
suggests that individuals with the AA genotype at a specific SNP—rs762551—within this gene 
metabolise caffeine quicker than C allele carriers (Sachse et al., 1999), an example of pharmacokinetics 
specific to sports nutrition. Additionally, variation in ADORA2A appears to modify the binding 
characteristics of caffeine to the adenosine-2a receptor, which in turn alters caffeine’s effects on 
downstream dopamine transmission (Fulton et al., 2018); an example of pharmacodynamics.  
 
Knowledge of the differences in CYP1A2 and ADORA2A genotype may, as suggested in Chapter 
5, inform pre-competition caffeine strategies. For example, CYP1A2 AA genotypes appear to experience 
greater ergogenic effects following caffeine ingestion than C allele carriers (Womack et al., 2012; Guest 
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et al., 2018); indeed, CC genotypes may even find some doses of caffeine ergolytic (Guest et al., 2018). 
Similarly, early research suggests that individuals with the TT genotype of ADORA2A experience 
enhanced ergogenic effects of caffeine (Loy et al., 2015). These SNPs also have the potential to modify 
habitual caffeine use (Cornelis et al., 2007), along with both anxiety (Alsene et al., 2003) and sleep 
disturbances (Byrne et al., 2012) following caffeine ingestion, suggesting that knowledge of genotype 
may enhance the decision-making process (Chapter 5). 
 
Whilst caffeine offers the best example of pharmacogenomics within sporting contexts, a recent 
review (Heibel et al., 2018) demonstrated similar inter-individual variation in response to extracellular 
buffering agent supplementation (e.g. sodium bicarbonate). The inter-individual variation is partially 
determined by differences in MCT1 genotype. MCT1 encodes for monocarboxylate transporter 1, which 
influences lactate ion transport. As such, variation in this gene may modify the effectiveness of buffering 
agent supplementation. As research in this area evolves, it may be possible to identify those athletes 
expected to see a greater response to a particular supplement, as well as modifying dosage and timing of 
various ergogenic aids (Pickering 2018), as a means to enhance performance.  
 
 
6. The integration of other “omes” 
 
Alongside an understanding of the microbiome, genome, and epigenome, along with the utility 
of other markers, such as cfDNA, to act as novel markers of exercise adaptation and readiness, there are a 
variety of other “omes”, including the transcriptome, proteome, and metabalome, which may enhance the 
personalised medicine approach to elite athlete preparation. At present, these aspects are poorly studied 
within an exercise setting, partly due to the complex technology and sampling methods required, and 
partly due to the vastness of all quantifiable aspects of each -ome.  
 
The proteome is the term used to describe all the proteins expressed by the genome (Wilkins et 
al., 1996). Given that these proteins are the direct drivers of exercise adaptation, involved in, for example, 
skeletal muscle hypertrophy and mitochondrial biogenesis (Timmons, 2011), understanding the extent of 
protein expression in response to exercise, along with an understanding of inter-individual variation in the 
expression of a given protein in response to a specific stimulus, may assist in the matching of the athlete 
to the training programme best suited to the desired adaptation, along with their personal biology. At 
present, proteomic measurement can be extremely invasive, requiring a biopsy of the required tissue; this 
is problematic for muscles, causing trauma which may reduce exercise performance and increase this risk 
of infection, and is impossible (at present) for organs such as the heart (Petriz et al., 2012). As a result, 
the majority of the studies exploring the proteomic response to exercise are carried out in rats, hampering 
the ability to achieve clarity from their findings within human contexts.   
 
Transcriptomics refers to the examination of mRNA levels genome-wide (Hasin et al., 2017), 
with these RNA levels in turn thought to act as a measure of genetic expression. Interestingly, there have 
been wide differences in measured mRNA expression within muscle between trained and untrained 
individuals in response to exercise (Wittwer et al., 2004; Stepto et al., 2009), suggesting that 
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transcriptomics may hold promise as a “predictor” of training outcomes. More recently, however, authors 
have suggested that the association between increased mRNA expression and increased gene expression 
may not be as strong as once thought (Burniston & Hoffman, 2011), and, indeed, may be due to technical 
error or random biological variation (Islam et al., 2019); as a result, transcriptomics may not be as useful 
as proteomics within the personalised medicine approach to athlete preparation.  
 
Metabolomics refers to the measurement of multiple small molecule types that are downstream 
products of biochemical reactions (Hasin et al., 2017). Within the muscle, such metabolites could give 
insight into the type and rate of fuel being utilized, allowing for a personalised approach to sports 
nutrition. As an example, Starnes and colleagues (2017) reported significantly reduced a-tocopherol 
levels following exercise training in rats, suggesting that the maintenance of vitamin E levels around 
exercise may be important in attenuating post-exercise muscle damage. Metabolites linked to epigenetic 
modifications, such as folate in the case of methylation (Friso et al., 2002) could also be monitored; this is 
of importance given that lower levels of methylation are potentially advantageous following a 
hypertrophy-orientated training session (Terruzzi et al., 2011), again allowing for targeted, personalised 
nutritional practices to be recommended. Similar to proteomics and transcriptomics, measurement of the 
metabolome is, at present, highly invasive (Alves et al., 2015), limiting its potential applications to 
inform training programme design.  
 
In summary, whilst proteomics, transcriptomics, and metabolomics hold potential promise as 
monitoring tools within the personalised training process, at present there are significant difficulties in 
utilising these technologies, given the highly invasive sample collection procedures, along with a lack of 
research within sporting contexts. As research in this field progresses, and sample collection techniques 
simplify, such an approach may become more feasible.  
 
 
7. The use of technology in the personalised training process 
 
The increasingly popular utilisation of various different technologies within sport has grown 
over the last twenty years, from simple global positioning systems able to determine distance covered 
(Wing 2018) to implantable devices able to measure force and strain on a muscle or tendon (Sperlich et 
al., 2017). The increased growth of technology has led to a number of recent reviews on the subject 
(McGuigan et al., 2013; Duking et al., 2016; Duking et al., 2018; Peake et al., 2018), with interest on 
using these technologies to design training that better matches competition performance (McGuigan et al., 
2013; Wing, 2018), manage fatigue (Duking et al., 2017; 2018), and reduce injury prevalence (Duking et 
al., 2017), although the level of validation of these technologies is highly variable (Peake et al., 2018). 
 
An in-depth overview of the various different technologies is beyond the scope of this chapter 
(and would likely be a thesis in itself), but it is worth considering how these various technologies could fit 
into the personalised training process. From the perspective of training programme design, real-time and 
retrospective data gained from these technologies can be used to design optimised programmes. For 
example, in the preparation of an elite sprinter, power, force and velocity profiles can be determined 
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through the use of timing gates (Haugen et al., 2018), force platforms (Mero et al., 1986), wearable 
technology (e.g. senor insoles [Nagahara & Morin, 2018]), smartphone apps (Romera-Franco et al., 
2017), accelerometers embedded in external training aids (Cross et al., 2018), and high-speed video 
(Bezodis et al., 2008). In recent times, many of these technologies have been integrated into Inertial 
Measurement Units (IMUs), reducing the number of separate systems that require on-going 
administrating, and streamlining the data management process (Dellaserra et al., 2014; Marin et al., 
2016). The data collected allows the coach and support team to determine the athlete’s current strengths 
and weaknesses in relation to their preferred gold-standard model and/or competition performance data, 
with specific exercises developed to address these weaknesses (Morin & Samozino, 2016). Such an 
approach has been utilised to personalise optimal loading strategies in resisted sprint training (Cross et al., 
2017). Additionally, McGuigan and colleagues (2013) discussed the use of a battery of strength tests to 
determine strength and weaknesses across the strength and power domain, again allowing for enhanced 
personalisation of the training process.  
 
Technologies can also be utilised to quantify training load, which is useful in assessing fatigue 
and readiness to train (Halson et al., 2014; Campbell et al., 2017; Sands et al., 2017). This occurs via the 
quantification of both external (e.g. running velocity, duration and intensity; weightlifting sets, reps, and 
weight) and internal (e.g. heart rate [HR], heart rate variability [HRV]) loads, along with the 
determination of environmental aspects that might affect such loads, such as temperature and altitude 
(Hargreaves 2008; Born et al., 2014). This can also be the case in contact sports, where wearable 
technologies such as accelerometers may assist in the quantification of “contact load”, which in turn has 
its own recovery requirements (Gabbett 2013). This information can then be used to better understand 
whether the training load is sufficient to promote the required adaptations and protect against injury, or 
too great, increasing injury risk (Blanch et al., 2016; Gabbett, 2016; Gabbett et al., 2016; Hulin et al., 
2016a, 2016b).  
 
Technologies can also be used to assist the coach and practitioner in determining readiness to 
train. For example, the use of a pre-training countermovement jump (CMJ) or measurement of bar 
velocity can assist in understanding the neuromuscular fatigue status of the athlete prior to training 
(Sanchez-Medina & Gonzalez-Badillo, 2011; Jovanovic & Flanagan, 2014; Gathercole et al., 2015), 
whilst metrics such as HR and HRV (measured via chest straps or smartphone apps) assist in 
understanding the athletes readiness to train (Plews et al., 2013; Buchheit 2014; Plews et al., 2014).  
 
Furthermore, technologies are becoming increasingly ubiquitous within the athlete’s non-
training life, leading to the creation of the “24-hour athlete” (Sperlich & Holmberg, 2017). This includes 
the assessment of sleep measures, including duration and quality (Halson 2014), which, given the impact 
of poor sleep on performance (Leeder et al., 2012a), recovery (Bird 2013), cognitive function (Ferrie et 
al., 2011), and overall health (Irwin et al., 1996) is an important management metric.  
 
Whilst it is easy to get carried away with the latest technology, it is worth keeping in mind that 
subjective markers of training load and athlete wellbeing, such as mood and perceived stress, have been 
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shown to outperform a more high-tech approach (Saw et al., 2016), demonstrating that a more targeted 
use of technology, along with common subjective markers, may represent the best approach at present.  
 
 
8. Prediction, data mining & machine learning 
 
 With an abundance of information available to the coach, recent research has focused on being 
able to better utilise this information to underpin decision making via prediction, either in terms of injury 
risk (Kampakis 2016; Larruskain et al., 2018), post-injury recovery times (Kampakis 2013), physiology 
(such as muscle fibre type [Borisov et al., 2018]), training loads and fatigue (Gonzalez et al., 2017; 
Vandewiele et al., 2017), talent identification (McCullagh 2010), and training plans (Mezyk & Unold, 
2011; Fister et al., 2015). These approaches utilise a variety of different statistical modelling techniques, 
including simple data analysis with a hold-out set for validation (e.g. Larruskain et al., 2018), more 
complex data mining techniques (e.g. Ofoghi et al., 2013), and machine learning tools (e.g. Vandewiele et 
al., 2017).  
 
 As the predictive ability of these various models tends to increase with both the amount and 
quality of data inputs, such methods represent promise as part of the personalised training process. 
Predictive modelling has been used in medicine with some success. For example, using a relatively 
simple Genetic Risk Score (GRS) of just 13 single nucleotide polymorphisms (SNPs), Ripatti and 
colleagues (2010) were able to identify individuals with a 70% increased chance of developing coronary 
heart disease. In building on a single data-type (i.e. genetic information) model, Khera and colleagues 
(2018) recently developed a GRS algorithm utilising 6.6 million SNPs to identify individuals with a 
threefold increased risk of developing coronary artery disease. Similar single data input models have been 
utilised in sport. For example, Borisov and colleagues (2018) utilised a 14 SNP model to predict muscle 
fibre type in 55 participants, with a Receiver Operating Characteristic (ROC) of 81% for professional 
athletes, demonstrating strong concordance with muscle biopsies. Such a finding could be very useful 
within elite sport because muscle biopsy testing is highly invasive, limiting its use, whilst genetic testing 
is non-invasive.  Similarly, Larruskain et al. (2018) collected hamstring injury data over five seasons in 
an elite soccer team, along with genetic information. They then created a model of five SNPs, which 
demonstrated acceptable discriminatory ability to explain previous hamstring injury within that cohort. 
However, when applied to a hold-out data set used as validation, the model performed only as well as 
chance, demonstrating a lack of ability to predict injury.  
 
 As a result of the Larruskain and colleagues (2018) study, it is clear that the use of individual 
pieces of data is likely insufficient in the prediction of complex phenotypes and outcomes, such as injury, 
whilst it perhaps is sufficient for less complex phenotypes, as demonstrated by Borizov et al. (2018), who 
used genetic information to predict muscle fibre type with success. Data mining refers to the conversion 
of raw data—such as that collected by the various technological and testing practices utilised in elite 
sport—to information which can then be analysed (Ofoghi et al., 2013). Machine learning focuses on the 
development of algorithms to analyse that information, with those algorithms adapting and correcting 
themselves as the number of inputs increases (Sajda 2006). Again, these techniques have been utilised in 
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medicine, with success in predicting heart attack risk and breast cancer survivability (Delen et al., 2004; 
Srinivas et al., 2010; Soni et al., 2011). Within a sporting context, Vandewiele and colleagues (2017) 
developed a machine learning model that predicts the session rating of perceived exertion (sRPE) of the 
whole training group, allowing the coach to understand the general training load of a prescribed training 
session before it occurs. Additionally, their model predicted sRPE of individual athletes prior to training, 
allowing for the tailoring of individual workloads, and, with the addition of data collected within the 
training session (such as total distance covered), predict the post-training sRPE for individuals, allowing 
the coach to better understand the load of a given session and make changes to following sessions 
accordingly. This approach is potentially important, given difficulties in coaches and athletes accurately 
quantifying sRPE (Kraft et al., 2018), and has the potential to enhance training adaptations and reduce 
injury risk. The model itself was reasonably complex, with the implementation of environmental data 
(e.g. temperature and humidity), individual characteristics (e.g. age, current fitness level, muscle fibre 
type, previous sRPE scores), and training statistics (e.g. distance, duration, heart rate zones).  
 
 In summary, the use of various different models to predict a given outcome—such as injury risk, 
training load, or fatigue—holds promise in sport; however, as of yet it has not been extensively studied. 
The quality of any predictive model depends on the ability to have effective informative inputs, with an 
emphasis on collecting reliable and valid data. Genotype remains a promising input to such models, 
having been utilised in both disease (Khera et al., 2018) and sporting (Larruskain et al., 2018) domains. 
The ability to record an increasing richness of information, such as epigenetic modifications, along with 
better quantification of present metrics, such as training load, should assist in the production of valuable 
predictive models in the future, which, with the application of machine learning, will constantly evolve to 
increase predictive power with the increasing amounts of data being entered into the model.  
 
 
9. A centralised framework for the development of a personalised training process 
 
Having identified a number of different emerging technologies that, if the current understanding 
of them grows, hold potential in the development of the personalised training process, the next step is to 
understand their integration into a framework for their use.  
 
This thesis has focused on the potential utility of genetic information in elite sport. What has 
(hopefully) been demonstrated is that genetic variation provides an influence on every aspect of elite 
athlete performance, including training adaptation (Chapter 2), injury risk (Chapter 7), ergogenic aid use 
(Chapter 5), post-exercise recovery (Chapter 11), athlete development (Chapter 8), and, potentially at 
some point in the future, the identification of future talented athletes (Chapters 8 and 12). Additionally, 
other researchers have identified the effects of genetic variation on important aspects such as skill 
acquisition (Jacob et al., 2018), psychological traits (Leznicka et al., 2018), and post-exercise fatigue (Del 
Coso et al., 2018), along with tangential factors which may impact athletic performance and preparation, 
such as nutrient requirements (Ashfield-Watt et al., 2002), microbiome composition (Goodrich et al., 
2014), and bone health (Varley et al., 2018a). As such, it is clear that genetic influences are a fundamental 
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and consistent modifier of athletic preparation, the harnessing of which should enhance the preparation 
process.  
 
However, genetic variation does not exist in a vacuum, and indeed it is not the only aspect 
affecting athletic preparation. As such, it needs to be placed in the correct context; for any single SNP, the 
likely effect on a given outcome is often very small. As discussed in Chapter 8, the identification of large 
numbers of SNPs that affect a given trait, along with the creation of Total Genotype Scores (TGS) for that 
trait, will likely improve the predictive accuracy of genetic information. But genetics will only ever serve 
as part of the picture; it allows an understanding of predispositions, which can be used to predict 
outcomes—and, as demonstrated, serve as a useful, but incomplete, input to statistical models (Borisov et 
al., 2018; Larruskain et al., 2018)—but the addition of further pieces of information, explored in this 
chapter, should enhance the personalisation process.  
 
Figure 20 serves as an overview example of how these various technologies might be integrated 
to enhance athlete preparation. When devising a training plan, it is important to have a good idea of where 
the coach and athlete want to get to—i.e., what are the performance requirements of the athlete? This can 
be determined through the use of historic performance data, along with more complex predictions and 
trend analysis achievable through data mining and machine learning (Cust et al., 2018). Once an 
understanding of the destination has been achieved, the next step is to know where the athlete is starting 
from. This can be achieved by collecting baseline fitness data, along with some of the adaptive markers 
discussed in this chapter (e.g. cfDNA), in conjunction with health and wellness data (e.g. microbiome). 
This information is then used, along with the integration of exercise “predictors” such as genetics (Jones 
et al., 2016) and miRNAs (Timmons et al., 2011) to develop the optimal training programme, based 
around what the athlete is expected to adapt most favourably to. This plan should represent an initial 
outline, as opposed to a set prescription, given the highly variable nature of adaptation (Kiely 2018)—
some, but not all, of which will be predictable from the information gained via the personalised training 
framework. 
 
 
 
 
Figure 20 – An overview of the development of the personalised training process 
 
 Recognising this need for constant reformatting and reworking of the plan, figure 21 provides an 
overview of how the various emerging technologies discussed in this chapter can be used for the daily 
manipulation of training load, intensity, and stimulus, to meet the desired demands. Here, readiness to 
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train and the adaptive state of the athlete is determined prior to training through the integration of metrics 
such as sleep, HRV, readiness testing (e.g. CMJ or bar velocity), and assessment of the psycho-emotional 
state, along with on-going data on training load and current adaptive status determined from previous 
sessions. This information can then serve as an input to a statistical model which calculates the required 
training sRPE, similar to Vandewiele and colleagues (2017) as detailed in section 8 of this chapter. As 
training commences, data can be collected on aspects such as load, intensity, duration, heart rate response, 
environmental conditions, etc., and integrated to calculate the individual and team sRPE. Individual 
markers of adaptation and fatigue can then be collected from the athlete; cfDNA and miRNA can be used 
to assist in the quantification of fatigue and training load, with epigenetic markers used to establish 
whether the desired adaptations are occurring, and to what extent. Both aspects can then be compared to 
historical data, such as previous training load, and individual factors, such as genetics and fitness level, to 
understand whether the current training load is sufficient to promote adaptations, but not excessive 
enough as to increase the risk of injury. Similarly, in future it may be possible to use genetic information 
to determine a maximum threshold of possible adaptation, along with understanding what this adaptation 
looks like at the molecular level; this information can be compared to where the athlete is at a given point 
in time to determine if they have met this threshold—requiring a change in training goal—or if they can 
continue with the same training plan.  
 
 
 
Figure 21 – A framework for the implementation of various emerging technologies to enhance daily 
training practice 
 
 Many additional technologies, both existing and novel, can be factored into these models as 
required. For example, blood testing for health markers, such as serum vitamin D, may be required; here, 
genetic variation can be used to predict the response to vitamin D supplementation (Gaffney‐Stomberg et 
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al., 2017), and used to create individualised target reference values and nutrient requirements, an 
approach which has been highly successful in recent trials (Westerman et al., 2018). Microbiome 
sampling can occur less frequently, perhaps every three months, to monitor for changes. 
Pharmacogenomic principles can be utilised in the development of personalised sports nutrition 
strategies, such as the caffeine example described in section 5 of this chapter, or to guide the selection of 
medications required to manage issues such as pain and trauma associated with daily, high level training 
and competition.  
 
 With a variety of different information types that can serve for inputs into data models, data 
mining and analysis will be able to identify those with the largest effects on performance, adaptation, 
fatigue, and injury risks, allowing for a more targeted approach to be taken to data collection if required. 
Furthermore, the integration of current technologies, such as urinary and salivary biomarkers (Lindsay & 
Costello, 2017), along with more standard physiological assessments, will likely enhance the predictive 
accuracy of these models. 
 
 The effectiveness of, and compliance to, a personalised training programme is currently 
unknown. In a pilot programme of 14 athletes, genetic information integrated into personalised injury 
prevention advice and techniques was found to reduce 12-month injury incidence, with more than half of 
the group finding the advice useful and implementing the recommendations (Goodlin et al., 2015). The 
use of optimisation software to determine pre-season training loads has proved successful in Australian 
Rules Football (Carey et al., 2018), whilst machine learning tools have been shown to outperform 
traditional methodologies in the prediction of response to training loads (Bartlett et al., 2017). 
Furthermore, a personalised approach to training has demonstrated effectiveness, with individualised 
training based on force-velocity profiling (Jimenez-Reyes et al., 2016) and HRV (Vesterinen et al., 2016) 
shown to enhance training adaptations. A major challenge will be to get athletes to accurately and 
consistently collect data—such as sleep metrics and HRV—away from the training field, with ease of use 
and lack of perceived invasiveness important factors for technology developers to consider in this regard. 
Nevertheless, despite these challenges, the development of a personalised training process appears to hold 
promise in the optimisation of athlete performance.  
 
 
10. Summary 
 
 This chapter has explored the use of other novel technologies that, along with genetic 
information—the subject of this thesis—may combine in the development of the personalised training 
process. Whilst highly speculative and poorly researched, there is clearly scope for, and the acceptance of 
(Goodlin et al., 2015; Varley et al., 2018a), an increasingly personalised training process as a method to 
enhance athlete performance. An important aspect of such a model is that athlete adaptation and 
performance is highly complex, with a number of biological systems interacting to create the outcome. 
The purpose of this chapter is to demonstrate that, whilst genetic information likely does hold utility 
within elite athlete preparation, and likely does enhance the training process, it is crucial to keep in mind 
that genetic information represents only part of the picture. As research in this area grows, it should be 
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possible to achieve a better understanding of how genetics, and genetic variation, influence elite athlete 
performance, as well as how to best integrate the information from genetic testing within a holistic athlete 
preparation model, which in turn will enable a more personalised approach to athlete preparation. This 
could become highly complex, with the collection of large swathes of data to act as an input for complex 
predictive models, but there is a simple message contained within this; that each athlete has their own 
unique biology, and every day presents in a slightly different state—adaptive or maladaptive—that 
requires the coach to make changes on the fly. The better informed the coach is, the better the decisions 
he or she can make, but, more importantly, it is clear that all athletes should not be treated the same way, 
with one size fits all training programmes planned months in advance. Despite the potential complexity of 
a personalised training process, perhaps the simplest message—that all athletes need to be treated 
differently—is the most important.  
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CHAPTER 15: DISCUSSION – IS THERE UTILITY TO GENETIC INFORMATION IN ELITE 
SPORT? 
 
 
1. Discussion 
 
As stated in the introduction, the specific aim of this thesis was to explore the question “Is there 
utility to genetic information in elite sport?” Throughout this thesis, I believe that I have built the case 
that there is potentially significant utility for genetic information within elite sport, but, at present, more 
research is required to provide evidence-based guidelines to practitioners hoping to use genetic 
information to improve athlete performance—with some areas of this future research identified within the 
thesis.  
 
In Section 2, which acted as my literature review, I explored the research around inter-individual 
variation in response to a training programme. Here, I suggested that three broad factors combine to 
determine the magnitude and type of exercise adaptations; genetic factors, environmental factors, and 
epigenetic factors (which can essentially be thought of as the effect of environmental influences on 
genetic expression). The interactions between these three aspects are highly complex and tangled; whilst, 
for example, consumption of vitamin D may modify the response to strength training (Chiang et al., 
2017), variation in a number of genes can affect both baseline vitamin D levels, and the response to a 
vitamin D supplement (Didriksen et al., 2013); as such, many environmental factors are partially affected 
by genotype. Epigenetic modifications are also partially under the control of genetic factors; for example, 
variation in MTHFR may modify methylation efficiency (Nojima et al., 2018), which can affect post-
exercise training adaptations (Terruzzi et al., 2011). Accordingly, it is clear that genetic variation is a 
consistent and fundamental modifier of variation in response to a stimulus—including exercise training—
indicating that there the potential that understanding of an individual’s genotype may assist in developing 
training programmes they are best able to adapt to.  
 
Of course, the quality of scientific evidence within a field is only as good as the quality of the 
underlying studies, and in Chapters 3 and 4 I cast a critical eye over some of the outstanding issues within 
the exercise genomics literature. First, I discussed just how applicable and appropriate the term “non-
responder”, which is increasingly becoming part of the modern exercise scientist and coach’s vocabulary, 
is. The main conclusion from that section was that exercise non-response is most likely a misnomer; by 
increasing the number of variables measured, as well as increasing training intensity, duration, and 
frequency, exercise non-response can be abated. Accordingly, it is my belief that there are no global non-
responders to exercise, which is clearly good news from a public health perspective. Secondly, I asked 
whether, in many of the exercise genomics studies, we are truly finding what we think we’re finding; i.e., 
are the results signal, or noise? There are many examples of genetic variants that appear to have one 
effect, but potentially have another; for example, the CC genotype of COL5A1 has been associated with a 
reduction in exercise-associated muscle cramps (EAMC) (O’Connell et al., 2013). However, the same 
study also reported that CC genotypes were slower over a half-marathon run; as such, it’s not clear 
whether COL5A1 is directly protective against EAMC, or, given that neuromuscular fatigue is associated 
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with increased EAMC (Bergeron, 2008), the slower athletes (i.e. the CC genotypes) were protected 
against cramp by virtue of less fatigue. Aspects of my literature review were turned into three papers, 
published in Sports Medicine (Pickering & Kiely, 2018b), BMJ Open Sports & Exercise Medicine 
(Pickering & Kiely, 2017b), and The Open Sports Science Journal (Pickering & Kiely, 2017a). 
 
In Chapter 4, I explored the history of exercise genetics research from twin studies, to candidate 
gene analysis, to genome-wide association studies. I wrote that, whilst current research is able to 
determine the impact of a specific genetic variant on sporting related traits, such as elite athlete status, 
training adaptations, and injury risk, at present there was a lack of research exploring how best to utilise 
this information. I proposed that a promising method to increase the utility of genetic information in the 
real-world would be the formation of total genotype scores (TGS), where a number of genetic variants are 
combined into a single output or score. I took this approach in the experimental section of the thesis 
(Chapters 10-12), where I utilised TGSs comprised of 5, 7, 48 and 64 genetic variants respectively; the 
latter two representing the most comprehensive TGS within the exercise genetics literature to date.  
 
In Section 3 (Chapters 5-8), I attempted to “join the dots”, providing an overview of how it 
might be possible to use genetic information to inform ergogenic aid use (Chapter 5), hamstring injury 
risk and prevention (Chapter 7), and talent identification (Chapter 8). These sections were subsequently 
published as papers in journals such as Sports Medicine (Pickering & Kiely, 2018a), Medical Hypotheses 
(Pickering & Kiely, 2018c), Genes (Pickering et al., 2019b), and Sports Medicine Open (Pickering & 
Kiely, 2017c). In Chapter 6, I also explored the wider implications of ACTN3—perhaps the gene most 
well-researched in terms of elite athlete status—to determine how it might affect training adaptations, 
post-exercise recovery speed, and injury risk. This was published in Frontiers in Physiology (Pickering & 
Kiely, 2017d), representing the first review article to explore this topic; more recent reviews have 
developed this topic further (Del Coso et al., 2018b; Houweling et al., 2018; Pickering & Kiely, 2018d). 
These studies have added to the present body of knowledge by demonstrating how genetic information 
might be effectively utilised within sport, pulling together previous research into a coherent analysis, and 
allowing practitioners to better understand the relative impact of genetic variation on a number of 
important aspects. 
 
Section 4 (Chapters 9-12) then provided the experimental aspect of the thesis. Chapter 9 was a 
questionnaire which aimed to better understand the prevalence of, and attitudes towards, genetic testing 
within sport. Two hundred and fifty-six participants responded to the survey, consisting of 110 current or 
former athletes, of which 51% had competed internationally, and 133 members of support staff, of which 
54% stated they most frequently worked with international athletes. Whilst the overall prevalence of 
genetic testing within sport at present is low (~10%), most participants stated that they believed genetics 
had a sizeable (>25%) effect on an athlete’s chance of being an elite athlete, the adaptive response to 
training, and nutritional requirements. One of the main barriers to the use of genetic testing within sport is 
a perceived lack of evidence (cited by 39% of support staff), demonstrating the importance of an 
increased amount of research studies exploring the use of genetic information in sport, including both 
intervention and randomised controlled trials. This chapter adds to the current body of knowledge by 
quantifying the prevalence of genetic information within sport, building upon an earlier initial study by 
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Varley and colleagues (2018a) by increasing the sample size, and widening the number of sports 
explored. Furthermore, this study represents the first to explore the perceived barriers to the use of genetic 
information at this level.  
 
In Chapter 10, I utilised a five SNP TGS in attempting to identify those athletes who would be 
expected to see larger improvements in aerobic fitness following an eight-week training block, and those 
expected to see smaller improvements. Using the results from the five SNP test, the players were 
stratified into three groups; “low”, “medium”, and “high”. There were no differences in Yo-Yo test 
performance between the groups at baseline; however, following an eight-week small-sided-games 
training programme, those in the “high” group had demonstrated significantly greater improvements in 
Yo-Yo performance than those in the “low” group. This suggests that those in the “low” group may be 
better suited to a different training intervention, although further work is required to determined what that 
intervention might be. This chapter was subsequently published in PLoS One (Pickering et al., 2018). 
This study is the first to use a commercially available panel of genes to predict the magnitude of response 
following an aerobic training intervention in sportspeople. Previous work (Timmons et al., 2010) has 
demonstrated that such an approach may be efficacious, but this had not been tested in a sporting 
population. Furthermore, the use of a readily available panel of genes is potentially advantageous as it 
represents a tool available to practitioners; as discussed in Chapter 4, one of the main issues in utilising 
genetic information in sport is a lack of validated multi-SNP panels. This study goes some way to 
addressing this information deficit.  
 
In Chapter 11, I used the results of a seven SNP TGS to determine whether players were 
expected to exhibit a faster or slower time-course of recovery following a repeated sprints session. The 
players in the faster recovery genotype score group demonstrated smaller reductions in countermovement 
jump height immediately post-training, and at 24- and 48-hours post training. The effect sizes for these 
time points ranged from 0.5 (medium) to 1.0 (large), suggesting that the predictive ability of this 
algorithm is potentially useful, although the real-world utility was somewhat unclear. Similar to Chapter 
10, this study is the first to utilise a commercially available panel of genes as a method to identify 
differences in recovery speed between individuals. Whilst previous studies (Del Coso et al., 2017a; 
2018a) have utilised polygenic models to determine the magnitude of post-exercise muscle damage, the 
time-course of recovery was not determined in these studies. As a result, the study detailed in Chapter 11 
represents the first study, to my knowledge, to use a polygenic score to explore the time course of post-
exercise recovery, which could have large implications for practice in elite sport.  
 
Finally, in Chapter 12, I explored whether a TGS comprised of 48 (power) or 64 (endurance) 
SNPs could discriminate between five elite athletes and 503 Caucasian non-athletic controls. Whilst the 
elite power athletes in the cohort—including an Olympic Champion—scored higher than the elite 
endurance athletes on the power score, they were outscored by 68 non-athletic controls. Conversely, the 
elite speed athletes outscored the elite endurance athletes in the endurance TGS. These results suggest 
that, even when a very large number of genetic variants are combined into a TGS, the information gained 
is insufficient to discriminate elite athletes from non-athletic controls, demonstrating that genetic testing 
cannot be used as a talent ID tool at this point in time. This paper is currently submitted to a journal, and 
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is undergoing peer-review. This study utilised polygenic scores comprised of the largest number of 
genetic variants that I am aware of within a sporting context. Accordingly, it represents the most 
comprehensive TGS studied from the perspective of talent identification, and as such represents a 
significant contribution to the knowledge base in this area.  
 
 
2. Strengths & limitations 
 
As with many studies within the exercise genetics field, the main limitation pertaining to the 
experimental aspect of my thesis is a lack of participant numbers. For example, in the aerobic training 
study (Chapter 10) I recruited 42 participants, and in the recovery study (Chapter 11) just 18. Low 
participant numbers are a commonly cited criticism within exercise genomics research (Bouchard, 2015). 
However, it is also worth noting that one of the aims of this thesis was to translate existing research—
often utilising single genetic variants to explain observed effects—into useable information for those 
involved in elite level sport. As such, these elite sports coaches and support staff will often be working 
with lower numbers of athletes; a first-team football squad could conceivably be comprised of just 18 
members, whilst the first and reserve team pools could number 42. As such, the participant numbers 
utilised here, whilst low, represent the real-world application of research to practice, something that is 
often lacking (Buchheit, 2017), and also mirror the samples sizes utilised within other exercise genetics 
studies (Del Coso et al., 2017a; Erskine et al., 2013; Santiago et al., 2010). Furthermore, large participant 
numbers are often required in exercise genomics research as the effect size of any given genetic variant is 
often low; increasing the participant numbers enhances the statistical power of the study. However, within 
this thesis I have combined the number of genetic variants utilised (using 5 for Chapter 10 and 7 for 
Chapter 11), which increases the effect size expected from a given result, and, again, provides increased 
real-world utility.  
 
Conversely, in Chapter 12, I recruited five elite athletes, and utilised the data of 503 non-athletic 
controls. This represents a large sample size—in part required due to the low number of elite athletes—
which is a particular strength of that Chapter. Furthermore, the recruitment of five elite athletes is an 
additional strength, particularly when the examination of highly elite athletes (my cohort included an 
Olympic Champion) is uncommon within the literature. Additionally, the questionnaire study detailed in 
Chapter 9 recruited a large number of elite athletes, with more than 50% of the sample having competed 
internationally, along with coaches and support staff working at a similar level. Being able to determine 
the attitudes of these individuals represents a further strength of the present thesis, although the vast 
majority (~80%) of participants recruited were males.  
 
 
3. Implications for future research 
 
This thesis has, hopefully, demonstrated how genetic variation exists as a fundamental and 
consistent modifier of many aspects affecting elite performance, from the attainment of elite athlete 
status, to training adaptations, injury reduction, and ergogenic aid use. In the theoretical aspects of this 
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thesis (Chapters 5 to 8), I have formalised various hypotheses around how genetic information may 
impact aspects related to sports performance and training. An obvious next step is to test these hypotheses 
experimentally, allowing us to better understand: 
• Can the early results demonstrating a modifying effect of CYP1A2 on caffeine ergogenicity be 
replicated? Do CC genotypes truly find moderate doses of caffeine ergolytic, as per the work of 
Guest and colleagues (2018), or do they merely require manipulation of dose and timing 
(Pickering, 2018)? Are other SNPs, such as those found in ADORA2A, able to modify the 
ergogenic effects of caffeine? How do these SNPs modify performance-related aspects such as 
pre-competition anxiety post-competition sleep? 
• Can we discover a greater number of SNPs associated with the development of elite athlete 
status? How do genetic variants affecting wider aspects, including psychological and skill 
acquisition processes, affect the attainment of elite athlete status? Will it be possible to develop 
Total Genotype Scores (TGS) that are able to discriminate between elite athletes and non-
athletes, given that current TGS do not (Chapter 12)? 
• Do the genetic variants identified in Chapter 7, such as ACTN3, modify the strength adaptations 
seen following a period of eccentric hamstring loading? Do genetic variants associated with 
muscle structure and fascicle length, such as TTN, modify changes in these aspects following 
eccentric hamstring training? Is it possible to use this information to modify training 
programmes, with particular reference to managing the muscle damage and inflammatory 
response to damaging eccentric contractions? Are we able to use genetic information to 
“predict” injury susceptibility, and therefore reduce that risk prior to injury occurring? 
• Can we use genetic information to modify training programme design, and drive increased 
adaptations? Whilst evidence suggests that genetic variants explain the inter-individual variation 
present in response to a training programme, far less research explores using this information to 
make changes to future training programmes.  
 
Chapters 9-12 of this thesis explore the use of genetic information in sport experimentally, again 
raising additional questions for exploration: 
• In Chapter 9, it was determined that one of the main perceived barriers to the use of genetic 
information within sport is that of a lack of evidence base as to both its utility, and its practical 
application. As such, a key aim for researchers moving forward should be to better understand 
whether and how genetic information might be used within sporting teams. Furthermore, many 
of the ethical considerations identified within that chapter require rectification before genetic 
testing can be widely adopted; researchers, bioethicists, and practitioners in the field need to 
work together to explore best practice guidelines aimed at protecting the athlete from potential 
harm and exploitation.  
• Chapter 10 details the association of genetic information with the magnitude of post-exercise 
adaptations in terms of aerobic fitness. Can these results be replicated? Does the addition of 
other genetic variants tentatively associated with improvements in aerobic fitness, such as those 
identified by Williams and colleagues (2017), further strengthen the predictive ability of the 
current panel? Can those predicted to exhibit the smallest improvements be given alternative 
training methods in order to better enhance their fitness and/or performance? 
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• Chapter 11 demonstrates the potential utility of a seven SNP panel in predicting the time course 
of post-exercise recovery. As per the above point, can these results be replicated? Does the 
addition of further genetic variants to this panel improve its predictive ability? How can this 
information be used in the real-world? 
• Finally, Chapter 12 explores the use of genetic information in talent identification, finding it to 
be ineffective. Can this ineffectiveness be resolved by increasing the number of genetic variants 
tested for? Does a weighted as opposed to unweighted TGS perform better in this regard? Can an 
increased number of genetic variants improve the predictive power of genetic information, such 
that it could be used in practice? Should genetic information—even if effective—ever be used as 
a talent identification tool?  
 
Clearly, the work of this thesis has presented some additional questions, which is to be expected 
given the evolving nature of the subject matter. The resolution of some of these outstanding questions 
should go some way to enhancing the understanding of whether, and how, genetic information can best be 
utilised within sport, and provide evidence-based guidelines pertaining to its use. Given that a common 
criticism of genetic testing, particularly within sporting domains, is its lack of evidence base (Webborn et 
al., 2015), and that this is also a commonly cited reason for its lack of use in elite sport, such outcomes 
potentially represent a priority for researchers in this area.  
 
 
4. Potential wider applications 
 
Whilst those involved in sport are most often interested in increasing the performance of already 
high-level athletes to that required for elite performance, exercise also has a crucial role to play in the 
maintenance of optimal health (Pareja-Galeano et al., 2015), including disease prevention and 
management (Latino-Martel et al., 2016), as well as the maintenance of function—both physical and 
cognitive—with aging (Kuh et al., 2014). As a result, it is important to consider how breakthroughs at the 
level of elite sport might filter down to impact practice in this area. In Chapter 13, I explored this in 
extended detail across three parts. 
 
Part One was an exploration of how ACTN3, the most well-researched gene in regard to elite 
athletic performance (Ma et al., 2013), might modify the healthy aging process. This section was turned 
into a paper, which was published in Frontiers in Genetics (Pickering & Kiely, 2018d), and was later 
built upon by Houweling and colleagues (2018). In summary, I concluded that ACTN3 appeared to play a 
robust role in the maintenance of muscle mass and function with aging, and was also implicated in the 
maintenance of bone mineral density, although this was potentially due to the maintenance of physical 
function seen in R allele carriers. I also speculated that knowledge of ACTN3 genotype had the potential, 
in future, to inform risk-management and risk-reduction strategies for attenuating sarcopenia and 
osteoporosis in elderly populations, as well as in the development of optimal training programmes to 
minimise this risk, either alone or in combination with other genetic variants, as per the work of Jones and 
colleagues (2016).  
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Part Two of Chapter 13 introduced the term “Exercise Response Efficiency”, which relates to 
the ability of an individual to respond to a given exercise stimulus. Despite the fact that exercise has such 
broad and wide-ranging disease protective effects (Piepoli 2005; Fiuza-Luces et al., 2013; Pareja-Galeano 
et al., 2015; Sanchis-Gomar et al., 2015), many individuals do not meet the minimum guidelines, with 
some undertaking no exercise whatsoever (Ladabaum et al., 2014). The concept of exercise response 
efficiency refers to the matching of individuals to the type of exercise they are most likely to demonstrate 
the largest improvements from, with the suggestion being that this type of exercise will drive the greatest 
reductions in disease risk, along with increasing motivation through early positive changes, and hence 
have a large influence on public health. This part of the chapter is published as a paper in Lifestyle 
Genomics (Pickering & Kiely, 2019b). In Part Three, I explored whether genetic information may 
positively influence dietary management, which suggests that genetic information may enhance dietary 
adherence. 
 
 
5. Implementation of genetic information into the athletic preparation process 
 
Finally, in Chapter 14, I attempted to place genetic information into the context of the complete 
athlete preparation process, particularly in reference to a variety of emerging technologies. Whilst, as 
demonstrated in Chapters 2-12 of this thesis, there is utility to genetic information in elite sport, with 
genetics appearing to be a consistent and fundamental modifier of the training response, genetic 
information itself is static; a genetic test performed on the embryo of an athlete would return the same 
results as one carried out one the last scrap of biological material on that athlete’s body long since they 
became deceased. As such, it’s important to explore the wider use of genetic information in sport 
alongside other more plastic metrics, such as wellness markers or blood data. By combining all these 
pieces of information into a single model, we better understand the value of genetic information in the 
real world—that it represents a small, but potentially important, piece of information that can enhance 
athletic preparation. This chapter has been published as a paper in the Journal of Functional Morphology 
and Exercise Kinesiology (Pickering & Kiely, 2019a). 
 
 
6. Real-World Impact 
 
As identified in the introduction, the majority of research in the field of exercise genomics tends 
to focus on explaining what has previously happened, as opposed to attempting to use this information to 
better enhance the outcomes for athletes. One of my aims in undertaking this professional doctorate was 
to increase the depth of scientific research exploring the use of genetic information in this way. As a 
result, 13 publications have resulted directly from this thesis (detailed in table 11). A further paper is 
currently submitted to a journal and undergoing peer-review. As a result, I believe I have been successful 
in increasing the base of knowledge in this field.  
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Chapter Paper Comments 
Chapter 2 - Inter-subject 
variation in exercise adaptation: 
Contributing factors & the 
potential utility of genetic 
testing 
Pickering C, Kiely J. Understanding 
Personalized Training Responses: 
Can Genetic Assessment Help? 
Open Sports Sci J. 2017;10(1). 
 
 
Chapter 3 - Contemporary 
issues regarding exercise non-
response and exercise genomics 
 
Pickering C, Kiely J. Do non-
responders to exercise exist—and if 
so, what should we do about them? 
Sports Med. 2018; 
https://doi.org/10.1007/s40279-018-
01041-1 
 
 
Chapter 3 - Contemporary 
issues regarding exercise non-
response and exercise genomics 
 
Pickering C, Kiely J. Exercise 
genetics: seeking clarity from noise. 
BMJ Open Sport Exerc Med. 
2017;3(1). 
 
Chapter 5 - Are the current 
guidelines on caffeine use in 
sport optimal for everyone? 
Inter-individual variation in 
caffeine ergogenicity, and a 
move towards personalised 
sports nutrition 
 
Pickering C, Kiely J. Are the 
current guidelines on caffeine use 
in sport optimal for everyone? 
Inter-individual variation in 
caffeine ergogenicity, and a move 
towards personalised sports 
nutrition. Sports Med. 
2018;48(1):7-16. 
 
Twenty-nine citations, 
including an additional 
review on the effects of 
genetics on the individual 
response to caffeine 
(Southward et al., 2018), 
and one on the use of 
personalised nutrition from 
the BMJ (Ordovas et al., 
2018). 
Chapter 5 - Are the current 
guidelines on caffeine use in 
sport optimal for everyone? 
Inter-individual variation in 
caffeine ergogenicity, and a 
move towards personalised 
sports nutrition 
 
Pickering C. Caffeine, CYP1A2 
genotype, and sports performance: 
is timing important? Ir J Med Sci. 
2018; doi: 10.1007/s11845-018-
1811-4. 
 
 
Chapter 6 – ACTN3: More than 
just a gene for speed 
Pickering C, Kiely J. ACTN3: 
More than just a gene for speed. 
Front Physiol. 2017;8:1080. 
 
Six citations, including a 
more recent review (Del 
Coso et al., 201b8).  
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Chapter 7 – Genes, hamstring 
injury, and the response to 
eccentric training 
 
Pickering C, Kiely J. Hamstring 
injury prevention: A role for 
genetic information? Med 
Hypotheses. 2018;119:58-62. 
 
 
Chapter 8 – Can genetic testing 
identify “talent” (whatever that 
might be)? 
 
Pickering C, Kiely J. Can the ability 
to adapt to exercise be considered a 
talent—and if so, can we test for it? 
Sports Med Open. 2017;3(1):43. 
 
 
Chapter 8 – Can genetic testing 
identify “talent” (whatever that 
might be)? 
 
Pickering C, Kiely J, Grgic J, Lucia 
A, Del Coso J. Can genetic testing 
identify talent for sport? Genes. 
2019b;10(12):972. 
 
Chapter 10 – The magnitude of 
Yo-Yo test improvements 
following an aerobic training 
intervention are associated with 
total genotype score 
 
Pickering C, Kiely J, Suraci B, 
Collins D. The magnitude of Yo-Yo 
test improvements following an 
aerobic training intervention are 
associated with total genotype 
score. PloS One. 
2018;13(11):e0207597. 
 
 
Chapter 13 – Wider 
implications: Genetic 
information from a public health 
perspective 
 
Pickering C, Kiely J. ACTN3, 
Morbidity, and Healthy Aging. 
Front Genet. 2018;9:15. 
 
 
 
Cited by an additional 
review exploring the impact 
of ACTN3 on human health 
and ageing (Houweling et 
al., 2018).  
Chapter 13 – Wider 
implications: Genetic 
information from a public health 
perspective 
Pickering C, Kiely J. Exercise 
Response Efficiency – A novel way 
to enhance population health? 
Lifestyle Genom. 2019. 
 
 
Chapter 14 – The 
implementation of genetic 
information within a 
personalised training framework 
Pickering C, Kiely J. The 
Development of a personalised 
training framework: 
Implementation of emerging 
technologies for performance. J 
Functional Morphol Kinesiol. 
2019;4(2):25. 
 
 
Table 11 – Publications arising directly from this thesis 
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Furthermore, my work has achieved attention in the lay press. During the course of the writing 
of this thesis, I have appeared on two TV programmes to discuss the potential utility of genetic testing for 
general health; BBC’s Trust Me I’m a Doctor (December 2017), and ITV Tonight (January 2018). 
Additionally, I was requested to write articles summarising my research for the BMC blog network “On 
Medicine” (https://blogs.biomedcentral.com/on-medicine/2017/11/30/a-better-approach-to-talent-
identification/), and the website “Science Trends” (https://sciencetrends.com/can-genetic-information-
help-prevent-hamstring-injury/). Finally, as a direct result of some of the work contained within this 
thesis, I have been invited to meet with, and in some cases, directly support, a number of elite sporting 
teams (https://www.independent.co.uk/sport/football/international/mohamed-salah-liverpool-goals-
olympics-craig-pickering-dnafit-gene-mapping-a8266576.html). As such, the work contained within this 
thesis has been impactful, both from an academic and real-world perspective, and my hope is to build on 
this in the coming years.  
 
 
7.   Conclusion – Is there utility to genetic information in elite sport? 
 
In pulling the various strands of this thesis together, the main findings are that: 
1. Genetic variation is a fundamental and consistent modifier of the response to a given 
stimulus. As such, genetic variation helps to explain the demonstrated differences in terms 
of training response, ergogenic aid effectiveness, injury risk, and the chances of becoming 
an elite athlete.  
2. At present, many high-level athletes and support staff understand this genetic influence on a 
variety of sporting outcomes. However, approximately only 10% of athletes have 
undertaken a genetic test, with one of the main reasons cited for not utilising such tests in 
sport being a lack of evidence supporting their use.  
3. Accordingly, research within the exercise genetics sphere needs to focus not just on 
explaining the observed variation in response to a stimulus, but on how to use this 
information to modify training- and lifestyle-based parameters in order to enhance athlete 
performance.  
4. The grouping together of genes associated with a specific trait appears to improve the utility 
of a genetic test. In this thesis, Total Genotype Scores were able to determine participants 
likely to exhibit greater improvements in aerobic fitness following a training programme, as 
well as those expected to have increased recovery times following an exercise bout.  
5. However, the creation of a Total Genotype Score comprised of a large number of genetic 
variants was not able to successfully discriminate a cohort of elite power and endurance 
athletes from non-athletic controls. As a result, there is no evidence, at present, that genetic 
information can be used to identify future talented performers.  
 
At the start of this thesis, I asked whether there was any utility to genetic information within elite 
sport. Based on the findings reported throughout, and detailed above, I believe that it is clear that there is 
a strong potential utility of genetic information within elite sport, and, as such, genetic profiling has the 
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potential to improve sporting performance. In 2014, Williams and colleagues asked if we were at the 
starting line regarding the use of genetic information within sport. I believe that the gun has now fired, 
and we are making our first tentative steps towards the finish line. The outcomes of Sections Two and 
Three of the present thesis suggest there is a clear theoretical basis for the use of genetic information in 
sport. The results of Section Four, the practical part of this thesis, provide some evidence for how this 
would work in practice. Finally, Chapter 14 explores how genetic information may integrate along with 
other technologies, both emerging and current, to enhance athletic preparation. As future research 
develops and expands upon the findings of this thesis, evidence-based guidelines as to the use of genetic 
information within sport should evolve, further driving the field forwards, and assisting athletes and their 
support staff towards their common goal of enhancing performance. 
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ETHICS 
 
 The experimental studies carried out for this thesis, and detailed in Chapters 9-12, were carried 
out following ethics board approval, in line with the Declaration of Helsinki. The ethics board numbers 
were BAHSS 575, BAHSS 230, and SFEC 2016-020.  
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APPENDIX 1 – QUESTIONS GIVEN TO ATHLETES AS PART OF THE STUDY DETAILED 
IN CHAPTER 9 
 
1. I am an: 
a. Athlete (continue to Q2) 
b. Member of the support staff (coach, sports science, medicine) (go to support staff questionnaire) 
 
2. What is your sex? 
a. Male 
b. Female 
 
3. . Which sport are you primarily involved in? 
a. Football / Soccer 
b. Rugby (League / Union) 
c. Australian Rules Football 
d. American Football 
e. Basketball 
f. Ice Hockey 
g. Athletics (Track & Field, Road Running, Cross Country) 
h. Swimming 
i. Golf 
j. Racquet Sports (Tennis, Badminton) 
k. Baseball 
l. Winter Olympic Sports 
m. Other (please state) 
 
4. What is your highest level of competition? 
a. Olympic Games or World Championships (including World Cup) 
b. International (you have represented your country) 
c. National (you have competed at the highest level within your country; i.e. national 
championships or top league).  
d. Regional (you have competed at county level, or in a league outside of the top league) 
e. Below-Regional / Recreational  
 
5. What is your age range? 
a. <25 years old 
b. 26-35 years old 
c. 36-45 years old 
d. 46-55 years old 
e. 56-65 years old 
f. >66 years of age 
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6. Which region are you based in? 
a. UK / Ireland 
b. Russia 
c. Europe (not including the UK, Ireland, or Russia) 
d. USA 
e. North America (not including USA) 
f. South America 
g. Africa 
h. Middle East 
i. Australia and New Zealand 
j. Asia 
k. Other (please specify) 
 
7. What is your highest level of completed education? 
a. High School (GSCE/A-level equivalent) 
b. University Undergraduate (e.g. BSc) 
c. University Post-Graduate (e.g. MSc) 
d. Doctorate (e.g. PhD) 
e. Other (please specify) 
 
8. What impact do you think an individual’s genetic make-up has on their chances of being an elite 
athlete? 
a. None 
b. Minimal (<25%) 
c. Somewhat (25-75%) 
d. Almost entirely (75%+) 
 
9. What impact do you think an individual’s genetic make-up has on their sporting/fitness 
improvements following exercise? 
a. None 
b. Minimal (<25%) 
c. Somewhat (25-75%) 
d. Almost entirely (75%+) 
 
10. What impact do you think an individual’s genetic make-up has on their nutrition requirements? 
a. None 
b. Minimal (<25%) 
c. Somewhat (25-75%) 
d. Almost entirely (75%+) 
 
11. Have you ever used a genetic test targeted at sports performance? 
a. Yes (go to Q15) 
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b. No (go to Q12). 
 
12. Why haven’t you used genetic testing (please select all that apply) 
a. Too expensive 
b. Didn’t know it existed 
c. Insufficient evidence 
d. Concerns about data protection 
e. Concerns about negative press coverage 
f. Ethical issues 
g. Other (please specify) 
 
13. Do you envision using genetic testing in the future? 
a. Within the next year? 
b. Within the next 5 years 
c. Within the next 10 years 
d. Never 
 
14. What would cause you to consider genetic testing (please select all that apply).  
a. Publication of case-studies 
b. Increased number of scientific studies utilizing genetic testing 
c. More teams/athletes using it 
d. Increased advertising and greater awareness of product 
e. Lower price 
f. Other (please specify) 
All answers; go to end of Questionnaire 
 
15. If you have used genetic testing, what was the main purpose of this? 
a. To see what sport/event you should compete in 
b. To inform training programme design 
c. Injury prevention 
d. Nutrition 
e. Screening for disease risk 
f. Commercial agreement/sponsorship 
g. General interest 
h. Other (please specify) 
 
16. Did you find the information you received from the genetic test useful? 
a. Yes 
b. No 
 
17. Why didn’t you find the information you received useful? 
a. Too generic 
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b. Not targeted at sports people 
c. Incorrect 
d. Results were hard to understand 
e. Other (please specify) 
 
18. Who carried out your genetic testing? 
a. University / Academic Institution 
b. Commercial Company 
c. Other (please specify) 
 
19. Did you find the results of the genetic test easy to understand? 
a. Yes 
b. No 
 
20. Did you receive additional support from the genetic testing provider to enable you to understand 
the report? 
a. Yes, and it was helpful 
b. Yes, but it wasn’t helpful 
c. No 
 
21. Did you make any lifestyle, dietary or training-based changes based on the results of the genetic 
test? 
a. Yes 
b. No 
 
22. What changes did you make? 
a. Lifestyle 
b. Diet 
c. Training 
d. Recovery 
e. Other 
f. Box for further details.  
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APPENDIX 2 – QUESTIONS GIVEN TO COACHES AND SUPPORT STAFF AS PART OF THE 
STUDY DETAILED IN CHAPTER 9 
 
1. I am an: 
a. Athlete (go to support athlete questionnaire) 
b. Member of the support staff (coach, sports science, medicine) (Continue to Q2) 
 
2. What is your sex? 
a. Male 
b. Female 
 
3. Which sport are you primarily involved in? 
a. Football / Soccer 
b. Rugby (League / Union) 
c. Australian Rules Football 
d. American Football 
e. Basketball 
f. Ice Hockey 
g. Athletics (Track & Field, Road Running, Cross Country) 
h. Swimming 
i. Golf 
j. Racquet Sports (Tennis, Badminton) 
k. Baseball 
l. Winter Olympic Sports 
m. Other (please state) 
 
4. With which level of athlete do you most frequently work with? 
a. Olympic Games or World Championships (including World Cup) 
b. International (you have represented your country) 
c. National (you have competed at the highest level within your country; i.e. national 
championships or top league).  
d. Regional (you have competed at county level, or in a league outside of the top league) 
e. Below-Regional / Recreational  
 
5. What is your role within your sporting organisation? 
a. Sports medicine 
b. Physiotherapist 
c. Sports coach 
d. Strength & Conditioning coach 
e. Sports Scientist 
f. Nutritionist 
g. Other (please specify) 
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6. What is your age range? 
a. <25 years old 
b. 26-35 years old 
c. 36-45 years old 
d. 46-55 years old 
e. 56-65 years old 
f. >66 years of age 
 
7. Which region are you based in? 
a. UK / Ireland 
b. Russia 
c. Europe (not including the UK, Ireland, or Russia) 
d. USA 
e. North America (not including USA) 
f. South America 
g. Africa 
h. Middle East 
i. Australia and New Zealand 
j. Asia 
k. Other (please specify) 
 
8. What is your highest level of completed education? 
a. High School (GSCE/A-level equivalent) 
b. University Undergraduate (e.g. BSc) 
c. University Post-Graduate (e.g. MSc) 
d. Doctorate (e.g. PhD) 
e. Other (please specify) 
 
9. What impact do you think an individual’s genetic make-up has on their chances of being an elite 
athlete? 
a. None 
b. Minimal (<25%) 
c. Somewhat (25-75%) 
d. Almost entirely (75%+) 
 
10. What impact do you think an individual’s genetic make-up has on their sporting/fitness 
improvements following exercise? 
a. None 
b. Minimal (<25%) 
c. Somewhat (25-75%) 
d. Almost entirely (75%+) 
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11. What impact do you think an individual’s genetic make-up has on their nutrition requirements? 
a.   None 
b.   Minimal (<25%) 
c. Somewhat (25-75%) 
d. Almost entirely (75%+) 
 
12. Have you ever used a genetic test within your sporting organisation? 
e. Yes (go to Q16) 
f. No (go to Q13). 
 
13. Why haven’t you used genetic testing within your organisation? (please select all that apply) 
a.   Too expensive 
b.   Didn’t know it existed 
c. Insufficient scientific evidence 
d. Concerns about data protection 
e. Concerns about negative press coverage 
f. Concerns around whether it is ethical  
g. Other (please specify) 
 
14. Do you envision using genetic testing in the future? 
a.   Within the next year? 
b.   Within the next 5 years 
c. Within the next 10 years 
d. Never 
 
15. What would cause you to consider genetic testing (please select all that apply).  
a. Publication of case-studies 
b. Increased number of scientific studies utilizing genetic testing 
c. More teams/athletes using it 
d. Increased advertising and greater awareness of product 
e. Lower price 
f. Other (please specify) 
All answers; go to end of Questionnaire 
 
16. If you have used genetic testing, what was the main purpose of this? 
a. To see what sport/event you should compete in 
b. To inform training programme design 
c. Injury prevention 
d. Nutrition 
e. Screening for disease risk 
f. Commercial agreement/sponsorship 
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g. Other (please specify) 
 
17. Did you find the information you received from the genetic test useful? 
a. Yes 
b. No 
 
18. Why didn’t you find the information you received useful? 
a. Too generic 
b. Not targeted at sports people 
c. Incorrect 
d. Results were hard to understand 
e. Other (please specify) 
 
19. Who carried out your genetic testing? 
a. University / Academic Institution 
b. Commercial Company 
c. Other (please specify) 
 
20. Did you find the results of the genetic test easy to understand? 
a. Yes 
b. No 
 
21. Did you receive additional support from the genetic testing provider to enable you to understand 
the report? 
a. Yes, and it was helpful 
b. Yes, but it wasn’t helpful 
c. No 
 
22. Did you make any lifestyle, dietary or training-based changes based on the results of the genetic 
test? 
a. Yes 
b. No 
 
23. What changes did you make? 
a. Lifestyle 
b. Diet 
c. Training 
d. Recovery 
e. Other 
f. Box for further details.  
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